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An appreciation of the complexity of the mammalian transcriptome has expanded our 
understanding of eukaryotic genome regulation with the discoveries of functional non-coding 
ribonucleic acids (RNAs). In recent years, the number of studies in the field of long non-
coding RNA (lncRNA) biology has increased dramatically. Transcriptomic analyses of the 
eukaryotic genome revealed that the genome is pervasively transcribed and contains a vast 
number of lncRNA transcripts, most with unknown functions. Although relatively little is 
known about lncRNAs in general, a few have been shown to function in the regulation of 
gene expression during development and have been associated with a number of diseases. The 
aim of my dissertation is to investigate the impact of lncRNAs loss of function during 
embryogenesis of Drosophila melanogaster. I chose this model organism for its well 
documented developmental stages and the plethora of established tools available to facilitate 
genetic studies. Twenty-two lncRNA candidates were chosen based on their conservation at 
the sequence level and similar expression profiles across 5 Drosophila species, suggesting 
their potential for biological importance. The CRISPR/Cas9 system was used to generate 
lncRNA mutants and their requirement for development and the phenotypic consequences of 
losing each lncRNA was investigated. 13 lncRNA mutants were generated and two of them, 
lncRNA-9 and lncRNA-3 respectively, were required for viability, with homozygous mutants 
showing full lethality. Majority of the lncRNA-9 null mutant embryos were found to be 
unable to complete embryonic development and whereas lncRNA-3 null mutants had a pupal 
lethal phenotype. None of the lncRNA mutants were found to be required for fertility.  I 
characterised the sub-cellular localization of lncRNA-9 during embryogenesis using a 
combination of RNA Fluorescence In Situ Hybridization (RNA-FISH) and 
Immunofluorescence (IF) approaches. An analysis of the transcriptome of lncRNA-9 mutants, 
in comparison to controls, was carried out to discover the genes that were mis-regulated and 
responsible for the observed lethality. Our investigation of lncRNA-9 revealed a nuclear 
lncRNA that is expressed in neurons and preliminary results from GO analysis revealed a loss 
of lncRNA-9 resulted in a reduction in the expression of neuronal genes involved in chemical 
synaptic transmission activities. Further characterization of lncRNA-9 will allow us to 
understand how lncRNAs contributes to various neural circuits and the overall signalling in 
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Chapter 1 | 
Introduction 
 
1.1 Regulatory Ribonucleic acid: a brief history of the RNA world  
 
Understanding the regulatory programs that are involved in coordinating various cellular 
activities has been a central theme in molecular biology since the elucidation of the double 
helical structure of deoxyribonucleic acid (DNA) in the 1950s (Watson and Crick, 1953; 
Franklin and Gosling, 1953; Langridge et al., 1960). Since then, there have been many 
advances towards understanding the processes that translate genotype into phenotype. In 
1957, the lecture on protein synthesis and functions of the gene by Nobel laureate Francis 
Crick had grounded our understanding of how life begins (Crick, 1958). The genetic 
information of every organism was considered to be defined by the genetic code and 
determine the messenger RNA (mRNA) transcript that is coded and the amino acid sequence 
of a protein. The central dogma of gene expression that Crick had proposed made such a 
lasting impact on our understanding of the connection between nucleic acid and proteins that 
it is considered to be the “rule” even today (Figure 1). Together with the concept of one gene-
one protein articulated by Beadle and Tatum, this framework became the cornerstone in every 
aspect of molecular biology research and teaching (Beadle and Tatum, 1941).  
 
For many years, proteins were recognised to be the final effector of many regulatory 
functions in the cell, and the production of dysfunctional proteins contributed to 
developmental abnormalities and diseases (Scheper et al., 2007; Reynaud, 2010). Although 
many ribonucleic acid (RNA) transcripts had been discovered throughout the years, they were 
only assumed to serve as intermediaries between DNA and proteins during gene expression.  
Within the last decade or so, many other components that are involved in different gene 
regulatory networks were unravelled and the passive role that was presumed to be played by 
RNAs is now considered to be misrepresentative in biology. Since the 1990s, different classes 
of RNA molecules were shown to be involved in gene expression and changes to the central 
dogma of molecular biology that was proposed by Crick now include our understanding of the 
roles that RNAs play in genome regulation today (Figure 1).  




Several important discoveries of regulatory RNA molecules over the last decade revealed 
the diverse roles of RNA and triggered a gradual paradigm shift away from a protein-centric 
view in molecular biology (Higgs and Lehman, 2015; Prasanth and Spector, 2007). Beginning 
in the 1960s, scientists discovered that cell produce a large group of heterogenous nuclear 
RNAs (hnRNAs) that mainly reside in the cell nucleus and are degraded rapidly after 
synthesis. Only a small proportion of the RNA synthesized is exported out to the nucleus to 
interact with the ribosome complex in the cytoplasm (Harris and Watts 1962; Scherrer et al., 
1963; Soeiro et al., 1966). It was hypothesized that these transcripts may be involved in gene 
regulation and could be interacting with the chromatin. However, little evidence was available 
due to technical limitations at that point in time (Britten and Davidson, 1969; Britten and 
Davidson, 1971). Transfer ribonucleic acids (tRNAs) were the first non-coding RNAs 
discovered in 1965 to have a function in protein synthesis. These molecules are capable of 
folding into structures and are involved in the protein translation process by base-pairing 
amino acids with the matching codon on the mRNA transcript (Holley et al., 1965). The 
translation process takes place on the ribosome and when the tRNA adaptor encounters its 
corresponding codon, it transfers the amino acid that it was carrying to the end of the growing 
amino acid chain (Quigley and Rich, 1979). Today, advancement in tRNA research revealed 
the diverse roles of tRNAs beyond the process of translation. These highly versatile molecules 
are capable of adopting different post-transcriptionally modified profiles and have a role in 
maintaining cellular homeostasis (Dittmar et al., 2006; Geslain and Pan, 2010; Parisien et al., 
2013).  
 
The discovery of alternative splicing in the late 1970s greatly changed our perception that 
one gene led to the production of only one protein (Burge et al., 1999; Caceres et al., 1997; 
Morris and Mattick, 2014). Protein coding genes were found to be harbouring segments of 
coding (exons) and non-coding sequences (introns). During transcription, the pre-mRNA 
transcript copied from DNA contains both exonic and intronic regions. The non-coding 
regions undergo a process known as “splicing” and the adjacent exons are joined to form a 
contiguous coding sequence (Sharp, 2005). The splicing machinery is controlled by a group 
of RNAs known as small nuclear RNAs (snRNAs) that assembles in a ribonucleoprotein 
complex in the cytoplasm and are imported back into the nucleus to carry out their functions. 
The removal of introns and the joining of exons must be carried out precisely to prevent the 
formation of defective proteins (Wahl et al., 2009; Will and Luhrmann, 2011). This landmark 
discovery earned Phillip Sharp and Richard Roberts the Nobel Prize for Medicine in 1993. 
Within the nucleolus, the production of mature and functional tRNAs, snRNAs, and 




ribosomal RNAs (rRNAs) requires a different class of ncRNAs know as small nucleolar 
RNAs (snoRNAs). SnoRNAs have specific sequences and assemble into small nucleolar 
RNPs (snoRNPs) with a set of proteins in the cytoplasm (Dieci et al., 2009). This snoRNP 
complex shuttles to the nucleolus to direct the modification of different groups of RNA 
molecules for them to be functional, such as in the case of the 2’-O-ribose methylation of 
rRNAs (Tollervey, 1997; Kiss, 2002; Züst et al., 2011).  
 
 
Figure 1. Gene Expression: From past to present. 
The central dogma of gene expression was a concept introduced by Francis Crick to explain the route 
of DNA transcription and mRNA translation during protein synthesis. Extensive research in the last 
decades has revealed that the transcriptome is highly complex and pervasive.  Many RNA transcripts 
do not code for proteins and instead they contribute to gene regulatory processes. These discoveries 
provided an important new perspective on the significance of RNA in gene regulation. 
 
The discoveries of RNase P and riboswitches in the 1980s brought about a new wave of 
evidence that ncRNAs also have the ability to catalyse chemical reactions. Riboswitches are 
regulatory elements that form different secondary structures upon ligand binding and this 
allows them to regulate gene expression without the need for any proteins (Nudler and 
Mironov 2004; Tucker and Breaker 2005; Winkler, 2005). They are important RNA 
thermosensors that are activated in response to environmental or metabolic signals (Johansson 
et al., 2002). A Nobel Prize in Chemistry was awarded to Sydney Altman and Thomas Cech 




for their breakthrough in the catalytic properties of RNAs. Today, emerging evidence from 
different organisms is revealing that many RNA transcripts not only relay important 
informational genetic material in the form of messenger RNAs but also serve in catalytic and 
regulatory capacities (Soshnev et al., 2011; Briggs et al., 2015; Spadaro et al., 2015).  The 
completion of the human genome project (HGP) and subsequent annotation efforts indicated 
that approximately 1% of the human genome comprises of protein-coding sequence, whereas 
the rest of the genomic sequences were widely regarded as “junk” or non-coding DNA 
(Lander et al., 2001; Venter et al., 2001; Ponting et al., 2009). Although it is currently widely 
acknowledged that RNAs are involved in various biological processes, the total number of 
ncRNAs, classifications and functions of many of these transcripts are still highly debated 
even today. 
 
1.2 Non-coding RNAs: multi-functional cellular molecules 
 
The human genome can be considered to be more than just the transcription of 
protein-coding sequences and the production of some non-coding RNAs (e.g., tRNA, rRNA, 
and snoRNA) that have important biological functions in this post-genomic era. One of the 
most important discoveries since the publication of the DNA structure was the HGP that 
provided us with a glimpse of the genetic blueprint that makes up a human (Lander et al., 
2001; Venter et al., 2001). What came as a surprise in this report for many was the diversity 
of transcriptional products that are produced from the genome. A variety of transcriptomic 
studies were performed since then and it was indicated that expression of the mammalian 
genome is highly pervasive with transcription from both strands of the DNA and initiation of 
transcription from different transcriptional start sites (TSS) (Hayashi et al., 2001; Okazaki et 
al., 2002; Carninci et al., 2005; Mattick and Makunin, 2006; Djebali et al., 2012; Zhao et al., 
2016). Transcripts were found to be mapping to intronic, intergenic and antisense regions 
which added another layer of complexity to the transcriptome (Okazaki et al., 2002; 
Katayama et al., 2005).  
 
Data from the ENCODE project estimated that approximately >80 % of the human 
genome was actively transcribed with a majority of these transcripts produced lacking 
protein-coding capacity and were thus named ‘non-coding RNAs’ (ncRNAs) (The ENCODE 
Project Consortium, 2012). Even protein-coding genes are mainly composed of intronic 
sequences and only 1 % of the genome is considered to be coding for exons (Tripathi et al., 
2010, Tripathi et al., 2013). The recognition that vast numbers of ncRNA transcripts are 




generated by the genome resulted in countless debates about their roles in development and 
evolution. Irrespective of the developmental complexity of the organism, the number of 
protein-coding genes has been shown to be constant across vertebrates and metazoans. On the 
other hand, the number of ncRNAs was increasing with developmental complexity and it was 
proposed that they had crucial roles in regulatory processes and perhaps related to the 




Figure 2: The proportion of ncRNAs expands with developmental complexity. 
There is a wide range in genome sizes from the simplest to the most complex organism. The 
complexity of an organism increases with the amount of non-coding RNAs in the genome rather than 
protein-coding genes. [Image taken from Taft et al., 2007]. 
 
Advances in sequencing technologies such as high-throughput sequencing brought to 
light the existence of many different classes of ncRNAs that serve vastly different roles within 
the cell (Figure 3). During development and reproduction, the normal function of cells is 
dependent on precise expression of both proteins and non-coding RNAs. Precise control of 
gene expression is essential for all organisms. Examples of gene regulation events include 
transcription, mRNA splicing, mRNA export, mRNA stability, translational control, and 
RNAi (Fire et al., 1998). Two major classes of ncRNAs have been shown to be important in 
different biological processes. Here, they are distinguished based on the length of the mature 
transcript, namely small RNAs (sRNAs, which are shorter than 200-nt) and long non-coding 
RNAs (lncRNA, larger than 200-nt in size). This form of classification was used to 
distinguish the sRNAs from the longer non-coding transcripts and can be considered to be 




arbitrary. Extensive studies carried out in the last decade had shown that sRNAs were crucial 
in a plethora of biological process including the regulation of gene expression as well as 
transcriptional and post-transcriptional gene silencing (Pauli et al., 2011). 
 
Well-studied sRNAs include microRNAs (miRNAs), endogenous small interfering 
RNAs (endo-siRNAs), and PIWI-interacting RNAs (piRNAs). As the core component of the 
RNAi pathway, these sRNAs repressed the expression of protein-coding genes. Single-
stranded sRNAs, typically 19- to 30- nt in length, form a complex with proteins of the 
Argonaute family. The specificity of small RNA pathways is determined by the small 
regulatory RNA, which guides the Argonaute proteins via complementary base pairing to its 
target RNA. These sRNA pathways are able to regulate gene expression at the transcriptional 
or post-transcriptional level, as well as via translational repression (Bartel, 2004; Lippman 
and Martienssen, 2004; Chapman and Carrington, 2007; Wu and Belasco, 2008). RNAi was 
shown in many studies to mediate resistance to parasitic nucleic acids such as transposons and 
viruses (Hannon, 2002) (Figure 3).  
 
Lin-4 and let-7 were the first miRNAs to be identified in Caenorhabditis elegans. 
miRNAs are the most extensively studied class of ncRNAs and since their discovery, 
hundreds of miRNAs have been identified to be involved in various developmental processes 
including control of cell proliferation, apoptosis, differentiation and development (Bartel, 
2004; Stefani and Slack; 2008). Changes in the sequence or expression levels of miRNAs 
have been shown to play a part in many human diseases such as cancer (Iorio et al., 2005; 
Yanaihara et al., 2006). The field of miRNAs expanded rapidly with thousands of transcripts 
annotated in 271 species on miRbase (version 22), including humans (Kozomara and 
Griffiths-Jones, 2011, Kozomara et al., 2019).  In the case of endogenous siRNAs, they were 
first reported from studies in plants, fungi and Caenorhabditis elegans (Hamilton and 
Baulcombe, 1999; Baulcombe, 2003; Pak and Fire, 2007). A mature dsRNA (~22-nt in 
length) was formed after processing by the RNAse III enzyme Dicer (Ketting et al., 2001; 
Bernstein et al., 2003; Murchison et al., 2007). One of the strand of the dsRNA (guide strand) 
associates with the RNA-induced silencing complex and it will bring the complex to a 
complementary target RNA to direct its cleavage. (Song et al., 2004; Rivas et al., 2005). Fire 
and Mello were awarded a Nobel Prize for their discovery of short RNA interference in 2006. 
The third class of sRNAs are piRNAs, which were first observed in Drosophila melanogaster 
for transposon silencing (Aravin et al., 2007; Brennecke et al., 2008; Czech et al., 2013; 
Czech et al., 2018). Most of the sequences that belongs to this class of sRNA (24- to 29-nt) 




were found to map to transposons and genomic repeats and they interact with Piwi-clade 
Argonaute proteins to maintain genome stability in germline cells (Figure 4) (Saito et al., 
2006; Vagin et al., 2006; Brennecke et al., 2008; Gunawardane et al., 2007). Research in the 
piRNA field has grown progressively over the years with some studies also in stem cell and 
cancer biology (Gonzalez et al., 2015; Cantarella et al., 2012; Fagegaltier et al., 2016). 
 
 
Figure 3: Schematics of described animal RNA transcripts without protein-coding potential.  
These include transfer RNAs (tRNAs), ribosomal RNAs (rRNAs), small nuclear RNAs (snRNAs), 
long non-coding RNAs (lncRNAs) as wells as variety of small non-coding RNAs such as endogenous 
small interfering RNAs (endo-siRNAs), PIWI-interacting RNAs (piRNAs) and microRNAs 
(miRNAs). [Image taken from Morceau et al., 2013]. 
 
Besides sRNAs, another subset of ncRNA transcripts were shown to have important 
regulatory functions in the genome. Large transcripts known as lncRNAs were reported even 
before the identification of sRNAs with the discovery of H19 in 1988 and Xist in 1991 
(Pachnis et al., 1988, Borsani et al., 1991). LncRNA H19 was shown to be a highly abundant 
lncRNA and was first indicated to be involved in muscle development. This imprinted 
lncRNA gene was found to be expressed from the maternal allele and regulates the expression 
of insulin-like growth factor 2 (IGF2) (Nordin et al., 2014; Wilkin et al., 2000). Following the 
discovery of lncRNA H19, another lncRNA was found to function as an epigenetic switch 
during X chromosome inactivation. (Brown et al., 1992; Ballabio and Willard, 1992). The X 
inactive specific transcript (Xist) silences one of the X-chromosomes and renders it inactive 
by spreading itself along the X chromosome and recruiting the Polycomb repressive 




complexes 1 and 2 (PRC1/PRC2) along the inactive X chromosome (Borsani et al., 1991; 
Brown et al., 1992; Brockdorff et al., 1992).  
 
 
Figure 4: Basic outline of three different regulatory sRNAs pathways.                                        
MicroRNAs, endo-siRNA and piRNAs undergo different biogenesis pathways and differ in their 
substrates recognition and target regulation. An siRNA duplex containing a guide strand and a 
passenger strand is form after Dicer-2 processes the dsRNA precursor. The guide strand is loaded onto 
Argonaute2 (AGO2) protein and guide the protein to cleave target RNA transcripts. Mature miRNA 
strands are formed from the processing of primary miRNAs (pri-miRNA) and precursor miRNA (pre-
miRNA) by Dicer-1 and Argonaute1 (AGO1) protein respectively. The miRNA-AGO1 complex binds 
to RNA transcripts and regulates gene expression post-transcriptionally.  piRNAs form the third major 
class of small RNAs and one of their function is to silence transposons within the germline.  
[Image taken from Grosshans and Filipowicz, 2013]. 
 
The first insight of lncRNAs that were involved in epigenetic phenomena had 
prompted researchers to search for other functional lncRNAs that were involved in 
developmentally regulated processes. Since then, the extent of lncRNA-related research has 
risen with studies in different animal models and diseases (Figure 5). Other examples of well-
studied lncRNAs that have tissue-specific and developmental expression patterns includes 




Tsix, MALAT1, HOTAIR, ANRIL, NEAT1 and Braveheart (Lee et al., 1999; Ji et al., 2003; 
Rinn et al., 2007; Broadbent et al., 2008, Sunwoo et al., 2009; Klattenhoff et al., 2013). In 
summary, the discovery of ncRNAs has underlined the surprising roles and functions of 




Figure 5: Number of lncRNA-related publications since the late 1970s. 
The number of queried publications is obtained from PubMed library with keyword 'lncRNA' or 'long 
non-coding RNA'. Since the discovery of lncRNA H19 and Xist, there is a surge in the number of 
publications in this field. This upward trend reflects the increase in interest in this area of research and 
is made possible with the advancement of biochemical and molecular technologies.  
[Data accessed on 30th January 2019]. 
 
 
1.3 Identification and Characterisation of lncRNAs 
 
The introduction of high-throughput sequencing methods has revolutionized and 
accelerated the identification and annotation of ncRNAs in different model organisms (Akay 
et al., 2019, Wen et al., 2016; Zhao et al., 2018). In order to discover the number of lncRNA 
transcripts in the genome, a combination of different biochemical and molecular biology 
methods have been used to map the mammalian transcriptome. An international effort was 
established for the first time to generate the first lncRNA collection from the mouse and 
human transcriptome (Carninci et al., 2005; Derrien et al., 2012).  The FANTOM (Functional 
Annotation of The Mouse) consortium and GENCODE project (that is part of the ENCODE -




ENCyclopedia Of DNA Elements - in humans) performed deep-sequencing of large pools of 
cDNA clones from mouse and human and reported the identification of thousands of lncRNA 
transcripts. The number of protein-coding genes generated from the genome across different 
organisms remains relatively constant but the number of lncRNA transcripts discovered 
continues to increase. Statistics first release by the GENCODE v7 consortium identified 
14,880 human lncRNAs in 2012. In the latest release of GENCODE v29, a total of 58,721 
genes were transcribed within the human genome, of which ~28 % (16, 066) were labelled as 
lncRNA transcripts. 
 
Besides the improvement in sequencing methods, the development of innovative 
methods and bioinformatics pipelines provided scientists with better tools to assemble the 
transcriptome and enhanced the process of identifying genes and annotating them in the 
genome. Technologies to map TSSs such as CAGE (cap analysis of gene expression) and 
RAMPAGE (mapping of promoters for analysis of gene expression) and the development of 
RNA-sequencing technologies not only allowed us to identify novel transcripts but also 
construct their full-length sequence and identify the exon/intron boundaries of the transcripts 
(Guttman et al., 2009, Sun and Kraus, 2015, Trapnell et al., 2010). Today, lncRNAs have 
been identified across many organisms such as humans, mice, Drosophila melanogaster, 
Saccharomyces cerevisiae, Caenorhabditis elegans, Arabidopsis thaliana, Dario rerio (Cabili 
et al., 2011; Guttman et al., 2009; Brown et al., 2014; Yamashita et al., 2016; Nam and 
Bartel, 2012; Swiezewski et al., 2009; Kaushik et al., 2013). The collection of data available 
through various systematic databases such as lncRNAtor (Park et al., 2016), GENCODE 
(Derrien et al., 2012), LNCipedia (Volders et al., 2013), NONCODE (Zhao et al., 2016) and 
lncRNAdb (Amaral et al., 2011) served as a rich resource for the acceleration of lncRNA-
related research.  
 
The definition of lncRNAs remains fluid as compared to sRNAs and it is constantly 
evolving with new insights being made in the field.  LncRNA molecules were shown to share 
many features with messenger RNAs (mRNAs) except that they are non-coding transcripts 
(Figure 6). They are transcribed by RNA polymerase II and most of the transcripts undergo 
processing such as 5′-capping, splicing, and polyadenylation (Gomes et al., 2013). They are 
usually defined as transcripts with length greater than 200-nt that lack significant protein 
coding potential (Rinn and Chang, 2012, Sun and Kraus, 2013). These transcripts can be 
generated from intergenic regions, promoter regions and sequences overlapping or in an 
antisense orientation to annotated protein-coding genes (Gomes et al., 2013). Instead of being 




used as templates for protein synthesis, lncRNAs are able to carry out various biological 
functions. In contrast to small ncRNAs, which typically feature processed transcripts of 
defined length, long non-coding RNAs vary dramatically in their size, with RNAs up to 
several mega-bases in length (Dinger et al., 2008). Although the expression of lncRNAs is 
regulated spatiotemporally, their expression levels are typically significantly lower compared 
to those of protein-coding mRNAs (Tsoi et al., 2015).  
 
Although these features had been widely applied in the field to define lncRNAs, this 
has led to many false positive and false negative results. For example, it has been shown that 
lncRNAs consist of both polyadenylated and non-polyadenylated transcripts (Hangauer et al., 
2013). Similarly, studies have suggested that many lncRNAs harbour the capacity to encode 
miniORFs that could be functional (Andrews and Rothnagel, 2014; Bazzini et al., 2014). 
Examples of lncRNAs that encode for small peptides and could have been placed in the 
protein-coding gene classification include lncRNA Xist, lncRNA ENOD40 and lncRNA 
HOXB-AS3 (Dinger et al., 2008; Matsumoto et al., 2017; Huang et al., 2017). Several 
computational methods such as Coding Potential Assessment Tool (CPAT) and Phylogenetic 
Codon Substitution Frequency (PhyloCSF) were generated to tackle this issue and they were 
commonly used as a filtering step to identify putative lncRNA transcripts. These methods rely 
heavily on the properties on known lncRNAs as training datasets and could be biased during 
selection. With the increasing amount of sequencing data generated, a more specific and 
sensitive computational algorithm is required to separate coding genes from non-coding 
transcripts. Another option to define lncRNAs and distinguish them from miniORFs and 
small peptides is ribosome profiling or shotgun proteomics (Ingolia et al., 2012; Giambruno 
et al., 2018) 
 
Evolutionary conservation has always been used to understand the functions of 
protein-coding genes. In comparison to protein-coding genes, many lncRNAs lack 
conservation of their primary sequences. However, this criterion should not be mistaken for a 
lack of function in lncRNAs (Diederichs, 2014). LncRNA Xist and Megamind/Tuna are 
examples of lncRNAs that were highly conserved in terms of function across zebrafish, 
mouse and human yet displayed low sequence conservation across the species (Brockdorff et 
al., 1992, Utilisky et al., 2011, Lin et al., 2014). LncRNA Megamind/Tuna was an ultra-
conserved lncRNA that was first identified in zebrafish that had important neural 
development function. This observation suggested that sequence conservation may not be as 
an important factor for RNA function compared to proteins. Furthermore, a comparison of 




lncRNAs in different species has revealed that lncRNAs stem from syntenic loci between 
different species. The order of syntenic transcripts along the chromosomes in different species 
is conserved (Herriges et al, 2014).  
 
 
Figure 6: Properties of long non-coding RNA 
The mammalian genome is pervasively transcribed by RNA Polymerase II, generating both protein-
coding messenger RNAs (mRNAs) and long non-coding RNAs transcripts of more than 200 
nucleotides. These strands of lncRNA are mostly poly-adenylated and capped at the 5’ end.  The 
majority of these ncRNA transcripts also lack conserved or long open reading frames (ORFs).  
[Image taken from Sun and Kraus, 2014]. 
 
In conclusion, the task of distinguishing lncRNA transcripts within the transcriptome 
could is complex and challenging as the current definition may not be the best to define a 
lncRNA transcript.  A good example to illustrate this concept is the lncRNA steroid receptor 
RNA activator (SRA1).  The human SRA1 was first identified as a lncRNA that is involved in 
transcriptional regulation and associated with human diseases such cancers (Lanz et al., 1999; 
Cooper et al., 2009; Liu et al., 2016; Yan et al., 2016; Kyung et al., 2017). Interestingly, this 
bifunctional locus that codes for the lncRNA SRA also encodes for the SRA protein (SRAP). 
Both SRA and SRAP have been shown to be involved in interacting with a variety of proteins, 
demonstrating the presence of bifunctional RNAs that have the ability to exert coding- and 
coding-independent functions (Nam et al., 2016; Liang et al., 2018). For these reasons, the 
identification of lncRNAs should to be accompanied by a range of experiments in order to 
annotate them accurately.  
 
1.4 Classification of lncRNAs  
 
1.4.1 Cataloguing lncRNAs based on genomic location 
 
With the increasing number of lncRNAs being discovered and thought to be involved 
in a myriad of biological processes, it is vital to organise them into categories to have a better 




understanding of their biological significance. One common way to distinguish the various 
types of lncRNA transcripts is to categorize them based on their genomic origin. Due to our 
poor understanding of this class of ncRNA, thousands of RNA transcripts fall into the class of 
lncRNAs due to the size selection criteria for lncRNA transcripts. They are annotated as 
sense, antisense (NAT), bidirectional, intronic, intergenic lncRNAs (Khandelwal et al., 2015). 
This form of annotation considers the position of the transcript relative to annotated protein-
coding genes (Figure 7). However, it is not mutually exclusive and some transcripts can be 
classified into two or more categories. An example would be MALAT1, an intergenic, 
antisense lncRNA transcript (Louro et al., 2009). 
 
Sense transcripts are transcribed on the same strand as protein-coding genes whereas 
natural antisense transcripts (NATs) are located on the opposite strand. The sense transcripts 
can be further divided into sense overlapping or sense intronic lncRNAs.  An example of a 
sense lncRNA would be SNHG4. NATs are considered to be one of the most abundant forms 
of lncRNA transcripts (Kung, 2013). These lncRNAs are endogenous molecules that partially 
overlap with their sense counterparts. There are many examples of NATs in the genome and 
some well-known examples include BACE1-AS and MALAT1 that will be discuss in the later 
chapters. On the other hand, bidirectional refers to transcripts that are expressed on the 
opposite strand of an annotated protein-coding transcript. The transcription start site of these 
transcripts is usually <1,000-nt away from protein coding genes (Liang et al., 2014). 
Although the term lncRNA and long intervening RNA (lincRNA) is often used 
interchangeably, it should be noted that the latter is a subclass of lncRNAs derived from 
regions between known protein-coding genes. In order to qualify as a lincRNA, transcripts 
should be outside of known protein-coding genes, harbour chromatin methylation marks such 
as H3K4me3 and H3K36me3 and contain <35 % open reading frame (ORFs) in the sequence 
(Khalil et al., 2009). Another class are intronic lncRNAs. These transcripts can be in sense or 
antisense orientation and they are embedded within intronic regions of protein-coding genes 
(Nakaya et al., 2007).  
 
Several studies have shown that intronic lncRNAs have autonomous transcriptional 
regulation and they are expressed independently from the protein-coding genes that they 
reside in (Louro et al., 2009; Laurent et al., 2015). However, lncRNA-related research is a 
relatively new field and many of these transcripts do not just fit into one particular category. 
With the vast number of genome sequencing projects that have been carried out, it is now 
apparent that the genome produces a large number of transcripts, both coding and non-coding, 




with a multitude of isoforms. Similarly, lncRNAs that are transcribed have low expression 
levels and undergo the process of alternative splicing and thus making it challenging to 
assemble the full-length transcripts. A better understanding of the transcriptome is required in 
order to better annotate lncRNAs as a functional class of molecules. 
 
 
Figure 7: A broad overview of different forms of lncRNA transcripts.  
LncRNA transcripts can be annotated as sense, antisense, bi-directional, intronic or intergenic. (A, B) 
With reference to the location of protein genes, sense and antisense lncRNA transcripts are usually 
found to be overlapping with the exons of protein-coding genes or within the exonic regions. A sense 
lncRNA is transcribed from the same strand as the protein-coding gene, whereas an antisense one 
from the opposite strand. (C) A ncRNA is known as a bidirectional lncRNA when its TSS is on the 
opposite strand and is located within 1-kb from the TSS of a protein-coding gene. (D) Intronic 
lncRNAs refers to transcripts that are found within the intronic regions of protein-coding genes. (E) 
LncRNA transcripts that are transcribed from genomic regions between separate gene loci are 
classified as intergenic lncRNAs, or sometimes also known as intervening lncRNAs (lincRNAs). 
[Image taken from Liu et al., 2018] 
 
 
1.4.2 Classification based on molecular mechanisms of lncRNAs 
 
The discovery of ncRNAs and their mode of actions expanded our understanding of 
gene regulation. Compared to lncRNAs, the molecular modes of action of sRNAs are well 
established. For many years, the research community has been divided on whether lncRNAs 
are functional or just represent transcriptional noise (Blake et al., 2003). Recent work in a few 




of the lncRNAs have demonstrated that these transcripts are important mediators of cellular 
functions acting at different levels (Pintacuda et al., 2017). Given the flexibility of lncRNA 
strands, it has been proposed that lncRNA transcripts are able to interact with DNA, RNA and 
protein partners to form DNA: RNA hybrids; RNA: RNA hybrids and RNA-protein 
interactions so as to modulate different biological processes (Rinn and Chang, 2012). In 
recent years, the formation of RNA-DNA triplex has been proposed to be the fourth type of 
interaction between an RNA transcript and the double-stranded DNA (Yue et al., 2016). 
Through the different types of interaction between a lncRNA and its partners, a wide range of 
regulation is carried out and they can be divided into four classes – molecular decoys, 
molecular scaffolds, molecular signals and molecular guides. Given the versatility of 
lncRNAs, they are not restricted to a fixed mode of action and some have been shown to have 




Regulation of transcription is essential for proper development of an organism. During 
transcription, lncRNAs can influence gene expression either positively or negatively. 
LncRNAs that function as a decoy behave like a molecular “sink” and hinders the action of 
transcriptional regulators such as transcription factors (TF) or post-transcriptional regulators 
such as miRNAs (Figure 8a). One well-studied example is the inhibition of the NF-YA 
nuclear transcription factor activity by lncRNA PANDA (Hung et al., 2011). The function of 
PANDA is to impede the expression of apoptotic genes during DNA damage, thereby 
preventing activation of apoptosis and promoting cell survival. Its interacting partner, NF-YA, 
is a nuclear transcription factor that normally drives the expression of apoptotic genes. During 
cell cycle arrest, PANDA acts as a decoy and prevents NF-YA from binding to apoptotic 
genes and thereby preventing apoptosis (Hung et al., 2011). Besides proteins, lncRNAs can 
also sequester miRNAs and prevent them from carrying out gene silencing (Poliseno et al., 
2010). The 3’ UTR of lncRNA PTENP1 possess similar binding sequences for regulatory 
miRNAs that targets PTEN, a tumour suppressor gene. Binding of lncRNA PTENP1 to 
regulatory miRNAs sequesters their availability to PTEN mRNA, which in turn increases the 











The second mode of action of lncRNAs is through cellular signalling. Cells have the 
ability to process different stimuli and perform a series of changes to the cellular state through 
a wide range of different signalling pathways (Figure 8b). LncRNAs in this category are 
important biomarkers to coordinate spatio-temporal events during various biological 
processes (Peng et al.,2017). An example of a signal lncRNA is lincRNA-p21. In the event of 
DNA damage, lincRNA-p21 functions as a signalling molecule and triggers apoptosis (Tran 
et al., 2015). LincRNA-p21 is located upstream of the CDKN1A gene and its activity is 
tightly regulated by p53 (Huarte et al., 2010). The above mentioned lncRNA PANDA does 
not just function as a molecular decoy, but it is also able to act as a signalling molecule during 
DNA damage. The induction of DNA damage leads to the expression of a set of signalling 
lncRNAs and one of them is the lncRNA PANDA. Its activity is p53-dependent and requires 
p53 activation during DNA damage (Hung et al., 2011; Baldassarre and Masotti, 2012). Both 
lncRNA PANDA and lincRNA-p21 regulate and fine tune the process of apoptosis by keeping 




The third mode of action for lncRNAs is molecular guides where they interact with 
specific proteins and guide them to specific DNA targets (Moran et al., 2012; Froberg et al., 
2013). Guide lncRNAs are essential to help ribonucleoprotein (RNP) targeting to specific 
locations. The resulting lncRNA-protein complex is able to influence gene expression either 
in cis or in trans. Target proteins recognized by the lncRNA may be a repressor or activator 
complex, consequently transcription can be influenced negatively or positively, respectively. 
Transcriptional repression is one of the best understood functions of lncRNAs. For example, 
Air is a cis-acting lncRNA that interacts with the promoter of target genes on the paternal 
chromosome (Nagano et al., 2008; Braidotti et al., 2010). The accumulation of lncRNA Air 
on its target locus results in the recruitment of G9a methyltransferase. This enzyme then 
methylates histone H3 on lysine 9 (H3K9), which leads to transcriptional silencing (Nagano et 









Molecular scaffolds for other molecules 
 
 The last category comprises of lncRNAs that function as an anchoring structure for 
regulatory proteins. Some lncRNA transcripts are able to form secondary and tertiary 
structures and these structures contain multiple domains that allow interaction with protein 
partners (Yoon et al., 2013). These RNP complexes bind to target loci and regulate gene 
expression. For example, the HOX transcript antisense RNA (HOTAIR) interacts with 
proteins on both the 5’ and 3’ end. The first 300-nt on the 5’ end of the transcript are able to 
interact with Polycomb Repressive Complex 2 (PRC2) and inhibit transcription by 
methylation of H3K27 (Tsai et al., 2010). On the other hand, the 3’ end of HOTAIR activates 
gene expression when bound to LSD1/CoREST/REST protein complex (Tsai et al., 2010). 
This phenomenon suggests that lncRNAs are able to act as a scaffold for multiple protein 
complexes and can result in the deposition of different histone modifications (Figure 8d). 
 
 
Figure 8: Schematic diagram depicting four modes of action by lncRNAs. 
a) Molecular decoy: lncRNAs function as a molecular sponge that tethers RNA/protein factors and 
prevents these factors from binding to target genes. b) Molecular signal: Upon receiving an external 
stimulus, lncRNAs are used as biomarkers to rely in signalling pathways to activate gene expression. 
c) Molecular guides: lncRNAs that function as guides recruit chromatin modifying complexes to target 
genes in cis or in trans. d) Molecular scaffolds: lncRNAs act as a platform for multiple proteins to 
form a RNP complex for downstream processes such as histone modification.  









1.4.3 From actions to functions - The diverse roles of LncRNAs 
 
LncRNA research is an exciting and fast-moving area in the non-coding RNA world 
with new discoveries and annotations of lncRNA transcripts in different biological systems. 
One of the challenges of detecting and deciphering functional lncRNAs is due to their low 
expression levels and restricted spatio-temporal expression. Certain lncRNAs are only 
expressed in specific cell types, tissues or conditions such as stress or specific developmental 
time points. Therefore, understanding the cellular localisation of each lncRNA transcript will 
provide a clue into their functions. With the improvements in biochemical and molecular tools 
in the last few years, we now have a better understanding of this new class of molecular 
regulators and their molecular mechanisms of action and biological functions within the cell. 
LncRNAs can be enriched in either the nucleus, cytoplasm or present in both, and depending 
on the compartment in which they are located, they play diverse roles ranging from cis- to 
trans-regulators of gene expression in the nucleus to post-transcriptional regulators in the 
cytoplasm (Miyagawa et al., 2012; Lubelsky and Ulitsky, 2018; Shukla et al., 2018). I will 
discuss some of the roles of lncRNAs and it should be noted that these are just the tip of the 
iceberg and focused mainly on the RNAs as the functional units themselves. As the field 
continues to mature, I expect the categories to expand to encompass the diverse roles that 
lncRNAs play.  
 
Epigenetic Regulators and chromatin organisers 
 
Since the discovery of lncRNAs, their capacity to facilitate epigenetic regulation has 
been a hallmark of lncRNA research. Many studies have shown that lncRNAs are central in 
regulating allelic expression and are implicated in processes such as dosage compensation and 
imprinting (Davidovich and Cech, 2015). Amongst the many processes lncRNAs are involved 
in, their association with proteins of the polycomb group repressive complex (PRC) and 
trithorax chromatin-activating complex (TAC) to deposit repressive or activating histone 
marks, respectively, is well documented. The process of X-Chromosome inactivation (XCI), 
which takes place in placental mammals, results in the suppression of gene expression on an 
entire female X chromosome due to local epigenetic effects. XCI is carried out randomly on 
one of the two chromosomes in females and is required to balance the expression of genes on 
the X chromosome between males and females (Figure 9). These epigenetic changes are 
mediated by the lncRNA Xist (X-inactive specific transcript). The ncRNA RepA is expressed 
from within the Xist locus and together with Xist, they recruit PRC2, which catalyses the 




deposition of the repressive H3K27me3 chromatin mark across the X chromosome. On the 
other hand, tight regulation of the XCI process is required to prevent both X chromosomes 
from being inactivated. Tsix, a lncRNA expressed on the sister X chromosome, is able to 
suppresses Xist expression by inhibiting RepA recruitment of polycomb in only one of the X 
chromosomes in females. Both lncRNAs are important for viability and deletion of either Xist 
or Tsix lncRNA have shown to be lethal in mice (Marahrens et al., 1997; Sado et al., 2001). 
The study of dosage compensation has led many groups to explore this phenomenon in 
greater detail and it has taken a decade of research to decipher the mechanisms. Today, we 
understand that besides the recruitment of the PRC2 complex, Xist itself is highly methylated 
containing N6-methyladenosine (m6A) residues and the recruitment of RNA-binding motif 
proteins such as RBM15 is essential for XIST-mediated gene silencing (Patil et al., 2018). 
Besides the role in X inactivation, Xist have been shown to be associated with a number of 
cancers with the reactivation of the second X chromosome (Yildirim et al., 2013). 
 
 
Figure 9: Xist, a well-studied lncRNA that is involved in chromatin remodelling. 
The process of X chromosome inactivation is orchestrated by Xist. The lncRNA interacts with 
proteins in the PRC complex to impart repressive histone marks such as H3K27 trimethylation on 
target genes, which results in the inhibition of gene expression at that locus.  
[Image modified from Lee, 2012]. 
 
LncRNAs have also been found to induce transcriptional gene silencing in plants 
through the recruitment of the PRC2 complex. Flowering plants have developed the ability to 
respond to environmental cues so as to flower at the right time of the year. The promotion of 
flowering by vernalisation in Arabidopsis is regulated by PRC2 and two lncRNAs, COLDAIR 
and COOLAIR, on the floral repressor, FLOWERING LOCUS C (FLC). During winter, the 




antisense lncRNA COOLAIR is highly expressed and with the processing of the 3′ end of FLC 
triggers silencing of the sense FLC transcript and promotes the PRC occupancy (Swiezewski 
et al., 2009). An additional layer of gene silencing is carried out by the COLD-ASSISTED 
INTRONIC NONCODING RNA (COLDAIR) that is transcribed from the first intron of the 
FLC locus when FLC is repressed. In comparison to COOLAIR, lncRNA COLDAIR directly 
interacts with the PRC2 complex and increases the PRC2-mediated H3K27me3 histone mark 
on the FLC gene including the promoter region (Heo and Sung, 2011; Heo et al., 2013). The 
act of transcription termination by COOLAIR and the recruitment of PRC2 to propagate 
repressive chromatin marks by COLDAIR completely silences the FLC locus. 
 
LncRNAs are capable of guiding chromatin modifiers in a trans-acting manner to 
mediate epigenetic modification on specific loci across the genome (Rinn et al., 2007; Tano 
and Akimitsu, 2012). Since the discovery of Xist, a number of lncRNAs that interact with the 
PRC2 complex to mediate gene silencing have been identified (Khalil et al., 2009; Nagano et 
al., 2008; Swiezewski et al., 2009; Mohammad et al., 2011). Hox transcript antisense 
intergenic RNA (HOTAIR) is one such lncRNA that is expressed from the HOXC cluster and 
recruits PRC2 to induce repressive histone marks on the HOXD cluster in multiple tissues (Li 
et al., 2013). The PRC2 complex was identified to associate with HOTAIR using an RNA-
protein interaction assay and is required for the proper localization the PRC2 across the 
HOXD cluster. Mutants of HOTAIR undergo gene de-repression on the HOXD cluster and 
display several phenotypes such as homeotic transformation and malformation of the skeletal 
structure (Li et al., 2013). HOTAIR was also shown to be associated with cardiovascular 
diseases and a number of human cancers (Lai et al., 2017; Gupta et al., 2010; Li et al., 2013).  
 
Although epigenetic silencing is considered one of the major process lncRNAs are 
involved in, it is not the only form of epigenetic control of gene transcription by lncRNAs. 
Improved sequencing technologies have shed some light on the presence of a less defined 
class of lncRNA known as promoter-associated lncRNA (pa-RNAs) that bind to protein 
factors and target promoters of coding regions (Wang et al., 2008; Song et al., 2012). An 
example of pa-RNA is lncRNA-CCND1/Cyclin D1, which is expressed upstream of the 
CCND1 promoter during DNA damage. This lncRNA transcript binds to the Cyclin D1 
promoter and modulates the activity of the RNA-binding protein TLS. Alterations in TLS 
protein prevent histone acetylation of the CREB binding protein as well as p300 and 
consequently suppresses the expression of Cyclin D1 protein, which is required for cell cycle 
progression (Wang et al., 2008). LncRNA HOXA transcript at the distal tip (HOTTIP) is 




another example of a cis-acting lncRNA that mediates gene activation. It is transcribed from 
the HOXA locus and promotes HOXA activation through its interaction with the WRD5/MLL 
histone methyltransferase (HMT) complex. The loss of HOTTIP results in lumbosacral 
homeotic transformation in mice and a number of studies have also demonstrated that 
HOTTIP plays a major role in genome maintenance and is associated with a number of human 




Besides interacting with epigenetic factors and chromatin modifiers, lncRNAs have 
been shown to regulate gene expression via other processes. LncRNAs can influence 
transcription directly and prevent DNA binding by transcription factors via several 
mechanisms such as inhibiting or mediating the recruitment of RNA polymerase II, 
transcription factors, and/or cofactors to gene promoters. Studies have shown that the growth 
arrest-specific transcript 5 (Gas5) lncRNA acts as a decoy and competes with glucocorticoid 
response elements for binding to the DNA-binding domain of glucocorticoid receptors (Kino 
et al., 2010). Gas5 is a starvation-associated repressor and have been shown to be associated 
with promoting apoptosis (Mourtada-Maarabouni et al., 2008; Kino et al., 2010; Liu et al., 
2018). The lncRNA Lethe has also been shown to prevent the NF-κB-driven inflammatory 
responses in mouse fibroblasts by binding with the RelA subunit and preventing it from 
binding to DNA and thus promoting anti-inflammatory responses (Minton, 2013; Rapicavoli 
et al., 2013). The lncRNA Jpx is an important player in XCI besides lncRNA Xist. JPX is a 
trans-acting lncRNA found to be expressed on the active X chromosome. It is able to 
upregulate Xist expression on the inactive X allele by binding to CCCTC-binding factor 
(CTCF) and removing it from the inactive X locus (Tian et al., 2010; Sun et al., 2013; 
Carmona et al., 2018).  
 
Two lncRNAs have been shown to have a role in the nervous system by controlling 
the fates of neural cells. The interaction between lncRNA rhabdomyosarcoma 2-associated 
transcript (RMST) and the transcription factor SOX2 is necessary to promote specific 
neuronal-related gene expression programs (Ng et al., 2013; Wang et al., 2017). Here, RMST 
was found to be a brain-specific lncRNA and modules neural differentiation. RMST co-
regulates SOX2 target genes upon binding and the association of SOX2 with the regulatory 
regions of neurogenic genes such as DLX1, ASCL1, HEY2, and SPS has been shown to be 
greatly reduced upon knockdown of RMST, and thus inducing changes in the gene profiles of 




the neural stem cells (Ng et al., 2013). The second lncRNA is an ultra-conserved ncRNA 
known as TUNA/Megamind that regulates gene expression in a similar fashion as RMST. 
Three RNA-binding proteins (NCL, PTBP1 and hnRNP-K) have been shown to interact with 
TUNA and activates neural genes in differentiating mouse ESCs such as SOX2 (Ulitsky et al., 
2011; Lin et al., 2014). 
 
Functions of post-transcriptional lncRNAs 
 
Examples of lncRNAs that act as post-transcriptional gene regulators have emerged in 
recent years (Yoon et al., 2014; He et al., 2019). Compared to lncRNAs that execute their 
function in the nucleus, the roles of many cytoplasmic lncRNAs only began to surface 
recently. Some of the post-transcriptional roles played by lncRNAs in the cytoplasm are 
mRNA stabilisation, regulation of target mRNA translation and serving as competing 
endogenous RNAs (ceRNAs). Many RNA-binding proteins (RBP) and microRNAs were 
known to regulate the stability of mRNAs and influence the half-life of the mRNA transcript. 
In recent years, lncRNAs have emerged as another class of molecules that possessed the 
ability to perform a similar task. The lncRNA known as antisense, longer base pairing of β 
amyloid-cleaving enzyme (BACE1-AS) transcript that is expressed from the BACE1 locus had 
been found to increase the stability of the BACE1 mRNA for translation by competing with 
miR-485-5p (Faghihi et al., 2010). The formation of an RNA-RNA duplex between BACE1 
mRNA and lncRNA-BACE1-AS mask the binding site that is recognised by miR-485-5p and 
prevents the miRNA from carrying out gene silencing, which has broad implications in 
Alzheimer’s disease (Faghihi et al., 2008; Hu et al., 2018).  
 
A different class of lncRNAs known as half STAU1 binding site RNA (1/2-SBS1RNA) 
interacts with mRNA transcripts directly and altering them for recognition and degradation by 
Staufen 1 (STAU1) proteins (Kim et al., 2007; Ravel-Chapuis et al., 2012). The mRNA 
transcripts that would be subject to mRNA degradation via the STAU1-mediated mRNA 
decay (SMD) pathway would contain a double-stranded RNA motif within the 3′UTR of 
translationally active mRNA that encodes an ADP-ribosylation factor 1 (ARF1) (Gong and 
Maquat, 2013; Park and Maquat, 2013). A proportion of mRNA transcripts have been found 
to lack this stem loop structure and would not be recognised by STAU1 protein. Interestingly, 
some of the active mRNA transcripts contained an Alu element that allowed imperfect base-
pairing with the Alu element of the 1/2-SBS1RNA, resulting in a decrease in the overall half-
life of the mRNA transcript by triggering the formation of a double-stranded RNA binding 




motif for the STAU1 and mRNA decay factor UPF1 complex (Kim et al., 2005). Conversely, 
the terminal differentiation-induced ncRNA (TINCR) stabilises mRNA through the binding of 
the ‘TINCR box’ motif with the target mRNA. Similar to 1/2-SBS1RNA, TINCR was found to 
be bound to STAU1 but in this case, it aids in the stabilisation of the target mRNA transcript 
(Kretz et al., 2013). The STAU1-TINCR complex was found to stabilise a range of mRNAs 
that drive somatic tissue differentiation. The association of 1/2-SBS1RNA or lncRNA TINCR 
with mRNA transcripts do not trigger SMD but changes the overall stability profile of the 
mRNA. Recent studies have shown that the STAU proteins are considered to be 
multifunctional and able to stabilise and destabilise target mRNA (Heraud-Farlow and 
Kiebler, 2014; Heraud-Farlow et al., 2013). The actual mechanism remains obscure and 
further investigation is needed to unravel the other conditions that influence the mRNA 
turnover upon lncRNA binding.  
 
Besides influencing the stability of mRNAs, lncRNAs were found to be repressors 
(e.g. lincRNA-p21, BC1) or activators (e.g AS Uchl1) of target mRNA translation. The 
dynamics between human antigen R (HuR) and lincRNA-p21 in the cell influenced mRNA 
translation of target genes (Tang et al., 2015; Yang et al., 2016). LincRNA-p21, also known 
as Tumour protein p53 pathway corepressor 1 (Trp53cor1), was found to be an important 
translation modulator highly enriched in the cytoplasm. In an experiment using RNA 
immunoprecipitation (RIP) to search for RNA binding with the RNA-binding protein HuR, 
lincRNA-p21 was found to be one of the interactors in the pool. In the presence of HuR, 
lincRNA-p21 have been shown to be degraded rapidly (Yoon et al., 2012; Wilusz and Wilusz, 
2012). HuR acts as an mRNA stabiliser and promotes CTNNB1 and JUNB mRNAs 
translation. In the absence of HuR, lincRNA-p21 transcript levels are elevated and bound to 
CTNNB1 and JUNB mRNAs (Turner et al., 2014). This base-pairing event further recruits 
the translation repressor Rck to prevent translation of target mRNAs and also increased the 
ribosome drop-off rate (Yoon et al., 2012). The rodent brain cytoplasmic 1 (BC1) lncRNA is 
a brain-specific transcript acting as a translational repressor through its interaction with 
eukaryotic translation initiation factor eIF4A and poly(A)-binding protein (PABP) 
(Muddashetty et al., 2002; Wang et al., 2005). The transport of BC1 to the dendrites of 
neurons would thus influence the local translation processes and the loss of BC1 was shown 
to result in neuronal excitability and susceptibility to epileptic seizures (Zhong et al., 2009; 
Gitaí et al., 2009). On the other hand, the expression of dopaminergic neuron-specific 
lncRNA known as antisense Ubiquitin carboxy-terminal hydrolase L1 (AS Uchl1) promotes 
cap-independent translation of Uchl1. The repetitive domain SINEB2 that was found to be 




embedded in the AS Uchl1 recruits polysomes and was found to be essential for promoting 
translation (Carrieri et al., 2012; Podbevšek et al., 2018). 
 
The search for lncRNAs that interact with other ncRNAs transcripts such as miRNAs led 
to the discovery of a group of ncRNA known as ceRNAs. As the name suggested, these group 
of lncRNA transcripts lncRNA stabilise mRNA levels by serving as a molecular ‘decoy” for 
miRNAs or proteins that targets them (Poliseno et al., 2010; Salmena et al., 2011).  The 3′-
UTR region of muscle-specific, long intergenic non-coding RNA, muscle differentiation 1 
(LINCMD1) harbours miRNA-binding sites for miR-133 and miR-135 and thereby sequester 
these miRNAs away from their mRNA targets. The reduction in miRNA availability 
positively upregulates the expression of transcription factors such as Mastermind-like 1 
(MAML1) and Myocyte enhancer factor 2C (MEF2C) and thereby drives muscle-specific 
gene expression programs (Cesana et al., 2011). Increasing evidence has pointed towards 
lncRNA-miRNA interactions as contributors to several cancers such as breast, prostate, 
gastric, lung and liver cancer. Some of the well-known lncRNAs were also found to attenuate 
miRNA regulation. The binding of HOTAIR to miR-331-3p relives the repression of human 
epidermal growth factor receptor 2 (HER2) by the miRNA and drives the progression of 
gastric cancer (Liu et al., 2014). Similarly, H19 lncRNA functions as a molecular sponge for 
miRNAs let-7 and promote cancer cell proliferation and metastasis with the elevation of c-
Myc expression (Zhou et al., 2017; Kallen et al., 2013). The lncRNA Human universal load 
carrier (HULC) indirectly stimulate gene expression programs by sequestering miRNA-372 
and thus increased the phosphorylation activity of CREB proteins by PRKACB (Protein 
Kinase CAMP-Activated Catalytic Subunit Beta).  The upregulation of HULC has been found 
to be associated with different cancers such as hepatocellular carcinoma and gastric cancer 
(Wang et al., 2010; Panzitt et al., 2007; Yang et al., 2015; Chen et al., 2017).  
 
1.5 Emerging roles of lncRNAs in Drosophila 
 
Genome-wide transcriptional studies indicated that the genome of Drosophila 
melanogaster codes for more than 1,000 lncRNAs, yet the functions of these non-coding 
RNA molecules remains largely unknown (Brown et al., 2014). The first lncRNA discovered 
in Drosophila was the transcriptional elongation of bithoraxoid (bxd) ncRNA (Lipshitz et al., 
1987). It is expressed within the HOX gene cluster and positioned adjacent to the 
Ultrabithorax (Ubx) gene. The bxd lncRNA functions as a repressor of Ubx gene, with 
mutations resulting in homeotic transformations and the generation of a four-winged fruit fly 




(Petruk et al., 2006, Pease et al., 2013). However, subsequent studies have revealed 
confounding results using different methods of generating bxd mutants. It was suggested that 
it was the act of transcription of this lncRNA that affected the expression the Ubx gene rather 
than the lncRNA itself. The inversion of the promoter region had little effect on the 
expression of Ubx even though transcription was occurring in the other direction (Pease et al., 
2013). Similarly, a Cdx-like gain of function of Ubx was observed when the promoter region 
of Ubx was deleted (Sipos et al., 2007). This has prompted the need for more in depth studies 
and careful analysis of lncRNA functions and the need to be cautious when drawing 
conclusions from loss of function studies.  
 
Other well-studied Drosophila lncRNAs are roX1, roX2 and heat shock RNA omega 
(hsr ω). Both roX1and roX2 lncRNAs were found to be involved in the dosage compensation 
process of the X chromosome in male flies and implicated in epigenetic gene regulation 
through histone modification (Khalil et al., 2009; Ilik and Akhtar, 2009). These two lncRNAs 
interact with the Male-specific lethal (MSL) complex to acetylate histones on the X 
chromosome, leading to hyperactivation of transcription. Hsr ω is transcribed from the heat 
shock response hsr-omega locus in response to cellular stress and has been detected at high 
levels in many tissues, particularly in the nucleus (Bendena et al., 1991). Three long 
transcripts are generated during transcription from the hsr-omega locus by RNA pol II after 
undergoing alternative splicing and polyadenylation. These lncRNA transcripts were found to 
be regulating apoptosis and have been implicated in coordinating stress responses and 
recruiting various RNA-binding proteins into omega speckles upon stress induction (Mallik 
and Lakhotia, 2009; Singh and Lakhotia, 2015). The majority of fly strains carrying hsr ω 
mutations are embryonic lethal (Jolly and Lakhotia, 2006). 
 
A number of studies have found that lncRNAs also play a role in Drosophila 
behaviour and cognition. For example, the lncRNA bereft (bft) is expressed in the 
extrasensory organ and was shown to be vital for bristle formation (Hardiman et al., 2002). 
Another lncRNA known as CASK regulatory gene (CRG) is a cis-acting ncRNA transcript 
that positively regulates its neighbouring gene CASK (Ca2+/calmodulin-dependent protein 
kinase). Loss of lncRNA CRG has been found associated with defects in Drosophila 
locomotor activity and climbing ability (Li et al., 2012). Two lncRNAs have been found to 
influence the behaviour of the fruit fly. Sphinx lncRNA was shown to associate with male 
courtship behaviour whereas lncRNA yellow-achaete intergenic RNA (yar) was found to 
have an impact on the circadian rhythm and is important for proper sleep regulation (Wang et 




al., 2002; Soshnew et al., 2011). Apart from these few examples, we know relatively little 
about lncRNAs in Drosophila. 
 
1.6 Tools to understand lncRNAs functions 
 
The application of single-molecule RNA fluorescence in situ hybridization (smFISH) 
has been a molecular biology technique used in the field for many years (Gall JG and Pardue, 
1969). This method was commonly employed to reveal the subcellular localisation and 
expression pattern of lncRNAs so as to have an insight towards the role the play in the cell 
(Levsky JM and Singer, 2003; Dunagin et al., 2015; Orjalo and Johansson, 2016). The 
innovations in smFISH technologies in recent years have increased the sensitivity of the 
assays and allowed the detection and quantification of lncRNA transcripts that have been 
known to be low-abundance (Wang et al., 2012; Jandura et al., 2017; Choi et al., 2018).  
Using RNA fluorescence in situ hybridization methods, two cis-acting lncRNAs called RNA 
on the X 1 and 2 (roX1 and roX2), were found to be expressed from the male X chromosome 
and were shown to be involved in the dosage compensation process (Meller and Rattner, 
2002). The use of RNA fluorescence in situ hybridization coupled with immunofluorescence 
subsequently revealed that the roX RNAs co-localise with the subunits found in the male-
specific lethal protein complex that is made up of five proteins. The assembly of this complex 
was essential for the spreading of the roX RNAs and hyperactivation of the X chromosome 
(Franke and Baker, 1999; Kelly et al., 1999; Meller and Rattner, 2002; Oh et al., 2003).  
 
Interestingly, due to an overlap in function, the male sterility phenotype requires the 
deletion of both lncRNAs and either lncRNA was found to be functionally redundant 
(Stuckenholz et al., 2003). Genome engineering methods such as recombination- 
TALEN/CRISPR technologies to target lncRNA genes have allowed the perturbation of 
lncRNAs of interest to investigate their function. Various methodical advances have greatly 
improved the in vivo functional characterization of lncRNAs. The study of lncRNA function 
in vivo is necessary as it has been shown in some lncRNA mutants that the mutation had little 
or no phenotype during development compared to the in vitro studies performed on the same 
lncRNA (Oliver et al., 2015; Sauvageau et al., 2013; Mattick, 2003; Grote et al., 2013). An 
example of such a lncRNA is MALAT1 that have been found to be highly abundant in 
vertebrate cells. MALAT1was found to be localised to the nuclear speckles and have been 
shown to have important roles in cancer metastasis and synapse formation in vitro (Gutschner 
et al., 2013; Schmitt and Chang, 2016). However, MALAT1 KO mouse models were found to 




be viable and fertile with no apparent developmental abnormalities (Eißmann et al., 2012; 
Nakagawa et al., 2012; Zhang et al., 2012).  
 
In recent years, various RNA-centric and protein-centric methods have been 
developed to probe for lncRNA interactions with DNA, RNA and protein molecules (König et 
al., 2012, West et al., 2014; Chu et al., 2015; Yang et al., 2015; Cheetham and Brand, 2018). 
Mechanistic studies to identify lncRNA binding partners have helped researchers discern the 
pathways and understand the mode of action of the lncRNA of interest. Through their 
interaction networks, we can gain a better insight into the diseases that may be associated with 
lncRNA dysregulation. Chromatin isolation by RNA purification (ChIRP), chromatin 
isolation by RNA purification (CHART) and RNA antisense purification (RAP) are some of 
the methods widely used in the field to investigate lncRNA binding sites in the genome (Chu 
et al., 2011; Quinn et al., 2014; Engreitz et al., 2015). Using Drosophila roX RNAs as an 
example, it was shown that dosage compensation is carried out by roX RNAs and the male-
specific lethal protein complex (Georgiev et al., 2011). The MSL complex encompasses the 
maleless (MLE) subunit, male-specific lethal 1 to 3 (MSL1 to MSL3) subunits and males 
absent on the first (MOF) subunit (Bhadra et al., 1999; Bhadra et al., 2005). For a long time, 
the binding sites on the X chromosome by roX RNAs were unknown. Using dChIRP, the 
authors generated biotinylated oligo probes antisense to the roX RNAs and pulled down 
regions that were bound to the probes (Quinn and Chang, 2015). This method can be paired 
with sequencing to look for the regions that were bound by the lncRNA. Similarly, the 
interacting sites of the lncRNA with the protein subunits was revealed using dChIRP coupled 
with mass spectrometry. The domains D1, D2 and D3 of the MSL proteins were discovered to 
be interacting with the roX lncRNAs (Chu et al., 2012). In a different experiment, the 
CHART method was used to study roX2 lncRNA and found similar binding sites for the 
lncRNA on the X chromosome with the MSL proteins (Simon et al., 2011).  
 
1.7 Drosophila – a model organism for the study of lncRNAs 
 
Drosophila melanogaster, also known as the fruit fly, has been used as a model organism 
for many biological enquiries as it shares many molecular and cellular features with 
mammals. Ever since it was introduced as a scientific research tool by Thomas Hunt Morgan 
in the 1900s, the fruit fly has been used extensively for many ground-breaking genetic studies 
from mechanistic studies to genetic variation as well as pathway studies (St Johnston, 2002; 
Bier, 2005).  Biologists have used the fruit fly in many additional areas of research such as 




developmental biology, cancer, metabolism and behavioural studies (Halder and Mills, 2011; 
Nichols et al., 2012). It can be considered to be a relatively complex organism but at the same 
time have an unrivalled ease of usage in the lab. The are many compelling reasons why 
Drosophila is such an amazing and fascinating tool to work with. Drosophila can be 
considered one of the most understood organisms in the lab given its long history. It has a fast 
generation time of 10.5-11 days at 25 ºC and it is easy to breed in the lab and given its small 
size it occupies little space. The fruit fly has a compact genome (∼180 Mb in size) and it is 
known that approximately 60-75% of human disease-linked genes have a functional 
orthologue in Drosophila, allowing researchers to use the fruit fly to understand biological 
functions that are conserved among animals (Reiter et al., 2001). The fruit fly genome has 
been fully sequenced and a large amount of transcriptomic data and metabolomic data sets 
were made available from the modENCODE project as reference datasets (Adams et al., 
2000; Chintapalli et al., 2007; Chintapalli et al., 2013; Brown et al., 2014). Other positive 
factors include low maintenance cost, high fecundity and the wide range of genetic tools, 
gene-specific knockdown and mutant lines that have been generated over the years.  
 
The success of Drosophila as a model for genetic studies was made possible with the wide 
variety of genetic tools that have been created over the century. The development of balancer 
chromosomes that prevent recombination allow the maintenance of deleterious mutations 
(Wallace, 1956). The balancer chromosomes are an essential component of mating schemes in 
genetic crosses even today. They contain multiple inversions that were lethal in homozygotes. 
The presence of dominant marker mutations ensured that a recessive mutant allele would be 
kept over the dominantly marked chromosomes. Different balancer chromosomes have been 
generated and some of the commonly used markers on different chromosomes are FM7 (X 
chromosome), CyO/SM6a (2nd chromosome) and TM3/TM6B (3rd chromosome) (Roote and 
Prokop 2013). The wide range of genome editing methods from chemical mutagenesis to 
CRISPR/Cas system allow the disruption of genes for functional analysis making Drosophila 
an attractive model to work with (Nasrat et al., 1954, Lin et al., 2015). The availability of 
RNAi lines for almost every gene have made Drosophila a model of choice for many fields of 
research (Ni et al., 2009; Perkins et al., 2015). A few Nobel prizes have been awarded 
throughout the years for work performed with the fruit fly. Besides the Nobel prize in 
Physiology or Medicine that was awarded to Thomas Morgan Hunt in 1933 for “for his 
discoveries concerning the role played by the chromosome in heredity”, the other noteworthy 
discovery was the identification of key developmental genes that were involved in the 
patterning of the body and were also conserved in other organisms (Nusslein-Volhard and 




Wieschaus, 1980; Lewis, 1978). For this ground-breaking work, Edward B. Lewis, Christiane 
Nüsslein-Volhard and Eric F. Wieschaus received the Nobel Prize in Physiology or Medicine 
for “their discoveries concerning the genetic control of early embryonic development” in 
1995. Today, Drosophila is commonly used as a genetic model to study many pathological 
conditions and to understand the physiological mechanisms involved in processes such as 
ageing, cancer, metabolic diseases and, neurodegenerative disorders (Zou et al., 2000; Baker 
and Thummel, 2007; Rudrapatna et al., 2012; Lu and Vogel, 2009; Polesello et al., 2011). 
 
According to the Ensembl database, lncRNAs comprise 2,366 of the 17,559 genes in the 
Drosophila genome and make up 13.5 % of the total number of expressed transcripts. 
Although a wealth of information such as the loci, sequence information, conservation and 
expression data sets for lncRNAs in Drosophila are available, only a small fraction of 
lncRNAs have been investigated experimentally. The availability of genetic tools such as 
GAL4-UAS system and CRISPR/Cas9 to functionally characterise lncRNAs makes the fruit 
fly an excellent model organism to study their function in vivo.  
 
1.8 Drosophila life cycle 
 
One of the attractive features of using the fruit fly is its well-studied development from 
embryo to adult (Figure 10). The fruit fly has a relatively short generation time and the life 
cycle of a fly is about 10.5-11 days at 25 °C. After the fertilized eggs are laid, embryogenesis 
takes about 22-24 hrs to complete before hatching into first instar larvae. The embryonic 
development of Drosophila melanogaster consists of 17 stages defined by Volker Hartenstein 
and José Campos-Ortega and during this period, the blueprint of organs and the appendages 
of the adult fly are formed (Campos-Ortega and Hartenstein, 1985). Drosophila go through 
three larval stages over a time of 4 days before transforming into pupae. The metamorphosis 
process takes another 5-6 days before the emergence of an adult fly (Wixon and O'Kane, 
2000). During pupation, the larval tissues are degraded to make room for the development of 
adult organs by the different imaginal disks. There are 10 pairs of imaginal disks that establish 
the different adult organs and extensive research using these imaginal discs led to an 
understanding of the reshaping process that takes place during Drosophila metamorphosis 
(Bate and Arias, 1991; Beira and Paro, 2016, Dye et al., 2017). The virgin fruit flies that are 
newly hatched have physically distinctive features compared to the more mature adults and 
thus making it easy to isolate and obtain virgin males and females for genetic crosses.  
 





Figure 10. The life cycle of Drosophila melanogaster. 
After eggs are laid, it takes approximately 10.5-11 days to complete the life cycle at 25 ºC. The 
Drosophila development comprises embryogenesis, larval, pupal and adult stages. During the larval 
stages, the larvae molt from first instar, to second instar and eventually third instar stage before 
undergoing pupation. [Image taken from Ong et al., 2014]. 
 
1.9 Genetic Manipulations using Drosophila 
 
The advances in genome editing techniques have allowed researchers to perform 
mutagenesis with higher precision and accuracy. The use of conventional methods such as X-
rays and chemical mutagens such as ethyl methanesulfonate (EMS) were some of the earlier 
approaches used to generate mutant flies for loss of function studies (Alderson, 1965; Epler, 
1966). However, the mutants generated were random. Hypomorphic alleles with subtle 
phenotypes make up a substantial portion of the mutants due the EMS-based mutagenesis 
method that generated single point mutations. It was difficult to trace the mutations as there 
were no traceable sequences or markers tagged to the lesion. Furthermore, it had to be tested 
if mutagenesis had occurred on more than one site in the genome (Blumenstiel et al., 2009). 
The verification process was laborious as complementation assays or whole-genome 
sequencing were required. P-element-mediated transformation became one of the 




revolutionary tools that is still used to generate mutant flies today. The method enables 
disruption of genes and also the introduction of transgenes into the fly genome (Venken and 
Bellen, 2007). The P-element is a Drosophila transposon that contains an inverted repeat. P-
elements have the ability to excise themselves from the genome and re-insert at a different 
location with the aid of a transposase encoded in the P-element sequence (Huang et al., 2009; 
Majumdar and Rio, 2015). Since the enzyme is encoded within the P-element sequence, the 
insertion would not be controllable and would allow the transposon to “jump” around. 
Therefore, one way of overcoming this problem was to separate the two components of the P 
element into separate flies and providing the transposase when needed (Rubin and Spradling, 
1982). P-elements had the tendency to be inserted near actively transcribed genes and this 
insertion event often disrupts the gene directly or via imprecise excisions after a second 
translocation event. However, there were caveats when choosing this method. Similar to 
earlier methods, the nature of P-element-mediated transformation in the genome are a random 
process and require a large amount of time to identify and map the site of insertion in the 
genome. On top of that, multiple insertion lines would be required for analysis so as to certify 
that the phenotype observed was not due to an insertion artefact but rather the expression of 
the transgene itself. Compared to the mutagenesis with either X-ray or EMS, the P-element 
system had a variable transformation effectiveness and a strong tendency to be inserted at 
“hotspots” whereas the PhiC31 system allows targeted transgenesis which is more efficient. 
(Bateman et al., 2006).  
 
Zinc-finger Nucleases (ZFNs) and Transcription Activator-Like Effector Nucleases 
(TALENs) are two important tools that alter a genomic site by inducing DNA double-
stranded breaks (DSBs) and activating the DNA repair mechanism of the cell to repair the 
genomic loci via non-homologous end joining (NHEJ) or homology-directed repair (HDR) 
(Gaj et al., 2013). Both are artificial chimeric enzymes containing a Fok1 DNA-cleavage 
domain as well as a DNA binding domain that has been engineered to recognise a specific 
sequence. ZFNs and TALENs can also be merged with other enzymes such as nucleases and 
DNA-histone methyltransferases which allow researchers to study effects on the genomic 
structure and function. The disadvantage of ZFNs and TALENs is the DNA-binding affinity 
and specificity of the designed proteins as these factors are important determinants of the 
capacity of the enzymes to modify the gene of interest. These tools are rarely used as it is 
difficult to clone and they are often not successful in modifying the genome. 




The GAL4/UAS expression system (Brand and Perrimon, 1993) is an important genetic 
tool used in Drosophila melanogaster to express a gene of interest in a time-dependent 
manner with tissue specificity. The system is made up of two components to drive the 
expression of a particular gene. The yeast transcriptional activator domain Gal4 is placed 
under the control of a Drosophila enhancer/promotor in one fly whereas the ‘Upstream 
Activating Sequence’ (UAS) followed by the gene of interest is placed in a separate fly line. 
When the two flies are mated, Gal4 binds to the UAS sequence, leading to transcription of the 
gene of interest. In this binary system the promoter driving Gal4 determines the expression 
pattern in which the gene of interest downstream of the UAS sites is going to be expressed. 
Gal4 drivers that are ubiquitous (Actin5c), tissue-specific (pan- neuronal elav), or those 
inducible by heat-shock have allowed us to perform targeted gene expression. 
Clustered regularly interspaced short palindromic repeats (CRISPR) is currently one of 
the most popular genome-editing tools that is used in a wide range of model organisms (Cho 
et al., 2013; DiCarlo et al., 2013; Gratz et al., 2013; Hwang et al., 2013). Compared to the use 
of ZFN/TALEN that would require the engineering of proteins for the specific gene target; the 
use of a variety of single guide RNA (sgRNA) allows the Cas9 protein to target different 
regions of the genome. Briefly, CRISPR/Cas9 allows the user to easily target and perform 
site-specific gene modifications using an sgRNA to target the DNA of interest (Port et al., 
2014; Gaj et al., 2013). The only requirement is that the sgRNA sequence in the genome is 
directly adjacent to a NGG sequence known as the protospacer adjacent motif (PAM) that is 
required for recognition by Cas9 proteins (Jinek et al., 2012; Cong et al., 2013). Selection of 
the sgRNA plays an important part in the editing efficiency of Cas9 and since the introduction 
of the CRISPR/Cas9 system, several studies have been performed to improve the efficiency of 
selected sgRNAs (Liang et al., 2017; Meier et al., 2017, Erard et al., 2017). The sgRNA 
guides the Cas9 protein to the target site to induce a double stranded DNA break that is then 
repaired by the DNA repair machinery using either homology-directed repair (HDR) or non-
homology directed repair (NHEJ) pathways (Glaser et al., 2016). The “knock-in” process of 
co-injecting a donor vector carrying different selection markers such as 3xP3-RFP with the 
guide RNA plasmid allow HDR pathway to take place and accelerates the screening process. 
On the other hand, the study of structure-function can also be performed using the NHEJ 








1.10 Characterising lncRNA functions in vivo: the pros, the cons and the challenges 
 
With the expansion in the number of lncRNAs discovered, it is tempting to believe 
that many of these play some important biological roles (Consortium et al., 2007; Lander et 
al., 2001). Indeed, lncRNAs have been suggested to carry out a plethora of biological 
functions in the cell and careful experimental dissection for each of this ncRNA is needed to 
differentiate them from transcriptional noise (Mattick, 2009). One of the concerns pertaining 
to the study of gene function in vivo is that it is much more time-consuming and therefore 
expensive to generate lncRNA mutants as compared to knocking them down or out in 
cultured cells. Although the function of several lncRNAs has been revealed by in vitro models 
(Bernard et al., 2010; Cabezas-Wallscheid et al., 2014; Zhang et al., 2009), there is limited 
genetic evidence to support their in vivo functions.  
 
Animal models with simple biological complexity such as Caenorhabditis elegans 
(nematode), Drosophila melanogaster (fruit fly), Danio rerio (zebrafish) have been widely 
used for genetic screens to understand biological processes and they are well suited for the 
physiological study of lncRNAs (Kapusta and Feschotte, 2014; Ulitsky, 2016). Gain-of-
function and loss-of-function genetic models are common strategies used to investigate the 
roles of protein-coding genes and have been employed to understand some of the lncRNAs 
discovered earlier such as Xist and AIRN (Marahrens et al., 1997; Sleutels et al., 2002). A 
small fraction of lncRNAs have been tested in a similar manner subsequently and many of 
them have been discovered to be dispensable (Zhang et al., 2012; Sommerkamp et al., 2019; 
Goudarzi et al., 2019; Schor et al., 2019). Despite the in vivo results observed, outcomes 
obtained can sometimes be inconsistent with cell-based studies and extra care must be taken 
to interpreting both positive and negative results (Bassett et al., 2014; Li and Chang, 2014; 
Boettcher and McManus, 2015). 
 
Functional studies have been widely conducted by attenuating or ablating the 
expression of a gene of interest. Each of these methods has its own advantage and drawback 
and thus a combination of approaches is required to validate the observed effect (Figure 11). 
Genetic tools can be used to target lncRNA transcripts at the RNA level such as the 
introduction of morpholinos or RNA interference (RNAi) or at the DNA level through the 
manipulation of lncRNA genomic loci (Wilk et al., 2016; Chen, 2016). To functionally 
characterize a lncRNA, an important point to note is that the combination of several methods 




rather than a single approach is required to fully characterise a lncRNA locus (Goff and Rinn, 
2015). 
 
shRNA, siRNA or dsRNA knockdown  
 
RNA-targeting techniques are frequently used to knockdown gene expression through 
the introduction of siRNA, shRNA or morpholinos (Guttman et al., 2011; Flynn et al., 2015; 
Goudarzi et al., 2019). RNA-targeting methods degrade the lncRNA transcript itself and 
allow the study of the functions mediated by the RNA. Tissue-specific suppression of 
lncRNA Gomafu/MIAT/Rncr2 in mouse models using shRNA has revealed a role of this 
lncRNA in the mediation of anxiety-like behaviour and the development of neuropsychiatric 
disorders (Rapicavoli et al., 2010; Spadaro et al., 2015;). Likewise, the use of shRNA-
mediated knockdown of lncRNA AT-rich interactive domain 2-IR (Arid2-IR) in mouse has 
unveiled a potential therapy target for renal inflammatory disease (Zhou et al., 2015; Yang et 
al., 2019). Besides mouse models, zebrafish is a well-known model for vertebrate studies and 
thousands of lncRNAs have been found to be expressed at various stages during its embryonic 
development. The injection of morpholinos antisense oligos (MO) into zebrafish is an 
alternative knockdown approach that is independent of the RNAi machinery (Ulitsky et al., 
2011; Goudarzi et al., 2019). These synthetic molecules target splice junctions or conserved 
regions and can be administer into zebrafish embryos when they are still at the one cell stage 
to knockdown lncRNA expression throughout development. Megamind and Cyrano are 2 
examples of lncRNAs whose function has been elucidated using MO. Attenuation of these 
lncRNAs has been shown to disrupt the nervous system development and affect proper 
embryonic development (Ulitsky et al., 2011; Lin et al., 2014).  
 
These use of RNA-targeting methods is not without limitations. The advantages of 
using RNAi is allowing the user to conditionally control gene expression in a temporal or 
spatial manner and also the ability to perform a high throughput screening of a list of 
lncRNAs to determine their physiological function. However, the relative ability of RNAi or 
antisense oligos to suppress a lncRNA target is dependent on its subcellular location. Many 
lncRNAs are found to be confined to the nucleus and some of them have been found to 
regulate gene expression in a cis-acting manner (Derrien et al., 2012; Lennox and Behlke, 
2016; Kopp and Mendell, 2018). Besides the potential off-target and toxicity effects in using 
both siRNA or shRNA, it remained a challenge to effectively knockdown lncRNAs that are 
chromatin associated or localised to the nucleus (Zeng and Cullen, 2002; Vickers et al., 




2003). As the RNAi machinery is located mainly in the cytoplasm, the general efficiency in 
depleting nuclear-retained lncRNAs is limited (Zong et al., 2015).  
 
Alternative methods that uses steric interfering RNA analogs such as locked nucleic 
acids (LNAs) and morpholino have been shown to target nuclear lncRNAs but these synthetic 
oligos cannot be encoded genetically and instead have to be injected or supplied externally 
(Ulitsky et al., 2011; Qu et al., 2016). Due to the mode of delivery, performing high-
throughput screening is possible with RNAi but not with these analogs. Another consideration 
for the use of both methods is its knockdown efficiency as sufficient levels of knockdown is 
required to repress the lncRNA transcript for a phenotypic effect to be observed (Atkinso et 
al., 2018). Furthermore, some studies have compared the use of gene editing methods and 
morpholino knockdowns in zebrafish. From the gene editing results, it is observed that a 
higher rate of non-specific phenotypes in found in morpholino knockdowns compared to 





DNA-targeting approaches that manipulate the genomic loci have been widely used to 
study lncRNA mutants in vivo.  One of the shortcomings for the use of RNA-based method is 
its inability to distinguish cis-acting from trans-acting lncRNAs and this issue can be 
circumvented with the deletion of the lncRNA itself (Figure 11). Gene deletion methods are 
strong proof of functionality, a lncRNA locus can be considered to be dispensable with the 
absence of an observable phenotype. However, caution should be placed when interpreting 
these results as an absence of overt phenotype does not necessarily dictate an absence of 
function. Transgenic mutants defective for a lncRNA of interest can be generated with the 
disruption at the germline level compared to RNA-targeting methods. In addition, the deletion 
of the whole lncRNA locus can be combined with other methods such as the introduction of a 
reporter gene for phenotypic investigation (Valenzuela et al., 2003; Chen et al., 2017). 
Replacement of the lncRNA with a fluorescence protein construct enables the expression 
profiling of the lncRNA of interest and have been used to study 18 mice lncRNAs (Sauvageau 
et al., 2013). LncRNA Peril, Mdgt, Pantr2 are some examples of lncRNAs which had their 
tissue expression patterns elucidated using KO models (Sauvageau et al., 2013).  
 




LncRNA MALAT1 and lncRNA C130071C03Rik/LINC00461 are examples of 
lncRNA knockouts that have been found to be more context-specific and important under 
certain physiological conditions and not required for normal development (Zhang et al., 2012; 
Nakagawa et al., 2012; Eißmann et al., 2012; Oliver et al., 2015). MALAT1 is a well-known 
lncRNA that is conserved, highly abundant and localises to the nuclear speckles (Tripathi et 
al., 2010). It was hypothesized that MALAT1 could possess critical biological functions for 
normal physiological development as it was observed that the lncRNA plays an important role 
in cell proliferation, cancer invasion and metastasis (Zhou et al., 2015; Yang et al., 2015; 
Arun et al., 2016). However, in three separate loss-of-function genetic studies, this ncRNA 
was surprisingly found to be dispensable for the viability of the animal. Furthermore, the 
dysregulation of MALAT1 in these knockout mice did not display any changes in splicing 
factor levels (Zhang et al., 2012; Nakagawa et al., 2012; Eißmann et al., 2012). Likewise, 
previous studies have indicated that lncRNA C130071C03Rik/LINC00461 contributes to cell 
proliferation and migration in glioma cells (Oliver et al., 2015). However, a lack of overt 
phenotype has been observed with the deletion of the genomic locus of this lncRNA (Oliver 
et al., 2015). Even though no obvious defects were observed in MALAT1 knockouts in normal 
physiological conditions, crossing of these KO mutants with the MMTV-PyMT human breast 
cancer mouse model led to a decrease in metastatic burden and suggested a role for lncRNAs 
during cellular responses to stress or disease conditions such as cancer progression (Arun et 
al., 2016; Kim et al., 2018; Wang et al., 2019).  
 
Integration of a premature polyadenylation cassette 
  
During the removal of a whole DNA locus, underlying regulatory elements close to 
the lncRNA genomic locus may contribute to the observed phenotype when they are deleted. 
Therefore, the use of multiple independent genetic models allows proper separation of the 
effects due to the loss of the lncRNA from effects due to the loss of underlying DNA 
elements (Bassett et al., 2014; Kopp and Mendell, 2018). The insertion of transcriptional 
terminators is an elegant approach that serves as a complementary method to whole gene 
ablation mutagenesis (Grote et al., 2013; Engreitz et al., 2016). LncRNA mutants with 
premature transcriptional termination can be generated by introducing multiple poly 
adenylation (poly-A) signals close to the 5’ end of the lncRNA locus (Sleutels et al., 2002; 
Bond et al., 2009). Using the Fendrr lncRNA as an example, both methods have been applied 
to the genomic locus of this ncRNA and a reduction in viability was observed in both 
instances (Grote et al., 2013; Sauvageau et al., 2013). However, when using the polyA 




termination method, an embryonic lethal phenotype was seen in the in vivo study performed 
by Grote et al., 2013 whereas a perinatal lethality was observed in mouse mutants generated 
by Sauvageau et al., 2013 that featured the deletion of the lncRNA genomic locus. Even 
though a similar phenotype was observed, the authors were able to distinguish between the 
DNA element from the RNA product itself. The lncRNA was found to be the functional 
element in this case as the phenotype for the Fendrr mutant was rescued using a transgene 
without its functional Foxf1 neighbour (Grote et al., 2013). The use of rescue experiments 
allows proper differentiation between effects caused by the loss of DNA elements and loss of 
the lncRNA itself. DNA fragments containing the lncRNA can be introduced back into the 
system by using bacterial artificial chromosomes (BACs) or cDNA transgenes or by injection 




The use of inversion is a method whereby the direction of transcription is changed and 
while retaining the DNA elements at the lncRNA genomic loci. It is a less commonly used 
methodology compared to the other two approaches mentioned above. Nonetheless, valuable 
information can be obtained with inversion of the promoter or whole lncRNA locus as 
exemplified by studies of the Drosophila bxd lncRNA.  As with RNA-targeting methods, 
there are caveats also with the use of DNA-targeting techniques. While deleting a large 
genomic region is direct and little or no residual transcript is left behind, the drawback with 
using this method is that it could generate phenotypes contributed by underlying DNA 
regulatory elements rather than due to the loss of the lncRNA itself, as discussed above. 
Neighbouring gene expression could be affected when specific domains or promoters 
embedded in the lncRNA locus are removed (Mancini-Dinardo et al., 2006; Mohammad et 
al., 2010; Sigova et al., 2013). Compared to the former method, the insertion of a premature 
termination sequence in the gene body is less disruptive and produces a reduced lncRNA 
expression. It should be noted that the efficiency of termination cassettes is dependent on the 
site of insertion and does not prevent the act of lncRNA transcription (Latos et al., 2012). 
Residual RNA expression can still be detected and may contribute to a different phenotype 
obtained. In addition, there is also a risk of modification to the spacing of underlying DNA 
elements which could have an effect on neighbouring gene expression.  
 
The preceding experimental methodologies have demonstrated that there are many 
challenges when studying lncRNA function in vivo and it is more complex and difficult than 
that of protein‐coding genes. Manipulation of lncRNA expression requires a good 




understanding of the lncRNA genomic locus itself as well as its neighbouring genes. The 
absence of an observable phenotype does not necessarily equate to redundancy as shown in 
the examples above. In addition, the latent phenotypes displayed by lncRNAs such as 
MALAT1 and C130071C03Rik/LINC00461 highlight the importance of gene-environment 
interactions (Arun et al., 2016; Kim et al., 2018; Wang et al., 2019).  
 
 
Figure 11: A schematic of genetic strategies to evaluate lncRNA functions in vivo. 
The lncRNA locus is indicated in orange, neighbouring protein-coding gene in dark blue, transcription 
start sites are indicated by the direction of the arrows, the process of transcription by orange and grey 
dotted lines. RNAi is carried out using sh/siRNA sequences that bind to Argonaute proteins (Ago2, 
purple oval) within the cell and target lncRNA transcripts that are found in the cytoplasm for 
degradation. The deletion of the full-length lncRNA locus or its transcriptional start site sequences can 
be achieved using homologous recombination. This method can be combined with a reporter gene to 
create lncRNA null mutants and at the same time reveal in vivo expression patterns. The expression of 
the lncRNA of interest can be suppressed through the inversion of the lncRNA itself or its promoter 
sequence. Lastly, the insertion of a strong transcriptional stop signal, such as SV40 polyadenylation 
(polyA) signal or the chicken β-globin polyA signal, close to the start of the transcript unit allows 
early termination of the transcription. However, this method does not prevent the act of transcription 
and the ability to generate loss-of-function mutation is highly dependent on the genomic site.  









1.11 Aim of the thesis 
 
RNAs are not simply intermediate products of gene expression but play pivotal roles 
in many biological processes. The transcription machinery is pervasive throughout the 
genome of various organisms, generating a plethora of RNA transcripts. Non-coding RNAs 
have been shown to be key regulators of a range of biological processes relevant to 
development and disease. An increasing number of studies have described the involvement of 
lncRNAs in numerous processes such as epigenetic, transcriptional and post-transcriptional 
regulation. Little is known about the function of lncRNAs in Drosophila and how these 
lncRNAs are classified. The fruit fly was chosen as a model to study the molecular phenotype 
of the lncRNAs due to its unmatched flexibility for genetic manipulation. The stages of 
embryonic development are very well characterized and make an excellent model for studies 
of the roles of lncRNAs. 
 
One of the many challenges faced in lncRNA studies is to resolve the issue of 
functionality of lncRNAs during animal development. The first aim of the project was to 
investigate the organismal functions of a limited set of lncRNAs through targeted disruption 
of their genomic loci. My approach was to first curate a list of conserved lncRNAs that show 
expression during Drosophila embryogenesis as observed from high-throughput sequencing 
data generated using the RAMPAGE (RNA Annotation and Mapping of Promoters for the 
Analysis of Gene Expression) method. In order to systematically screen for functional 
lncRNAs, this study generated a catalogue of lncRNA mutants, using state-of-the-art genetic 
engineering technologies such as CRISPR/Cas9. A phenotypic analysis was subsequently 
performed to investigate the effects of lncRNA loss on the development and survival of 
Drosophila (chapter 3).  LncRNA mutants that display overt phenotypes were further 
characterised in the following chapter. 
 
The second part of the thesis is focused on the characterisation of one of the lncRNA 
mutants during embryogenesis (chapter 4). In this chapter, I made use of single-molecule 
fluorescent in situ hybridization (smFISH) to determine the cellular and intracellular 
localization of this lncRNA. This is followed by comparative RNA-Seq experiments between 
lncRNA mutants and wild-type flies to understand the specific targets of this lncRNA for 
further systematic studies. LncRNA-9 is required at stage 16/17 as the GO analysis suggests 
that it affects the expression of downstream genes in neuronal pathway associated with 





Chapter 2 | 
Materials and methods 
 
2.1 Drosophila melanogaster work 
 
2.1.1 Drosophila Stocks 
 
A list of Drosophila melanogaster strains used for genetic crosses or transgenesis in 
this study are listed in Tables 1, 2.1 and 2.2. Most fly stocks were obtained from the Vienna 
Drosophila Resource Center (VDRC) or the Bloomington Drosophila stock centre (Indiana 
University, Bloomington, USA). The Cas9 strains used were provided by the fly facility at the 
Department of Genetics, University of Cambridge. 
 
2.1.2 Drosophila husbandry 
 
All fly strains were maintained in standard fly food (cornmeal) that was purchased 
from the Department of Genetics, University of Cambridge. Egg production was stimulated 
through yeast (Red Star Active Dry Yeast) supplementation. Fly stocks were kept at either 18 
ºC or 25 ºC at a 12 hr:12 hr light: dark cycle with 65 % - 70 % humidity.  
 
2.1.3 Fly crosses 
 
Males and virgin female flies were collected every 6 hrs after eclosion and were kept 
in separate vials. Depending on the nature of the cross, each vial generally contained around 
10-20 flies and each bottle contained around 150-200 flies. For the crosses to be maintained 
for a longer period, the flies were flipped into a new vial with food and fresh yeast every 4 
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2.1.4 Embryo microinjections and transgenesis 
 
Microinjection into Drosophila embryos was carried out according to standard 
protocol by the University of Cambridge Department of Genetics Fly Facility. All plasmids 
used were purified using QIAGEN’s Midi Plasmid purification kit (QIAGEN) and eluted in 
nuclease-free water (Thermofisher Scientific). The concentration of each plasmid was 
measured using a NanoDrop Spectrophotometer (Thermofisher Scientific) and the DNA 
samples had an OD260/280 ratio of 1.80-1.90. To generate transgenic lncRNA knockout 
lines, plasmid pools containing the donor construct and dual gRNA expression vector for each 
lncRNA were combined at a ratio of 2:1 respectively (Table 3 and 4). The plasmids were 
injected into TH_attp2 or vas-Cas9.RFP- (Bloomington Stock BL #55821) embryos and the 
RFP+ marker encoded by the donor plasmid was used to identify transgenic offspring. The 
offspring were subsequently balanced with respective balancer lines based on the genomic 
location of the lncRNA. To test whether the cassette was inserted into the appropriate locus of 
interest, the region flanking the deletion was amplified by PCR and sequenced for 
verification. For the flies with the SV40 polyA insertion, PCR was used to validate the 
insertion. 
 
2.1.5 Drosophila embryo staging and collection 
 
Agar plates containing apple juice hardened with agar were produced by the Department of 
Genetics, University of Cambridge and were used for embryo collection. To obtain 
developmentally staged embryos, ~200-300 adult flies (~4-5 days old) were transferred to a 
large embryo population cage (Flystuff #59-101) featuring a 90 mm apple juice agar plate 
containing ample amount of yeast paste. Prior to the actual collection, the flies were 
accustomed to the cage and transferred to new cages every day with fresh apple juice agar 
plates containing yeast paste. The apple juice plates were changed twice a day for two days. 
Embryo collections were performed after 2 x 1 hr pre-lays in the morning. Depending on the 
developmental stage required, the agar plates containing the embryos were incubated in the 
same incubator to allow embryogenesis to continue (0 – 24 hrs). The embryos were harvested 
using a paintbrush and rinsed in a 40 μM EASYstrainer (Greiner Bo-One) with deionised 
water. For the control, wildtype fly embryos were collected from a different cage from the 
lncRNA mutants. Each of the lncRNA mutant was crossed to a fluorescence balancer which 
allows stable populations of mutants to be maintained as balanced heterozygotes. The 
balancer chromosomes expressing the yellow fluorescent protein (YFP) allowed easy 
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identification, scoring and collection of live embryos with specific genotypes (Le et al., 
2006). The YFP signal can be detected from heterozygotes during embryonic development 
and this in turn allows us to differentiate the homozygous null mutants from the heterozygous 
siblings.   
 
2.2 Molecular Biology Work 
 
2.2.1 Polymerase Chain Reaction (PCR) 
 
All PCR reactions were performed using KOD Hot start DNA Polymerase (Merck 
Millipore). A typical PCR reaction mix consist of 5 μL 10X buffer, 5 μL dNTP solution (2 
mM), 5 μL DMSO, 3 μL primer mix (10 μM), 3 μL MgSO4 (25 μM), 1 μL KOD Hot Start 
DNA polymerase, 1-2 μL template DNA (1-100 ng/μL), and topped up to 50 μL with 
nuclease-free water (Thermofisher Scientific). The amount of DNA that was used for each 
PCR reaction varied depending on the template: ~10 ng of plasmid DNA or ~100 ng of 
genomic DNA was used for each PCR reaction. PCR reaction conditions were according to 
the manufacturer’s instructions (Table 5). PCR products were analysed using a 1-2 % agarose 
gel (Invitrogen).  
 
2.2.2 Primer design 
 
Primers were designed using the Primer3web (version 4.0.0) online software. Standard 
DNA oligos were ordered and produced by Integrated DNA Technologies 
(https://eu.idtdna.com/site) or Sigma Aldrich (https://www.sigmaaldrich.com/life-
science/custom-oligos.html). The genomic sequences used for primer design was obtained 
from the University of California, Santa Cruz (UCSC) Genome Browser (BDGP Release 
5/dm3 assembly or BDGP Release 6 + ISO1 MT/dm6 assembly). The oligonucleotides were 
delivered as a lyophilised pellet and resuspended resuspended in nuclease-free water 
(Thermofisher Scientific) to make a stock solution of 100 μM. Oligonucleotides were stored 
at -20 ºC. A full list of oligonucleotides can be found in Tables 3, 4, 6 and 7. 
 
2.2.3 High-quality genomic DNA extraction for molecular cloning 
 
Genomic DNA was extracted from Drosophila melanogaster using the ZYMO (ZR) 
Research Tissue and Insect DNA Midiprep kit (Zymo Research). Approximately 300 flies 
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were snap frozen with liquid nitrogen and ground into a fine powder using a sterile mortar and 
pestle. The powder was transferred to a 15 mL falcon tube and mixed with 6 mL of Genomic 
lysis buffer containing 0.5% ß-mercaptoethanol. The suspension was mixed gently and 
transferred to a ZR Bashingbead Lysis/filtration tube. The suspension was manually shaken 
by hand for 3 mins before it was centrifuged at 4,000 × g for 5 mins. The lysate was filtered 
using a Zymo-Spin V-E column/Zymo-Midi Filter assembly fixed on a QIAvac vacuum 
manifold (QIAGEN) and the column containing the genomic DNA was transferred to a 2 mL 
collection tube and spun at 10,000 × g for 1 min. The flow through was discarded and 300 µL 
of DNA Pre-Wash Buffer was added to the column and spun for 1 min at 10,000 × g. The 
column was washed with 400 µL of DNA wash buffer and centrifuged twice at 10,000 × g for 
1 min before it was transferred to a sterile 1.5 mL tube. Genomic DNA was eluted from the 
column by adding 150 mL of nuclease-free water (Thermofisher Scientific) and centrifuged 
for 1 min at 10,000 × g. DNA quantity and quality was assessed using a NanoDrop 
Spectrophotometer (Thermofisher Scientific). DNA was stored at -20 °C until further use.  
 
2.2.4 Preparation of genomic DNA for genotyping 
 
A separate protocol was used for fly genotyping. Single fly genomic DNA extraction 
was performed according to a protocol obtained from Dr. Yawen Chen in Dr. Stephen 
Cohen’s Lab (IMCB, Astar Singapore). In brief, a single fly was placed in a 1.5 mL 
Eppendorf tube and frozen at -20 °C for at least 5 min or until processing. 50 µL of chilled 
Squishing buffer (10mM Tris-Cl pH 8.0, 1 mM EDTA, 25mM NaCl) was added to the 
Eppendorf tube with 1 µL of proteinase K (Thermofisher Scientific). The fly was ground 
against the tube wall using a nuclease-free pestle (VWR) and subsequently placed on a heat 
block for 45 min at 37 °C to allow protein digestion by the proteinase K. This was followed 
by heat-inactivation of the enzyme at 95 °C for 5. The sample was centrifuged at 14,000 × g 
for 10 min and the supernatant containing the genomic DNA was transferred to a fresh 
Eppendorf tube and stored at 4 °C for up to one week.  
 
2.2.5 Agarose Gel Electrophoresis 
 
Agarose gel electrophoresis was used to separate DNA fragments by their sizes. 
Samples were mixed with 6 x purple loading dye (NEB) and the sizes of the fragments were 
compared to a Quick-Load® 100bp or 1 kb DNA Ladder (NEB). Agarose gels were cast with 
an appropriate amount (~0.5 µg/mL) of Ethidium Bromide solution (Invitrogen). The samples 
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were loaded into the gel and separated in 1x TAE buffer at 10V per cm gel length. DNA 
fragments were visualized by UV-light using a Bio-doc-it imaging system (UVP). 
 
2.2.6 Purification of DNA with QIAquick gel extraction kit 
 
DNA fragments from agarose gel slices were purified using the Qiaquick gel 
extraction kit (QIAGEN) according to the manufacturer’s protocol. All centrifugation steps 
were performed at 17,900 x g for 1 min. In brief, gel slices were obtained under Visi-blue 
Trans-illuminator (UVP) and mixed with 3 volumes of Buffer QG per volume of gel. The 
samples were incubated at 50 °C for 10 min to allow for gel dissolving and then loaded onto a 
QIAquick column.  The column was washed once with 500 μL of Buffer QG. The column 
was washed four times with 750 μL of Buffer PE. Residual ethanol was removed by an 
additional minute of centrifugation and the columns were transferred to a fresh 1.5 mL 
microcentrifuge tube. DNA was eluted using 30 μL of nuclease-free water (Thermofisher 
Scientific).  
 
2.2.7 Purification of DNA with MinElute PCR purification kit 
 
All centrifugation steps were performed at 17,900 x g for 1 min. 5 volumes of Buffer 
PB were added to 1 volume of PCR reaction and 10 μL of 3M sodium acetate at pH 4.8 
(prepared by the media kitchen at the institute) was subsequently added. The sample was 
applied to a QIAquick column and centrifuged. The flow-through was discarded and the 
column washed with 750 μl of Buffer PE and then centrifuged for 1 min. The washing step 
was repeated three times. The flow-through was discarded and the column centrifuged again 
to remove trace ethanol. DNA was eluted by addition of 30-50 μl nuclease-free water 
(Thermofisher Scientific), followed by centrifugation for 1 min. 
 
2.2.8 Nucleic acids quantification 
 
The purity and concentration of DNA and RNA samples were assessed using a 
Nanodrop 1000 Spectrophotometer (Thermofisher Scientific). Purity of each sample was 
determined by the ratio of OD260:OD280. The acceptable readings for DNA samples 
was >1.8 and >2.0 for RNA samples. For a more accurate measurement of the concentration, 
the Qubit 3.0 Fluorometer (Thermofisher Scientific) was used for preparing libraries.  
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2.2.9 Sanger Sequencing 
 
Sanger sequencing was carried out by GATC/Eurofins Genomics. Sequencing primers 
were designed according to the company’s recommendations and only the template DNA and 
the sequencing primer were sent to the sequencing facility. The results (‘.seq‘ and ‘.ab1‘ files) 
were analysed using an online software (www.benchling.com). 
 
2.2.10 Quantification of expression levels by qRT-PCR 
 
Quantitative PCR (qPCR) experiments were performed on a QuantStudio Real-Time 
PCR Light Cycler (Thermo Fisher Scientific). RNA levels were quantified using the ∆∆CT 
method (Livak and Schmittgen, 2001), normalized to Act5C and fold changes were calculated 
relative to the indicated controls. The primers used for qPCR can be found in Table 7.  
 
2.3 Molecular Cloning 
 
2.3.1 Digestion with restriction enzymes 
 
Restriction enzymes were purchased from New England Biolabs (NEB). The NEB 
Double Digest Finder tool (http://www.neb.com/nebecomm/DoubleDigestCalculator.asp) was 
used to identify suitable buffers when two restriction enzymes were required. Restriction 
digests were carried out for 2-4 hours at the optimal reaction temperature (usually 37 °C).  
Each restriction enzyme reaction mix consists of 5 μL of 10x reaction buffer, 1 μL of DNA 
template (~1µg/μl), 1 μl of each restriction enzyme and topped up to 50 μL with nuclease-free 
water (Thermofisher Scientific). Plasmid digests were subsequently incubated with Alkaline 
Phosphatase, Calf Intestinal (CIP, NEB) for 0.5 hrs at 37 °C prior to separation on an agarose 
gel.  
 
2.3.2 Construction of dual gRNAs targeting vectors 
 
Dual guide RNAs (gRNA) were assembled and cloned into pCDF4 (Addgene #49411) 
(Port et al., 2014).  A pair of target specific sequence (sgRNA) were designed using the 
online CRISPR design tool (http://www.flyrnai.org/crispr/) for each target site. Only guides 
without off-targets were chosen. Using pCDF4 as the template, PCR products corresponding 
to each dual guide RNA were generated with KOD Hot Start DNA polymerase (Merck 
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Millipore) and purified with MinElute PCR purification kit (QIAGEN). The pCDF4 vector 
was digested with BbsI-HF (NEB) restriction enzyme and dephosphorylated with CIP (NEB) 
before gel purification. Cloning procedures were performed using 2x Gibson/HiFi Assembly 
Master Mix (NEB). The ligated product was transformed into One Shot TOP10 Chemically 
Competent bacteria (Invitrogen). To identify correct plasmids, the insert was screened by 
PCR using primers pCDF4_fwd and pCFD4_rev, and positive plasmids were subsequently 
verified by Sanger sequencing (GATC/Eurofin). Bacteria culture containing plasmids with the 
desired insert were used as starter culture for large-scale plasmid DNA isolation using 
QIAGEN Plasmid Midi/Maxiprep kit (QIAGEN). 
 
2.3.3 Donor Vector Construct for HDR at each locus 
 
CRISPR/Cas9 combined with homology directed repair (HDR) templates were used to 
create specific mutations or insertions. The donor vector contained a 3xP3-driven RFP marker 
to allow detection of a successful integration event. The pBluescript II KS (+/–) vector 
backbone and a plasmid containing the 3xP3-RFP-αtub-3′UTR sequence were gifts from Drs. 
Fillip Port & Simon Bullock (LMB Cambridge). A pair of homology arms (~1-1.2 kb each) 
flanking the predicted double-strand break was generated from fly genomic DNA by PCR. 
The pBluescript II KS (+/–) vector, the backbone for the construct, was digested with HindIII-
HF (NEB) and NotI-HF (NEB) restriction enzymes and dephosphorylated with CIP (NEB). A 
pair of PCR primers (3xP3-RFP_fwd and 3xP3-RFP_rev) was used to amplify the 3xP3-RFP-
αtub-3′UTR fragment from the template plasmid. The PCR products were loaded onto a 1 % 
agarose gel and the DNA was extracted using a Qiaquick gel extraction kit (QIAGEN). 
NEBuilder HiFi DNA Assembly Master Mix (NEB) was used to assemble the four fragments 
into the final donor construct in a one-step reaction. A similar protocol was used to generate 
donor constructs with the transcriptional stop signal of Simian vacuolating virus 40 (SV40) 
instead of the 3xP3-RFP-αtub-3′UTR sequence. 
 
2.3.4 Cloning of single guide RNAs into the pCDF3 expression vector 
 
A single gRNA (sgRNA) for the various lncRNAs was designed using the online 
CRISPR design tool (http://www.flyrnai.org/crispr/). The guide RNAs were assembled into a 
pCDF3 (Addgene #49410) expression vector as previously described (Port et al., 2014). 
Briefly, the pCDF3 plasmid was cut with BbsI-HF (NEB) and purified using Qiaquick gel 
extraction kit (QIAGEN). A pair of oligonucleotides containing the sgRNA sequence was 
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phosphorylated using T4 PNK (NEB) and annealed. The phosphorylated, annealed fragment 
was ligated into the digested pCDF3 vector using T4 DNA ligase. The final construct was 
verified by restriction enzyme digestion and sequencing using pCDF3_seq_fwd and 
pCDF3_seq_rev primers. 
 
2.3.5 Gibson/HiFi DNA assembly reaction 
 
Gibson DNA assembly mix (NEB, 2x) and HiFi DNA assembly mix (NEB, 2x) were 
used to assemble multiple fragments into a vector. The reaction mixture consists of a 
mesophilic exonuclease, a thermophilic ligase and a high-fidelity polymerase, allowing for 
the rapid assembly of DNA fragments. A 2-3 factor excess of insert was used for every 50 ng 
of vector added.  The assembly reaction was carried out at 50 °C for 1 hr and stored on ice 
before transformation into competent cells.  
 
2.3.6 T4 PNK and T4 DNA ligation reaction 
 
DNA ligation was used to assemble oligonucleotides containing a single sgRNA into a 
pCDF3 vector. A pair of oligonucleotides was annealed and phosphorylated in a reaction mix 
consisting of 1 µL of 100 µM oligonucleotide 1, 1 µL of 100 µM oligonucleotide 2, 1 µL of 
10x T4 Ligation Buffer (NEB), 0.5 µL of T4 PNK (NEB) and 6.5 μL of nuclease-free water 
(Thermofisher Scientific). The samples were incubated in a thermocycler for 30 min at 37 °C, 
95 °C for 5 min and then the thermocycler was set to cool down to 25 °C at 5 °C/min. The 
DNA fragment was ligated into a cut vector using T4 ligase. The ligation reaction consists of 
1.5 µL 10 x T4 Ligation Buffer (NEB), 1 µL diluted fragment from the previous reaction 
(1:200 dilution), 1 µL of digested vector (50 ng/µL) , 1 µL of T4 DNA ligase (NEB) and 
topped up to 15 µL with nuclease-free water (Thermofisher Scientific). The ligation reaction 
was carried out at 16 °C overnight and transformed into One Shot TOP10 Chemically 
Competent bacteria (Invitrogen).  
 
2.3.7 Transformation of commercial Endura electro-competent E. coli 
 
Endura electro-competent cells were purchased from Lucigen and stored at -80 °C. 
The DNA assembly reaction was diluted 5 times and 1 μL was added to 20 μL of Endura 
Electro-competent cells. The mixture was pulsed with Bio-Rad Gene Pulser II (#165- 2105) in 
chilled 0.1 cm electroporation cuvettes (Bio-Rad). 980 μl of recovery media was added to 
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each cuvette and mixed with the pulsed cells. The cells were recovered at 37 °C for in a 
incubator for 1 hr with shaking at 225 rpm. 100 μL of reaction mix from each transformation 
was spread on a pre-warmed Lysogeny broth agar plate with appropriate antibiotics using 
plating pearls (Merck Millipore). The plates were incubated over night at 37 °C. 
 
2.3.8 Transformation of commercial Chemically Competent bacteria 
 
One Shot TOP10 Chemically Competent cells were purchased from Invitrogen and 
stored at -80 °C. The DNA ligation mixture was diluted 5 times and 1 μL was added to 25 μL 
of chemically competent cells. The vial was incubated on ice for 30 min, heat shocked at 42 
°C for 30 sec and incubated again on ice for 2 min. 200 µL of pre-warmed SOC media was 
added and placed in a incubator for 1 hr with shaking at 225 rpm to allow the cells to recover.  
The culture was diluted 1:100 and 100 µL of diluted culture were spread on LB plates 
(prepared by the media kitchen at the institute) containing appropriate amounts of antibiotic. 
The LB plates were incubated at 37 °C overnight. 
 
2.3.9 Plasmid DNA purification with the QIAprep Spin Miniprep Kit 
 
A single colony was inoculated in 5 mL LB medium containing the appropriate 
antibiotic and incubated in a shaker incubator overnight at 37 °C. 2 mL of culture were 
pelleted by centrifugation at 6,800 x g for 5 min. The supernatant was discarded and the cells 
were thoroughly resuspended in 250 μL Buffer P1. Cell lysis was induced by adding 250 μL 
Buffer P2. After incubation for 3 min, 350 μL Buffer P3 were added and the reaction mix was 
centrifuged at 17,900 x g for 15 min to pellet cell debris and proteins. The cleared lysate was 
transferred into a QIAprep spin column and centrifuged at 17,900 x g for 1 min. 500 μL 
Buffer PB were added, followed by centrifugation at 17,900 x g for 1 min. The column was 
washed twice with 750 μL Buffer PE with centrifugation at 17,900 x g for 1 min between 
each wash. In order to remove residual ethanol, the column was centrifuged for an additional 
2 min at 17,900 x g before it was transferred to a sterile 1.5 mL microcentrifuge tube. 50 μL 
pre-heated water were applied to the column and following incubation for 2 min at room 
temperature, DNA was eluted by centrifugation at 17,900 x g for 1 min. A Nanodrop 1000 
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2.3.10 High yield plasmid isolation with the QIAGEN Plasmid Plus Midi Kit 
 
Large amounts of plasmid DNA were isolated from E.coli using the QIAGEN Plasmid 
Plus Midi Kit (QIAGEN) and the protocol provided. In brief, 350 μL of bacteria culture from 
the miniprep culture was inoculated into 350 mL of fresh LB medium containing the 
appropriate antibiotic and the culture was incubated in a shaker incubator overnight at 37 °C. 
Bacteria were pelleted by centrifugation at 4,000 rpm for 20 min at 4 °C. The pellet was 
thoroughly resuspended with 4 mL of Buffer P1 and lysis was induced with the addition of 4 
mL Buffer P2. The reaction mix was incubated for 3 min at room temperature. 4 mL Buffer 
P3 was added to stop the lysis reaction and the sample was centrifuged at 4,000 rpm for 5 min 
at 4°C. The clear lysate was filtered through a QIAfilter Cartridge and 2 mL of Buffer BB 
was mixed with the filtered lysate. The mixture was transferred to a QIAGEN Plasmid Plus 
spin column on the QIAvac 24 Plus. The column was subjected to ~300 mbar vacuum until 
all the liquid was removed. The column was first washed with 700 μL of Buffer ETR 
followed by two washes with Buffer PE. Residual ethanol was removed by centrifugation at 
10,000 x g for 2 min. 200 μL preheated water was applied to the column and after incubation 
for 2 min at room temperature, DNA elution was performed in a clean 1.5 mL Eppendorf tube 
by centrifuging at 10,000 x g for 1 min. The concentration and purity of the plasmid was 
assessed using Nanodrop 1000 Spectrophotometer (Thermofisher Scientific). 
 
2.4 RNA-related experiments 
 
2.4.1 Tissue lysis for RNA extraction 
 
For each replicate, 100-200 embryos were collected and placed in a 1.5 mL Eppendorf 
tube containing 1 mL of chilled PBS. The embryos were centrifuged at 5,000 × g for 5 min at 
4 ºC and washed with 1 mL of chilled PBS for two additional times. The tissue was 
homogenized in 50 µL of TRIzol Reagent (Invitrogen) for 1 min using a disposable RNase-
free polypropylene pellet pestle and pestle motor mixer. An additional 100 µL of TRIzol 
Reagent was added to the lysate and, after grinding the sample by hand for 1 min, 850 µL of 
TRIzol Reagent were added and the tube was incubated at room temperature for 5 min before 
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2.4.2 RNA extraction and purification 
 
Prior to all RNA work, the work area and pipettes were cleaned with RNase Zap 
(Sigma) to reduce the risk of RNase contamination. The samples were thawed on ice and 
centrifuged for 1 min at 12,000 × g before transferring them to a pre-spun 5PRIME Phase 
Lock Gel-Heavy tube (Quantabio). The lysate was incubated with the gel for 5 min at room 
temperature before adding 200 µL of chloroform to the tube and shaken vigorously for 30 sec. 
The samples were incubated for 3 min at room temperature and centrifuged at 12,000 × g for 
15 min at 4 ºC. The upper phase was transferred to a new RNase-free tube containing an equal 
amount of RNase-free ethanol. The RNA was subsequently purified using the RNeasy Mini 
kit (QIAGEN) according to the manufacturer’s protocol. Briefly, the sample was loaded onto 
a RNeasy column and spun at 10,000 × g for 30 sec. Buffer RW1 was added to the RNeasy 
spin column and centrifuged for 30 s at 10,000 × g. DNase I pre-mix containing 70 µL of 
Buffer RDD and 10 µL DNase I stock solution (QIAGEN) was added to the centre of the 
membrane and incubated for 15 min at room temperature.  The spin column was loaded with 
Buffer RW1 and centrifuged for 30 s at 10,000 × g. Buffer RPE containing ethanol was used 
to wash the membrane and centrifuged at 10,000 × g for 1 min for two times. The column was 
transferred to a new 2.0 mL collection tube and spun at 10,000 × g for 2 min to remove excess 
ethanol. To elute the RNA, the spin column was transferred to a new 1.5 mL Eppendorf tube 
and 30 µL of nuclease-free water (Thermofisher Scientific) were added to the membrane to 
elute the RNA. Quantification of the RNA sample was performed using Qubit RNA BR 
(Broad-Range) Assay Kit (Thermofisher Scientific) and Qubit 3.0 Fluorometer (Thermofisher 
Scientific). The quality of the total RNA was analysed on the Agilent 4200 TapeStation 
system using the RNA ScreenTape assay (Agilent). 
 
2.4.3 RNA sequencing (RNA-seq) library production 
 
The RNA-seq libraries were prepared using the NEBNext Ultra II Directional RNA 
Library Prep kit for Illumina (NEB) and NEBnext Poly(A) mRNA magnetic isolation module 
(NEB) according to manufacturer’s protocol. Embryos from the control strain were collected 
at hourly intervals after egg laying (AEL) from 4 to 24 hrs. The mutant fly strain for the 
lncRNA mutant strain was crossed to a fluorescence balancer which is an important element 
for our experiment. The homozygous null mutant does not carry the balancer and will not 
express the fluorescence protein. On the other hand, a fluorescence signal can be detected in 
the heterozygous flies due to the expression of the YFP protein on one of the the balancer 
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chromosome.  The mutant embryos were collected from 10 to 24 hrs by manually sorting 
these from the heterozygote YFP+ embryos (the balancer produces YFP protein in embryos). 
For each timepoint, the samples were collected in replicates of two. Total RNA was extracted 
from these two groups of embryos using the RNeasy Mini kit (QIAGEN) with DNase I 
(section 2.3.13) and kept at -80 ºC. For the library preparation, all the reactions were 
performed on ice unless otherwise stated. The Agencourt RNAClean XP system (Beckman 
Coulter) was used instead of the NEBNext Sample Purification Beads. The first part of the 
library preparation was aimed to enrich for polyA+ mRNAs and convert them to cDNA 
products. This means that any putative non-polyA targets will be missed in this RNAseq.  
Using 0.5 µg of total RNA as starting material, mRNA transcripts were isolated using oligo-
dT-attached magnetic beads and fragmented to ~200 bp RNA inserts using divalent cations in 
the NEBNext First Strand Synthesis Reaction Buffer (5X) at 94 ºC for 15 min. The first 
strand cDNA synthesis reaction mix also contains NEBNext random hexamer primers and M-
MuLV Reverse Transcriptase (RNase H-) to assemble the first stand cDNA. In the second 
cDNA synthesis reaction, NEBNext second strand synthesis reaction buffer containing dUTP, 
DNA Polymerase I and RNase H was added to the first strand synthesis product. The cDNA 
was purified and stored at -20 ºC until the next step. The DNA fragments with overhangs 
undergo a process of blunting followed by DNA dA-tailing so as to prepare them for ligation 
with NEBNext adaptors. The DNA fragments were then purified using the AMPure XP 
system and incubated with the USER Enzyme (NEB) supplied at 37 °C for 15 min followed 
by 95 °C for 5 min. To enrich for adaptor ligated DNA products, PCR was performed with 
Universal PCR primers, Index (X) Primer and NEBNext Ultra II Q5 Master Mix that contains 
Q5 High Fidelity DNA Polymerase. The PCR reaction was carried out according to the 
manufacturer’s protocol and the PCR products were purified with AMPure XP system. The 
library was eluted in 20 µL of 0.1X TE (NEB) and stored at -20 °C. The library quality was 
assessed on the Agilent 4200 TapeStation system using the DNA ScreenTape assay (Agilent). 
The samples were quantified using the KAPA Library Quantification kit (KAPA Biosystems) 
and the pooled library was sequenced on a Hiseq 4000 at a mean depth of 30 million reads 
and 50bp single-end reads per sample. The RNA-seq run was performed by the CRUK 
Cambridge Institute genomics core facility.  
 
2.5 Test of survival to adulthood 
 
Heterozygous mutant stocks for each lncRNA were assessed for their viability. Before 
the assay was carried out, males and virgin females were collected in separate vials three days 
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earlier (section 2.1.3). After setting up a cross with heterozygous parents, the vials were kept 
at 25 ºC and the parents were transferred to a new vial after 24 hr for 2 more times. The 
progeny from each of the crosses was allowed to develop further and hatching adult flies from 
each of the three vials were counted after 14 days. 
 
2.6 Embryo, Larval and Pupal Survival test 
 
Wildtype, heterozygous and homozygous embryos were collected according to the 
method stated in section 2.1.5. Homozygous mutant progenies were identified by the absence 
of fluorescence expression from the balancer. The flies used as the control was collected from 
a different cage containing wildtype flies. A 4-hr collection window was used to collect large 
quantities of embryos. Apple juice plates containing the embryos were placed in the 25 ºC 
incubator and allowed to develop for another 12 hrs (12 hr -16 hr). For each genotype, 
embryos were transferred to 6 x 48-well plates containing cornmeal in each well. The plates 
were placed in the incubator for another 24 hrs and the number of first instar larvae that 
hatched were counted and transferred to a standard fly vial containing cornmeal. To determine 
the number of larvae that complete larval development and undergo pupation, the vial was 
kept in the 25 ºC incubator for another eight days and the number of larvae that became pupae 
were counted. To determine the number of pupae that completed pupation and hatched into 
adult flies, the vials were incubated for another 8 days and the emerging adults flies were 
counted.  
 
2.7 Test of Fertility 
 
The test of fertility (Yawen et al., 2014) was used to differentiate the homozygous 
mutants into 3 categories: sterile (no progeny), low fertility (<10 larvae/vial) or fertile (≥10 
larvae/vial). Using the observations from the viability test, the fertility test was only 
performed for lncRNAs that were viable as homozygous mutants. For each cross, a single fly 
mating strategy was used. In each vial, a single homozygous mutant male was mated with a 
single w1118 virgin female and vice versa. 10 crosses (5 mutant males and 5 mutant females) 
were set up for each lncRNA mutant. The parents were removed after 5 days and the number 
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2.8 Measurement of larval behaviour with a simple locomotion assay 
 
A modified locomotion assay (Nichols et al., 2012) was used to determine if the larvae 
showed any neuromuscular defects due to the lncRNA deletion.  A 100 mm apple juice agar 
plate was used as the platform for the test. For each experiment, 50 first instar larvae were 
collected and arranged in one end of the plate that contained yeast paste on the other end. The 
number of larvae that moved toward the yeast was scored following 30 mins. The experiment 
was performed in five replicates. For each genotype, control larvae, heterozygous and 
homozygous lncRNA mutant larvae were used.  
 
2.9 RNA fluorescence in situ hybridization (RNA-FISH) and immunohistochemistry 
 
2.9.1 RNA-FISH probe synthesis 
 
The reagents, nucleic acid probes and hairpin sequences used in this study were 
obtained from Molecular Instruments, Inc (www.molecularinstruments.org) and Advance Cell 
Diagnostics (ACD). The sequence of lncRNA-3 and lncRNA-9 were provided and probes 
were designed and synthesized by the companies.  
 
2.9.2 Embryo dechorionation and fixation 
 
Embryos of the appropriate stages were used for smFISH and IF (section 2.1.5). 
Embryos were placed in a 40 μM EASYstrainer (Greiner Bo-One, Austria) and rinsed gently 
with water to remove excess yeast. The embryos were then dechorionated by immersing the 
mesh in a solution of diluted bleach (50%) and shaken gently for 3 minutes. The embryos 
were washed with PBST (0.1 % Tween 20) to remove the remaining bleach solution and 
transferred to a 20 mL scintillation glass vial containing 8 mL of 4.5 % formaldehyde fixation 
solution (4.5 % formaldehyde, 0.5 x PBS, 25mM EGTA, 50% Heptane). The vial was rotated 
gently for 25-30 min to ensure that the embryos are exposed uniformly to the fixative 
solution. The lower phase containing the formaldehyde was removed subsequently and 8 mL 
of methanol were added to the vial and shaken vigorously by hand for 1 min. The vial was 
incubated for 2 min to allow the devitellinized embryos to sink to the bottom. The 
devitellinized embryos were transferred to a glass scintillation vial and rinsed three times with 
fresh methanol before being stored at -20 ºC until future use. 
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2.9.3 Florescence In situ hybridization 
 
The spatio-temporal expression pattern for lncRNAs of interest were analysed using in 
situ HCR v3.0 probes from Molecular Instruments, Inc. The experiment was performed 
according to the protocol provided by the manufacturer with some modifications. In brief, the 
embryos from section 2.8.2 were transferred to a clean 1.5 mL Eppendorf tube and rinsed 
with ethanol before incubation in a xylene: ethanol mixture (1:1) for 2 hrs on a rotator. The 
supernatant was removed and the embryos were rinsed with ethanol followed by a series of 
methanol washes (100 %, 70 %, 50 %, 30 %). The embryos were washed with PBST and 
fixed in 4 % formaldehyde for 25 min. After fixation, the samples were washed with PBST 
and incubated with pre-hybridisation buffer for 30 min at 37 ºC. The pre-hybridisation buffer 
was removed and 100 μL of probe hybridisation buffer containing the probe set was added to 
the embryos and incubated for at least 16 hr at 37 ºC. After the hybridisation stage, the 
samples were washed with probe wash solution (pre-heated to 37 ºC) to remove excess probes 
followed with amplification buffer for 30 mins at room temperature. The amplification stage 
was performed in the dark and the samples were wrapped with aluminium foil to reduce 
exposure to light. The snap-cooled hairpins (95 ºC for 1 min 30 sec followed by 30 min at 
room temperature in the dark) were mixed with 100 μL of amplification buffer and added to 
the samples. The amplification stage took place in a dark room for 16 hr at room temperature 
and excess hairpins were washed away with 5 x SSCT at room temperature. The samples 
were mounted on slides using ProLong Diamond Antifade Mountant (Thermofisher 
Scientific) and visualized on a Leica Sp8 confocal microscope. 
 
A separate set of probes from ACD was used to probe for lncRNA localization in 
sectioned embryos. Simultaneous detection of Drosophila Act79d and Drosophila lncRNA-9 
was performed on embryo sections using RNAscope® 2.5 LS Duplex Reagent Kit (ACD). 
The fixed, dechorionated embryos stored in methanol were transferred to 70 % ethanol and 
embedded in paraffin. For each experiment, 4 μm sections of the embryos were collected. The 
sections were incubated at 60 °C for 1 hr and subsequently loaded onto a Bond RX instrument 
(Leica Biosystems). Prior to the treatment with Epitope Retrieval Solution 2 (Leica 
Biosystems), the slides were deparaffinised and rehydrated on board. The probe hybridization 
and signal amplification processes were carried out according to the manufacturer's 
instructions. The processed slides were mounted using VectaMount Permanent Mounting 
Medium (Vector Laboratories) and imaged on an Aperio AT2 (Leica Biosystems) at 40x 
magnification. The embedding, sectioning and staining of the embryos were performed 
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entirely by Bev Wilson and Julia Jones from the Histopathology/ISH Core Facility without 
any contributions from me. 
 
2.9.4 Embryo Immunofluorescence 
 
Primary antibodies were obtained from the Developmental Studies Hybridoma Bank 
(DSHB). Rat anti-Elav (1:100; 7E8A10, DSHB), mouse anti-Fas2 (1:100; 1D4, DSHB), and 
mouse anti-Repo (1:100; 8D12, DSHB) antibodies were used. Secondary antibodies were 
either goat anti-mouse or anti-rat conjugated to the Alexa 488 fluorophore (Thermofisher 
Scientific). For double labelling of whole-mount embryos, the samples prepared above were 
post-fixed with 4 % formaldehyde for 25 min and washed with PBST before antibody 
staining. The embryos were incbuated with 50% BSA on a rotator at room temperature for 1 
hr. Primary antibody was added to the tube and incubated at 4 ºC for 12-16 hr. The embryos 
were subsequently incubated with secondary antibody overnight at 4 ºC. Hoechst 33342 
(1:10,000) was used to stain the cell nuclei.  
 
2.9.5 Image acquisition 
 
Confocal imaging was carried out at the CRUK Cambridge Institute light microscopy 
core facility. Embryos were imaged using a Leica SP8 confocal microscope equipped with a 
405 nm laser diode, white light laser, and hybrid detectors. The samples were imaged using 
40× and 63 x glycerol objective with a ∼AU=1 pinhole. For each acquisition, 80-100 slices 
were imaged. Fluorescence and light microscope images of whole mount embryos, pupae and 
adult flies were acquired using a Leica fluorescence MZ10F fluorescence stereoscope fitted 
with a Leica DFC 7000T camera. The images have been obtained at 4x magnification and 
were processed using ImageJ and Fiji software. 
 
2.10 Statistical analysis of phenotypic data 
 
All statistical analysis was performed using Microsoft excel and prism GraphPad 8 unless 
otherwise stated. All data sets were compared to appropriate controls using Student’s t test or 
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2.11 RAMPAGE library preparation and lncRNA selection 
 
The RAMPAGE experiments, data analysis and lncRNA candidate selection was 
performed by Dr. Philippe Batut from Dr. Thomas Gingeras’s lab at Cold Spring Harbor 
Laboratory, USA without contributions from me.  
 
The full experimental design and analysis for the 5 Drosophila species was carried out 
by Dr. Philippe Batut and have been reported previously (Batut et al., 2013; Batut and 
Gingeras, 2013; Batut et al., 2017). In brief, 5 different Drosophila species were used in the 
study [Drosophila ananassae (#14024-0371.13), Drosophila erecta (#14021-0224.01), 
Drosophila melanogaster (#14021-0231.36), Drosophila pseudoobscura (#14011-0121.94) 
and Drosophila simulans (#14021-0251.195)]. The embryos were collected similarly to the 
protocol described in section 2.1.5 at hourly time points and aged appropriately. A total of 
120 samples were collected by Dr. Batut and used for library production. 
 
Briefly, extraction of total RNA was performed using a Beatbeater (Biospec) and 1.0 
mm zirconia beads (Biospec) to lyse the embryos and then the RNAdvance Tissue kit 
(Agencourt) with DNaseI treatment for RNA extraction. TEX digest (Epicentre) was used in 
order to remove RNAs with 5’-monophosphate and the RNA was purified by RNAClean XP 
(Agencourt) according to the manufacturer’s instructions. To ensure that the RNA used was 
of high quality, the Bioanalyzer RNA Nano chip (Agilent) was used prior to reverse 
transcription. A double-selection strategy allowed for precise identification of the 
transcriptional start site (TSS) along with sequencing of the transcript. A template-switching 
reverse-transcriptase was employed to enrich for 5’-complete cDNAs, while a cap-trapping 
technique was used to further select only the cDNAs retrotranscribed from capped RNA. 
Linker sequences were affixed to the ends of 5′-complete cDNAs and capped RNA molecules 
were biotinylated. Streptavidin-coated magnetic beads (PureBiotech LLC) were used to pull-
down the biotinylated caps on the RNA along with the associated 5′-complete cDNAs. The 
purified libraries were subsequently subjected to PCR amplification followed by a size 
selection step. During the reverse transcription step, for every time series, a distinctive 
sequence barcode was incorporated to tag each sample. A single library was generated from 
pools of samples from the same time point. DNA High Sensitivity Bioanalyzer chip (Agilent) 
was used to check for the quantity and quality of the libraries produced. Paired-end 
sequencing was performed for each library using an individual lane on the Illumina HiSeq 
2000 platform.  
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2.12 Bioinformatic Analysis - Quantification and statistical analysis 
 
The bioinformatic analysis of RAMPAGE data in was performed by Dr. Philippe Batut 
from Dr. Thomas Gingeras’s lab at Cold Spring Harbor Laboratory, USA without 
contributions from me.  
 
2.12.1 RAMPAGE: primary data processing 
 
The primary data processing in this section was performed by Dr. Philippe Batut from Dr. 
Thomas Gingeras’s lab at Cold Spring Harbor Laboratory, USA without contributions from 
me. In brief, reference sequences and annotations used for analysis were acquired from 
Flybase (http://flybase.org) for Drosophila ananassae release 1.3, Drosophila erecta release 
1.3, Drosophila melanogaster release 5.49, Drosophila pseudoobscura release 2.9 and 
Drosophila simulans release 1.4. Reads were trimmed by removing the sequences 
corresponding to the library identification barcode as well as the non-templated Gs resulting 
from the template switching and the reverse-transcription primer. Trimmed reads were 
subsequently mapped to the appropriate reference genome using STAR aligner (Dobin et al., 
2013). Filtering steps were applied to remove PCR duplicates and select only uniquely 
mapping reads. In order to identify TSSs, the density of 5’ ends for each transcript as well as 
the coverage for the rest of the transcript was determined using the whole dataset. Then a 
peak caller algorithm was applied using a sliding-window approach to assess the statistical 
enrichment of 5’ signal for each position in the genome considering a window surrounding 
that position. When multiple significant windows were found in adjacent to each other they 
were attributed to the same TSS cluster (TSC). TSC were then assigned to the best matching 
annotated gene and normalised for sequencing depth to give a precise measure of the 
promoter activity for each transcript (Batut et al., 2013; Batut and Gingeras, 2013). Peaks that 
were found to coincide with Flybase-annotated rDNA were removed (Batut et al., 2017). 
The .sra files for each of the Drosophila species can be found in Table 8. 
 
2.12.2 RAMPAGE: TSS clusters (TSCs) and conservation 
 
This section of the work was performed by Dr. Philippe Batut from Dr. Thomas 
Gingeras’s lab at Cold Spring Harbor Laboratory, USA without contributions from me. The 
TSC peaks identified in section 2.11.2 were subsequently evaluated for functional 
conservation. For each species, peaks passing certain criteria (> 15 RAMPAGE tags, absent 
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in the heterochromatic regions or chromosome 4 in Drosophila melanogaster, or orthologous 
regions in other species) were selected for further analysis. To be able to compare different 
species, the genomic coordinates for each of the peak were transformed to coordinates in the 
multiple sequence alignment of all genomes (15-way MultiZ alignment from UCSC, 
http://hgdownload.soe.ucsc.edu/goldenPath/dm3/multiz15way).  A list of parameters was then 
used to assess if each peak possesses unique syntenic alignment in all other species. From the 
middle of the peak, both ends of an 800 bp window had to map to the same strand of the same 
chromosome. Peaks with less than 50% of bases aligned (i.e., not in assembly gaps) and less 
than 25% of bases matching orthologous bases (not alignment gaps) were discarded. Only 
syntenic peaks were used for further analysis and, in order to compare the peaks in different 
species, the raw 5’ signal for these peaks in each genome was also translated into multiple 
alignment coordinates. The RAMPAGE tags for each peak from each species were then 
counted to evaluate conservation across species. A peak was considered absent in one species 
if it had 100-fold lower signal than in the reference species. In addition, any peak that had 
<100 tags in the reference species was also filtered out if no signal was detected in a target 
species (Batut et al., 2017).  
 
2.12.3 RAMPAGE: Reconstruction of lncRNA transcripts and ORF analysis 
 
This section of the work was performed by Dr. Philippe Batut from Dr. Thomas 
Gingeras’s lab at Cold Spring Harbor Laboratory, USA without contributions from me. 
Focusing mainly on lncRNAs, De novo assembly of lncRNA transcripts was performed using 
Cufflinks (version 2.2.1) and Cuffmerge with default parameters on a recently published 
RNA-seq developmental time course (Graveley et al., 2011). Each published dataset in the 
developmental series was ran independently using the program. For a transcript model to be 
identified as a RAMPAGE TSC, a boundary of 150 bp from the 5’ end of the transcript was 
used. Models that did not match any TSC were filtered out and omitted from future analyses. 
In order to distinguish coding and non-coding transcripts, coding potential analysis was 
performed with phyloCSF on the annotation sets and the 15-way multiZ whole-genome 
alignments (Lin et al., 2011). Positive phyloCSF scores were indicative of protein-coding 
genes whereas non-coding transcripts scored negatively. The coding capability of our lncRNA 
gene set was also measured using CPAT version 1.2.1 (Wang et al., 2013). Following the 
developers’ indications, a cut-off value of 0.39 was taken to assign evidence of coding 
potential by this method. If the value of a transcript was less than 0.39, it was considered to be 
a ncRNA. Another method used to exclude coding potential was Coding-Non-Coding-Index 
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(CNCI) (Sun et al., 2013). Transcripts with coding potential greater than the cutoff score of 0 
were filtered out, and those with a score of less than 0 were considered to be without coding 
potential.  
 
2.12.4 RAMPAGE: Time series alignment 
 
The time series alignment work was performed by Dr. Philippe Batut from Dr. Thomas 
Gingeras’s lab at Cold Spring Harbor Laboratory, USA without contributions from me. In 
order to compare gene expression for the different species on a relative time scale, an 
alignment of time series data (or time warping) was applied. A Z-score transformed gene 
expression was computed for each species and for the entire time series and they were 
registered to one another according to the recommendations of the software documentation 
(Goltsev and Papatsenko, 2009). The gene expression profiles between species were paired 
using one-to-one orthology calls from Flybase (2012 release 2). In order to offset for the 
variances in annotation quality and peak calling between species, sets of datasets (Drosophila 
melanogaster and another species) were subjected to preliminary processing. Sometimes this 
brought to the identification of additional orthologous TSCs that were expressed (≥10 tags) 
but initially missed in one of the two species. In the event that a functionally conserved peak 
was attributed to an annotated gene in only one of the species pair, this inconsistency was 
corrected by assigning it the same gene in both species. A 5-fold up-sampling was applied to 
all of the time series and a 2-hr window size was used for data smoothing with the RZ-
Smooth version 4.1 program. The UCSC liftOver tool 
(http://hgdownload.cse.ucsc.edu/....x86_64/liftOver) was used to align Drosophila 
melanogaster TSCs to all the other genomes. An alignment is considered to be good if it has 
≥50% of bases aligned. Only the temporal expression profiles of these orthologous genomic 
positions were aligned. T-Warp version 3.2 with Pearson distance matrices (3 hr window) was 
used to optimised the global alignment paths between Drosophila melanogaster and the other 
datasets. The alignment of each series with Drosophila melanogaster as the reference was 
performed using M-Align version 2.8 and the data was subsequently smoothened for the final 
aligned series (1 hr window). The expression profiles of individual TSCs were registered to 
one another with M-Align, using the optimal alignment path computed for gene expression 
profiles. The 8th time point in the Drosophila ananassae dataset was omitted from further 
analysis because of poor data quality (Batut et al., 2017).  
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2.12.5 RAMPAGE: Conservation analysis and assembly of TSC expression profiles 
 
This section of the work was performed by Dr. Philippe Batut from Dr. Thomas 
Gingeras’s lab at Cold Spring Harbor Laboratory, USA without contributions from me. The 
conservation of individual expression profiles (TSCs or genes) across a clade was defined as 
the mean Pearson R2 value for all pairwise comparisons of species within the clade. 
Functionally conserved TSCs in all five species (n = 240 and n = 3,824, respectively) were 
identified and were used for the selection of lncRNA candidates. 
 
2.13 Bioinformatic Analysis - Quantification and statistical analysis 
 
The mapping of the modENCODE data and analyses of the RNA-seq data were 
performed by colleagues at our in-house bioinformatics core facility team (Dr. Ashley Sawle 
and Dr. Abigail Edwards).  
 
2.13.1 De novo transcript assembly and transcript mapping  
(GEO Accession GSE36212) [Batut et al., 2013] and 32 modENCODE RNA-seq libraries 
that were submitted by the Berkeley Drosophila Genome Project (BDGP) group were 
retrieved from the SRA database. These data were produced as part of the modENCODE 
project with high quality (http://www.modencode.org/). Before mapping, quality checking of 
raw reads (http://www.bioinformatics.babraham.ac.uk/projects/fastqc) were performed using 
FASTQC version 0.11.5 (Table 9 and 10). Sample reads were aligned to the Drosophila 
melanogaster genome dm6 (corresponding to BDGP6) using tophat2 version 2.1.0 [Kim et 
al., 2013] with options  
tophat --GTF dme.dm6.gtf --bowtie1 --min-anchor 3 --num-threads 4 --
output <OutputBam> <Tophat_dm6_index> <FASTQ_Read1> <FASTQ_Read2>  
The alignment QC was carried out using from Picard tools version 1.122 
(https://broadinstitute.github.io/picard/command-line-overview.html). The tools 
CollectAlignmentSummaryMetrics and CollectRnaSeqMetrics were used with the following 
options, respectively:  
java –jar picard.jar CollectAlignmentSummaryMetrics I=<InputBam> 
O=<OutputFile> REFERENCE_SEQUENCE=<dm6 FASTA file> 
VALIDATION_STRINGENCY=SILENT MAX_INSERT_SIZE=100000 ASSUME_SORTED=true 
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java –jar picard.jar CollectRnaSeqMetrics I=<InputBam> O=<OutputFile> 
REF_FLAT=<ReferenceFile> STRAND_SPECIFICITY=”None” ASSUME_SORTED=”false” 
VALIDATION_STRINGENCY=SILENT  
Using the coordinates of the lncRNAs that were obtained using RAMPAGE, we converted 
them to dm6 coordinates using the UCSC lift-over tool (https://genome.ucsc.edu/cgi-
bin/hgLiftOver). For each library, de novo transcripts were called using Trinity version 2.4.0 
[Haas et al., 2013], as follows: 
Trinity --left <Read1.fq> --right <Read2.fq> --seqType fq --max_memory 8G 
--SS_lib_type RF --no_version_check --output <OutputDirectory>  
Well-defined genes were used as positive controls during the transcript assembly (HERC2, 
pigeon, IA-2, CG10189, nkt, CG9706, luna, CG32181, Shrm). The coding potential of the 
transcripts was assessed using the Coding Potential Calculator (CPC, score < 0, Kong et al., 
2007), Coding-Potential Assessment Tool (CPAT score < 0.403, Wang et al., 2013) as well as 
Coding-Non-Coding Index (CNCI, score<0, Sun et al., 2013).  
 
2.13.2 Differential Gene expression analysis for lncRNA-9 
 
The protocol used for the RNA extraction and purification is described in section 2.4.1 
and 2.4.2. The embryos were first homogenized in TRIzol Reagent (Invitrogen) and the RNA 
was purified using the RNeasy Mini kit (QIAGEN) according to the manufacturer’s protocol. 
A total of 56 RNA-seq libraries were first prepared using NEBnext Poly(A) mRNA magnetic 
isolation module (NEB) kit for polyA enrichment followed by NEB NEBNext® Ultra™ II 
Directional RNA Library Prep Kit for Illumina kit according to the according to the 
manufacturer's protocol (and as described in section 2.4.3). The sequencing reaction was 
carried out on a Illumina HiSeq 4000 using single end (SE) 50 bp reads by the genomics core 
facility at the CRUK Cambridge Institute. For each replicate in the time series, all of the 
samples exceeded the recommended depth of 20 million reads for differential gene expression 
with at least 30 million reads per replicate obtained. The strand-specific, single-end raw 
sequencing reads were downloaded and the quality of these raw reads were verified using 
FASTQC version 0.11.5 (http://www.bioinformatics.babraham.ac.uk/projects/fastqc). The 
reads were subsequently aligned to the Drosophila melanogaster reference genome with 
HISAT2 version 2.1.0 [Kim et al., 2013] against dm6 using the following options: 
Hisat2 –x <indexFILE> -U <inputFg> --summary-file <summaryFileName> -p 6 
–rg-id Rg1 –rna-strandness R 
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 To check for alignment quality, we used Picard tools version 2.60 
(https://broadinstitute.github.io/picard/command-line-overview.html), with the following 
options for CollectRnaSeqMetrics and CollectAlignmentSummaryMetrics, respectively:  
java –jar picard.jar CollectRnaSeqMetrics I=<InputBam> O=<OutputFile> 
REF_FLAT=<ReferenceFile> STRAND_SPECIFICITY=”None” ASSUME_SORTED=”false” 
VALIDATION_STRINGENCY=SILENT  
java –jar picard.jar CollectAlignmentSummaryMetrics I=<InputBam> 
O=<OutputFile> REFERENCE_SEQUENCE=<dm6 FASTA file> 
VALIDATION_STRINGENCY=SILENT MAX_INSERT_SIZE=100000 ASSUME_SORTED=true 
Alignment rates of the libraries to the Drosophila dm6 genome ranged from 84.5% to 
96.7% (at least 95% in a good quality RNAseq library) and the intragenic alignment rates for 
the libraries were just slightly lower than the standard (95% or higher) at 93.9%.  
 
Once the reads have been aligned, gene-specific read counts were performed with 
FeatureCounts from the Subread package v1.5.2 against the dm6 annotation [Liao et al., 
2014] and the predicted de novo transcripts from Trinity, with the following options: 
 FeatureCountsBinary –s 2 --primary –C –T 4 –S –a <.saf > –o <outputFile> 
<BamFile> 
 
Reads overlapping with two or more features (regions of the genome where two or 
more genes overlap) were listed as ambiguous and not counted. The threshold for determining 
if a gene was genuinely detected was set at a minimum of five reads. There were 16,750 
features (genes) in the annotation that were covered by at least one read in at least one sample. 
Coverage profile plots were generated to check for uniformity and to identify the presence of 
any 3’/5’ bias which may arise due to RNA degradation or other issues during library 
preparation. In the RNA sequencing libraries that were made, a uniform coverage plot was 
observed for all of the samples, indicating good quality RNA-Seq libraries. In order to further 
investigate correlation of counts between replicate, the distribution of correlation per gene 
count between sample pairs was examined. The raw counts were normalised to transcript per 
million (TPM) and the Pearson correlation coefficient for all possible sample pairs was 
calculated. From the analysis, lncRNA mutant samples collected from 22-23 hr were the 
worst correlated sample pair with a correlation score of 0.8558841. Differentially expressed 
transcripts/genes (DEGs) were predicted in R version 3.3.3 with the defaults of DESeq2 in a 
per time point analysis. During the differential analysis, default parameters were used with the 
‘DESeq’ command. When determining if a gene was statistically significantly differentially 
expressed, we used a p-adjusted value (p-adj) cutoff of 0.05. 
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2.13.3 Gene ontology (GO) analysis 
 
GO functional enrichment analysis is a commonly used tool to interpret functional 
roles of large-scale transcriptomics data (Ashburner et al., 2000; The Gene Ontology 
Consortium, 2018). The differentially expressed gene lists for each time point were subjected 
to enriched GO categorisation that characterises the relationship between genes and 
categorize them into broad categories such as molecular function, biological processes and 
cellular component. The Gene Ontology Consortium’s online tool 
(http://www.geneontology.org/) was used to carry out the enrichment of our gene list 
(PANTHER version 15.0 Released 2020-02-14). During the analysis, an overrepresentation 
test was performed using the PANTHER Overrepresentation Test (Released 20200407) and 
all of genes in the database for Drosophila melanogaster (reference List). The gene names 
from our list were pasted into the GO tool and I have selected the species (Drosophila 
melanogaster) and specific ontology (GO-Slim molecular function, GO-Slim biological 
process and GO-Slim cellular component) for our enrichment analysis. At the end of each 
analysis, the various GO terms associated with the gene set were presented along with 
information on their degree of fold enrichment, a p-value, and a false discovery rate (FDR). 
When a GO term is over represented, it will be shown as a positive value and a negative value 
when it is underrepresented. The GO terms will be ranked from the highest to the lowest fold 
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Table 1: Drosophila stocks used for genetic crosses or transgenesis. 
 
Control Stocks 
Name Source Reference 
w[1118] 
Gift from The University of 
Cambridge Department of 
Genetics Fly Facility 
 
OregonR 
Gift from The University of 
Cambridge Department of 
Genetics Fly Facility 
 
Stocks with balancer chromosomes 
Df(1)m13, Gs2[m13]/FM7a, w[+] 
 
The University of Cambridge 





The University of Cambridge 




The University of Cambridge 
Department of Genetics Fly 
Facility 
 
w[1118]; If/Cyo ; MKRS/TM6B, Tb[1] 
Gift from The University of 
Cambridge Department of 
Genetics Fly Facility 
 
y1 w* baz4 P{FRT(whs)}9-2/FM7c, P{Dfd-GMR-
nvYFP}1, sn+ 
2Stock ID: BL #23229 Tien et al., 2006 
w[*]; sna[Sco]/CyO, P{Dfd-GMR-nvYFP}2 2Stock ID: BL #23230 Tien et al., 2006 
w[*]; ry[506] Dr[1]/TM3, P{Dfd-GMR-nvYFP}3, 
Sb[1] 
2Stock ID: BL #23231 Tien et al., 2006 
Cas9-expressing stocks 
y1 M{vas-Cas9.RFP-}ZH-2A w1118 
The University of Cambridge 
Department of Genetics Fly 
Facility 
 
y[1] sc[1] v[1];; {y[+t7.7] v[+t1.8]=nanos-Cas9}attp2 
3The University of Cambridge 
Department of Genetics Fly 
Facility 
Port et al., 2015 
Deficiency lines 
w[1118]; Df(3L)BSC414/TM6C, Sb[1] cu[1] 2Stock ID: BL #24918  




2Stock ID: BL #9355  
Stock with microRNA gene mutation 
w*; TI{TI}mir-276aKO/TM3, P{GAL4-twi.G}2.3, 
P{UAS-2xEGFP}AH2.3, Sb1 Ser1 
2Stock ID: BL #58906 Chen et al., 2014 
Other lines 
y1 v1 P{nos-phiC31\int.NLS}X; P{CaryP}attP40 2Stock ID: BL #25709  
1Flies obtained from Vienna Drosophila Resource Center (VDRC) (Vienna BioCenter, Vienna, AUSTRIA). 
2Flies obtained from Bloomington Drosophila stock centre (Indiana University, Bloomington, USA). 
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Table 2.1: List of transgenic flies generated during this study. 
 
Stocks containing 3xP3 transgene (KO lines) 
Name  gRNA plasmid ID Donor plasmid ID Mutation Type 
w*; +; lncRNA-3 [RFP+]/Tm3-YFP 2M pES03 pES33 TSS-deletion 
w*; +; lncRNA-3 [RFP+]/Tm3-YFP 3M pES03 pES33 TSS-deletion 
w*; +; lncRNA-3 [RFP+]/Tm3-YFP 6M pES03 pES33 TSS-deletion 
w*; lncRNA-4 [RFP+]/CyO-YFP; + 1M pES04 pES34 TSS-deletion 
w*; lncRNA-4 [RFP+]/CyO-YFP; + 3M pES04 pES34 TSS-deletion 
w*; lncRNA-4 [RFP+]/CyO-YFP; + 5M pES04 pES34 TSS-deletion 
lncRNA-5[RFP+]/Fm7a-YFP; +; + 1M pES05 pES35 TSS-deletion 
lncRNA-5[RFP+]/Fm7a-YFP; +; + 2M pES05 pES35 TSS-deletion 
lncRNA-5[RFP+]/Fm7a-YFP; +; + 3M pES05 pES35 TSS-deletion 
w*; +; lncRNA-6 [RFP+]/Tm3-YFP 2M pES06 pES36 TSS-deletion 
w*; +; lncRNA-6 [RFP+]/Tm3-YFP 4M pES06 pES36 TSS-deletion 
w*; +; lncRNA-9 [RFP+]/Tm3-YFP 1M pES09 pES39 TSS-deletion 
w*; +; lncRNA-10 [RFP+]/Tm3-YFP 1M pES10 pES40 TSS-deletion 
w*; +; lncRNA-10 [RFP+]/Tm3-YFP 3M pES10 pES40 TSS-deletion 
w*; +; lncRNA-10 [RFP+]/Tm3-YFP 5M pES10 pES40 TSS-deletion 
w*; lncRNA-11 [RFP+]/CyO-YFP; + 1M pES11 pES41 TSS-deletion 
w*; lncRNA-11 [RFP+]/CyO-YFP; + 2M pES11 pES41 TSS-deletion 
w*; lncRNA-11 [RFP+]/CyO-YFP; + 3M pES11 pES41 TSS-deletion 
w*; lncRNA-11 [RFP+]/CyO-YFP; + 4M pES11 pES41 TSS-deletion 
w*; lncRNA-12 [RFP+]/CyO-YFP; + 1M pES12 pES42 TSS-deletion 
w*; lncRNA-12 [RFP+]/CyO-YFP; + 2M pES12 pES42 TSS-deletion 
w*; lncRNA-12 [RFP+]/CyO-YFP; + 3M pES12 pES42 TSS-deletion 
w*; lncRNA-12 [RFP+]/CyO-YFP; + 4M pES12 pES42 TSS-deletion 
lncRNA-13[RFP+]/Fm7a-YFP; +; + 1M pES13 pES43 TSS-deletion 
lncRNA-13[RFP+]/Fm7a-YFP; +; + 3M pES13 pES43 TSS-deletion 
lncRNA-13[RFP+]//Fm7a-YFP; +; + 5M pES13 pES43 TSS-deletion 
w*; lncRNA-14 [RFP+]/CyO-YFP; + 1M pES14 pES44 TSS-deletion 
w*; lncRNA-14 [RFP+]/CyO-YFP; + 2M pES14 pES44 TSS-deletion 
w*; lncRNA-14 [RFP+]/CyO-YFP; + 3M pES14 pES44 TSS-deletion 
w*; lncRNA-14 [RFP+]/CyO-YFP; + 4M pES14 pES44 TSS-deletion 
w*; lncRNA-15 [RFP+]/CyO-YFP; + 1M pES15 pES45 TSS-deletion 
w*; lncRNA-15 [RFP+]/CyO-YFP; + 2M pES15 pES45 TSS-deletion 
w*; lncRNA-15 [RFP+]/CyO-YFP; + 3M pES15 pES45 TSS-deletion 
w*; +; lncRNA-16 [RFP+]/Tm3-YFP 2M pES16 pES46 TSS-deletion 
w*; +; lncRNA-16 [RFP+]/Tm3-YFP 3M pES16 pES46 TSS-deletion 
w*; +; lncRNA-16 [RFP+]/Tm3-YFP 4M pES16 pES46 TSS-deletion 
w*; +; lncRNA-19 [RFP+]/Tm3-YFP 1M pES19 pES49 TSS-deletion 
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Table 2.2: List of transgenic flies generated during this study. 
 
Stocks with SV40 insertion downstream of lncRNA TSS 
Name  gRNA plasmid ID Donor plasmid ID Mutation Type 
w*; +; lncRNA-9 [SV40]/Tm3-YFP 2M pES103a pES107c SV40 insertion 
w*; +; lncRNA-9 [SV40]/Tm3-YFP 3M pES103a pES107c SV40 insertion 
Stocks expressing dual gRNA construct 
Name  gRNA plasmid ID Mutation Type 
y1 M{vas-int.DM}ZH-2A w*; 




Stocks expressing BAC construct 
Name  BAC plasmid ID Mutation Type Remarks 
1P{CH322-18B08}attP40/CyO 2M CHORI-CH322 -18B08 BAC insertion 
Venken et al., 
2009 
1P{CH322-151D21}attP40/CyO 3M CHORI-CH322 -151D21 BAC insertion 
1PBac{CH322-170N22}VK00001/CyO 2M CHORI-CH322 -170N22 BAC insertion 
1PBac{CH322-122O7}VK00002/CyO 1M CHORI-CH322 -122O7 BAC insertion 
Other Stocks generated 
w[1118]; If/Cyo ; lncRNA3[RFP+]/TM6B, Tb[1] 
w[1118]; If/Cyo ; lncRNA9[RFP+]/TM6B, Tb[1] 
1Flies generated by BestGene.Inc, USA. All of the other flies were generated by the University of Cambridge 
Department of Genetics Fly Facility.
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Table 3: List of gRNA plasmid and the primers used to generate the construct. 
 
1‘TATATAGGAAAGATATCCGGGTGAACTTC’ was added to the 5’ end of the first gRNA and ‘GTTTTAGAGCTAGAAATAGCAAG’ was added to the 3’ end. 




Dual gRNA plasmid list 
Candidates 
1sgRNA_1 2sgRNA_2 Dual-gRNA 
Plasmid # Sequence Genomic Coordinates Sequence Genomic Coordinates 
lncRNA-3 TATTAAAACGACTGGGGGGG chr3L:10,325,557-10,325,579 ATGTGATATGTTGTGGGCTG chr3L:10,327,299-10,327,321 pES_3 
lncRNA-4 GTGTACTTACAGATTTCCAT chr2R:10,263,671-10,263,693 GATGCGAAAGTATTCGATGG chr2R:10,263,888-10,263,910 pES_4 
lncRNA-5 AGGGTCTTTGTAGGTCTGCA chrX:3,861,568-3,861,590 AGTAAATTTAATCAGAGACC chrX:3,862,551-3,862,573 pES_5 
lncRNA-6 AGGGACATACATCTAAGGAA chr3R:16,772,794-16,772,816 GGGATTGAGCCAAGTTAAGG chr3R:16,773,734-16,773,756 pES_6 
lncRNA-9 TCGCTTGTCTGGTTTCGAACA chr3L:17,269,326-17,269,346 AAGGCTCTCCATTAGCTTAA chr3L:17,270,385-17,270,407 pES_9 
lncRNA-10 CGATGTGTAACGTGAGAGCT chr3L:13,112,379-13,112,401 GAAGTTTCCACTCATTTATC chr3L:13,113,943-13,113,965 pES_10 
lncRNA-11 CGGAAGGAGCCTGTATCCAT chr2L:20,483,035-20,483,057 AAAATGTTAAAAATTTACTG chr2L:20,485,049-20,485,071 pES_11 
lncRNA-12 AAGCTACTAAACGATACAGA chr2L:17,584,436-17,584,458 GCGAGGGTGAACCTGAACCC chr2L:17,585,337-17,585,359 pES_12 
lncRNA-13 GGCTGAAAACCCCTGGACCG chrX:7,265,450-7,265,472 GTGGACGAGTGATTTCAATT chrX:7,266,704-7,266,726 pES_13 
lncRNA-14 GTGCATTATCGCGGATAATT chr2R:9,549,757-9,549,779 GCAATTATCATCGTGCAGGT chr2R:9,550,909-9,550,931 pES_14 
lncRNA-15 ATGAAAAAAACCCGCCGACA chr2R:13,362,387-13,362,409 GCCGAAGTTCATGCGTCCTT chr2R:13,363,152-13,363,174 pES_15 
lncRNA-16 AGTTACGGGTTACGGGAATT chr3R:26,693,831-26,693,853 TTAAAATAACTGAAACCACT chr3R:26,694,666-26,694,688 pES_16 
lncRNA-19 CACCCTAACGGCAGCCTAAC chr3R:16,847,383-16,847,405 TGTTTGTTGATAACACACTT chr3R:16,849,367-16,849,389 pES_19 
white CGGGCCTCCCTCATAAAAAC chrX:2,791,303-2,791,325 AATTGATGGCGTAAACCGCT chrX:2,796,428-2,796,450 pES_26 
Single gRNA plasmid list 
Candidates 
sgRNA_1 sgRNA_2 sgRNA 
plasmid # Sequence Genomic Coordinates Sequence Genomic Coordinates 
lncRNA-9 AAATAGAAGAAAGACTGCCA chr3L:17,269,915-17,269,934 - - pES103a 
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Table 4: List of primers used for generating the donor construct. 
1 ‘GGTGGCGGCCGCTCTAGAACTAGTG’ was added to the 5’ end of the left homology arm primer 1. 
2 ‘ATTGAATTAGTCTCTAATTGAATTAGATCC’ was added to 5’ end of the left homology arm primer 2.  
3 ‘TGAAACAATTAGGCAAAACCATGCGAAGCT’ was added to 5’ end of the right homology arm primer 1. 
4 ‘ACGGTATCGATAAGCTTGATATCGAATTCC’ was added to 5’ end of the right homology arm primer  2. 














































































CGGCGGGTTTTTTTCATGCTT GTTCATGCGTCCTTCGGGTG AGGCCTGTCTGCCTCTTTATTT pES_45 











Plasmid used for insertion of SV40 stop signal 
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Table 5: Typical PCR reaction condition 
 
Temperature (°C) Time (min) Number of Cycles 
94 2:00 min 1 
94 0:30 min 
20-40 cycles 
55 to 60 0:20 
70 
0:20-2:00 
(20 sec per kb) 
70 1:00 1 
4 ∞  
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Table 6: Oligonucleotides generated for this study 
 
















Single fly sequencing primers (3xP3-RFP cassette insertion) 
3xP3_LHA_seq_rev CCGCCCGATTGTTTAGCTTGTT 
3xP3_RHA_seq_fwd TCGTGATGGCGTGTTGAAAGGA 
lncRNA-3 ACTCTTCTACGCATAAAATCAATATTCCCA GCGCTTTACCAACTTCACTTCAGCC 
lncRNA-4 ACACTTACCAAATCCGAAATCATGA TCAGCTCGGTTCCATTGATAAGATG 
lncRNA-5 ATGTCCCTTTTCGAGCGA TGGTAGCCCTCAGTACCG 
lncRNA-6 CCAAACGCTTCTGTTCGAGCTT TGGAACTTGTAACTGTGGAATTGT 
lncRNA-9 AGCAGCCCCATCTCCTTCACTG GCCAACTGACAGCCTACTTTCG 
lncRNA-10 AGCAAAGCGTTCACACACAGAG AAGGCGATCATCATGTTTCGC 
lncRNA-11 TGTTTGTCACGTTCCGCA TCTCTGGAAGTCGCCGAA 
lncRNA-12 AGTTCCACCCCACGTCTAA TTGGCTCGAACTAACGGC 
lncRNA-13 TCAGCTGAATGAGAGGGCT ATTGTGCGTGCTTTCGAC 
lncRNA-14 CCACTGCGATCCGAAACA CAACGGGTGCTAAGGAGG 
lncRNA-15 TGATTGTGACCGTTGCAGT ACTCATCATCGGCCAGGT 
lncRNA-16 TCATAATGCTCAGCGGACGGAT TGCTCTTTAATTGAGCACCCTG 
lncRNA-19 CGTTAGCCAATTTACGAGCGACT AGTTCCGCGATGCGATTTAAT 
Single fly sequencing primers (SV40 insertion) 
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Table 7: Oligonucleotides generated for qPCR 
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Table 8: Drosophila species embryonic development RAMPAGE time series (.sra) 
 












0-1 GSM2365603 GSM2365709 GSM2365625 GSM2365648 GSM2365687 
1-2 GSM2365604 GSM2365710 GSM2365626 GSM2365649 GSM2365688 
2-3 GSM2365605 GSM2365711 GSM2365627 GSM2365650 GSM2365689 
3-4 GSM2365606 GSM2365712 GSM2365628 GSM2365651 GSM2365690 
4-5 GSM2365607 GSM2365713 GSM2365629 GSM2365652 GSM2365691 
5-6 GSM2365608 GSM2365714 GSM2365630 GSM2365653 GSM2365692 
6-7 GSM2365609 GSM2365715 GSM2365631 GSM2365654 GSM2365693 
7-8 GSM2365610 GSM2365716 GSM2365632 GSM2365655 GSM2365694 
8-9 GSM2365611 GSM2365717 GSM2365633 GSM2365656 GSM2365695 
9-10 GSM2365612 GSM2365718 GSM2365634 GSM2365657 GSM2365696 
10-11 GSM2365613 GSM2365719 GSM2365635 GSM2365658 GSM2365697 
11-12 GSM2365614 GSM2365720 GSM2365636 GSM2365659 GSM2365698 
12-13 GSM2365615 GSM2365721 GSM2365637 GSM2365660 GSM2365699 
13-14 GSM2365616 GSM2365722 GSM2365638 GSM2365661 GSM2365700 
14-15 GSM2365617 GSM2365723 GSM2365639 GSM2365662 GSM2365701 
15-16 GSM2365618 GSM2365724 GSM2365640 GSM2365663 GSM2365702 
16-17 GSM2365619 GSM2365725 GSM2365641 GSM2365664 GSM2365703 
17-18 GSM2365620 GSM2365726 GSM2365642 GSM2365665 GSM2365704 
18-19 GSM2365621 GSM2365727 GSM2365643 GSM2365666 GSM2365705 
19-20 GSM2365622 GSM2365728 GSM2365644 GSM2365667 GSM2365706 
20-21 GSM2365623 GSM2365729 GSM2365645 GSM2365668 GSM2365707 
21-22 GSM2365624 GSM2365730 GSM2365646 GSM2365669 GSM2365708 
22-23 - GSM2365731 GSM2365647 GSM2365670 - 
23-24 - - - GSM2365671 - 
24-25 - - - GSM2365672 - 
25-26 - - - GSM2365673 - 
26-27 - - - GSM2365674 - 
27-28 - - - GSM2365675 - 
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Table 9: GEO Accession numbers linked to modENCODE RNA-seq 
 
Time after egg laying (hr) SRA accession files 
0-2 SRR767606, SRR1197337, SRR1197370 
2-4 SRR767626, SRR1197336, SRR1197368 
4-6 SRR767609, SRR1197338 
6-8 SRR767610, SRR1197333 
8-10 SRR767615, SRR1197335 
10-12 SRR767616, SRR1197334, SRR1197367 
12-14 SRR767613, SRR1197332, SRR1197369 
14-16 SRR767618, SRR1197331 
16-18 SRR767605, SRR1197330, SRR1197365 
18-20 SRR767622, SRR1197327, SRR1197363 
20-22 SRR767620, SRR1197329, SRR1197364 
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Table 10: GEO Accession numbers for RAMPAGE DATA 
 













































Chapter 3 | 
Pilot screen for lncRNAs that 
function during Drosophila 
embryogenesis 
Since this project was performed in collaboration with Drs. Philippe Batut & Thomas 
Gingeras (Cold Spring Harbor Laboratory, USA), I will describe our individual contributions. 
The bioinformatic analysis of RAMPAGE data was performed by Dr. Philippe Batut from Dr. 
Thomas Gingeras’s lab without contributions from me. The microinjection service and 
subsequent isolation and backcrossing of flies to a balancer was performed by the fly facility 
at the Department of Genetics, University of Cambridge without contributions from me. For 
the purpose of this thesis, I have designed and validated the plasmids and performed all the 





Following the advent of high throughput sequencing technologies, it is now well 
established that eukaryotic gene expression is highly pervasive in all organisms and is not 
limited to the protein-coding regions of the genome (Okazaki et al., 2002; Carninci et al., 
2005; Birney et al., 2007; Derrien et al., 2012). The transcriptome harbours only ~2% of 
protein-coding genes while for the vast majority of the transcriptome is made into ncRNAs. 
Among these ncRNAs are non-coding transcripts known as lncRNAs and characterised by a 
length above 200 nucleotides and the lack of apparent protein-coding potential (Guttman et 
al., 2009; Derrien et al., 2012). From large-scale transcriptome analyses, these long 
transcripts have been identified to be a major component of the ncRNA cohort, yet relatively 
little is known about their functions during development. Despite the emerging evidence of 
distinct lncRNAs with diverse physiological functions, very few of these have been studied 
experimentally in any detail and the functions of only a handful of lncRNAs have been 
described to date (Moran et al., 2012). 
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Previous characterisation of lncRNA functions was performed primarily in cell lines and 
thus only limited direct genetic evidence of their functional in vivo implications is available. 
Earlier studies on various animal models have demonstrated compelling evidence for the 
requirement of lncRNA transcripts for organ development, organismal survival and normal 
physiological functions (Grote et al., 2013; Sauvageau et al., 2013; Hardiman et al., 2002; Li 
et al., 2012). However, there are not many examples in which consequences of lncRNA loss 
of function were systematically assessed and thus making it challenging to perform 
subsequent analysis to understand the impact of the lncRNA deletion (Sauvageau et al., 
2013). Most of these screens have been carried out on cells rather than examining them in 
vivo. 
 
In recent years, lncRNAs have been identified and catalogued at different stages of 
development from embryo to a fully-grown adult in different model organisms. Focusing on 
the events that take place during embryonic development in mouse, lncRNAs were found to 
have a role in specifying the different lineages derived from the three germ layers including 
from neural, mesodermal and endodermal origin (Poirier et al., 1991; Jiang et al., 2015; 
Winzi et al., 2018). They were suggested to be important regulators during embryo 
morphogenesis and could potentially influence the development of embryos and organs when 
they are mutated. Examples of lncRNAs that were first discovered to have a role during 
embryogenesis include lncRNA H19 and Xist (Leighton et al., 1995; Rancourt et al., 2013; 
Penny et al., 1996; Marahrens et al., 1997). Subsequent efforts have identified lncRNAs such 
as Fendrr, Braveheart, Kcnq1ot1 that were involved in organogenesis during mouse 
embryonic development (Grote et al., 2013; Klattenhoff et al., 2013; Korostowski et al., 
2012). For example, the lncRNA Fendrr localises to the nucleus and plays an essential role in 
the differentiation of cardiovascular tissues (Schmitz et al., 2016). In the absence of Fendrr, 
the heart and the body wall of the embryo were not generated due to the inability of the cells 
from lateral mesoderm to undergo cellular differentiation which eventually resulted in 
embryonic lethality (Grote et al., 2013; Grote and Herrmann; 2013).  
 
The vast amount of developmental genetics and functional studies carried out throughout 
the years have made the Drosophila embryo one of the most understood examples of 
transcriptional regulation in developmental biology. The fruit fly has been extensively studied 
for over a century and it has many characteristics which makes it an ideal organism for the 
elucidation of lncRNA function during embryogenesis. The functional annotation of lncRNA 
transcripts in the Drosophila genome is an essential first step to appreciate the molecular and 
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cellular mechanisms that underpin the diverse roles that lncRNAs play in regulating various 
aspects of development. One of the goals of the MODENCODE Consortium was to annotate 
the Drosophila genome and identify functional transcriptional start sites (TSS) (Roy et al., 
2010). The expression pattern of lncRNAs has previously been reported to exhibit temporal 
dynamics during development or cellular differentiation and the choice of a lncRNA 
candidate for further in-depth study is often associated with a specific defect (Sauvageau et 
al., 2013; Yan et al., 2015). Of the few lncRNA mutant flies generated to date, most involved 
previously studied and classic examples such as rox1, rox2, bxd (Petruk et al., 2006; Franke 
and Baker, 1999; Meller et al., 1997), leaving the more recent large-scale RNA-Seq-derived 
catalogues of lncRNAs largely unexplored. In this project, I decided to explore the biological 
role of novel lncRNA candidates expressed during specific embryonic developmental stages 
in Drosophila as little is known regarding lncRNA function during this period. 
 
To this aim, we decide to use previously existing datasets generated by RNA 
Annotation and Mapping of Promoters for Analysis of Gene Expression (RAMPAGE) to 
select candidate lncRNAs for a functional genetic screen (Batut et al., 2017). These libraries 
had the advantage of a high temporal resolution (1-hour resolution throughout embryonic 
development) and deep sequence coverage across 5 Drosophila species, which allowed us to 
select for lncRNA candidates that were expressed during Drosophila embryogenesis with 
high confidence (Batut et al., 2017). Moreover, sequence conservation across species is 
usually interpreted as a sign of functional importance. As lncRNAs are poorly conserved at 
the sequence level, the RAMPAGE datasets were used to identify transcriptional start site 
clusters (TSCs) not associated with known coding genes or small RNAs and that also showed 
syntenic conservation across all 5 species and were transcriptionally active in all of them, 
suggesting critical functional roles for these lncRNAs. A stringent set of 631 lncRNA that are 
conserved across all 5 Drosophila species was identified (Batut et al., 2017).   
 
As it is time-consuming and costly to perform in vivo studies, we needed to further 
reduce this list of lncRNAs to a manageable number to functionally assess. Dr. Philippe Batut   
applied additional selection criteria to further narrow down this list and eventually he 
manually curated a small subset of twenty-two lncRNAs candidates, that I have then brought 
forward for the genetic screen. Besides 20 novel lncRNAs our list also included two well-
known Drosophila lncRNAs, bxd and rox1, which fulfilled all our criteria and served as 
positive controls for our functional studies (Batut et al., 2017; Petruk et al., 2006; Meller et 
al., 1997). CRISPR/Cas9-mediated deletion was used to specifically target the lncRNA 
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promoter regions via a pair of guide RNAs (gRNAs) (Port et al., 2014). Using 5′- and 3′-
flanking gRNAs that surround the transcriptional start site of each lncRNA candidate, large 
stretches of DNA can be deleted, thus allowing efficient disruption of lncRNA loci. The 
promoter deletion strategy was chosen as it will inhibit lncRNA transcription and therefore 
result in a phenotype that is caused by the lack of lncRNA (Gratz et al., 2014; Bottcher et al., 
2014; Port et al., 2014). To date, I have made use of the CRISPR/Cas9 technology to 
successfully generate 13 lncRNAs mutants out of the 22 candidates that were used for further 
analysis. CRISPR was also attempted for other 9 lncRNAs but no founders were successfully 
generated after 2 attempts. 
 
Here, I am reporting the initial characterisation of these new knockout strains which 
included testing the mutants for some of the phenotypes that have been commonly studied in 
lncRNA loss-of-function studies such as viability, fertility, locomotion and developmental 
process (patterning of the body plan) (Sauvageau et al., 2013; Goudarzi et al., 2019; Li et al., 
2012; Pease et al., 2013). In this chapter, I will describe the observed phenotypes for the 13 
lncRNA mutants that I have generated. While the majority of the lncRNA mutants do not 
have any observable developmental abnormalities, abrogation of two of the lncRNAs resulted 
in a homozygous lethal phenotype. As a whole, these data provided us with new evidence of 





3.2.1 Selection of lncRNA candidates for pilot screen 
 
The complete development of a multicellular organism is coordinated by a precise 
spatio-temporal expression of both protein-coding and non-coding genes. A robust regulation 
of gene expression from embryonic development to a complete adult requires an accurate and 
coordinated expression of both classes of molecules. The discovery and characterisation of 
transcriptional regulatory elements such as promoters and enhancers improved our 
understanding of eukaryotic transcription and regulation of gene expression in a complex 
genome. In recent years, the identification and characterisation of transcriptional start sites 
(TSSs) and promoters at the genome-wide level has been made possible with the development 
of high throughput sequencing technologies in combination with new advancement in TSS 
profiling methods. The use of RNA-seq methodology alone has its own caveats as it is 
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inaccurate at reconstructing the 5′ ends of transcripts; moreover, proper detection of lowly-
abundant transcripts such as lncRNAs requires an in-depth sequencing to be performed. A 
technique known as RAMPAGE (Batut et al., 2013) was developed to overcome these 
constraints. In this technique, the use of a template switching reverse transcriptase coupled to 
cap trapping by biotinylation and pulldown of capped RNA molecules allows to select 5’ 
complete cDNA replicas of capped RNAs for downstream library preparation. This system 
therefore enables a user to sequence 5'-complete cDNAs and allows the precise identification 
of TSSs and at the same time reveals the promoter activity of each gene at genome-wide level 
(Batut et al., 2013; Batut et al., 2017). RAMPAGE was first employed to characterise the 
promoter architecture throughout the 36 stages of the life cycle of Drosophila melanogaster. 
An extensive usage of transposon-driven alternative promoters was discovered during this 
analysis and it was shown to drive the expression of various developmental genes at different 
time points during development (Batut et al., 2013). A brief protocol of the RAMPAGE 
method can be found in Material and Methods and in Figure 12 and a more detailed 
methodology has been published (Batut et al., 2013, Batut and Gingeras, 2013).  
 
In order to examine the transcriptional regulation during fly embryonic development 
at the genome-wide level, RAMPAGE was used to analyse the activities of promoters across 
five Drosophila species (Drosophila melanogaster, Drosophila simulans, Drosophila erecta, 
Drosophila ananassae, Drosophila pseudoobscura) (Batut et al., 2017). In this manuscript, it 
was already established that close to 4,000 transcriptional start sites likely representing 
lncRNA promoters can be identified as functionally active during fly embryogenesis, with 
some of these promoters showing conserved activities across all five Drosophila species. We 
therefore took advantage of these already existing datasets and extended the previous analysis 
to select 20 novel lncRNAs of potential relevance during Drosophila melanogaster 
embryonic development for further functional studies. A flowchart of the experimental design 
can be found in Figure 13. The data that were used to select candidate lncRNAs were 
generated and analysed entirely by Dr. Philippe Batut (as part of a collaboration with the 
laboratory of Dr. Thomas Gingeras at Cold Spring Harbor Laboratory, USA). 
 
The RAMPAGE transcriptomic datasets were ideal for this purpose because they offer 
both a high temporal resolution (1 hr) as well as a high sequence coverage (137-180 million 
reads per species) for the period of embryonic development (Figure 13). Moreover, the 
comparison across different species allowed us to focus on lncRNAs that are syntenically 
conserved and expressed in all 5 species with a similar expression pattern, suggesting 
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functional importance. A total of 120 RAMPAGE libraries were previously generated for the 
five species and the different timepoints, each library was aligned against its reference 
genome using STAR aligner (Dobin et al., 2013) and the expression of annotated genes was 
quantified using Cufflinks. A novel peak-calling algorithm for TSS discovery was first used 
generate individual promoters by clustering neighbouring TSS into TSS clusters (TSC) 
followed by an evaluation of the activity of each these promoters (Batut et al., 2013, Batut 
and Gingeras, 2013). A total of 2.2x104 to 2.7x104 high-confidence TSCs were identified for 
each species during the analysis. An excellent reproducibility (Pearson R2 = 0.95) for TSCs 
with maximum expression of ≥ 25 reads per million (RPM) and reproducibility maximum 
expression ≥10 RPM (Pearson R2 = 0.92) was achieved when the activity of the promoters 
were compared across the biological replicates for the Drosophila melanogaster time series. 
Quantification across other Drosophila species also yielded similar results. In addition, the 
use of paired-end sequencing has allowed direct association of the 5’end of a transcript with 
its associated mRNA (Batut et al., 2017). 
 
Drosophila embryonic development time course is widely different across the various 
species. To be able to compare expression profiles across species, post-synchronisation of 
expression profiles was measured as follows. First, the raw read counts per TSC were 
normalized to library size for each sample, and subsequently expressed in reads per million 
uniquely mapped reads (i.e., RPM). Those RPM counts were then normalized to a Z-score 
across each developmental time series for each individual TSC. Following these 
normalization steps, the similarity of these Z-score “profiles” across 2 species was defined for 
each TSC as the Pearson R^2 for the 2 expression vectors being compared. Finally, the 
overall profile conservation metric used is the average Pearson R^2 across all possible species 
pairs. To compare the overall similarity between genome-wide expression profiles for the 
different species, the Z scores for all-time series for each species were registered to one 
another. Overall tightly conserved expression profiles were observed for genes with one-one 
orthologs across all species studied, even if the amount of conservation could be quite 
variable among different genes (Batut et al., 2017). 
 
During this analysis, thousands of novel promoters that could potentially drive the 
expression of long non-coding transcripts were found. To explore the functional relevance 
and pervasiveness of lncRNAs expression, the application of a phylogenetic framework 
allows the conservation of each lncRNA to be examined. In addition, RAMPAGE can 
pinpoint the TSSs with single-base resolution allowing for the identification of conserved 
  CHAPTER 3: Pilot screen for lncRNAs that function during Drosophila embryogenesis 
 
83 
sequence patterns. Starting with a list of 25,426 TSCs that have been confidently detected in 
Drosophila melanogaster through RAMPAGE, it was established that 3,682 of these TSCs 
could not be linked functionally to any Flybase annotation (protein-coding or small RNA 
gene). An additional 291 TSCs were identified to be associated with Flybase-annotated 
lncRNA genes, which brings the total number of putative lncRNA TSCs to 3,973. Despite the 
fact that lncRNA sequences are poorly conserved across species, both the primary sequence 
and the expression pattern of the identified lncRNA promoters was found to be conserved as 
many of them were found to be under a high degree of selective pressure compared to protein-
coding genes. It is hypothesised that these lncRNAs could potentially be playing a broad 
diversity of functions due to the similar expression patterns when compared to those of 
protein-coding genes. Furthermore, for the selection of a rigorous set of lncRNAs, a stringent 
boundary on the true number of conserved lncRNA promoters were placed. Emphasis was 
placed on those TSCs that were shared between all five Drosophila species and many TSCs 
have been filtered out solely because of the poorer quality of the genome assemblies. The 631 
TSCs that were confidently aligned to all genomes, as well as transcriptionally active in all 5 
species made up the list of potential lncRNA candidates (Figure 13). A high degree of 
promoter conservation was found in these TSCs, suggesting strong lineage-specific selective 
constraints.  
 
For the purpose of this study, initial emphasis was placed on the most highly 
transcribed TSCs in Drosophila melanogaster. Starting from the top of the list, the TSCs were 
ranked according to the conservation of their expression profiles across species. The final step 
of lncRNA candidate selection was based on a few criteria and was largely manual. We have 
selected TSCs with clean RAMPAGE signal, high-quality peak calls (minimum expression of 
at least 10 reads per million [RPM]), transcripts that were clearly independent of 
neighbouring units and preferentially those that were active during a short developmental 
window. The candidates were ranked accordingly and the first 20 candidates were selected. 
Two well-studied lncRNAs in Drosophila that satisfied all of these criteria were also included 
to serve as positive control. These are lncRNA-5 (FBgn0019661_05, rox1) and lncRNA-6 
(FBgn0020556_01, bxd). The biological function of the 20 potential lncRNA candidates will 
be studied in this project (Table 11).  
 





























  CHAPTER 3: Pilot screen for lncRNAs that function during Drosophila embryogenesis 
 
85 
Figure 12: A brief summary of the RAMPAGE library preparation protocol 
High quality, ribosome-depleted total RNA extracted from embryos is reverse-transcribed (RT) to 
synthesize first strand cDNA using a custom RT primer having an Illumina adaptor sequence 
overhang. During the reverse transcription reaction, amplifiable 5′-complete cDNAs are generated as a 
result of template switching by the reverse transcriptase induced by the presence of a template-
switching oligo (TSO) containing the other illumina primer, a unique barcode and three riboguanosine 
at its 3’ end. Oxidation and biotinylation of the 5’-m7G caps were used as part of the cap-trapping 
approach to bind the hybrid RNA/cDNA molecules to streptavidin beads. PCR amplification and size 
selection is carried out on the single-stranded cDNA released from the streptavidin-coated beads. The 
final RAMPAGE library is generated using custom oligonucleotides and can be directly sequenced on 
Illumina platforms. [Image taken from Batut et al., 2013]  
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Figure 13: Pipeline for the identification of potential lncRNA candidates. 
A genome-wide analysis of the core promoter activities during Drosophila embryogenesis was 
performed using RAMPAGE.  Hourly collection of embryos from five different Drosophila species 
allowed the examination of different promoter activity at various stages of development. The 
RAMPAGE reads were aligned to the respective Drosophila genomes with the 5’ end from each 
properly-paired read predicted as a potential transcriptional start site (TSS). Neighbouring TSS were 
grouped to form TSS clusters (TSC) and the raw read counts per TSC were normalized to library size 
for each sample, and subsequently expressed in reads per million uniquely mapped reads (i.e., RPM).  
A Z-score was obtained from the normalisation of RPM counts for each developmental time series for 
each individual TSC. A total of 2.2 x 104 to 2.7 x 104 TSCs were confidently identified from all five 
Drosophila species. Using all TSCs confidently detected in Drosophila melanogaster Replicate 1 
(25,426 TSCs), a total of 3,973 potential lncRNA TSCs not linked to any Flybase annotation were 
identified using paired-end RAMPAGE data. This number includes the 291 TSC associated with 
Flybase-annotated lncRNA genes. A stringent selection pipeline was chosen to identify TSCs that 
were confidently aligned to all genomes and also transcriptionally active in all 5 species. Following 
this analysis, 631 conserved lncRNA TSCs were confidently identified. Focusing on the most highly 
transcribed TSCs in Drosophila melanogaster, TSCs were ranked according to the conservation of 
their expression profiles across species. The final step of candidate selection was largely manual as we 
have picked TSCs with clean RAMPAGE signal, high-quality peak calls, transcripts that were clearly 
independent of neighbouring units and preferentially active during a short developmental window. The 
top 20 candidates were selected for further genetic screen to understand their functional relevance. 2 
known lncRNAs that satisfy all the criteria above (roX1 and bxd) were added to the list as positive 
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3.2.2 Analysis of lncRNA candidates in the new Drosophila genome assembly (dm6) 
 
With the introduction of the new Drosophila genome assembly (dm6, BDGP Release 
6 plus ISO1 MT), the “lift over” function on the UCSC genome browser was used to locate 
the new coordinates for each of the lncRNA candidates (Table 12).  The previous assembly of 
the Drosophila melanogaster genome (dm3, BDGP Release 5) was first used as the latest 
reference genome assembly (dm6, BDGP Release 6 plus ISO1 MT) was only released after 
the RAMPAGE analysis. During the changeover, the NCBI RefSeq and Ensembl databases 
were also updated and the number of annotated lncRNAs identified went up from 9 to 17. The 
functions of the newly annotated lncRNAs remained unknown. Noteworthily, lncRNA-8, 
which was previously identified as a non-coding RNA, had been annotated as a protein-
coding gene and will be removed from this study. Therefore, the total number of lncRNAs for 
this project became 21 instead of 22. The Coding-Non-Coding Index (CNCI) was applied to 
evaluate the coding potential of the 21 potential lncRNA candidates and all of them had a 
CNCI score of < 0, indicating that they were likely non-coding transcripts (Table 12). 
LncRNA-4, lncRNA-19 and lncRNA-22 had the best CNCI score (-0.0004096) of all the 
candidates.  
 
The TSS data generated using RAMPAGE was compared to the CAGE reads tracks 
provided by the EPD team at the Swiss Institute of Bioinformatics (Dreos et al., 2013). These 
tracks displayed information of putative TSS based on the 5′ end of transcripts (Chen et al., 
2014). In all cases, I did not observe any major inconsistencies between the TSS identified by 
CAGE and RAMPAGE. Although the CAGE reads do not align perfectly with the data from 
RAMPAGE all the time, transcripts for the lncRNA candidates were captured by both 
methods. The CAGE tracks provided by EPD for the dm6 genome assembly also contained 
additional information about the adult tissue (head, digestive system, testes, ovaries) and 
stage-specific (embryo, larvae, pupae) information for each transcript. This information 
provide us with the potential role that the lncRNA is involve in. For example, if a lncRNA is 
expressed in testes or ovaries, it is probably not involved in courtship behaviour All of the 
candidate lncRNAs transcripts were captured by CAGE during embryogenesis. However, the 
majority of them (16 out of 21) are not restricted to embryonic development and the 
transcripts were also found to be expressed during larvae and/or pupae development. Some of 
the candidates had tissue-specific expression and this information could give us clues as to the 
function of the lncRNA (Table 13). Some of the candidates had broad expression patterns and 
the transcripts was captured in almost all of the tissues (lncRNA-1, lncRNA-5, lncRNA-6) 
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whereas some had a specific tissue expression. I found that a subset of the candidates in our 
list had a specific expression in the head indicating a possible neurological or behavioural 
function (lncRNA-3, lncRNA-4, lncRNA-9, lncRNA-10, lncRNA-11, lncRNA-14, lncRNA-
15, lncRNA-21, lncRNA-22).  
 
3.2.3 Generation of fly lines for somatic CRISPR 
 
Generation of dual-gRNA expression constructs 
 
In order to determine if the disruption of a lncRNA candidate would have detrimental 
effects during development, I took advantage of the CRISPR/Cas9 system as a genome-
engineering tool to generate lncRNA mutants in Drosophila. A dual-gRNA expression 
construct strategy was utilized to target the lncRNA candidate of interest, as this would allow 
a defined, large genomic region to be deleted. It is relatively easy to create knockouts of 
protein-coding genes because a small deletion or insertion will disrupt the open reading 
frame, resulting in a non-functional gene product. Conversely, non-coding genes, especially 
lncRNAs, are very different. A small deletion or insertion may not necessarily result in a 
functional knockout as these lncRNAs lack open reading frames, some of these molecules 
have multiple functions which are likely connected to their three-dimensional structure and 
therefore it is extremely difficult to predict which parts of their primary sequence are 
essential. 
 
I have tested different strategies to achieve the production of the lncRNA mutants.  A pair 
of gRNA target sequences (20-nt) was selected for each lncRNA using online tools 
(http://www.flyrnai.org/crispr/) and cloned into the pCDF4 expression vector. The D. 
melanogaster genome assembly (dm3, BDGP Release 5) provided by the Berkeley 
Drosophila Genome Project (BDGP, http://www.fruitfly.org/) was used during the design of 
the gRNAs. The protocol and expression vector used (pCDF4) were similar to those 
previously described for Drosophila (Port et al., 2014). The pCDF4 vector contains two 
promoters – a U6-1 promoter and a U6-3 promoter – which drive the expression of each 
gRNA, respectively. Each genomic target sequence also harbours an NGG protospacer 
adjacent motif (PAM), which is required for Cas9 cleavage (Bassett et al., 2013). Primers 
were designed using the vector as a template. Each forward and reverse primer contains a 
proto-spacer sequence, an overlapping region with the promoter and an overlapping region 
with the gRNA core sequence (Figure 14). Both PCR fragments and digested vector were run 
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on a gel to check for the correct product. The size of the PCR fragments should be ~600 bp 
while the size of the digested vector should be ~6.4 kb (Figure 14). PCR products for all 
lncRNAs yield products of the same size and are not shown. The final construct was verified 
via sanger sequencing. The genomic coordinates for each of the gRNA can be found in 
Chapter 2 (Table 3). The genomic region excised for each lncRNA is shown in 
Supplementary Figures 5-16. 
 
Mutagenesis using somatic transgenesis produces mosaic patterns  
 
The dual-gRNA plasmid targeting the individual lncRNAs or the white gene, were 
injected into Drosophila embryos (attP40 GFP- RFP-: y[1] w* M{vasint.Dm}ZH2A;; attP40) 
using the phage phi31 site-specific integration system to establish stable fly lines. The white 
gene is found on chromosome X and its mutation results in a visible eye-colour change that is 
easily detectable in adult flies. In addition, single copy mutations will produce a visible eye 
phenotype in male flies. The dual-gRNA stable lines can then be crossed to appropriate Cas9-
expressing lines to generate mutants. I chose the strategy of separating the dual-gRNA and 
Cas9 expression in different lines because it guarantees better control of the system and 
potentially allows to study lethal mutants by using flies with conditional or tissue-restricted 
Cas9 expression.  For the first attempt I have decided to assess somatic mutagenesis by 
utilising for the crosses flies expressing Cas9 in somatic tissues. As a pilot test for the 
feasibility of this approach, I used the white gene to assess the penetrance of the 
CRISPR/Cas9 system. Crosses between dual-gRNA-white flies and Act5c-Cas9 expressing 
flies resulted in the following phenotypic outcome. Analysis of the offspring revealed that 
~25 % of the G1 had completely white eyes and ~25 % with wild-type eyes. The remainder 
(~50 %) produced varying degrees of mosaic eyes, with some eyes showing small red patches 
whereas others have large patches (Figure 14). The result of this preliminary experiment 
showed that only ¼ of the progeny generated by somatic mutation was fully mutant (white 
eyes) and all the rest of the flies were either a mosaic of mutant and wild-type cells or were 
completely wild-type. The somatic mutation strategy relies on nonhomologous end joining 
(NHEJ) repair. The overall low efficiency and a high probability of generating mosaic flies, 
makes it difficult to assess potential phenotypes. Moreover, the absence of an easy to follow 
marker was also a drawback of this initial strategy as significant time and effort would be 
needed to identify full lncRNA mutants in this approach. I therefore decided not to proceed 
further with this strategy and develop a more efficient approach to obtain full mutants and 
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easily select the mutant progeny. Nevertheless, the flies generated could potentially still be 
useful for conditional knockouts, if the mutant cells or tissues are identified. 
 
3.2.4 Genetic deletion of large genomic fragment using Cas9-HDR 
 
To overcome some of the limitations of the somatic transgenesis method described above, 
I decided to test the use of homology-directed repair (HDR) and germline-driven Cas9 as an 
improved strategy to generate lncRNA mutants as it allows for the germline mutations which 
gets rid of the mosaic issue. Having a mosaic pattern would be a big problem because it is 
unknown if the phenotype will be observable if only part of the cells is mutated. As the 
functions of the novel lncRNAs were unknown, I required a method able to reliably identify 
the geno- and phenotypes. Cas9-HDR was used to induce double-stranded breaks (DSBs) at 
the target loci and subsequent repair by HR using a donor construct containing a reporter for 
visual scoring. When the dual gRNAs guide the Cas9 protein to the target sites and cleave 
both DNA strands upstream of the PAM sequence, the DNA repair pathway is activated. If a 
donor plasmid containing homology arms close to the DSB site is present, it will act as repair 
template for HDR generating a knock-in of the repair template which might be designed to 
incorporate a reporter gene (Gratz et al., 2014). In order to replace the segment between the 
pair of gRNAs through HDR, a cocktail containing a donor construct with the appropriate 
homology arms and a selective marker and its respective dual-gRNA expression vector was 
injected into embryos expressing Cas9 in germ cells. Each donor construct contained a 3xP3 
promoter-driven red fluorescence protein (RFP) that is flanked by a pair of homology arms 
(approximately 1-1.5 kb in length each). In the event of a successful insertion, the RFP+ 
marker would replace the excised region by HDR and be visible in the adult eyes (Figure 16). 
Similar to the gRNAs, the homology arms were designed using the D. melanogaster genome 
assembly (dm3, BDGP Release 5) and visualised on the UCSC genome browser.  
 
In addition to the use of HDR to insert a visible marker to easily identify mutant founders, 
we decided to use flies expressing Cas9 in the germline to ensure the recovery of stable 
lncRNA mutant lines. For lncRNAs that were on the X chromosome, the plasmid pool was 
injected into embryos expressing Cas9 in the germline (TH_attP2: y[1] sc[1] v[1];; {y[+t7.7] 
v[+t1.8]=nanos-Cas9}attp2). The rest of the pools were injected into Cas9 expressing 
embryos under the control of vasa regulatory sequences (BL55821: y[1] M{vas-
Cas9.RFP-}ZH-2A w[1118]/FM7a, P{w[+mC] = Tb[1]}FM7-A). For each round of 
microinjection, the pool of gRNA and donor construct mix was injected into ~200 
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dechorionated embryos before cellularisation could take place (Figure 15). Staff at the 
Department of Genetics Fly facility performed the microinjection and subsequent isolation 
and backcrossing of RFP-positive flies to a balancer. The expression of the 3xP3-RFP cassette 
can be observed in larvae as well as in adult stages, thus flies with successful integration can 
be identified using a fluorescence dissecting scope. 
 
In previous studies, the targeting efficiency of CRISPR/Cas9 have been reported to 
fluctuate significantly depending on the locus (Bassett et al., 2013; Ren et al., 2014; Gratz et 
al., 2014; Port et al., 2014). For the candidates that were successfully established, the success 
rate of genomic integration of the 3xP3-RFP cassette was low to moderate.  Of the injected 
eggs that were viable for each lncRNA candidate, approximately 5 % of all embryos (200 
embryos) that were co-injection with a dual-gRNA plasmid and donor construct had 
successful integration. On the other hand, only 0.5 % of all the progeny were RFP+. The 
majority of mutants that were generated required two rounds of transformation in order to 
have positive founders. The plasmids had to be re-purified, quantified and pooled for the 
second round of embryo injection. 13 lncRNA mutants were created in this study whereas 
none of the remaining 9 candidates yielded RFP-positive progeny after two rounds of 
injection (Table 14). In order to validate the targeted events that had occurred in the RFP- 
positive flies, genomic DNA was isolated and PCR was performed using primers flanking the 












Figure 14: Somatic lncRNA transgenesis. 
CRISPR-Cas9 catalyzed genome engineering using nonhomologous end joining (NHEJ) repair 
system. (a) Each pair of gRNAs were designed to target the promoter region of the lncRNA of interest. 
PCR products for lncRNA-1 to lncRNA-12. The expected size of the PCR fragment is ~600-nt. The 
bands corresponding to the desired size were excised extracted. (b) pCDF4 backbone was digested 
with BbsI-HF and dephosphorylated with CIP. The digested vector was size-selected by gel 
electrophoresis and a size of ~6,400bp was expected as shown. Uncut vector was used as a control. (c) 
CRISPR/Cas9 induced deletions of white gene. Transgenic lines expressing dual-gRNAs were 
generated by standard PhiC31-integrase–mediated transformation using injected DNA constructs. The 
dual gRNAs were expressed by U6:1and U6:3 promoters. Act5c-Cas9 expressing Drosophila was 
used to cross with dual-gRNA expressing flies that target the white gene as a pilot test. The first 
generation produces flies with mosaic patterns in both males and female. Approximately 50 % of the 
flies had mosaic expression patterns with small to large red patches in their eyes.  
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Figure 15: Schematic diagram of creating Transgenic CRISPR flies using HDR.  
Genome editing with the use of homology-directed repair (HDR) mechanism to mend double-strand 
DNA breaks. This is a 2-parts strategy that requires a donor plasmid containing the repair template and 
the expression of gRNA from another DNA construct to be injected into embryos expressing Cas9. (a) 
The dual gRNA construct was generated using a forward and reverse primer sequence. Each 
oligonucleotide contains a gRNA sequence (black), a short sequence complementary to the 5’ end of 
the pCFD4 backbone as well as the 3’ end of the backbone. The dual gRNA plasmids have been 
generated previously in section 3.2.3 and will be used as one of the two DNA plasmids that will be 
injected into embryos. (b) A donor construct was generated and composed of a RFP expression 
cassette that is driven by a 3xP3 promoter. A pair of specific homology arms adjacent to genomic site 
to remove are amplified from Drosophila genomic DNA and cloned to flank the RFP cassette. (c) The 
dual-gRNA construct was co-injected with the donor construct into Cas9-expressing flies. The donor 
construct is used as a template during HDR to replace the endogenous lncRNA locus with the RFP 
cassette. The use of HDR permits precise incorporation of the reporter gene at the genomic loci of the 
lncRNA and the expression of the fluorescence protein in the adult eye allows easy identification of 
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3.2.5 Test of survival to adulthood 
 
To investigate the effects of the lncRNA mutation on the viability, heterozygous flies 
were crossed and their progeny were analysed for their ability to develop into an adult. The 
heterozygous mutant stocks possessed the lncRNA mutation over the balancer 
(balancer/mutant) and the crosses were maintained at normal temperature (25 °C). The total 
number for each genotype from the cross (balancer/mutant, mutant/mutant) were counted and 
the ratio of heterozygous/homozygous progenies was used to evaluate viability. From each 
cross, a 2:1 ratio of heterozygous to homozygous, lncRNA mutant flies is expected if the 
mutation is not lethal. However, there would be a change in the ratio if the knockout was 
lethal. The results of the crosses are shown in Table 15. LncRNA-3 and lncRNA-9 null 
mutants were found to be homozygous lethal. All of the progeny from these crosses were 
heterozygous mutants and none of them were homozygous for the lncRNA mutation, 
providing evidence that these two lncRNAs are essential for survival. For the other lncRNA 
mutants, I did not observe a change in the heterozygous/homozygous ratio, indicating that 
these lncRNAs are not essential for viability. 
 
3.2.6 Validation of lncRNA mutagenesis  
 
Validation with the use of deficiency line 
 
For the lncRNA mutants with significant changes in the heterozygous/homozygous 
ratio, several methods were used to probe their viability. It has been shown in several studies 
that besides knockdown using siRNAs, CRISPR/Cas9 genome engineering was also an 
imperfect system and prone to off-target effects (Mali et al., 2013, Cradick et al., 2013, 
Schaefer et al., 2017, Hsu et al., 2013). These off-target mutations in other regions of the 
genome have been reported in other model organisms due to the binding specificity of each 
gRNA. Depending on the loci targeted and the design of the gRNA, the effect observed may 
vary from one gRNA to another. In this study, although the guide RNAs were selected with 
the highest stringency and sequences with no predicted off-target effects were chosen during 
the design phase, additional measures had to be taken to ensure that the potential off-targeting 
loci in lncRNA mutants were minimised and not affecting sequences in the genome that are 
influencing expression of nearby genes. The first strategy to verify the phenotype observed 
was to perform a genetic cross between the lncRNA heterozygous mutant and a deficiency 
(Df) line collection of Drosophila melanogaster that were generated with chromosomal 
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aberrations yet maintaining an isogenic background in the remainder of the genome (Ryder et 
al., 2007). Most of these deletions are homozygous lethal and thus the deletions are kept in 
heterozygosity. The deficiency lines were obtained from Bloomington Drosophila Stock 
Centre and listed in Table 1. To unambiguously determine the link between the lethality and 
the lncRNA, the Bloomington deficiency line, Df(3L)ED4457 (BL9355) was crossed to 
lncRNA-3 heterozygous mutants, whereas Df(3L)BSC414 (BL24918) and Df(3L)BSC432 
(BL24936) were used for the cross with lncRNA-9 heterozygous mutants (Figure 16a and 
Figure 16b respectively).  
 
In case the lncRNA is required for viability, mutant/Df flies would not be observed in 
the next generation and the expected ratio would be skewed towards heterozygous flies. If the 
lethal phenotype observed in the homozygous CRISPR lines was due to an off-target effect, 
the mutant/Df flies would instead be expected to be viable as the two allele will complement 
each other. For lncRNA-9, both deficiency lines contained a deletion covering the lncRNA-9 
genomic locus and only heterozygous flies were observed indicating that the deletion 
contained essential genes for survival (Figure 16b). In this case, I found that the none of the 
crosses produced KO/Df flies, indicating that the lncRNA was indeed required for survival. 
For lncRNA-3, Df(3L)ED4457 (BL9355) was the only fly stock available whereby the 
deleted segment in the deficiency line overlaps with miR-276a and only partially coincided 
with the 3’ end of the lncRNA transcript. When the deficiency line was crossed to the 
lncRNA heterozygous siblings, flies that were Df/lncRNA-3-/- were found to be viable. The 
result suggests that the lncRNA-3 mutant phenotype observed is likely due to an off-target 
effect. However, the result has to be taken with caution as it might also highlight that the 
5’end of the lncRNA transcript is sufficient for its function, with deletions of the 3’end 
tolerated. A similar cross was performed with a validated knockout strain for mir-276a 
(BL58906). In the F1 generation, flies with the Df/mir-276a-/- genotype was also found to be 
viable. The presence of viable Df/mir-276a-/- flies might also indicate that the annotation of 
this deficiency might be incorrect. Further investigation will be needed to validate this mutant 
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Figure 16: Validation of lncRNA mutagenesis  
(a,b) Genome browser view of lncRNA-3 and lncRNA-9. (a) Df(3L)ED4457 (BL9355) is a deficiency 
line found on the third chromosome. The cytological bands 67E2 through 68A7 shows the position of 
the deficiency strains used for complementation tests with lncRNA-3.  This deficiency line only 
overlaps partially at the 3’ end with lncRNA transcript. (b) As lncRNA-9 was unannotated in the 
genome browser, the arrows (green) were used to indicate the approximate location of the lncRNA. 
The lncRNA is located between CG13723 and lncRNA:CR45436 (indicated by green arrow). 
Df(3L)BSC414 (BL24918) is a deficiency line that encompasses a deletion from cytological band 
73E1 to 74C3 whereas Df(3L)BSC432 (BL24936) includes a deletion from cytological band 73F2 to 
74E4. Both deficiency lines overlap with the lncRNA locus and were used to validate the lncRNA 
phenotype.  (c) Insertion of SV40 transcriptional stop signal into lncRNA loci using Cas9-HDR. A 
donor construct was generated and contained a SV40 transcriptional stop signal sequence that is 
flanked by a pair of specific homology arms that are cloned from Drosophila genomic DNA. The 
gRNA construct was co-injected with the donor construct into Cas9-expressing flies and used as a 
template during HDR replacing the endogenous lncRNA locus with the SV40 stop signal. With the 
introduction of an early polyA signals close to the TSS to terminate transcription, a presumably non-
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LOF mutation following integration of transcriptional termination signal 
 
A parallel approach to prove the specificity of the observed phenotype was undertaken by 
inserting a transcriptional stop signal (SV40) downstream of the transcriptional start site 
(TSS) for lncRNA-3 and lncRNA-9 using CRISPR/Cas9. We argue that this method would 
give us an independent mutation that was different from the knock-in and it was also 
improbable for the same off-target effects to be observed using different gRNAs. Details of 
the cloning strategy are shown in Figure 15c. Instead of a dual-gRNA strategy, I opted for a 
single cut strategy with the use of a gRNA to target the genomic loci of the lncRNA. The aim 
of this approach is to insert a transcriptional stop signal cassette into the cut site. The gRNA 
target sequence (20-nt) was again selected using online tools (http://www.flyrnai.org/crispr/) 
and cloned into the pCDF3 expression vector. For each lncRNA candidate, 2 gRNAs that 
target different regions of the lncRNA transcript were designed to be close to the TSS and 
more than 1000 nucleotides away from any annotated gene. Similarly, the protocol and 
expression vector used (pCDF3) used were described for Drosophila earlier (Port et al., 
2014). The pCDF3 vector containing a U6-3 promoter that drives the expression of the 
gRNA. The protocol used for the Cas9-HDR design in paragraph 3.2.4 was taken to clone the 
donor vector. The final constructs were verified via sanger sequencing prior to fly injection 
(Figure 15c).  
 
The pool containing a single gRNA with one donor was injected into Cas9 expressing 
embryos under the control of vasa regulatory sequences (BL55821: y[1] M{vas-
Cas9.RFP-}ZH-2A w[1118]/FM7a, P{w[+mC] = Tb[1]}FM7-A). Due to the low efficiency 
of the Cas9 mutagenesis, I requested the injection of ~400 embryos (equivalent to 2 
microinjection) with each pool set. As the donor plasmids do not contain any selection 
marker, the founders had to be screened by PCR and sanger sequencing. For the first round of 
microinjection, no positive insertion was detected from the PCR screen that was carried out 
on 60-80 viable founders from each pool. A second round of microinjection (~400 embryos) 
was performed with re-purified plasmids and the founders were screen for positive insertion 
using the same method. Out of the 2 gRNAs that were used to target lncRNA-9, positive 
founders were found from one of them (pES103a, pES107c) and the fly stock were balanced 
(Table 16). A similar viability assay in section 3.2.5 was performed with the two lncRNA-9 
mutant lines using heterozygous mutants and the null mutants were found to be homozygous 
lethal, confirming the earlier results observed with the CRISPR HDR mutant line for 
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lncRNA-9 (Table 15). For lncRNA-3, also the second round of microinjection failed to 
generate positive founders for both gRNAs (Table 16). 
 
3.2.7 LncRNA-9 is essential for the completion of embryogenesis 
 
The assay probing the survival to adulthood identified two lncRNAs, lncRNA-3 and 
lncRNA-9, as required for Drosophila development, with null mutants for these lncRNA 
candidates not surviving to the adult stage. To investigate at which stage of development 
these mutants perish, the embryos (wildtype, sibling heterozygous mutant and homozygous 
mutant) were plated in a 6 x 48 well plates containing cornmeal and allowed to develop at 
25 °C for at least 36 hr. For each lncRNA candidate, the heterozygous were sorted from the 
homozygous mutants by hand using the YFP signal from fluorescence balancer. From this 
screen, I found that both heterozygous and homozygous null mutant embryos for lncRNA-3 
were viable as they emerge into first instar larvae and phenotypically indistinguishable from 
the control wild-type embryos. This suggesting that despite the fact that lncRNA-3 is 
expressed at embryonic stages, it is not essential for embryonic development which can still 
complete successfully in its absence. On the other hand, the majority of the lncRNA-9 
homozygous null mutant embryos failed to hatch (Figure 17a). A close examination of these 
embryos under a brightfield microscope revealed that some of them were still viable as they 
appeared to be moving their mouthpiece within the membrane. A very small proportion of the 
lncRNA-9 homozygous null mutant embryos hatched into first instar larvae but their growth 
arrested and they died before the second instar stage (Supplementary figure 1).  
 
3.2.8 Homozygous lncRNA-3 null mutants were embryonic viable but die during 
pupation 
 
In order to decipher the in vivo consequences of lncRNA-3 loss of function, the larvae 
obtained from the embryogenesis screen (section 3.2.7) were transferred to fresh vials and 
incubated at 25 °C. The heterozygotes displayed similar viability as wildtype control larvae 
and completed metamorphosis as they continued to develop through larval and pupal stages 
(Figure 17b). On the other hand, the lncRNA-3 homozygous null embryos survived 
embryogenesis and hatched into first instar larvae. They are able to complete all stages of 
larval development (Figure 17b).  However, they arrest during pupation and eventually 
developed into pharate adults without emerging from the puparium (Figure 17c). A separate 
gross examination of the homozygous null mutants revealed that during the larval-pupal 
  CHAPTER 3: Pilot screen for lncRNAs that function during Drosophila embryogenesis 
 
102 
transition, the larvae appeared to have developed to different extents compared to wildtype 
and heterozygous siblings (Supplementary figure 2). Compared to wildtype and heterozygous 
larvae, it took the 3rd instar larvae of the homozygous mutant more than 24 hrs to begin 
crawling up the side of the vial and enter the pupal stage. The vials containing homozygous 
mutants were allowed to developed for a total of 30 days from the time that the embryos were 
collected and checked every five days. I observed that the mutants were at different stages of 
pupal development and at the end of 30 days, all of them were arrested at the pharate adult 
stage. The pharate adults were subsequently removed from their puparium and examined 
under a dissection microscope. In contrast to a control flies, the head of the pharate adults 
were located much more anteriorly than normal and was unable to extend fully 
(Supplementary figure 3). 
 
3.2.9 Expression of miR-276a is independent of lncRNA-3  
 
To further investigate the biological function of lncRNA-3, we looked at its genomic 
locus and found that the transcript for the lncRNA candidate did not overlap with any 
annotated coding and noncoding genes when the RAMPAGE data was mapped to the D. 
melanogaster genome assembly (dm3, BDGP Release 5). However, following lift-over of the 
lncRNA to the latest genome assembly (dm6, BDGP Release 6 plus ISO1 MT), five different 
isoforms were identified for lncRNA-3. Surprisingly, all of the isoforms for lncRNA-3 
overlapped with the Drosophila microRNA miR-276a. This miRNA was initially found to be 
located >37Kb downstream of lncRNA-3 in the previous genome assembly. Previous studies 
have shown that a recessive lethal mutation of miR-276a is associated with Drosophila 
learning behaviour. To investigate whether the mutation of the lncRNA-3 transcript had a 
detrimental effect on the expression of miR-276a, we performed a complementation cross 
between the heterozygous mutants for the lncRNA and miR-276a (BL58906: w*; TI{TI}mir-
276aKO/TM3, P{GAL4-twi.G}2.3, P{UAS-2xEGFP}AH2.3, Sb1 Ser1). The lncRNA 
deletion complemented the lethality and confirmed that decreased viability observed in our 
lncRNA-3 mutant could not be ascribed  to the loss of miR-276a activity. This observation 
excludes that our mutation strategy could have inadvertently generated the loss of essential 
DNA sequences driving miR-276a expression and it also confirms that the expression of miR-
276a is independent of that of lncRNA-3 (Figure 18).  
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Figure 17: Analysis of lncRNA mutants at different stages of development 
(a) Mutants of lncRNA-9 display reduced embryo viability. In the screen for completion of 
embryogenesis, the frequency of egg-hatching was used as a measurement of embryo viability. The 
embryos were collected and plated in 48-well plates containing apple juice agar and incubated at 
25 °C for further development. A total of six data points were collected (n=288). The number of larvae 
that have emerged were counted and plotted in percentage as a function of survival relative to 
wildtype controls. (b) LncRNA-3 is not necessary for larval development. To extent the analysis, the 
larvae that hatched were allowed to continue developing in fresh vials containing cornmeal at 25 °C. 
The number of third instar larvae that have emerged from the food and have undergone pupation were 
counted and plotted in percentage as a function of survival relative to wildtype. Although majority of 
lncRNA-3 mutants undergoes pupation, a significant increase in mortality is observed in homozygotes 
during the larval-pupal transition when compared to both controls and heterozygotes. In addition, the 
homozygous mutant larvae for lncRNA-3 completed larval development at a much slower rate 
compared to the wildtype and heterozygous mutants. For lncRNA-9 homozygous null mutants, the 
escapees arrested at the first instar larval stage and did not complete the larval life cycle. (c)  
LncRNA-3 mutant is necessary for eclosion. The pupae that have completed pupation and emerged 
into adult fruit flies were counted and plotted similarly to the earlier stages of development. Flies 
carrying homozygous mutation for lncRNA-3 were found to develop to pharate adults but did not 
emerge from the eclosion. Homozygous null mutants for lncRNA-9 were omitted from the analysis as 
the mutants were mainly embryonic/larval lethal. A comparison of the wildtype with the lncRNA-9 
heterozygous siblings did not display any statistical difference in development following pupation. Bar 
graphs represent mean values and error bars are ± SEM. The statistical significance was determined 

























Figure 18: Expression of lncRNA-3 is independent of Drosophila miR-276a.  
miRNA-276a overlaps with the 3’ end of lncRNA-3. A genetic cross was carried out to determine if 
the progeny carrying the lncRNA-3 mutant allele and the miR-276a[KO] allele were viable. The 
parental strains were used as control. The number of adult offspring was counted and each column 
represents the fraction of the total number of progenies. For both lncRNA and miRNA single mutants, 
only heterozygous siblings were viable. However, the lncRNA-3/miR-276a double mutants were 
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3.2.10 Male and female fertility test 
 
LncRNAs have previously been reported to be required for the fertility of an organisms 
and to be important for proper spermatogenesis and ovary development in Drosophila (Wen 
et al., 2016; Nyberg et al., 2016). To investigate if any of the lncRNAs under analysis had a 
role in fertility, genetic crosses were setup using homozygous viable lines and wildtype flies. 
The experiment was performed using a protocol described earlier (Chen et al., 2014). To set 
up the crosses, freshly hatched wildtype males and null mutant virgin females were collected 
in separate vials and mated after 3 days (Figure 19). A reciprocal cross was also set up as 
shown in Figure 19. Each vial was visually examined to ensure eggs had been laid after 5 
days and the parents were discarded. The total number of larvae was recorded. A male/female 
will be considered to be sterile if there were no larvae hatched in any vial, and fertile if there 
were more than 10 larvae in each vial. The mutant would be considered to show reduced 
fertility in the event that there were between 1 to 10 larvae in each vial. LncRNA-3 and 
lncRNA-9 were excluded from this experiment as they do not generate homozygous mutant 
adults. Overall, I did not observe sterility for any of the novel lncRNA null mutants in either 
of the reciprocal crosses. I have also dissected the ovaries of all homozygous lncRNA mutants 
and did not observe different morphology compared to wildtype ovaries (Figure 19). 
Therefore, I concluded that none of the eleven lncRNAs under analysis has a role in fertility 
in either male or female flies.  
 
3.2.11 Simple larvae locomotion assay 
 
LncRNAs have also been reported to contribute to cognition and behavioural changes (Li 
et al., 2012). To investigate if any of the candidates had a locomotion defect, 50 null mutants 
from each lncRNA candidate were transferred onto a larva crawling assay. The assay setup is 
shown in Figure 20a. Yeast paste was placed behind the finishing line and used as a food 
attractant for the larvae. The larvae were arranged behind the starting line and the number of 
larvae that crossed the finishing line was scored at the end of the test (after 30 min). I found 
no significant differences between the tested lncRNA null mutants and the wildtype flies 
(Figure 20b). I have also collected ten lncRNA-9 homozygous null first instar larvae and 
assayed them in this setup. None of the larvae moved beyond the starting line, thus they 
appear to have a locomotion defect. Due to the small number of mutants used and the fact that 
these larvae are likely to have additional defects, however, the data for lncRNA-9 was not 
included in the data analysis for this test. 
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3.2.12 Gross anatomical examination of the adult fruit fly 
 
To investigate if any of the lncRNA null mutants had any anatomical abnormalities, I 
performed a gross examination of the external morphology of the lncRNA mutant adult flies 
using six qualities (a pair of wings, a pair of halteres, 3 pair of legs, a head, thorax and the 
eight abdominal segments). Wildtype flies were used as a reference point when the 
comparisons were made. For each lncRNA candidate, six heterozygotes and six homozygous 
null mutants were examined carefully under a dissecting microscope for any possible 
developmental defects (three males and females each). Except for lncRNA-6 (bxd) 
homozygous null mutants, I did not observe anatomical differences in any of the lncRNA 
mutants. For bxd lncRNA, it was previously reported that the pair of halteres is replaced by a 
second pair of wings in the bxd mutant (Lewis, 1978; Bassett et al., 2014). Here, besides a 
partial transformation of the halteres in homozygous mutant adults, I did not find any other 
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Figure 19: Individual lncRNA have no overt function in fertility  
A fertility screen was set up using a reciprocal genetic cross between wildtype flies and homozygous 
null lncRNA mutants. In this experimental setup, ten crosses were performed with each vial 
containing a single male and virgin female fly (10 replicates). Cross #1 was set up using a 
homozygous null virgin female with a wildtype male. Cross #2 was performed using a homozygous 
null male with a wildtype virgin female to determine if either male or female mutant are sterile or 
showed reduced fertility. For both crosses, the parents were discarded after five days and the total 
number of larvae that hatched from the vials were counted. For each vial, the male or female mutant 
were considered to be sterile if no larvae were found, low fertility if there were between 1-10 larvae 
and fertile if there were more than ten larvae observed in each vial. From this screen, the majority of 
lncRNA mutant flies were fertile and an average of 12 larvae were counted in each vial. For bxd 
lncRNA (lncRNA-6), the number of embryos that hatched were between 1-10 and thus it was 
considered to be lowly fertile. No significant difference was observed between lncRNA homozygous 
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Figure 20: LncRNA mutation did not affect larvae locomotion.  
(a) Schematic representation of the larval crawling assay performed on an apple juice agarose plate.  
(b) The larval crawling assay of wild-type (WT) and the various homozygous lncRNA mutants 
generated. The lncRNA candidates (lncRNA-3 and lncRNA-9) with a homozygous lethal phenotype 
were excluded from this assay. Larvae (n = 50 each per datapoint) were plated behind the starting line 
and allowed to crawl to toward the yeast paste without any interference. The number of larvae that 
crosses the finishing line were scored after 30 min (Not to scale). For each genotype, a total of 5 data 
points were collected. During each new set of experiment, a fresh agar plate containing fresh yeast 
paste was used. No significant difference was observed between lncRNA homozygous mutants and 
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1 FBgn0051781_01 chr2L:16869345-16869508 + 2.58 CR31781 4.57E-02 CG6012 1.35 8.07 CG32832 0.68 0.30 
2 FBgn0264479_01 chr3L:11686221-11686254 + 0.53 CR43887 1.3E-01 CG14135 1.11 0.38 CG11652 3.13 0.19 
3 FBgn0265415_02 chr3L:10319728-10319881 + 9.40 - 6.92E-07 Or67d 1.42 52.00 CG12362 1.96 86.19 
4 FBgn0050009_02 chr2R:6151308-6151344 - 2.50 
CR30009-
RA 8.36E-04 CG12911 4.59 1.32 CG12910 2.34 3.03 
5 FBgn0019661_05 chrX:3756065-3756103 - 2.45 roX1-RA 5.53E-04 ec 45.68 1.27 yin 5.36 0.54 
6 FBgn0020556_01 chr3R:12598828-12598999 - 1.26 Bxd-RC 1.86E-02 Ubx 78.25 9.29 Glut3 1.71 15.12 
7 FBgn0263380_02 chr3L:14970662-14970908 - 0.69 - 3.38E-02 Ocho 1.19 0.59 CG3349 2.24 2.48 
8 FBgn0047095_01 chrX:19068891-19068949 - 0.55 
pncr004:X-
RA 1.70E-02 Inx5 1.89 0.44 CG7556 2.98 2.10 
9 RAMPAGEpeak_002227 
chr3L:17262841-
17262866 + 0.70 - 6.11E-08 CG13723 0.33 4.91 CG6485 0.85 50.22 
10 RAMPAGEpeak_005280 
chr3L:13106986-
13107015 - 0.77 - 7.97E-03 CG11251 1.39 23.90 trn 3.82 0.39 
11 RAMPAGEpeak_006440 
chr2L:20484386-
20484497 + 0.90 - 4.98E-03 CG2493 1.87 20.94 CG34007 0.34 10.61 
12 RAMPAGEpeak_008667 
chr2L:17585024-
17585143 - 0.37 - 1.11E-01 CG7094 1.41 29.26 Oli 1.76 4.48 
13 RAMPAGEpeak_011922 
chrX:7160282-
7160322 - 0.73 - 1.53E-01 CG9650 13.97 25.83 CG1958 0.98 0.66 




The information in this table relate to the mapping of the lncRNAs on the dm3 Drosophila genome. The first column indicates the lncRNA number, the second 
indicates the name of the RAMPAGE peak for unknown lncRNAs or the ID for already annotated lncRNAs. The column highlighted in blue indicates the direction 
of transcription in the genome. The neighbouring protein-coding genes closest to the lncRNA are indicated and their direction of expression relative to the lncRNA is 

































5437834 + 0.83 - 2.38E-02 CG1888 1.78 3.28 CG12931 1.47 9.36 
15 RAMPAGEpeak_016800 
chr2R:9250322-
9250340 - 1.01 - 5.47E-03 CG17048 0.53 8.49 CG10814 1.74 13.15 
16 RAMPAGEpeak_018802 
chr3R:22519840-
22519855 + 0.59 - 2.68E-02 TwdlQ 0.89 0.60 amon 16.46 3.58 
17 RAMPAGEpeak_024168 
chr3R:22443183-
22443186 - 0.76 - 2.87E-03 CG5467 6.39 13.44 TwdlM 1.11 1.66 
18 FBgn0264857_02 chr3R:12748808-12749095 - 2.63 iab-8 5.01E-03 Abd-A 22.41 1.08 Abd-B 6.90 4.59 
19 FBgn0264857_05 chr3R:12674246-12674550 - 1.72 iab-8 1.49E-02 Abd-A 22.41 1.08 Abd-B 6.90 78.85 
20 FBgn0262972_01 chr3R:7081835-7081859 - 3.48 CR43283 5.01E-03 CG5214 2.58 1.24 KP78b 2.08 90.25 
21 RAMPAGEpeak_001315 
chr3L:10299762-
10299782 + 7.94 - 1.02E-05 Or67d 1.42 32.04 CG12362 1.96 106.15 
22 RAMPAGEpeak_021570 
chr3R:8070463-
8070515 + 0.36 - 1.73E-02 Cyp313a3 1.83 5.63 CG3942 2.41 9.45 
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Table 12: LncRNA Candidates and their Coordinates (dm6) 
 
LncRNA- ID TSS_Coordinates (dm6) *CNCI score Flybase Annotation Remarks 
1 FBgn0051781_01 chr2L:16869345-16869508 -0.0937984 CR31781 - 
2 FBgn0264479_01 chr3L:11693121-11693154 -0.0958464 CR43887 - 
3 FBgn0265415_02 chr3L:10326628-10326781 -0.0225280 CR46006 Overlaps with miR-276a 
4 FBgn0050009_02 chr2R:10263803-10263839 -0.0004096 CR30009 - 
5 FBgn0019661_05 chrX:3862032-3862070 -0.0393216 roX1 - 
6 FBgn0020556_01 chr3R:16773106-16773277 -0.0532480 bxd Overlaps with CG31275 
7 FBgn0263380_02 chr3L:14977562-14977808 -0.0303104 CR43432 - 
8 FBgn0047095_01 chrX:19174858-19174916 - CG33939 Protein-coding gene 
9 RAMPAGEpeak_002227 chr3L:17269741-17269766 -0.0860160 - May overlap with CR45436 
10 RAMPAGEpeak_005280 chr3L:13113886-13113915 -0.0532480 - - 
11 RAMPAGEpeak_006440 chr2L:20484386-20484497 -0.0536576 CR45361 Overlaps with miR-1 and CR44980 
12 RAMPAGEpeak_008667 chr2L:17585024-17585143 -0.0176128 CR45112 - 
13 RAMPAGEpeak_011922 chrX:7266249-7266289 undetermined Intronic region of CR44357? - 




*Transcripts with a CNCI score of less than 0 would be considered as non-coding. Due to lack of transcript structural information, three of the lncRNA candidates 
were not identified and the scores were underdetermined using CNCI.  
 
The information in this table refer to the lncRNA lift-over from dm3 to the dm6 Drosophila genome. LncRNA-8 was highlighted in grey as it was annotated as a 






LncRNA- ID TSS_Coordinates (dm6) *CNCI score Flybase Annotation Remarks 
14 RAMPAGEpeak_015813 chr2R:9550238-9550329 undetermined - - 
15 RAMPAGEpeak_016800 chr2R:13362817-13362835 -0.1187840 CR45312 - 
16 RAMPAGEpeak_018802 chr3R:26694118-26694133 -0.0245760 - - 
17 RAMPAGEpeak_024168 chr3R:26617461-26617464 undetermined -  
18 FBgn0264857_02 chr3R:16923086-16923373 -0.0253952 iab-8 Overlaps with iab-4 and CR43617 
19 FBgn0264857_05 chr3R:16848524-16848828 -0.0004096 iab-8 - 
20 FBgn0262972_01 chr3R:11256113-11256137 -0.0823296 CR43283 - 
21 RAMPAGEpeak_001315 chr3L:10306662-10306682 -0.0159744 CR46004 - 
22 RAMPAGEpeak_021570 chr3R:12244741-12244793 -0.0004096 CR45582 - 
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Table 13: Stage- and tissue-specific information of lncRNA candidates 
 




1 FBgn0051781_01 1 1 1 1 1 1 0 
2 FBgn0264479_01 1 0 0 0 0 0 0 
3 FBgn0265415_02 1 1 1 1 0 0 0 
4 FBgn0050009_02 1 1 1 1 0 0 0 
5 FBgn0019661_05 1 1 1 1 1 1 0 
6 FBgn0020556_01 1 1 1 0 0 0 0 
7 FBgn0263380_02 1 1 1 1 1 0 0 
8 FBgn0047095_01 - - - - - - - 
9 RAMPAGEpeak_002227 1 1 1 1 0 0 0 
10 RAMPAGEpeak_005280 1 1 1 1 0 0 0 
11 RAMPAGEpeak_006440 1 1 1 1 0 0 0 
12 RAMPAGEpeak_008667 1 0 0 0 0 0 0 
13 RAMPAGEpeak_011922 1 0 0 0 0 0 0 












This table contains information on the expression of the lncRNA during development according to CAGE reads tracks in Dreos et al., 2013. For any tissue or stage, 
the number “1” was used to denote expression and “0” to indicate an absence of the transcript.  













14 RAMPAGEpeak_015813 1 1 1 1 0 0 0 
15 RAMPAGEpeak_016800 1 1 1 1 0 0 0 
16 RAMPAGEpeak_018802 1 0 0 0 0 0 0 
17 RAMPAGEpeak_024168 1 0 0 0 0 0 0 
18 FBgn0264857_02 1 1 0 0 0 0 0 
19 FBgn0264857_05 1 1 0 0 0 0 0 
20 FBgn0262972_01 1 1 1 0 0 0 0 
21 RAMPAGEpeak_001315 1 1 1 1 0 0 0 
22 RAMPAGEpeak_021570 1 1 1 1 0 0 0 
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Table 14: CRISPR microinjection results (TSS replacement with 3xP3-RFP cassette) 
 
LncRNA- ID Dual-gRNA plasmid 
# 




Cas9 strain used 
# of founders / 
injection cycle Overall 
Success 
rate 1st 2nd 
1 FBgn0051781_01 pES_1 pES_31 TSS-del 1.67 BL55821 0 0 0 % 
2 FBgn0264479_01 pES_2 pES_32 TSS-del 0.63 BL55821 0 0 0 % 
3 FBgn0265415_02 pES_3 pES_33 TSS-del 1.76 BL55821 0 3 < 1 % 
4 FBgn0050009_02 pES_4 pES_34 TSS-del 0.24 BL55821 0 3 < 1 % 
5 FBgn0019661_05 pES_5 pES_35 TSS-del 1.00 TH_attP2 3 - < 1 % 
6 FBgn0020556_01 pES_6 pES_36 TSS-del 0.96 BL55821 2 - < 1 % 
7 FBgn0263380_02 pES_7 pES_37 TSS-del 1.25 BL55821 0 0 0 % 
8 FBgn0047095_01 pES_8 pES_38 TSS-del 1.12 TH_attP2 0 0 0 % 
9 RAMPAGEpeak_002227 pES_9 pES_39 TSS-del 1.00 BL55821 0 1 < 1 % 
10 RAMPAGEpeak_005280 pES_10 pES_40 TSS-del 1.59 BL55821 0 3 < 1 % 
11 RAMPAGEpeak_006440 pES_11 pES_41 TSS-del 2.04 BL55821 4 - < 1 % 
12 RAMPAGEpeak_008667 pES_12 pES_42 TSS-del 0.92 BL55821 4 - < 1 % 
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LncRNA- ID Dual-gRNA plasmid Donor plasmid Deletion 
type 
Deletion Size 
(Kb) Cas9 strain used 
# of founders / 
injection cycle Overall 
Success 
rate 1st 2nd 
13 RAMPAGEpeak_011922 pES_13 pES_43 TSS-del 1.28 TH_attP2 0 3 < 1 % 
14 RAMPAGEpeak_015813 pES_14 pES_44 TSS-del 0.87 BL55821 4 - < 1 % 
15 RAMPAGEpeak_016800 pES_15 pES_45 TSS-del 0.79 BL55821 3 - < 1 % 
16 RAMPAGEpeak_018802 pES_16 pES_46 TSS-del 0.86 BL55821 0 3 < 1 % 
17 RAMPAGEpeak_024168 pES_17 pES_47 TSS-del 1.35 BL55821 0 0 0 % 
18 FBgn0264857_02 pES_18 pES_48 TSS-del 2.54 BL55821 0 0 0 % 
19 FBgn0264857_05 pES_19 pES_49 TSS-del 2.00 BL55821 0 2 < 1 % 
20 FBgn0262972_01 pES_20 pES_50 TSS-del 1.03 BL55821 0 0 0 % 
21 RAMPAGEpeak_001315 pES_21 pES_51 TSS-del 2.16 BL55821 0 0 0 % 
22 RAMPAGEpeak_021570 pES_22 pES_52 TSS-del 2.53 BL55821 0 0 0 % 
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Table 15: Drosophila melanogaster viability test results 
 
Viability Assessment of KO lines 





Stocks with lncRNA TSS removed and replaced with 3xP3-RFP cassette 
w*; +; lncRNA-3 [RFP+]/Tm3-YFP 2M 166 0 3:0 
w*; +; lncRNA-3 [RFP+]/Tm3-YFP 3M 148 0 3:0 
w*; +; lncRNA-3 [RFP+]/Tm3-YFP 6M 161 0 3:0 
w*; lncRNA-4 [RFP+]/CyO-YFP; + 1M 127 72 ~2:1 
w*; lncRNA-4 [RFP+]/CyO-YFP; + 3M 127 77 ~2:1 
w*; lncRNA-4 [RFP+]/CyO-YFP; + 5M 111 51 ~2:1 
lncRNA-5 [RFP+]/Fm7-YFP; +; + 1M 169 95 ~2:1 
lncRNA-5 [RFP+]/Fm7-YFP; +; + 2M 174 80 ~2:1 
lncRNA-5[RFP+]/Fm7-YFP; +; + 3M 175 88 ~2:1 
w*; +; lncRNA-6 [RFP+]/Tm3-YFP 2M 96 23 ~2:1 
w*; +; lncRNA-6 [RFP+]/Tm3-YFP 4M 87 26 ~2:1 
w*; +; lncRNA-9 [RFP+]/Tm3-YFP 1M 168 0 3:0 
w*; +; lncRNA-10 [RFP+]/Tm3-YFP 1M 125 86 ~2:1 
w*; +; lncRNA-10 [RFP+]/Tm3-YFP 3M 140 87 ~2:1 
w*; +; lncRNA-10 [RFP+]/Tm3-YFP 5M 158 90 ~2:1 
w*; lncRNA-11 [RFP+]/CyO-YFP; + 1M 144 66 ~2:1 
w*; lncRNA-11 [RFP+]/CyO-YFP; + 2M 161 49 ~2:1 
w*; lncRNA-11 [RFP+]/CyO-YFP; + 3M 125 61 ~2:1 
w*; lncRNA-11 [RFP+]/CyO-YFP; + 4M 150 71 ~2:1 
w*; lncRNA-12 [RFP+]/CyO-YFP; + 1M 111 48 ~2:1 
w*; lncRNA-12 [RFP+]/CyO-YFP; + 2M 160 79 ~2:1 
w*; lncRNA-12 [RFP+]/CyO-YFP; + 3M 135 55 ~2:1 
w*; lncRNA-12 [RFP+]/CyO-YFP; + 4M 112 53 ~2:1 
lncRNA-13 [RFP+]/Fm7a-YFP; +; + 1M 164 87 ~2:1 
lncRNA-13 [RFP+]/Fm7a-YFP; +; + 3M 157 54 ~2:1 
lncRNA-13 [RFP+]/Fm7a-YFP; +; + 5M 128 40 ~2:1 
w*; lncRNA-14 [RFP+]/CyO-YFP; + 1M 169 95 ~2:1 
w*; lncRNA-14 [RFP+]/CyO-YFP; + 2M 137 87 ~2:1 
w*; lncRNA-14 [RFP+]/CyO-YFP; + 3M 157 65 ~2:1 
w*; lncRNA-14 [RFP+]/CyO-YFP; + 4M 134 57 ~2:1 
w*; lncRNA-15 [RFP+]/CyO-YFP; + 1M 145 65 ~2:1 
w*; lncRNA-15 [RFP+]/CyO-YFP; + 2M 141 86 ~2:1 
w*; lncRNA-15 [RFP+]/CyO-YFP; + 3M 133 66 ~2:1 
w*; +; lncRNA-16 [RFP+]/Tm3-YFP 2M 166 79 ~2:1 
w*; +; lncRNA-16 [RFP+]/Tm3-YFP 3M 180 86 ~2:1 
w*; +; lncRNA-16 [RFP+]/Tm3-YFP 4M 162 77 ~2:1 
w*; +; lncRNA-19 [RFP+]/Tm3-YFP  1M 144 70 ~2:1 
w*; +; lncRNA-19 [RFP+]/Tm3-YFP 2M 158 65 ~2:1 
Stocks with SV40 insertion downstream of lncRNA TSS 
w*; +; lncRNA-9 [SV40]/Tm3-YFP 2M 205 0 3:0 
w*; +; lncRNA-9 [SV40]/Tm3-YFP 3M 199 0 3:0 
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The viability test was carried out to check for lncRNAs that were essential for Drosophila 
development. For each genetic cross, ten heterozygous adults from each line (five males and females 
each) were placed in a vial and transferred to a new vial for two more consecutive times. The 
progenies from all three vials were scored based on their genotype. Visible markers from the balancer 
chromosome was used to distinguish the progenies. For the mutants that carry the CyO balancer, flies 
with indistinguishable wings or broken wings were discarded from count. The rows highlighted in 
grey indicates the lncRNAs for which no homozygous RFP-positive progenies were observed. Note 
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Table 16: CRISPR microinjection results (SV40 insertion) 
 
The rows highlighted in grey indicate that no positive founders were generated from the CRISPR 
microinjection. Out of the ten viable founders for lncRNA-9, two lines were selected and balanced 













































# of founders / 
injection cycle Overall Success 
rate 1st 2nd 
lncRNA-3 
pES_102a pES106c 898 BL55821 0 0 0 % 
pES_102b pES106d 80 BL55821 0 0 0 % 
lncRNA-9 
pES_103a pES107c 187 BL55821 0 10 < 1 % 
pES_103b pES_107d 410 BL55821 0 0 0 % 





The extensive use of next generation sequencing technologies has shown that tens of 
thousands of genomic sites are pervasively transcribed, producing several classes of ncRNAs 
such as miRNAs, endogenous siRNAs, piRNAs and lncRNAs (Derrien et al., 2012; Wen et 
al., 2014, Brown et al., 2014). In recent years, we have seen an explosion in the discovery and 
characterization of a class of biologically significant RNA transcripts that are now known as 
the lncRNAs (Ponting et al., 2009; Guttman et al., 2009; Hon et al., 2017). Compared to 
protein-coding genes, lncRNAs were found to be under less stringent evolutionary constraints 
in terms of their primary sequence, and they are generally expressed at lower levels (Derrien 
et al., 2012). To gain a better understanding of the biological functions of lncRNA, I have 
chosen Drosophila as a model organism given its long history in genetic studies and the large 
number of genetic tools available. I have decided to focus on development and particularly 
embryogenesis because of the availability of convenient datasets to mine. We posited that 
problems during this very well studied stage would likely result in recognisable and hopefully 
interpretable phenotypes. It is important to note that for our purpose it is not really critical 
whether the lncRNA expression is only restricted to embryonic development or shows 
broader expression.  
 
Using RAMPAGE data generated previously (Batut et al., 2014; Batut et al., 2017), we 
explored the expression profile of lncRNAs in five species (Drosophila melanogaster, 
Drosophila simulans, Drosophila erecta, Drosophila ananassae, and Drosophila 
pseudoobscura). Out of the 25,426 TSCs identified in Drosophila melanogaster, ~14% of 
them could not be associated with any known gene or sRNA based on paired-end RAMPAGE 
analysis and were therefore identified as putative lncRNA candidates. With the addition of 
291 TSCs that have been previously associated with Flybase-annotated lncRNA genes, a list 
containing 3,973 lncRNA TSCs was produced. The previous analysis of these RAMPAGE 
data already suggested a potential biological role for lncRNAs during embryonic development 
as evidenced by the strong conservation and sequence constraints that the promoters for some 
of these lncRNAs are under. Based on conservation of both promoter sequence and its activity 
across species, we have first narrowed down this list to 631 lncRNA TSCs that are expressed 
in all five Drosophila species. This is a more rigorous list of candidates compared to previous 
methods of annotation (Young et al., 2012) because it includes a much more comprehensive 
RNA-Seq dataset collected at hourly time-points during embryogenesis from across five 
species. We then decided to focus on a small group of candidate lncRNAs among the ones 
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that showed the best conservation also in terms their expression profile. We further narrowed 
down the selection to focus on lncRNAs with high expression in our model system, 
Drosophila melanogaster, and that were clearly distinct from neighbouring annotations as 
ideal candidates for further experimental investigation into their contributions to 
developmental processes. In the end, we obtained a list of 20 candidate lncRNAs plus 2 
control lncRNAs (lncRNA-6/bxd and lncRNA5/rox1) that I brought forward for CRISPR 
mutagenesis. 
 
Although the existing RAMPAGE libraries focused on samples collected during 
embryogenesis, the RAMPAGE method can theoretically be extended in the future to 
encompass other stages of development or tissue types. A comparison of the activity of each 
individual lncRNA TSC in all 5 species at other developmental stages would allow to further 
gauge the functional conservation of these lncRNA loci throughout the Drosophila life cycle. 
From the analysis of available modENCODE CAGE read data, we infer that some of the 
lncRNA candidates we chose are also expressed at other stages of development. As already 
pointed out, we choose for our analysis lncRNAs that showed expression during embryonic 
stages but we did not require for the lncRNAs not to be expressed in any other stage and our 
analysis of their potential function is not affected if a lncRNA is also expressed in other stages 
of development. Recently, several studies have proposed that functional lncRNAs are only 
activated at a specific stage of development (Sweta et al., 2019; Bhatia et al., 2019; Young et 
al., 2012) and this could be observed for five out of 21 of the lncRNA candidates analysed. 
On the other hand, lncRNAs can also be found to be transcribed at several developmental 
stages as seen for the bulk of the lncRNA candidates investigated. This is not surprising as 
Drosophila undergoes three main stages of growth that encompass several moulting cycles 
during larval development which are followed by a pupation stage before the final molt to the 
adult stage. The upregulation of lncRNAs at these respective stages could signify that they 
play an essential role for transformation and organogenesis and deserves further exploration 
(Chen et al., 2016).  
 
In order to understand the physiological functions of Drosophila lncRNAs, it is crucial to 
remove these transcripts in vivo and examine the phenotypic consequences of these mutations 
(Mattick, 2013). Previous studies investigating the functions of lncRNAs have indicated that 
these transcripts have roles in different developmental processes and diseases (Wu et al., 
2016; Ran et al., 2016). Our early understanding of lncRNA function in the regulation of gene 
expression were mainly derived from loss-of-function studies performed in vitro using a 
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myriad of animal cells lines (Ma et al., 2016; Iyer et al., 2015). Several lncRNAs, including 
MALAT1 and NEAT1 were found to have a function in diseases such as cancer (Serviss et al., 
2016). However, a disparity was observed between the phenotypes that were found in vitro 
versus those that were observed in vivo. Both MALAT1 and NEAT1 were found to be 
important regulators of cellular processes. However, mice with deletions that removed either 
lncRNAs had no detectable phenotypes (Zhang et al., 2012; Eißmann et al., 2012). These 
confounding results thus highlighted the need for loss-of-function studies in vivo as one of the 
gold standards when studying lncRNA functions.  
 
3.3.1 CRISPR/Cas9-mediated gene silencing of lncRNA transcripts 
 
Presently, phenotypic and functional information were provided for the majority of 
protein-coding genes identified through genetic screens. However, mutational analysis of non-
coding regions of the genome has largely been lacking. The identification of lncRNA 
transcripts has for a long time relied on computational predictions (Young et al., 2012; Kellis 
et al., 2014). However, to understand the functionality of lncRNAs, experimental validation is 
required. Follow-up experimental validation of the list of candidates has been the primary aim 
after comprehensive annotations from the RAMPAGE data. Beyond computational 
predictions of functionality from publicly available data, I have assessed the in vivo 
phenotypic effect of thirteen lncRNA knocking-outs. CRISPR/Cas9-mediated genome 
engineering is an efficient and rapid technique to create novel, targeted mutations in a chosen 
locus. In this study, I have used Drosophila as the model organism to test the application of 
HDR-mediated genomic editing of lncRNA transcripts using CRISPR/Cas9-based systems. 
Out of the 21 lncRNA candidates selected, I obtained an overall success rate of 62 %, with 13 
mutants generated that included two positive controls.  
 
I first tested to create Drosophila lncRNA mutants using a “somatic CRISPR” 
approach (Port et al., 2014). I have adopted the approach of having the dual-gRNA expressing 
flies and Cas9 expressing flies in a separate entity so as to avoid creating mutants with lethal 
phenotypes. Flies carrying dual-gRNA constructs targeting various lncRNAs were 
successfully established. I was able to observe a subset of offspring with mutations in the 
white gene, which served as a pilot test for a mutation with an observable phenotype. 
However, a large proportion of the G1 population presented mosaic patterns in the eyes. The 
mutation efficiency was not 100 % and required tools for rapid identification of targeted 
events. Two issues surfaced immediately. The first issue was genotyping. Without visible 
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marker, PCR-based molecular screening was the only option to screen for successful CRISPR 
knockout events, but it is time consuming and labour intensive to generate and maintain 
candidate fly stocks. The second issue was heritability of the mutant phenotype. Most of the 
CRISPR-based studies in Drosophila were performed in annotated protein-coding genes and 
mutants were backcrossed to check for inheritance of mutant genes. However, this was 
challenging in our case as the study focused on un-annotated lncRNAs with unknown 
functions. 
 
Most approaches that have been used to create CRISPR mutants were heavily 
dependent on readily identifiable phenotypes for identification of successful targeting events 
(Bassett et al., 2013; Gratz et al., 2013a; Port et al., 2014). The functions of these phenotypes 
were known prior to the study, which allowed for quick identification of mutant flies. In order 
to rectify the two issues mentioned above, I have taken a second approach to create lncRNA 
mutants using CRISPR/Cas9-mediated HDR with dsDNA donors. This is a more universally 
applicable method that allows screening for targeting events using visible markers. A pair of 
flanking homology arms and the visible marker 3xP3-RFP were incorporated into a donor 
vector. Using this technique, I was able to develop transgenic lines and also screen for 
successful targeting events without the need for large-scale genotyping by PCR to identify 
founders with the desired insertion. 
 
Nevertheless, the task of creating donor constructs was more challenging than 
previously imagined. The first issue was the quality and concentration of genomic DNA used.  
For the extraction of genomic DNA of higher purity (ratio of OD 260/280 is between 1.8 -1.9) 
from Drosophila, a commercial kit was used. The second problem I faced was the designing 
of primers to amplify each homology arm as it was difficult to amplify from some of the 
regions of genomic DNA such as those that were rich in GC sequences. The donor construct 
was initially assembled using a 4-way (pBS II vector backbone, a pair of homology arms, 
3xP3-RFP fragment) Hifi-DNA Gibson assembly mix. However, this is not efficient for 
assembling four fragments together. Therefore, I have made use of overlapping PCRs to join 
the inserts together before assembling them with the vector backbone. This resulted in a 
higher success rate overall linking two fragments together instead of joining four fragments.  
 
The Cas9/HDR efficiency had been reported to be generally low even in cell-based 
systems and it was not surprising that we had a <1 % efficiency with the majority of the 
candidates, requiring at least 400 embryos to be injected for each lncRNA locus (Liu et al., 
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2012; Yu et al., 2014; Bassett et al., 2014). To improve the efficiency of HDR when 
combining with CRISPR-Cas9, others have shown that by inhibiting components of the NHEJ 
pathway one could bias the repair system toward HDR (Bier et al., 2018; Beumer et al., 
2008). However, a higher efficiency was not always observed in flies and further research into 
cellular repair mechanisms during development would help us to develop better tools for 
manipulating the genome (Gratz et al., 2014; Ge et al., 2016). The study of lncRNA function 
using different genome editing methods have always been met with different methodological 
caveats. They can for example cause disruption of regulatory elements surrounding the 
genomic loci. Therefore, the use of additional tools such as RNAi would represent a useful 
complementary approach allowing to perturb the transcript without disturbing the locus itself 
(Guttman et al., 2011). RNAi would be more effective in suppressing cytoplasmic lncRNAs 
and the use of CRISPR interference (CRISPRi) would allow the investigation of nuclear 
lncRNA functions (Lennox and Behlke, 2016; Liu et al., 2017). Besides generating mutations 
in the lncRNA, little is known about the over- or mis-expression of these transcripts. The 
beauty of working with Drosophila was the availabilty of genetic tools that have been 
generated. It would be interesting to express the candidate lncRNAs in a tissue or temporal 
specific manner using different Gal4 lines and observe for other phenotypic changes. 
 
Challenges of the Cas9-HDR methodology 
 
The induction of targeted mutations in Drosophila has become possible through the 
advancement of genome editing tools such as CRISPR to induce mutations through DNA 
double-strand breaks followed by DNA repair with non-homologous end joining (NHEJ) or 
homology-directed repair (HDR) mechanisms. In this study, I have made used of 
CRISPR/Cas9 with HDR to replace the promoter region of the lncRNA with a reporter gene. 
Of the 21 lncRNA, 13 lncRNA mutants were successfully generated whereas no founders 
were established for the other eight candidates. Furthermore, compared to non-lethal 
mutations, little is known about the HDR recovery rates for recessive lethal alleles. Several 
factors such as the choice of injected Drosophila strain or the selection of gRNA could have 
contributed to the lower efficiency observed.  
 
One of the possible issues that led to the low number of positive offspring could be 
attributed to the preference of the cellular repair mechanism used. To compared the efficiency 
of CRISPR/Cas9 genome engineering, a cocktail of dsDNA construct, gRNA plasmids and 
Cas9 proteins were introduced in lig4 mutants and a higher targeting proficiency was 
observed (Gratz et al., 2014, Yu et al., 2014). However, more validation will be required for 
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the use of lig4 mutants to enhance HDR finding as contrasting results have been reported (Ge 
et al., 2016; Ren et al., 2014).  
 
The second important parameter is the prevalence of polymorphisms between distinct 
genetic backgrounds in Drosophila. The sequences used for the production of gRNAs and 
homology arms of the donor construct are generally taken from the reference genome 
assembly and may differ from the sequences in the injected strain. Mismatches between 
gRNAs and DNA sequences have been reported to decrease the overall the binding affinity 
and cleavage by Cas9 (Jinek et al., 2012, Cong et al., 2013, Mali et al., 2013). Similarly, 
polymorphism close to the cleavage site may also influence the binding of the DNA donor 
template with the genomic DNA and thus contributes to a lower HDR rate (Gratz et al., 
2015).  Therefore, sequencing of the target genomic locus in the genetic background in which 
the genome engineering experiment will be performed should ideally be performed as a single 
base pair change at the intended target site could have detrimental effect to the success of the 
experiment. Moreover, the majority of the cleavage efficiency scores have been obtained from 
high throughput experiments in S2 cells to predict the cleavage efficiency of a given gRNA 
(www.flyrnai.org/evaluateCrispr/).  It is however not fully understood if similar efficacy 
would be observed in vivo. 
 
The choice of gRNAs plays an important role as it has been shown that the 
mutagenesis efficiency is positively correlated to the number of GC content present at the six 
nucleotides that are closest to the PAM sequence (Ren et al., 2014; Bassett et al., 2013, 
Kondo and Ueda, 2013, Yu et al., 2013). Those gRNAs with low GC content close to the 
PAM sequence tend to produce sub-optimal mutagenesis efficiency rates due to the unstable 
gRNA:DNA heteroduplex in Cas9 (Jinek et al., 2014, Nishimasu et al., 2014). However, little 
is known regarding the association between efficiency and overall GC content and further 
experiments should be carried out. With the newer developments in algorithms for the 
selection of gRNAs, higher HDR rates can be obtained by careful selection of target sites 
(Heigwer et al., 2016; Port et al., 2019).  
 
From a procedural point of view, the overall concentration of the cocktail containing 
the gRNA plasmid and donor DNA template injected have been shown to influence the 
success rate of the experiment. In this study, the ratio of DNA template and dual-gRNA 
construct used was 2:1. Several studies have demonstrated that optimisation of plasmid 
concentration is needed for HDR-directed repair as it greatly increases the viability of the flies 
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(Ren et al., 2014, Port et al., 2014). Having a high concentration of gRNAs tend to induce an 
adverse effect on the embryos which results in the decreased number of progenies (Ren et al., 
2014). Therefore, to efficiently generate mutagenesis, an equal concentration of DNA donor 
template and gRNA construct in the range of 50 to 100 ng/μl was suggested (Ren et al., 
2014).  
 
As a whole, there were several factors that could have contributed to the low recovery 
rate seen in our experiment and it is difficult to pinpoint the exact reason. With the 
advancement of the CRISPR/Cas9 technology and algorithms for the selection of gRNAs, 
several improvements can be undertaken to improve the experimental design so as to enhance 
the overall efficiency of the CRISPR-Cas9 methodology and at the same time increase the 
number of offspring obtained with successful mutagenesis.  
 
3.3.2 Systematic analysis of lncRNA functions  
 
To date, many questions were raised about the relevance of these long molecules and 
what their functions in various biological processes are as only a small fraction of lncRNAs 
has been explored mechanistically, especially in Drosophila (Young et al., 2012; Matthews et 
al., 2015).  Therefore, the next step forward for this project was to characterise the mutants 
generated. A simple systematic functional study of the mutants for the 13 lncRNAs was used 
to address their significance in Drosophila melanogaster. The pipeline was broken down into 
three parts; namely viability and morphogenesis, fertility, and locomotion.  
 
Completion of Drosophila development 
 
The first part of the analysis was focused on understanding if these lncRNAs were 
required for survival and development as these are phenotypes that were identifiable under the 
microscope. The mutants for lncRNA-9 and lncRNA-3 were found to be essential for 
survival. The homozygous null mutants for these lncRNAs were unable to complete the full 
developmental cycle and no adult survivors were recovered. To further examine the 
authenticity of these lethal mutations, screens of deletion mutations, commonly known as 
deficiencies (Df), were used. Both KO/KO and KO/Df combinations for lncRNA-9 further 
confirmed that the lncRNA mutation phenotype observed was not due to an off-target effect 
of CRISPR/Cas9. In addition, similar to the validation of RNAi approaches, it is common 
practice to authenticate the results with a second independent gRNA construct. A second loss-
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of-function experiment was performed by inserting transcriptional terminators into the 
genomic loci of both lncRNAs. A strong polyadenylation signal was inserted close to the 5′ 
end of the lncRNA so as to arrest transcription and result in a likely non-functional transcript 
(Bond et al., 2009; Grote et al., 2013). Using this method, homozygous null mutants for 
lncRNA-9 displayed a similar lethal phenotype to that observed with the promoter deletion. In 
all instances, the lncRNA transcript itself was shown to be essential and not the DNA of the 
lncRNA locus.  
 
Due to the lack of cytologically mapped deficiencies that overlap the region that was 
removed or the entire genomic region of lncRNA-3, the phenotype was first validated using a 
deletion that overlapped with miR-276a and the 3’ end of the lncRNA. Surprisingly, both 
lncRNA-3KO/Df and Df/miR-276aKO progenies were viable and thus suggestive of a possible 
off-target effect. However, this result has to be carefully interpreted. Given that the lncRNA 
mutant was generated by removing the promoter region and the 5’ end of the transcript, there 
is a likelihood that the 3’ end of the lncRNA transcript is not essential for its biological 
function. The Df line should be sequenced to ensure that the deleted region really corresponds 
to the one annotated in databases and actually overlaps with mir-276. The fact that lncRNA-3 
mutants can complement mir-276a (BL58906) clearly indicates that the observed lncRNA-3 
phenotype does not depend on mir-276a and that lncRNA-3 does not influence the expression 
of this miRNA.  Secondly, I have attempted to generate loss-of-function mutants with 
transcriptional terminators as a complementary approach but was unsuccessful in obtaining 
any founders. The use of several gRNAs to specifically alter the genetic code at defined 
positions in the lncRNA genome loci is still the recommended approach to minimise the risk 
of off-targets and will be the method to further confirm the specificity to the lncRNA-3 
mutant phenotype.  
 
The regulation of Hox gene expression during animal development have been 
extensively studied in Drosophila melanogaster. Most Hox genes are important for the 
allocation of distinct morphological identities to each body segment of the organism. With the 
recent advances in technology, a myriad of lncRNA sequences embedded within the Hox 
gene clusters and their flanking regions have been discovered (e.g. bxd, lncRNA:iab-4, 
lncRNA:iab-8). These new players provide important regulatory inputs to both temporally and 
spatially restrict the patterns of Hox gene expression and mutations of these ncRNAs could 
possibly lead to homeotic transformations. To determine if the loss of lncRNA candidates 
results in developmental defects, I have compared the body segments of each homozygous 
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null lncRNA mutant to the wildtype adult. In this study, I have considered the adult fruit fly 
as composed of six sections (head, wings, legs, abdominal segments, haltere and thorax 
region). In all cases, I did not observe any morphological abnormalities in the homozygous 
null mutants under analysis except for lncRNA-3. Careful dissection of the puparium of the 
lncRNA-3 mutant revealed traces of developmental defects in the head region which 
resembles a mild form of head eversion during pupal ecdysis. This observation may hint 
towards a potential role of lncRNA-3 in head or brain development. Subsequent layers of 
investigation will be required to understand how lncRNA-3 contributes to this phenotype and 
the signalling pathways that are affected by its loss. 
 
Following the assessment of lncRNAs that were required for survival to adulthood, I 
have identified lncRNA-3 and lncRNA-9 as both required for development. From the tissue-
specific CAGE data, I was able to confirm that both lncRNAs are expressed during 
Drosophila development with peaks of expression spanning from embryogenesis to pupation. 
Furthermore, the expression of both lncRNA-3 and lncRNA-9 was detected in the adult head 
of the fruit fly. This observation made me question at which stage the lethality ensues. By 
performing a survivability test at three distinct stages of development (embryo-larvae, larvae-
pupae, pupae-adult), I was able to show that the majority of the lncRNA-9 homozygous null 
mutants were embryonic lethal with a significant reduction in embryonic hatching rate. 
Although there was a small number of escapees, they quickly arrested as 1st instar larvae with 
no animals developing into final instar larvae, pupae, or adults. LncRNA-3 homozygous null 
mutants, on the other hand, completed embryogenesis and hatched into first instar larvae. Our 
findings for larval and pupal development confirmed that lncRNA-3 homozygous null 
mutants were pupal lethal with the mutant flies arresting at late pupal stages. A significant 
increase in mortality rate was also observed during the larval and pupal transition. While the 
homozygous null mutants for lncRNA-3 were found to complete larval development as seen 
in wildtype embryos, they displayed unsynchronised and late larval-pupa transition, 
suggesting either a potential developmental delay in these mutants. A microRNA downstream 
of the TSS was found to overlap with lncRNA-3 and previous studies have shown that miR-
276a mutants were also pupal lethal (Li et al., 2013, Chen et al., 2014). Subsequent follow-up 





  CHAPTER 3: Pilot screen for lncRNAs that function during Drosophila embryogenesis 
 
132 
Other developmental analyses 
 
In this part of the analysis, homozygous null mutants were used and lncRNA-3 and 
lncRNA-9 were omitted from this study because viable mutants could not be obtained. The 
second part of the study was to analyse if lncRNAs were involved in reproduction and germ 
cell development. Recent studies have shown that lncRNAs were highly expressed in the 
testis and contributed to the reproductive fitness of the animal (Wen et al., 2016; Kurihara et 
al., 2017). We reasoned that defects in lncRNAs required for germ cell development would 
allow overall development to take place but cause infertility. The fertility of both male and 
females were measured and none of the homozygous null mutants were sterile. The result was 
not surprising as a further analysis of the tissue expression of these candidates showed that 
none of the lncRNAs tested were expressed in the testis or ovaries. The last part of the 
pipeline aims to characterise lncRNAs that may be involved in neurological disorders. An 
increasing number of studies have shown that lncRNAs play roles in the development of the 
nervous system and are expressed in specific cells of the central or peripheral nervous system 
(Graveley et al., 2011; Ponjavic et al., 2009; Chalei et al., 2014; Raveendra et al., 2018). 
Furthermore, lncRNAs (e.g. Drosophila bereft and yar) might be involved in regulating 
neural development and cognitive processes. Over the years, different behavioural assays 
were generated in Drosophila. Examples include larval locomotion, adult negative geotaxis 
assay and courtship behaviours of Drosophila (Sun and Heckscher, 2016; Nichols et al., 
2012). In this study, a simple larval locomotion assay was used to probe for lncRNA mutants 
impact this task (Nichols et al., 2012). Although the results did not reflect any difference 
between the wildtype and the larvae from the viable, homozygous null mutant flies, we 
examined few escapee larvae of lncRNA-9 mutants and found them to display uncoordinated, 
paralytic movements. Further functional studies will be required to determine the cause of the 
locomotion defect and also the extension of lncRNA roles in the development of the 
Drosophila nervous system. Another possible reason for the locomotion defect could also 
arise due to a compromised cuticle and subsequent examination of the cuticle in the mutant 
will allow us to determine if the cuticle is fully developed. 
 
From the phenotypic characterisation of the lncRNAs in this study, only two of the 
candidates displayed a homozygous lethal phenotype whereas the genomic deletions of the 
other lncRNA sequences failed to display any observable phenotype. This result is in line 
with other studies that have been performed using deletion mutagenesis of lncRNA candidates 
and a lack of noticeable phenotype was observed (Wei et al., 2019; Goudarzi et al., 2019; 
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Schor et al., 2018). It is likely that many lncRNAs are not master regulators but instead 
function as buffering mechanism of gene expression (Wei et al., 2019). In-depth studies of 
these candidates that do not display detectable phenotypes will allow us to test this 
hypothesis. Furthermore, during our investigation to examine the impact of the loss of the 
lncRNA candidates, the experiments that have been carried out were mainly based on overt 
features. However, it is possible that subtle defects or phenotypes were not detected. 
LncRNA-9 can be considered a bona fide lncRNA in Drosophila as the phenotype has been 
recapitulated using a second method, whereas further experiments have to be carried out to 
validate the phenotype observed for lncRNA-3. In addition, it is important to note that 
although computational algorithms were used to assess the protein-coding potential of these 
transcripts, experimental validation is still required to confirm that these lncRNAs are not 
translated into short polypeptides (Chew et al., 2013; Yeasmin et al., 2018). 
 
Considerations from the loss-of-function outcomes 
 
LncRNAs have emerged as an important class of regulators of gene expression during 
development and each of them have been known to possess unique features, characteristics 
and importance (Goff and Rinn, 2015; Kopp and Mendell; 2018). LncRNAs can be broadly 
divided into three groups based on their mechanisms of action from previous studies (Petruk 
et al., 2006; Sauvageau et al., 2013; Dimitrova et al., 2014; Andergassen et al., 2019). The 
first group include lncRNAs whose RNA product is important and contributes to gene 
regulation (e.g. Fendrr). The second group comprises of lncRNAs that do not generate a 
functional product. Instead, the initiation of transcription along the genomic loci is important 
for the expression of downstream genes. A good example is the act of transcription through 
the Drosophila bxd lncRNA that is needed to repress the expression of the downstream Ubx 
gene (Petruk et al., 2006). Lastly, the third group refers to the underlying DNA elements 
within the lncRNA locus that are more likely to be the source of regulatory activity than the 
actual lncRNA product itself. Different perturbation techniques can be employed to study 
these lncRNA properties. Each of these methods have its pros and cons which will allow us to 
examine if the resulting phenotype is triggered by the loss of the RNA product or the 
underlying DNA elements that are embedded within the genomic locus of the lncRNA. 
 
The first strategy that was used in this study made use of CRISPR/Cas9 to delete the 
lncRNA promoter so as to probe for the functional relevance of each lncRNA candidate in the 
list during Drosophila embryonic development. The TSS for each of lncRNA candidates were 
identified using RAMPAGE and the subsequent removal of the promoter region would 
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prevent the transcription of the lncRNA. I have taken a broad approach as the first step by 
removing the promoter region upstream from the TSS as well as part of the lncRNA sequence 
downstream from the TSS for each of the lncRNA candidates. This method was chosen as it 
would allow us to test if the lack of the lncRNA transcription and/or the lncRNA product 
itself would contribute to a phenotype. While most of the mutants that have been successfully 
generated did not exhibit any overt developmental defects, two of the lncRNA were found to 
be required for viability. I have also further validated the mutant phenotype using several 
methods to examine for possible off-targeting effects by CRISPR.  
 
Nevertheless, while I have addressed the off-target effects of the perturbation method 
used, additional studies will be needed to understand if the phenotype has risen due to the lack 
of transcription or the lncRNA product itself. To answer this question, the integration of a 
transcriptional stop signal at the beginning of the lncRNA transcript using CRISPR/Cas9 was 
adopted. This strategy was chosen as it generates a LOF mutation through the insertion of a 
SV40 polyadenylation signal (polyA). Due to the premature cleavage and subsequent 
polyadenylation, the production of a full lncRNA transcript was inhibited. As the promoter 
region would remain intact using this method, any phenotype observed would be due to the 
lncRNA transcript itself. Indeed, I have observed a similar phenotype for the lncRNA-9 
mutant which implies that the lncRNA product itself is important for its function. On the 
other hand, due to the unsuccessful attempts to generate founders for lncRNA-3 using this 
method, it was impossible to tease apart the two elements.  
 
While the two methods I used allowed me to identify the functional lncRNA product, 
this study did not examine the effect of possible underlying DNA elements. The presence of 
gene regulations by enhancers or insulators within the lncRNA loci have been reported to be 
common. The removal of these components while attempting to mutate lncRNAs have also 
been known to affect the expression of neighbouring genes (Engreitz et al., 2016; Dimitrova 
et al., 2014; Groff et al., 2016). Nevertheless, further validation using methods such as RNAi 
or CRISPRi that do not affect the genomic locus will be needed to completely exclude that the 
observed effects are due to the deletion of undetected DNA elements present in the lncRNA 
locus. Subsequently, deletions could be made along the lncRNA transcript so as to identify 









Considered as a whole, we have begun to appreciate the functions of lncRNAs using 
model organisms such as Drosophila melanogaster and this could open up many doors due to 
their specific spatio-temporal expression and undetermined functions. In this study, we made 
use of RAMPAGE data and identified a total of 3,973 lncRNA TSCs in Drosophila 
melanogaster. A total of 631 of these loci have displayed high sequence conservation and 
expression profiles across the five Drosophila species. This evidence has hinted that these 
lncRNA loci carry important biological functions and are ideal candidates for further 
experimental scrutiny into their contributions to developmental processes. Using genome 
editing methodologies, I have examined the functional relevance of thirteen of these lncRNA 
candidates and proven that two of them yield in vivo phenotypes when deleted. I have showed 
that the function of lncRNA-9 is likely to be conveyed by the RNA transcript. From the 
outcomes of the vivo assays, due considerations have to be made during the experimental 
design so as to decipher the fitness of each lncRNA loci as the bulk of the lncRNA candidates 
do not display any gross phenotypes. Although these mutants generated did not display any 
developmental defects nor were found to be essential for viability, the results do necessarily 
imply that they are not functional.  Due to the limitations of our assays, further studies are 
required to determine their functional roles. Although it would be easy to classify them as 
functionally redundant like the roX RNAs, recent findings have shown that it is not entirely 
true for the roX RNAs as roX1 and roX2 lncRNA were found highly expressed in different 
developmental stages, suggesting that may have different role during dosage compensation 
(Kim et al., 2018). As the lncRNAs selected were found to have a conserved expression 
profile across five Drosophila species, it would be interesting to find out if mutagenesis of 
these transcripts in a different genetic strain would produce the same results. This would 
allow us to understand if lncRNAs were strain-specific as most of the functional studies were 
only carried out in Drosophila melanogaster. While I was unable to generate any lncRNA 
mutants for eight of the lncRNA candidates in the list during my study, it has now been made 
possible with the advancement of the CRISPR/Cas9 technology which include mutagenesis at 
tissue-specific levels (Port et al., 2020). Lastly, multiple lines of evidences are needed when 
investigating each lncRNA loci as the phenotype observed could be caused by a loss of the 
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Supplementary Figure 1: Size difference between lncRNA-9 escapees and wildtype larvae. 
Drosophila larvae have three instar stages. The first and second instar lasts one day each whereas the 
third instar stage persists for two more days. A comparison of the (a) lncRNA-9 escapee with a 
wildtype larvae (right) 36 hr after hatching from the embryo is shown. The larvae have been arranged 
with the anterior end of the larvae at the top and the posterior end at the bottom of the image for both 
larvae. The trachea and mouth hook can be clearly seen in both larvae. One of the most striking 
features is the absence of posterior spiracles (orange arrow) and a much smaller size in the lncRNA 
escapee. In addition, the wildtype larvae entered the  second instar stage by this time and has a mouth 
hook that appears to be much more developed compared to the mutant in the first instar stage. The 
escapee arrest at L1 stage and no movement was observed even though a brush was used to gently 
push them. The majority of the wildtype larvae were in the second instar stage at this point. (Scale bar, 
1 mm.) 
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Supplementary Figure 2: Difference in pupal development stages found in lncRNA-3 
homozygous null mutants.  
The images illustrate the pupal development of lncRNA-3 homozygous mutants during the stages of 
pupariation to adult eclosion. LncRNA-3 mutants were manually separated from their heterozygous 
siblings during embryonic stage. The embryos were allowed to develop at 25°C and the images were 
taken 16 days after egg laying. All of the wildtype and heterozygous siblings had emerged into adults 
by this time. Compared to wildtype and heterozygous siblings, lncRNA-3 homozygous null mutants 
had vastly different rate of development even though the embryos were collected within a 4 hr 
window. (a,c) Ventral view of the lncRNA mutant. (b,d) Dorsal view of the mutant. (a,b) The mutant 
is in the early stages of pupation and have detached from the case. The body have turned yellow and 
the head has everted. (c,d) The mutant has completed most of the stages of pupal development with 
the formation of eyes and wings. A total of 100 homozygous mutant pupae were examined. Although 
all of them were incubated for a total of 30 days, none of the homozygous mutants completed eclosion 















Supplementary Figure 3: Difference in the anatomical morphology observed in lncRNA-3 
homozygous null mutants.  
Pupal lethal phenotypes associated with lncRNA-3 mutations. Dorsal and ventral view of (a) 
Dissected lncRNA-3 homozygous mutants in late pharate adult stage and (b) wildtype adult.    The 
majority of the homozygous null mutants were arrested at the pharate adult stage at the end of 30 days. 
A difference in the development of the head and appendages were observed when the mutants were 
compared to a wildtype adult. The mutants were found to be unable to extend head fully at the end of 
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For supplementary figures 4 – 16: 
 
Anatomical images of homozygous lncRNA null mutants except for supplementary figure 5 
(lncRNA-3) and supplementary figure 8 (lncRNA-9) whereby only heterozygous mutants 
were viable. Using wildtype flies shown in supplementary figure 4 as reference, we compared 
6 different anatomical features and we did not observe any difference between the wildtype 
adult flies and lncRNA mutants. All scale bars represent 500 µM. The images were arranged 
in the following order: 
 
(a) Examination of the side view of mutant fly with arrows pointing to the (1) head, (2) legs 
and (3) wings. For the head, we examined the overall shape of the head and eyes as well as 
the antenna. For the leg, we checked that there were 6 legs and the fly was able to walk 
properly. For the wings, they had to be developed fully and extend beyond the body of the 
fruit fly. 
 
(b) Top-down view of the mutant fly with arrow pointing to the (4) thorax, (5) pair of halters 
and (6) abdominal segments. For the thorax region, there should be the prothorax, mesothorax 
and metathorax. The flies would have a pair of haltere instead of a wing-like structure seen in 
Bxd mutants. We counted the abdominal segments to ensure that the flies have 8 abdominal 
segments. 
 
(c) CRISPR/Cas9 induced HDR with successful integration of the RFP-carrying donor vector. 
Compared to wild type flies in supplementary figure 4, a strong RFP signal could be seen 
under the fluorescence microscope in the eyes of flies with successful genomic integration of 
the donor plasmid. In the wildtype fly, the RFP signal should be absent. 
 
(d) Expression profiles throughout embryogenesis of 5 Drosophila species. LncRNA 
expression was normalized across the different Drosophila species and plotted using an 
arbitrary developmental time course. These expression profiles were generated by Dr. 
Philippe Batut.  
 
(e) Genomic loci of each lncRNA. The orange bar indicates the deleted region and 
replacement with a 3xP3-RFP cassette.  
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Supplementary Figure 4: Control w1118 
(a) Schematic of the Drosophila adult body axis as reference.  
An adult fly consists of a head region, a thoracic segment (T1-T3) and an abdominal segment (A1-
A8). (b) Lateral view of a control w1118 adult male. Examination of the lateral view of mutant fly with 
arrows pointing to the [1] head, [2] legs and [3] wings. For the head, we examined the overall 
development of the shape of the head, mouth, eyes as well as the antenna. For the leg, we checked that 
there were 6 legs and the fly was able to walk properly. For the wings, they had to be developed fully 
and extend beyond their body of the fruit fly. (c) Dorsal view of the control w1118 adult male. 
[4] The notum that is composed of the anterior scutum and posterior scutellum. [5] The haltere is 
made up of 3 components. They are the scabellum, the pedicel and the capitellum. [6] A normal adult 
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Supplementary Figure 5: lncRNA-3 (FBgn0265415_02) heterozygous mutant 
Homozygous null mutants for this lncRNA were pupal lethal and no homozygous adults were 
collected.  LncRNA-3 heterozygous mutants were viable (a,b) with normal anatomical features 
compared to wildtype (supplementary figure 4). A total of 10 heterozygous males and 10 heterozygous 
females were examined. (a) Lateral view of the adult male. (b) Dorsal view of the adult male. (c) Eye 
phenotype of flies with successful integration of 3xP3-RFP cassette at the lncRNA genomic locus. 
(Scale bar, 0.5 mm) (d) Comparative profiling of lncRNA-3 promoter activity during embryonic 
development. Embryos from five Drosophila species were collected and the libraries were generated 
using the RAMPAGE protocol. For lncRNA-3, the highest expression level of the lncRNA in 
Drosophila melanogaster is at 14 hr after egg laying. (e) Genomic locus of lncRNA-3 as visualised on 
the UCSC genome browser. Transcripts that have been annotated on Flybase are shown with dark blue 
bars with microRNA-276b located upstream of the lncRNA and lncRNA:CR45245 downstream of the 
transcript. From the RAMPAGE tracks, single nucleotide resolution of the TSS can be obtained (gray 
bar). The top RAMPAGE track shows the promoter activity from the plus strand of the DNA, whereas 
the bottom track shows the opposite strand. LncRNA-3 is expressed from the plus strand of the DNA 
and has been annotated on Flybase as lncRNA:CR46006 with 5 different isoforms. The new annotation 
of these transcripts indicated that the lncRNA overlaps with microRNA-276a. A pair of gRNAs was 
used to remove the promoter region of the lncRNA as shown (orange bar, blue highlight). The region 































  CHAPTER 3: Pilot screen for lncRNAs that function during Drosophila embryogenesis 
 
147 
Supplementary Figure 6: lncRNA-4 (FBgn0050009_02) homozygous mutant. 
LncRNA-4 homozygous mutants were viable (a,b) with normal anatomical features compared to 
wildtype (supplementary figure 4). A total of 10 homozygous males and 10 homozygous females were 
examined. (a) Lateral view of the adult male. (b) Dorsal view of the adult male. (c) Image show eye 
phenotype of flies with successful integration of 3xP3-RFP cassette at the lncRNA genomic loci. 
(Scale bar, 0.5 mm) (d) Comparative profiling of lncRNA-4 promoter activity during embryonic 
development. Embryos from five Drosophila species were collected and the libraries were generated 
using the RAMPAGE protocol. For lncRNA-4, the highest expression level of the lncRNA in 
Drosophila melanogaster is at 10 hr after egg laying. (e) Genomic loci of lncRNA-4 as visualised on 
the UCSC genome browser. Transcripts that have been annotated on Flybase are shown with dark blue 
bars with CG12911 and CG12910 as the two closest genes to the lncRNA. From the RAMPAGE 
tracks, single nucleotide resolution of the TSS can be obtained (gray bar). The top RAMPAGE track 
shows promoter activity from the plus strand of the DNA, whereas the bottom track shows the 
opposite strand. LncRNA-4 is expressed from the negative strand of the DNA and has been annotated 
on Flybase as lncRNA:CR30009 with two different isoforms. A pair of gRNAs was used to excise the 
promoter region of the lncRNA as shown (orange bar, blue highlight). The region excised is from 
























  CHAPTER 3: Pilot screen for lncRNAs that function during Drosophila embryogenesis 
 
149 
Supplementary Figure 7: lncRNA-5 (FBgn0019661_05, lncRNA: rox1) homozygous mutant. 
LncRNA: rox1 has been published in the literature and it is one of the most studied lncRNA in 
Drosophila. The lncRNA has been reported to be redundant with lncRNA: rox2 (Quinn et al., 2016) 
and we have used this transcript as a positive control. Homozygous rox1 mutants were viable and this 
result has been reported in previous studies (Bassett et al., 2014; Quinn et al., 2016).  (a,b) 
Homozygous lncRNA mutant with normal anatomical features compared to wildtype (supplementary 
figure 4). A total of 10 homozygous males and 10 homozygous females were examined. (a) Lateral 
view of the adult male. (b) Dorsal view of the adult male. (c) Image show eye phenotype of flies with 
successful integration of 3xP3-RFP cassette at the lncRNA genomic locus. Due to the red 
pigmentation of the adult eye, the RFP signal can only be visualised from the Drosophila Ocelli. 
(Scale bar, 0.5 mm) (d) Comparative profiling of lncRNA-5 promoter activity during embryonic 
development. Embryos from five Drosophila species were collected and the libraries were generated 
using the RAMPAGE protocol. For lncRNA-5, the highest expression level of the lncRNA transcript 
in Drosophila melanogaster is detected at the early stages of embryonic development. Two expression 
peaks have been identified from the expression data (5 hr, 9 hr after egg laying). (e) Genomic loci of 
lncRNA-5 as visualised on the UCSC genome browser. Transcripts annotated on Flybase are shown 
with dark blue bars. Echinus (ec) and yin are two protein-coding genes that are the closest to the 
lncRNA transcript. From the RAMPAGE tracks, single nucleotide resolution of the TSS can be 
obtained (gray bar). The top RAMPAGE track shows promoter activity from the plus strand of the 
DNA, whereas the bottom track shows the opposite strand. LncRNA-5 is expressed from the negative 
strand of the DNA and has been annotated on Flybase with five different isoforms. A pair of gRNAs 
was used to delete the promoter region of the lncRNA as shown (orange bar, blue highlight) and HDR 
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Supplementary Figure 8: lncRNA-9 (RAMPAGEpeak_002227) heterozygous mutant. 
The majority of the homozygous lncRNA null mutants were embryonic lethal. LncRNA-9 
heterozygous mutants were viable (a,b) with normal anatomical features compared to wildtype 
(supplementary figure 4). A total of 10 heterozygous males and 10 heterozygous females were 
examined. (a) Lateral view of the adult male. (b) Dorsal view of the adult male. (c) Image shows eye 
phenotype of flies with successful integration of 3xP3-RFP cassette at the lncRNA genomic loci. 
(Scale bar, 0.5 mm) (d) Comparative profiling of lncRNA-9 promoter activity during embryonic 
development. Embryos from five Drosophila species were collected and the libraries were generated 
using the RAMPAGE protocol. For lncRNA-9, the highest expression level of the lncRNA in 
Drosophila melanogaster is at 14 - 16 hr after egg laying. (e) Genomic locus of lncRNA-9 as 
visualised on the UCSC genome browser. Transcripts that have been annotated on Flybase were 
shown with dark blue bars with CG13723 located upstream of the lncRNA whereas lncRNA:CR45436 
is downstream. From the RAMPAGE tracks, single nucleotide resolution of the TSS can be obtained 
(gray bar). The top RAMPAGE track shows promoter activity from the plus strand of the DNA, 
whereas the bottom track shows the opposite strand. LncRNA-9 is expressed from the plus strand of 
the DNA and it is unannotated on Flybase or the Ensembl genome database. A pair of gRNAs was 
used to remove the promoter region of the lncRNA as shown (orange bar, blue highlight). The region 
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Supplementary Figure 9: lncRNA-10 (RAMPAGEpeak_005280) homozygous mutant. 
LncRNA-10 homozygous mutants were viable (a,b) with normal anatomical features compared to 
wildtype (supplementary figure 4). A total of 10 homozygous males and 10 homozygous females were 
examined. (a) Lateral view of the adult male. (b) Dorsal view of the adult male. (c) Image shows the 
eye phenotype of flies with successful integration of 3xP3-RFP cassette at the lncRNA genomic locus. 
(Scale bar, 0.5 mm) (d) Comparative profiling of lncRNA-10 promoter activity during embryonic 
development. Embryos from five Drosophila species were collected and the libraries were generated 
using the RAMPAGE protocol. For lncRNA-10, the highest expression level of the lncRNA in 
Drosophila melanogaster is at 5 - 6 hr after egg laying (AEL) and a smaller peak was seen at a later 
time point (9 – 10 hr). (e) Genomic locus of lncRNA-10 as visualised on the UCSC genome browser. 
Transcripts that annotated on Flybase are shown with dark blue bars with lncRNA:CR44554 and tartan 
(trn) as the two closest genes to the lncRNA. From the RAMPAGE tracks, single nucleotide resolution 
of the TSS can be obtained (gray bar). The top RAMPAGE track shows promoter activity from the 
plus strand of the DNA, whereas the bottom track shows the opposite strand. LncRNA-10 is expressed 
from the negative strand of the DNA and has not been annotated on Flybase or the Ensembl genome 
assembly. A pair of gRNAs was used to excise the promoter region of the lncRNA as shown (orange 
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Supplementary Figure 10: lncRNA-11 (RAMPAGEpeak_006440) homozygous mutant. 
LncRNA-11 homozygous mutants were viable (a,b) with normal anatomical features compared to 
wildtype (supplementary figure 4). A total of 10 homozygous males and 10 homozygous females were 
examined. (a) Lateral view of the adult male. (b) Dorsal view of the adult male. (c) Image shows eye 
phenotype of flies with successful integration of 3xP3-RFP cassette at the lncRNA genomic loci. 
(Scale bar, 0.5 mm) (d) Comparative profiling of lncRNA-11 promoter activity during embryonic 
development. Embryos from five Drosophila species were collected and the libraries were generated 
using the RAMPAGE protocol. For lncRNA-11, the highest expression level of the lncRNA in 
Drosophila melanogaster occurred around 14 - 15 hr although a smaller peak of expression was 
detected earlier at around 10 hr after egg laying (AEL). (e) Genomic loci of lncRNA-11 as visualised 
on the UCSC genome browser. Transcripts annotated on Flybase are shown with dark blue bars. 
LncRNA:CR43234 is located upstream of the lncRNA transcript whereas lncRNA:CR45360 is located 
immediately downstream of lncRNA-11.  From the RAMPAGE tracks, single nucleotide resolution of 
the TSS can be obtained (gray bar). The top RAMPAGE track shows promoter activity from the plus 
strand of the DNA, whereas the bottom track shows the opposite strand. LncRNA-11 is expressed 
from the plus strand of the DNA and is annotated on Flybase as lncRNA: CR45361 with 2 different 
isoforms. A pair of gRNAs was used to excise the promoter region of the lncRNA as shown (orange 



























  CHAPTER 3: Pilot screen for lncRNAs that function during Drosophila embryogenesis 
 
157 
Supplementary Figure 11: lncRNA-12 (RAMPAGEpeak_008667) homozygous mutant. 
LncRNA-12 homozygous mutants were viable (a,b) with normal anatomical features compared to 
wildtype (supplementary figure 4). A total of 10 homozygous males and 10 homozygous females were 
examined. (a) Lateral view of the adult male. (b) Dorsal view of the adult male. (c) Image shows eye 
phenotype of flies with successful integration of 3xP3-RFP cassette at the lncRNA genomic loci. 
(Scale bar, 0.5 mm) (d) Comparative profiling of lncRNA-9 promoter activity during embryonic 
development. Embryos from five Drosophila species were collected and the libraries were generated 
using the RAMPAGE protocol. For lncRNA-12, there were 2 peaks observed for the expression of the 
lncRNA transcript. The first peak occurred at 8 hr after egg laying and the second peak emerged at 
around 11-12 hr. (e) Genomic locus of lncRNA-12 as visualised on the UCSC genome browser. 
Transcripts annotated on Flybase are shown with dark blue bars with lncRNA:CR44411 located 
upstream of the lncRNA whereas lncRNA:CR45111 is located downstream. From the RAMPAGE 
tracks, single nucleotide resolution of the TSS can be obtained (gray bar). The top RAMPAGE track 
shows promoter activity from the plus strand of the DNA, whereas the bottom track shows the 
opposite strand. LncRNA-12 is expressed from the negative strand of the DNA and it is annotated on 
Flybase with one isoform. A pair of gRNAs was used to remove the promoter region of the lncRNA as 
shown (orange bar, blue highlight). The region excised is from chr2L: 17,584,436 – 17,585,359. 



















  CHAPTER 3: Pilot screen for lncRNAs that function during Drosophila embryogenesis 
 
159 
Supplementary Figure 12: lncRNA-13 (RAMPAGEpeak_011922) homozygous mutant. 
Homozygous null mutants were viable (a,b) with normal anatomical features compared to wildtype 
(supplementary figure 4). A total of 10 homozygous males and 10 homozygous females were 
examined. (a) Lateral view of the adult male. (b) Dorsal view of the adult male. (c) Image shows eye 
phenotype of flies with successful integration of 3xP3-RFP cassette at the lncRNA genomic locus. 
Due to the red pigmentation of the adult eye, the RFP signal can only be visualised from the 
Drosophila Ocelli. (Scale bar, 0.5 mm) (d) Comparative profiling of lncRNA-13 promoter activity 
during embryonic development. Embryos from five Drosophila species were collected and the 
libraries were generated using the RAMPAGE protocol. For lncRNA-13, the highest expression level 
of the lncRNA transcript in Drosophila melanogaster was detected at 9 hr after egg laying. (e) 
Genomic loci of lncRNA-13 as visualised on the UCSC genome browser. Transcripts annotated on 
Flybase are shown with dark blue bars. CG1958 and CG9650 are two protein-coding genes that are the 
closest to the lncRNA transcript. From the RAMPAGE tracks, single nucleotide resolution of the TSS 
can be obtained (gray bar). The top RAMPAGE track shows promoter activity from the plus strand of 
the DNA, whereas the bottom track shows the opposite strand. LncRNA-13 is expressed from the 
negative strand of the DNA and the transcript has not been annotated on Flybase or the Ensembl 
genome assembly. The transcript is found to be located in the intronic region of another lncRNA 
transcript (lncRNA: CR44357). A pair of gRNAs was used to replace the promoter region of the 
lncRNA with a 3xP3-RFP cassette as shown (orange bar, blue highlight). The region excised is from 
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Supplementary Figure 13: lncRNA-14 (RAMPAGEpeak_015813) homozygous mutant. 
A total of 10 homozygous males and 10 homozygous females were examined. LncRNA-14 
homozygous mutants were viable (a,b) with normal anatomical features compared to wildtype 
(supplementary figure 4). (a) Lateral view of the adult male. (b) Dorsal view of the adult male. (c) 
Image shows the eye phenotype of flies with successful integration of 3xP3-RFP cassette at the 
lncRNA genomic locus. (Scale bar, 0.5 mm) (d) Comparative profiling of lncRNA-14 promoter 
activity during embryonic development. Embryos from five Drosophila species were collected and the 
libraries were generated using the RAMPAGE protocol. For lncRNA-14, the highest expression level 
of the lncRNA in Drosophila melanogaster is at 13 - 14 hr after egg laying (AEL). (e) Genomic locus 
of lncRNA-14 as visualised on the UCSC genome browser. Transcripts annotated on Flybase are 
shown with dark blue bars with lncRNA:CR43651 and CG1888 as the neighbouring genes to the 
lncRNA. From the RAMPAGE tracks, single nucleotide resolution of the TSS can be obtained (gray 
bar). The top RAMPAGE track shows promoter activity from the plus strand of the DNA, whereas the 
bottom track shows the opposite strand. LncRNA-14 is expressed from the plus strand of the DNA and 
has not been annotated on Flybase or the Ensembl genome assembly. A pair of gRNAs was used to 
excise the promoter region of the lncRNA as shown (orange bar, blue highlight). The region excised is 
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Supplementary Figure 14: lncRNA-15 (RAMPAGEpeak_016800) homozygous mutant. 
Homozygous null mutants for lncRNA-15 were viable (a,b) with normal anatomical features 
compared to wildtype (supplementary figure 4). A total of 10 homozygous males and 10 homozygous 
females were examined. (a) Lateral view of the adult male. (b) Dorsal view of the adult male. (c) 
Image inserts displayed eye phenotypes of flies with successful integration of 3xP3-RFP cassette at 
the lncRNA genomic loci. The strong expression of the RFP protein in the adult eyes can be detected 
easily (Scale bar, 0.5 mm). (d) Comparative profiling of lncRNA-15 promoter activity during 
embryonic development. Embryos from five Drosophila species were collected and the libraries were 
generated using the RAMPAGE protocol. For lncRNA-15, the highest expression level of the lncRNA 
transcript in Drosophila melanogaster was detected at around 15 - 16 hr after egg laying. (e) Genomic 
loci of lncRNA-15 as visualised on the UCSC genome browser. Transcripts that have been annotated 
on Flybase were shown with dark blue bars. CG17048 and CG10814 are two protein-coding genes 
that are the closest to the lncRNA transcript. From the RAMPAGE tracks, single nucleotide resolution 
of the TSS can be obtained (gray bar). The top RAMPAGE track shows promoter activity from the 
plus strand of the DNA, whereas the bottom track shows the opposite strand. LncRNA-15 is expressed 
from the negative strand of the DNA and the transcript has been annotated on Flybase as 
lncRNA:CR45312 with one isoform. A pair of gRNAs have been used to replace the promoter region 
of the lncRNA with a 3xP3-RFP cassette as shown (orange bar, blue highlight). The region excised is 
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Supplementary Figure 15: lncRNA-16 (RAMPAGEpeak_018802) homozygous mutant. 
Homozygous null mutants for lncRNA-16 were viable (a,b) with normal anatomical features 
compared to wildtype (supplementary figure 4). A total of 10 homozygous males and 10 homozygous 
females were examined. (a) Lateral view of the adult male. (b) Dorsal view of the adult male. (c) 
Image shows eye phenotype of flies with successful integration of 3xP3-RFP cassette at the lncRNA 
genomic locus (Scale bar, 0.5 mm). (d) Comparative profiling of lncRNA-16 promoter activity during 
embryonic development. Embryos from five Drosophila species were collected and the libraries were 
generated using the RAMPAGE protocol. For lncRNA-16, a clear and distinct peak was observed and 
the highest expression level of the lncRNA transcript in Drosophila melanogaster was detected at 
around 15 - 16 hr after egg laying. (e) Genomic locus of lncRNA-16 as visualised on the UCSC 
genome browser. Transcripts annotated on Flybase are shown with dark blue bars. TweedleQ (TwdlQ) 
is located immediately upstream of the lncRNA transcript whereas amontillado (amon) is downstream. 
From the RAMPAGE tracks, single nucleotide resolution of the TSS can be obtained (gray bar). The 
top RAMPAGE track shows promoter activity from the plus strand of the DNA, whereas the bottom 
track shows the opposite strand. LncRNA-16 is expressed from the plus strand of the DNA and the 
transcript has not been annotated on Flybase or the Ensembl genome assembly. A pair of gRNAs was 
used to replace the promoter region of the lncRNA with a 3xP3-RFP cassette as shown (orange bar, 
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Supplementary Figure 16: lncRNA-19 (FBgn0264857) homozygous mutant. 
LncRNA-19 homozygous mutants were viable (a,b) with normal anatomical features compared to 
wildtype (supplementary figure 4). A total of 10 homozygous males and 10 homozygous females were 
examined. (a) Lateral view of the adult male. (b) Dorsal view of the adult male. (c) Image shows the 
eye phenotype of flies with successful integration of 3xP3-RFP cassette at the lncRNA genomic loci. 
(Scale bar, 0.5 mm) (d) Comparative profiling of lncRNA-19 promoter activity during embryonic 
development. Embryos from five Drosophila species were collected and the libraries were generated 
using the RAMPAGE protocol. For lncRNA-19, the highest expression level of the lncRNA in 
Drosophila melanogaster detected at 5 - 6 hr after egg laying (AEL). (e) Genomic loci of lncRNA-19 
as visualised on the UCSC genome browser. Transcripts annotated on Flybase are shown with dark 
blue bars with lncRNA:iab4 and abd-A as the two closest genes to the lncRNA. From the RAMPAGE 
tracks, single nucleotide resolution of the TSS can be obtained (gray bar). The top RAMPAGE track 
shows promoter activity from the plus strand of the DNA, whereas the bottom track shows the 
opposite strand. LncRNA-19 is expressed from the negative strand of the DNA and is denoted in 
FlyBase as lncRNA:iab8. There are 13 annotated transcripts for this lncRNA. A pair of gRNAs was 
used to excise the promoter region of the lncRNA as shown (orange bar, blue highlight). The region 











































Chapter 4 | 
A role for lncRNA-9 in the 
Drosophila nervous system  
 
For the purpose of this thesis, I will outline my specific contributions to this project.  
To perform the RNA-fish experiments, the design and production of the probes for the RNA-
fish were carried out by following companies with the lncRNA sequences provided by me. 
The Hybridization Chain Reaction (HCR) probes were ordered from Molecular 
Instrument, inc and the probes using the RNAscope® technology were made by Advanced 
Cell Diagnostics (ACD). The embedding, sectioning, staining and imaging of the embryos 
with the RNAscope® oligo probe set were performed by the staff from the CRUK CI 
Histopathology/ISH Core Facility (Bev Wilson and Dr. Julia Jones). Figure 26a was done by 
Dr Julia Jones. For the RNA-sequencing experiment, sequencing of the libraries was done by 
staff from the genomics core facility with the libraries prepared by me. The mapping of the 
modencode data and analyses of the RNA-seq data were performed by colleagues at our in-
house bioinformatics core facility team (Dr. Ashley Sawle and Dr. Abigail Edwards). The rest 




Cellular signalling and coordination from the embryo to a fully-grown adult are vital for 
the proper development of an organism. Different gene expression pathways have to be 
tightly regulated in time and space for the generation of different cell types and any mis-
regulation would be deleterious for the system (Lee and Young, 2013; Peter and Davidson, 
2011). During Drosophila embryonic development, the fertilised egg forms the future body 
axes and rapidly generates multiple cell lineages within 24 hr before the first instar larva 
emerges. This remarkable feat and speed thus require a well-coordinated system and logistics 
in place.  
 
In recent years, ncRNAs were shown to have an important role in regulating the 
Drosophila genome and the majority of the studies looked at how miRNAs were regulating 
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gene expression during embryogenesis (Chawla and Sokol, 2011; Aboobaker et al., 2005; Dai 
et al., 2012). While the general importance of microRNAs in regulating various aspects of 
development has been well-established, relatively little was known about how lncRNAs fit in 
the picture and their functions remain to be addressed. In the previous chapter, I have made 
used of RAMPAGE data that was generated from all stages of Drosophila embryogenesis to 
identify potential lncRNA candidates. The molecular impact of knocking out the lncRNA loci 
was then studied. From the list of potential lncRNAs, 22 that had conserved expression across 
five Drosophila species were used for functional studies. Out of the 22 candidates, one was 
omitted as it was later annotated as a protein-coding gene and for 13 candidates lncRNA 
mutant flies were successfully generated used CRISPR/Cas9. A series of assays were carried 
out to assess the phenotypic consequences of candidate lncRNA loss, and I found two 
mutants, lncRNA-3 and lncRNA-9, with homozygous lethal phenotype (Chapter 3).  
 
To better understand the role of Drosophila lncRNAs, I have chosen to focus on studying 
lncRNA-9 in greater depth in this chapter. To this date, thousands of lncRNAs have been 
identified in different organisms and many of these transcripts were found to be expressed in 
different tissues or were mis-regulated in many diseases (Xue et al., 2015; Sanchez et al., 
2018; Huarte, 2015). Several bioinformatics analysis platforms were developed over the years 
to accommodate the increasing amount of lncRNA-related data and these publicly available 
datasets served as a good starting point for the characterisation of lncRNAs (Park et al., 2014; 
Zhao et al., 2016; The RNAcentral Consortium). However, these information does not 
provide any form of functional visualisation of the lncRNA within the cell nor does it tell us 
about the impact of loss of the transcript.  Given that lncRNAs have been shown to be 
involved in many biological processes, it is imperative to invest efforts to decipher their roles 
and understand how these molecules contribute to development by further elucidating their 
mechanism of action. 
 
DNA and RNA in situ hybridisation methods has been used extensively in molecular 
studies to analyse mRNA transcripts and some of them have the potential to be used as 
biomarkers in clinical settings (Schulz et al., 2017; Lee et al., 2014). Many lncRNA-related 
studies showed that these transcripts had tissue-specific or even cell-specific expression 
(Cabili et al., 2015; Bindu et al., 2018).  RNA fluorescence in situ hybridization (RNA-FISH) 
has been the method of choice to study the localisation and expression of these often lowly 
abundant transcripts within the cell. From the information derived from the subcellular 
localisation of lncRNAs, we would have a better understanding of their expression dynamics 
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during embryonic development. The visualisation of their subcellular localisation could also 
provide insight into their physiological roles and allow researchers to carry out further 
investigations using different assays. Compared to mRNA for protein-coding genes, there 
remained a challenge to probe for lncRNA molecules using in situ hybridization (ISH) 
methods given their low abundance, poorly understood transcript structure and temporal 
expression within the cell. In order to solve this issue, several different ISH technologies have 
been developed throughout the years that greatly improved the visualisation of lowly 
abundant RNA transcripts.  
 
In this study, RNA-FISH was used to understand the expression pattern and tissue-
specificity of lncRNA-9 within the developing embryo and also probe for the compartmental 
location of the transcript within the cell. This was further paired with immunohistochemistry 
(IHC) to look for colocalization of the lncRNA transcript with proteins to determine in which 
cells the lncRNA was expressed within the tissue. Here, we identified that lncRNA-9 is 
expressed in the ventral nerve cord during Drosophila embryo development. This expression 
pattern coincides with a Drosophila neuron-specific marker ELAV (embryonic lethal 
abnormal vision) instead of REPO (reversed polarity), a marker that identifies glial cells.  
 
The RNA-FISH experiment and the RAMPAGE data revealed a temporally dynamic and 
spatially restricted expression profile of lncRNA-9 implying a tightly controlled 
transcriptional network. To investigate the molecular phenotype induced by lncRNA-9 loss 
and the genes that were affected in the mutants, I generated RNA-seq libraries from wildtype 
and homozygous null mutant embryos at hourly intervals when lncRNA-9 was expressed to 
compare the transcriptomic profile of lncRNA mutants and wildtype embryos. From the 
differential gene expression analysis, clusters of genes were identified to be significantly 
downregulated in the mutant background. I have made use of pathway enrichment and GO 
(Gene ontology) analysis to look for downstream genes that were affected by the loss of 
lncRNA-9. A significant enrichment of GO terms related to nervous system development and 
function was identified. The results generated thus far have underlined a potential role for 
lncRNA-9 in influencing the development of the nervous system during embryogenesis and 










4.2.1 Supporting evidence for lncRNA-3 and lncRNA-9 transcripts 
 
A number of high-quality and in-depth transcriptomic data pertaining to the development 
of Drosophila and C. elegans have been generated over the years by various groups within the 
modENCODE consortium.  One of the goals of the modENCODE project was to characterise 
the functional elements in the Drosophila genome and since then, a wealth of data was 
gathered from thousands of experiments including RAMPAGE, ChIP-seq, and RNA-seq 
(Boley et al., 2014; Brown and Celniker, 2015). In the previous chapter, two lncRNAs were 
found to be essential for Drosophila development but little was known about their function. 
Using available data from CAGE-seq (chapter 3), both transcripts were found to be expressed 
in the adult head. However, this information does not provide any other additional evidence 
about the localisation of the lncRNA and the tissue and cell types they were expressed in. 
Knowing the gene expression profile of the lncRNA transcript in the different tissues will 
greatly enhance our understanding of the possible role that is played by the lncRNA itself. 
 
Using the GBrowse2 tool available on FLYBASE, I have mined for information 
pertaining to the expression of the two lncRNA transcripts with the help of the TSS 
information generated from RAMPAGE as a reference.  To understand the characteristics of 
lncRNA-3 and lncRNA-9 genomic loci, I have mined existing data for chromatin signatures 
associated with the lncRNA transcripts. Active chromatin signatures such as H3K4me3, 
H3K36me3 and RNA Pol II occupancy have been previously used to identify transcribed 
regions (Shen et al., 2012; Ardehali et al., 2011; Huang et al., 2018). In addition, other 
histone marks that define the chromatin landscape can also be found on the GBrowse2. 
Instead of chromatin marks for gene expression, the mono-methylated histone H3 lysine 4 
(H3K4me1) mark was observed to occupy several regions throughout lncRNA-3 genomic 
loci. H3K4me1 is a chromatin signature found on inactive enhancers poised for activation 
during Drosophila development (Rada-Iglesias et al., 2011; Bonn et al., 2012; Koenecke et 
al., 2017). In addition, H3K27 methylation, a modification that is associated with gene 
repression was found to be deposited along the lncRNA transcript. The spread of both the 
enhancer-associated marker (H3K4me1) and a repression marker (H3K27me) from the gene 
body into the upstream promoter region of the lncRNA is suggestive that the expression of the 
lncRNA is likely to be tightly regulated. For lncRNA-9, only the recruitment of RNA Pol II 
just upstream from the TSS of the lncRNA was found. Neither H3K4me3 nor H3K36me3 
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chromatin marks were found to be associated with the genomic locus of lncRNA-9. Although 
an absence of chromatin signatures associated with active transcription (H3K4me3, 
H3K36me3 and Pol II) was observed for lncRNA-9, similar results were reported for 
Drosophila lncRNAs in the study by Chen et al., 2016. The authors observed that a large 
percentage of Drosophila lncRNA genomic loci were not occupied by chromatin signatures. 
While the histone marks may provide useful information about the chromatin state, further 
studies will be needed to understand which features are better suited for understanding the 
existence of a lncRNA and its expression. Furthermore, as lncRNA is only expressed in a few 
cells, it will be hard to detect chromatin mark signals in ChIP experiments as they are from 
whole embryos and not sorted cells. 
 
Besides the information gathered from ChIP-seq, the RNA sequencing data collected from 
various Drosophila tissues and developmental stages by the modENCODE consortium have 
provided an unparallel wealth of information for exploration of gene function. I have searched 
for the genomic loci of both lncRNA transcripts and found that both lncRNAs were expressed 
in the adult head, which is in line with the information that I have obtained from the CAGE-
seq data. Furthermore, both lncRNA transcripts have been found to be expressed in the central 
nervous system with five different isoforms constructed from RNA-seq data for lncRNA-3 
(Figure 21). Based on the PhyloCSF analysis, both lncRNAs are unlikely coding for 
functional peptides. Within the nervous system, lncRNA-9 had a modest expression in the 
neuroblast and neurons compared to lncRNA-3 (Figure 22). As lncRNA-9 was not annotated 
on Flybase, tissue specific expression data was only downloaded for lncRNA-3 (Table 17). 
The transcription factor (TF) HOT spots (high occupancy sites) track was generated to 
identify highly occupied target (HOT) regions using ChIP-seq data of 41 factors in embryos. 
Interestingly, the lncRNA-3 TSS and genomic loci was also a hotspot for transcription factors 
compared to lncRNA-9 and this may explain the rationale for its higher expression levels 
captured using RNA-seq and RAMPAGE. The expression of both lncRNA-3 and lncRNA-9 
in the Drosophila central nervous system does not come as a surprise. Thousands of lncRNA 
transcripts have previously been reported to be pervasive in specific tissues with a large 
fraction expressed in the head and brain (Mercer et al., 2008; Briggs et al., 2015; Schor et al., 
2018).  
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Figure 21: A Gbrowse2 view of lncRNA-3. 
Shown is a schematic screenshot of the Drosophila chromosome 3L (10,305,000 - 10,420,000) on the 
genome browser on FlyBase. Information on the directionality of expression for each of the transcript 
can be seen from the two sets of tracks provided. The top set of tracks refers to the positive strand 
whereas the bottom track denotes the minus strand. Using the data provided by the modENCODE 
Consortium, the full-length transcript for lncRNA-3 was identified with the help from the TSS 
information for this ncRNA (chr3L:10326628-10326781) previously downloaded from the 
RAMPAGE data. LncRNA-3 is annotated as lncRNA:CR46006 on FlyBase with five isoforms 
(lncRNA:CR46006-RA/B/C/D/E) and it is expressed from the positive DNA strand. All of the 
isoforms contain two exons that are separated by an intronic region except for lncRNA:CR46006-RE 
(not shown). In the browser, each TSS captured by RAMPAGE is indicated by a green bar/arrow 
under “Transcriptional start site (RAMPAGE), peak calls”.  For the convenience of identifying the 
TSS, a bigger cyan arrow has been drawn to indicate the TSS of the lncRNA. MiR-276b and 
lncRNA:CR46004 are located upstream of lncRNA whereas miR-276a is localised downstream of the 
lncRNA-3 transcript. A multi-species nucleotide sequence alignment tool used to denote protein-
coding regions is represented by the PhyloCSF track. Protein-coding regions are represented with a 
red bar/arrow as seen for CG12362. The Phylocsf track for lncRNA-3 indicates that no open reading 
frame has been detected, further demonstrating that this transcript is a ncRNA. The modENCODE 
tissue-specific stranded RNA-seq data contains a dynamic genome-wide expression profiling of 
Drosophila (Brown et al., 2014). RNA-seq data have been plotted from different tissue types 
including digestive system, fat body and salivary glands, imaginal disc and other carcass, CNS and 
adult head, gonads and male accessory glands, L3 CNS neuron and L3 CNS neuroblast (log2 scale). 
From the coverage profiles, lncRNA-3 was found to be highly expressed in the central nervous system 
tissues (3rd instar larvae CNS neuron, 3rd instar larvae CNS neuroblast and head of the adult). 
Transcription factor (TF) HOT spot analysis from whole embryo ChIP is not shown. For each of the 
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Figure 22: A Gbrowse2 view of lncRNA-9 
This diagram is a schematic screenshot of the genomic locus of lncRNA-9 on the Drosophila 
chromosome 3L (17,223,946 - 17,323,946). Information on the directionality of expression for each of 
the transcript can be seen from the two sets of tracks provided. The top set of tracks refers to the 
positive strand whereas the bottom track denotes the minus strand. Notice that the full-length 
transcript for lncRNA-9 is not annotated on FlyBase. The TSS for lncRNA (chr3L:17269741-
17269766) is captured by RAMPAGE and it is indicated with a green arrow/bar under 
“Transcriptional start site (RAMPAGE), peak calls”.  A bigger arrow in cyan has been drawn to 
indicate the TSS of the lncRNA. LncRNA-9 is expressed from the positive strand of the DNA with 
CG13723 located upstream of the transcript. LncRNA:CR45436 is expressed from the opposite 
direction and it is annotated downstream of the lncRNA. A multi-species nucleotide sequence 
alignment tool used to denote protein-coding regions is represented by the PhyloCSF track. Protein-
coding regions are represented with a red bar/arrow as seen for CG6497. NONCODE 2016 was used 
to search for the lncRNA transcript and using Phylocsf analysis, the ncRNA did not appear to have 
any short open reading frames within the transcript that was constructed on NONCODE (data not 
shown). The Phylocsf track displayed here indicates that no open reading frame has been detected, 
further suggesting that this transcript is a ncRNA. Transcription factor (TF) HOT spot analysis from 
whole embryo ChIP is not shown. For each of the tissue-specific RNA-seq profiles, the default log2 
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We next asked whether lncRNA-3 and lncRNA-9 carry out their function through a 
cis- or trans-acting mechanism. In order to answer this question, rescue transgenic models 
were created using clones from Drosophila melanogaster BAC libraries (Venken et al., 2009). 
For the rescue experiments, the transgenic flies generated for lncRNA-3 (CH322-18B08 and 
CH322-151D21) and lncRNA-9 (CH322-170N22 and CH322-122O7) are listed in Table 2.2. 
Each of these clones were between ~21 kb and 40 kb in size and overlapped with the deleted 
region of the corresponding lncRNA mutant (Figure 23). The transgenic rescue flies were 
established on the second chromosome and subsequently crossed to a double balancer 
(w[1118]; If/Cyo ; MKRS/TM6B, Tb[1]). The lncRNA mutants were crossed to the same 
double balancer fly and both stocks were subsequently mated to generate flies that only 
expressed the lncRNA transcript from the transgene. The number of adults of was scored to 
assess rescue of the mutant by the transgene. However, using these lines I was unable to 
revert the phenotype caused by both lncRNA-3 and lncRNA-9. These results suggest that both 
lncRNAs were unlikely to be regulating genes in a trans-acting manner. Following these 
analyses, while both lncRNA candidates have presented interesting phenotypes with 
CRISPR/Cas9 mutagenesis, I will be focusing on characterising lncRNA-9 in the next parts of 
this chapter as the phenotype of the lncRNA has been fully validated to be dependent on the 
lncRNA using alternative mutants. Additional supporting evidence will be needed to confirm 
the phenotype for lncRNA-3 is indeed depended on the lncRNA absence rather than 
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Figure 23: BAC rescue for lncRNA-3 and lncRNA-9. 
Schematic diagram of the genomic locus and the design of rescue lines for lncRNA-3 and lncRNA-9. 
BAC constructs containing the wild-type version of the deleted sequences (magenta bars) were used to 
reintroduce them. PACMAN Genome Browser and FlyBase gbrowse were used to search for the BAC 
Clones containing the lncRNA of interest. For each lncRNA, two clones were selected from the 
“CHORI-322” BAC library (Venken et al., 2009). (a) Genomic loci of lncRNA-3 with the TSS 
represented by an arrow in cyan (chr3L:10326628-10326781). For lncRNA-3, the deleted region spans 
from chr3L: 10,325,557 – 10,327,321. The BAC clones CH322-18B08 (3L: 10,324,751-10,348,381) 
and CH322-151D21 (3L: 10,320,125-10,339,114) were selected and separately introduced to rescue 
the phenotype. (b) For lncRNA-9, the region excised is from chr3L: 17,269,407 – 17,270,407. The 
BAC clones CH322-170N22 (3L: 17,264,834-17,284,252) and CH322-122O7 (3L: 17,264,275-
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4.2.2 LncRNA-9, a nuclear RNA transcript expressed during Drosophila 
embryogenesis 
 
Many studies have highlighted that lncRNAs present cell- and tissue-specific expression 
that would be the basis for their physiological functions (Wilk et al., 2016; Cabili et al., 
2015). RNA-FISH was used to probe the general expression pattern and subcellular 
localisation of lncRNA-9. In this study, the RNAscope® oligo probe set was designed and 
obtained from Advanced Cell Diagnostics (ACD). On the other hand, in situ hybridization 
chain reaction (HCR) probes against lncRNA-9 were generated by Molecular Technologies. 
Oligo probe sets from RNAscope® were first obtained to stain Drosophila embryo sections 
due to the lack of protocols for working with whole-mount Drosophila embryos. Probes from 
Molecular Technologies were used much later for the staining of whole-mount embryos. 
A chromogenic in situ hybridization assay was carried out using the RNAscope® oligo 
probe set on sectioned late stage Drosophila embryos (stage 16-17). The embedding, 
sectioning, staining and imaging of the embryos with the RNAscope® oligo probe set were 
performed by Bev Wilson and Dr. Julia Jones from the Histopathology/ISH Core Facility 
with the embryos prepared by me. The double Z probes were designed to bind to the lncRNA 
transcript in tandem with high specificity. Each Z probe consists of 2 components. The base 
region of the Z probe was made to be complementary to target sequence whereas the top end 
would bind to the pre-amplifier for subsequent signal amplification. Upon hybridisation with 
the target lncRNA sequence, the pre-amplifiers would interact with the top end of the double 
Z followed by the binding of amplifiers to the binding sites found on each pre-amplifier. 
Productive amplification only occurs when both Z probes are binding the target in tandem 
thereby reducing the background resulting from unspecific binding of each individual Z 
probe. Label probes containing chromogenic enzymes such as horseradish peroxidase were 
later added to allow conjugation with the 20 binding sites on each amplifier. The target 
lncRNA was visualised using a standard bright-field microscope after the addition of substrate 
(https://acdbio.com). To visualise the localisation of the lncRNA using DNA-HCR probes, 
fixed whole-mount embryos were prepared according to the protocol provided by the 
company (Choi et al., 2016).  Briefly, the technology consisted of three components: initiator 
probe, amplifier probe H1 and amplifier probe H2. The initiator probes consisted of two parts. 
One part of the initiator contains specific sequences for hybridising to regions of the lncRNA 
transcript. The other part of the initiator was made for initiating polymerisation of the two 
amplifier probes. Upon exposure to the unhybridized end of the initiator probe, a self-
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assembling cascade hybridization reaction with the two fluorescently labelled amplifiers 
would eventually lead to a linear amplification of the signal (Choi et al., 2016; Choi et al., 
2018). Using embryos at stage 16-17 of development, both methods revealed strikingly 
similar spatio-expression of the lncRNA. LncRNA-9 transcripts were localised to the the 
ventral nerve cord of the developing embryo (Figure 24, 25, 26). This localisation of lncRNA-
9 to the central nervous system consistently with the earlier results from the modENCODE 
data.  In addition, co-localisation of the transcript with DAPI staining indicated that the 
lncRNA is localised in the nucleus (Figure 24, 25, 26d), in agreement with a potential 
function in cis as suggested by the BAC rescue experiments. 
   
4.2.3 LncRNA-9 is a neuron-specific lncRNA 
 
The ventral nerve cord consists of a wide variety of cell types including neuroblasts, 
neurons and glial cells. To further characterise the lncRNA-9 transcript, we asked if it was 
localised in neuroblast/neuronal cells, glial cells or both. To visualise lncRNA expression in 
these cell types, I performed multiplexed RNA-FISH against this lncRNA and neurogenic 
gene markers expressed in stage 16-17 embryos. In this experiment, we have made use of the 
HCR protocol with antibodies as it would allow us to visualise co-localisation in a whole 
mount embryo. LncRNA-9 was found to be co-localised with the ELAV protein in the 
neuroblast/neurons and this result agreed with the modENCODE data in section 4.2.1 (Figure 
24, 25 and Figure 26). However, we observed that the co-localization of lncRNA-9 and ELAV 
was restricted to only a subset of the neuronal cells. This finding would explain the low 
expression levels detected for this transcript in a bulk RNA-seq experiment and also reflects 
the point that lncRNAs have cell-specific expression within the pool of neuronal cell types 
generated.  
 
Using this information, I hypothesized that in the homozygous null mutant, the neurons 
that expressed lncRNA-9 would not be created and we would see gaps or a much shorter form 
of the ventral nerve cord (VNC) in the mutant embryo. Interestingly, although the lncRNA 
was found at spots throughout the VNC, the phenotype of the mutant embryo did not match 
our expectation. Instead, the VNC was found to have retracted in the majority of the wildtype 
embryos at this stage whereas in the homozygous null mutants, the ventral nerve cord 
remained extended. This finding suggested that lncRNA-9 mutants could have been arrested 
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at stage 16 or even earlier. Alternatively, the loss of the lncRNA transcript could have 
affected the VNC condensation process, resulting in an embryo with an elongated ventral 
nerve cord. For the staining with the glial cell marker repo, we found that the lncRNA did not 



















Figure 24: Spatiotemporal expression of lncRNA-9 transcript with ELAV (Dorsal view) 
In situ hybridization of stage 16 embryos using a multiplexed RNA-FISH protocol. The lncRNA-9 
transcript was found to be expressed in the VNC of the developing nervous system (Stage 16-17 
embryos). Expression and localisation of lncRNA-9 and ELAV in the embryo are shown by 
immunofluorescence (DNA, cyan; ELAV, magenta; lncRNA-9, yellow). Both wildtype (left column) 
and lncRNA homozygous null mutant (right column) embryos were staged and collected for this 
experiment. In the homozygous null mutant generated with Cas9-HDR, I did not detect any lncRNA 
expression using the same settings on the microscope that was used for wildtype embryos. The VNC 
of the developing mutant embryo remain elongated compared to wildtype embryos of the similar 
stage. Images were taken with the anterior end on the left and the posterior side on the right. During 
the imaging of the embryos, 80-100 slices were taken for each embryo and a total of 20 embryos were 












Figure 25: LncRNA-9 is expressed in the embryonic ventral nerve code (Lateral view) 
Using a multiplexed RNA-FISH protocol, the lncRNA-9 transcript was found to be expressed in the 
VNC of the nervous system (Stage 16-17 embryos). Expression and localization of lncRNA-9 and 
ELAV in the embryo are shown by immunofluorescence (DNA, cyan; ELAV, magenta; lncRNA-9, 
yellow). Both wildtype (left column) and lncRNA homozygous null mutant (right column) embryos 
were staged and collected for this experiment. In the homozygous null mutant that have been 
generated with Cas9-HDR, I did not detect any lncRNA expression using the same microscope 
settings as for the wildtype embryos. Images were taken with the anterior end on the left and the 
posterior side on the right. During the imaging of the embryos, 80-100 slices were taken for each 
embryo and a total of 20 embryos were analysed for each genotype. All scale bars represent 50 µm. 
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Figure 26: Localisation of lncRNA-9 transcript in the developing embryo.  
 (a) Stage 16-17 wildtype embryos were stained with oligo probe sets for lncRNA-9 (brown) and 
act79b (blue). The signal from the RNA was visualised using horseradish peroxidase and depicted in 
brown. Similar to earlier results, lncRNA-9 transcripts were localised to the VNC of the developing 
embryo. Scale bar represent 30 µm. (b) The embryos were co-stained with the lncRNA smFISH 
probes (yellow) and ELAV (magenta) neuronal cell marker. A colocalization of the signals can be 
observed indicating that lncRNA-9 transcripts were expressed in neurons. (c) Co-staining of embryos 
with lncRNA smFISH probes (yellow) and glial cell marker, Repo (magenta). The lncRNA-9 
transcript was not found to be co-expressed with Repo. Zoomed in images taken with a 63x lens (d) 
The embryos were co-stained with the lncRNA smFISH probes (yellow) and DAPI. Zoomed in 
images taken with a 100x magnification lens. LncRNA-9 was found to co-localise with the DAPI 
staining in the nucleus. In all 3 images (b,c,d),  DAPI was used to stain for the nucleus (cyan). Unless 
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4.2.4 Differential expression analysis of lncRNA-9 mutant 
To investigate the molecular consequences of lncRNA-9 knockout on downstream targets, 
I carried out RNA-Seq. For the transcriptome analysis, RNA-seq libraries were generated 
from wildtype and homozygous lncRNA-9 mutant embryos that were collected at hourly 
timepoints from 10-24 hr (14 timepoints). The term used to describe each timepoint collection 
is as follow: T10 (10 hr – 11 hr AEL); T11 (11 hr – 12 hr AEL); T12 (12 hr – 13 hr AEL); 
T13 (13 hr – 14 hr AEL); T14 (14 hr – 15 hr AEL); T15 (15 hr – 16 hr AEL); T16 (16 hr – 17 
hr AEL); T17 (17 hr – 18 hr AEL); T18 (18 hr – 19 hr AEL); T19 (19 hr – 20 hr AEL); T20 
(20 hr – 21 hr AEL); T21 (21 hr – 22 hr AEL); T22 (22 hr – 23 hr AEL) and T23 (23 hr – 24 
hr AEL). For each mutant library, the embryos were manually collected by hand using the 
fluorescence balancer to distinguish them from their heterozygous siblings. The wildtype 
RNA-seq libraries were generated from control flies collected from a different cage. I 
collected 100 embryos for each library and a total of 56 libraries were generated (2 replicates 
per timepoint, 28 libraries per genotype). The sequenced reads were mapped to the 
Drosophila dm6 reference genome and alignment was carried out using HISAT2. For the 
purpose of differential gene expression analysis, all samples fulfilled the requirement of at 
least 30 million reads per library. Coverage plots for each sample were visualised in the 
UCSC genome browser (Figure 27).  The TSS of the transcript was located using information 
from the RAMPAGE data (Figure 27a). In agreement with the phenotype validation 
performed by PCR of the genomic locus and the RNA-FISH results, the RNA-sequencing 
data from the mutant embryos showed almost a complete lack of coverage for the genomic 
region of lncRNA-9 (Figure 27c) compared to wildtype embryos (Figure 27b). 
 
In this study, we looked for genes in the RNA-seq libraries that were differentially 
expressed when compared to wildtype embryos. We reasoned that because of the broad 
developmental defects observed, the main pathways affected would be differentially regulated 
across several stages. The first approach was to focus on the top 200 genes with the most 
significant changes based on their adjusted p-value (padj) (Supplementary Table 1.1-1.14). 
For each time point, I have subjected the gene cohorts to PANTHER Overrepresentation Test 
(Released 20200407) via The Gene Ontology (GO) Resource (The Gene Ontology 
Consortium, 2019). The annotation data sets used include PANTHER GO-Slim Biological 
Process, PANTHER GO-Slim Molecular Function and ANTHER GO-Slim Cellular 
Component (PANTHER version 15.0 Released 2020-02-14). During the GO enrichment 
analysis, only results with a false discovery rate [FDR] of less than 0.05 were used. The 
results from the GO analysis has been arranged in a “Hierarchical” fashion with the most 
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specific subclass indented directly above its parent term. GO terms that are over-represented 
or enriched will be selected for further studies.  
 
With reference to the RAMPAGE data for lncRNA-9 (Chapter 3, supplementary figure 8), 
there are a couple of key timepoints during the expression of the lncRNA. The lncRNA is 
expressed prior to T10 (corresponding to 10 hr – 11 hr AEL) and increases in expression level 
thereafter. This is followed by a peak in expression level at around T16 (corresponding to 16 
hr – 17 hr AEL). However, the samples were collected from T10 onward as the fluorescence 
signal is only detected in the embryos after this time due to the promoter of the balancer. 
From the results obtained (Table 18), GO term enrichment showed significant enrichment in 
neuronal processes (synaptic signalling, chemical synaptic transmission, synaptic 
transmission, glutamatergic) at 2 timepoints, T10 and T17. At T10, genes involved in 
ammonium transport, three of them (Syt12, Syt1, Amt) are found in our list (22.51 
enrichment). Genes involved in synaptic transmission include Syt12, Syt1, mGluR, 
nAChRalpha7, nAChRalpha1, Grik, SecCl and GluRIIE. While the expression of lncRNA-9 
starts to increase after T12, the TSS can be detected as early as T10 and peaks at T16. It is not 
surprising that biological processes associated with the nervous system were enriched at T17 
as this is the timepoint right after the highest expression of the lncRNA transcript itself. 
Besides an enrichment for terms related to the nervous system, biological processes pertaining 
to the DNA repair pathway were detected (double-strand break repair, metabolic process, 
cellular response to DNA damage stimulus).    
 
In order to examine the significantly up- and down-regulated genes, the gene lists were 
further sorted into two categories based on their log fold-change value (down- or upregulated) 
and then ranked based on their adjusted p-value (padj). The lists of genes for each timepoint 
used for the GO enrichment analysis can be found in Supplementary Table 2.1-2.14 
(downregulated genes) and Supplementary Table 3.1-3.14 (upregulated genes). As the 
expression of lncRNA-9 increases from timepoints T13 (corresponding to 13 hr – 14 hr AEL) 
and peaks at T16 (corresponding to 16 hr – 17 hr AEL), I first examined the genes that are 
differentially expressed at T16 as well as the two timepoints later (T17 and T18). From the 
analysis, GO term enrichment of downregulated genes revealed significant enrichment in 
biological processes related to neuronal function such as chemical synaptic transmission 
activity (synaptic signalling) and modulation of trans-synaptic signalling in all three 
timepoints (Table 19.1- 19.2). The molecular functions of these genes were associated with 
roles in transmitter-gated ion channel activity (neurotransmitter receptor activity, extracellular 
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ligand-gated ion channel activity), anion transmembrane transporter activity, inorganic cation 
transmembrane transporter activity and active transmembrane transporter activity (Figure 28). 
Further analysis of the cellular components revealed categories associated with neuronal 
function (neuron projection, synapse, postsynaptic membrane). Genes involved in synaptic 
transmission include Syt12, mAChR-B, DAT, nAChRalpha7, nAChRalpha2, Grik, and SecCl.  
 
Besides examining the immediate effects after lncRNA-9 expression reaches its peak, I 
also analysed the genes that are differentially expressed at earlier time points (T13 -T15). Just 
prior to the peak expression of lncRNA-9, the genes that are downregulated are enriched for 
small molecule catabolic processes (carboxylic acid catabolic process, branched chain 
metabolic process). However, the results observed for both molecular functions and cellular 
components domains for most of the timepoints were not statistically significant. While the 
metabolism of amino acids is essential during Drosophila embryogenesis and distinct roles 
are played by different amino acids in different stages during embryogenesis, little is known 
regarding the role of branched chain amino acid catabolism and their contribution to nervous 
system development (An et al., 2014; Esslinger et al., 2013). On the other hand, loss of 
lncRNA-9 appeared to have led to the activation and upregulation of genes associated with 
many terms related to cell cycle related activities such as DNA metabolism and DNA repair 
mechanisms (Table 20.1-20.3).  
 
Characteristics of differentially expressed genes using GO pathway analysis 
 
While the pathways enriched among the upregulated genes warrant further investigation, I 
have chosen to focus on the genes that were downregulated as the outcomes of the analysis 
were in line with results shown in the RNA-FISH data and further authenticate a role of 
lncRNA-9 in neural function. The analysis of Reactome (version 65 Released 2019-12-22) 
pathways enrichment was evaluated using the dataset available by the GO consortium. Using 
genes from T16-T18, pathways enriched for components in these lists include classes such as 
‘neuronal system’ and ‘transmission across chemical synapses’. Only results with an FDR of 
less than 0.05 is used. The genes identified under the ‘transmission across chemical synapses’ 
class include prt, nSyb, Nmdar1, Ggamma30A, CG44098, Ir76b, SecCl and Hsc70-2. Factors 
that have been identified in the class of ‘neuronal system’ contain all the genes mentioned 
earlier and CG18095.  
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LncRNAs are known to regulate mRNAs in cis and it is believed that their functions are 
related to their neighbouring protein-coding genes. Since I was unable to rescue the 
phenotype of lncRNA-9 using a BAC rescue experiment, this result suggested a possible cis-
acting role. Here, I have examined the expression of neighbouring mRNAs in the 200 kbp of 
sequence representing the region closest to the identified lncRNAs (Figure 29). From the 
RNA-sequencing analysis, 26 genes are found to be within 200 kbp from the TSS of the 
lncRNA. Target of Poxn (Tap) and Secretory Chloride Channel (SecCl, CG7589) are two of 
the genes that are located downstream of lncRNA-9 and their expression was found to be 
downregulated in the lncRNA mutant (padj<0.05, log2FC>1).  
 
SecCl is a cys-loop glycine-gated chloride ion channel that is 200 kbp from the TSS of 
lncRNA-9 and has also been identified from the GO pathway analysis previously. The only 
known function of this protein is that it is a mediator of fluid secretion and the molecular 
phenotype associated with SecCl has been annotated on FlyBase as partially lethal and 
increased mortality during development. It is involved in the biological processes negative 
regulation of neuronal action potential; chemical synaptic transmission and regulation of 
circadian rhythm (Frenkel et al., 2017). Proteins of the cys-loop glycine-gated chloride ion 
channel have previously been reported to be expressed in the nervous system and in muscle 
cells (Sine and Engel, 2006). They act as post-synaptic communicators and interact with 
neurotransmitters released from the pre-synapse (Sine and Engel, 2006). As little is known 
about the interactors with SecCl, I searched FlyBase for other glycine receptors and found 
CG7446 (Grd), CG17336 (Lcch3), CG12344 and CG10537 (Rdl). From the RNA-seq data, a 
significant downregulation was observed for CG10537 (Rdl) and CG12344 immediately after 
the peak of the lncRNA whereas both Lcch3 and Grd are downregulated from T14-T18 in the 
lncRNA-9 mutant (padj<0.05, log2FC>1). On the other hand, Tap is a basic helix-loop-helix 
(bHLH) neural transcription factor that is the homolog for Neurogenin/NeuroD. It is located 
92 kbp downstream from the TSS of lncRNA-9 and while there is little experimental evidence 
available for Tap, the molecular phenotype for flies lacking Tap is closely similar that 
observed in lncRNA-9 mutants. Even though there are a few escapers to early larval stages, 
the majority of the Tap mutants were reported as embryonic lethal (Yuan et al., 2016). 




Figure 27: Genomic locus of lncRNA-9 from RNA-sequencing data. 
All of the RNA-seq libraries were uploaded onto the UCSC genome browser and a portion of the 
RNA-seq libraries were shown here (chr3L: 17,269,000 – chr3L:17,277,300). The tracks for embryos 
collected from 13 hr–18 hr embryos were shown as it was the period of development where the 
lncRNA increasing faster before it reaches its highest expression at T16-T17. (a) As the lncRNA 
transcript was not annotated on FLYBASE or ENSEMBL, I made use of the RAMPAGE track to 
locate for the TSS of the lncRNA transcript (chr3L:17,269741 – chr3L:17,269766). (b) RNA-seq 
libraries generated with wildtype Oregon R flies. (c) RNA-seq libraries of homozygous null mutants. 
The results confirmed the KO of the lncRNA in the homozygous null mutant embryos. Orange bar 
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Figure 28: Drosophila lncRNA-9 knockout reveals an impact on neuronal genes.  
Depletion of lncRNA-9 results in downregulation of genes with important roles at the synapses. The 
plots are the results of functional annotation analysis of the top 200 downregulated genes based on 
their padj values. (a) GO analysis of genes that are downregulated at T10 our initial timepoint when 
the lncRNA is still lowly expressed. (b) GO analysis of genes at T16, T17 and T18. The lncRNA 
transcript peaks at T16 and decreases in expression levels after T18. Each GO domain has been 
coloured coded with Biological processes in cyan, molecular function in magenta and cellular 
components in yellow. In all of the timepoints, ‘chemical synaptic transmission’ is a common 
biological process with the lowest FDR. The enriched genes were also found to be localised with GO 












































Figure 29: Differential gene expression profile of neighbouring genes from lncRNA-9. 
RNA-seq heatmap of genes that are 200 kb from the genomic loci of the lncRNA transcript. The 
arrows represent the genomic location of the genes from lncRNA-9. The arrow pointing upwards 
indicates upstream whereas the arrow that is pointing downwards indicates downstream from the 
lncRNA. Genes that are closer to the arrowhead are the furthest away from the lncRNA locus.  
The heatmap has been plotted across indicated time points (14 time points, n = 2 biological replicates). 
The fold changes for each gene between lncRNA mutant and wildtype is represented in logarithmic 
(log2) scale as shown. FBgn0015550 (tap) and FBgn0036727 (CG7589, SecCl) are genes (highlighted 
in magenta) involved in neuronal functions and found to be downregulated in the mutants in at least 
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Table 17: modENCODE tissue expression data for lncRNA-3 
  




FBlc0000229 mE_mRNA_L3_Wand_imag_disc 2 
FBlc0000225 mE_mRNA_L3_CNS 2 
FBlc0000224 mE_mRNA_P8_CNS 1 
FBlc0000210 mE_mRNA_A_VirF_1d_head 0 
FBlc0000211 mE_mRNA_A_VirF_4d_head 0 
FBlc0000231 mE_mRNA_A_VirF_20d_head 0 
FBlc0000207 mE_mRNA_A_MateF_1d_head 1 
FBlc0000213 mE_mRNA_A_MateF_4d_head 1 
FBlc0000212 mE_mRNA_A_MateF_20d_head 0 
FBlc0000209 mE_mRNA_A_MateM_1d_head 1 
FBlc0000216 mE_mRNA_A_MateM_4d_head 1 
FBlc0000214 mE_mRNA_A_MateM_20d_head 1 
FBlc0000230 mE_mRNA_L3_Wand_saliv 0 
FBlc0000234 mE_mRNA_WPP_saliv 0 
FBlc0000227 mE_mRNA_L3_Wand_dig_sys 0 
FBlc0000219 mE_mRNA_A_1d_dig_sys 0 
FBlc0000223 mE_mRNA_A_4d_dig_sys 0 
FBlc0000221 mE_mRNA_A_20d_dig_sys 0 
FBlc0000228 mE_mRNA_L3_Wand_fat 0 
FBlc0000233 mE_mRNA_WPP_fat 1 
FBlc0000235 mE_mRNA_P8_fat 0 
FBlc0000226 mE_mRNA_L3_Wand_carcass 1 
FBlc0000218 mE_mRNA_A_1d_carcass 1 
FBlc0000222 mE_mRNA_A_4d_carcass 1 
FBlc0000220 mE_mRNA_A_20d_carcass 1 
FBlc0000232 mE_mRNA_A_VirF_4d_ovary 0 
FBlc0000208 mE_mRNA_A_MateF_4d_ovary 0 
FBlc0000217 mE_mRNA_A_MateM_4d_testis 0 
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Biological Process Molecular Function  Cellular Component 
T10 • chemical synaptic 
transmission (GO:0007268) 
• ammonium transport 
(GO:0015696) 
• synaptic transmission, 
glutamatergic 
(GO:0035249) 
*n.s.e • integral component of 
plasma membrane 
(GO:0005887) 
T11 • double-strand break repair 
via NHEJ (GO:0006303) 
• telomere maintenance  
(GO:0000723) 
• telomeric DNA binding 
(GO:0042162) 
• nuclear chromosome, 
telomeric region 
(GO:0000784) 
T12 *n.s.e • telomeric DNA binding 
(GO:0042162) 
• nuclear chromosome, 
telomeric region 
(GO:0000784) 
T13 *n.s.e *n.s.e *n.s.e 
T14 *n.s.e *n.s.e *n.s.e 
T15 *n.s.e *n.s.e *n.s.e 
T16 *n.s.e 
 
• telomeric DNA binding 
(GO:0042162) 
• nuclear chromosome, 
telomeric region 
(GO:0000784) 
• nuclear chromosome part 
(GO:0044454) 
T17 • synaptic vesicle cycle 
(GO:0099504) 
• chemical synaptic 
transmission (GO:0007268) 
• syntaxin binding 
(GO:0019905) 
• neuron projection 
(GO:0043005) 
T18 • double-strand break repair 
(GO:0006302) 
*n.s.e • replisome (GO:0030894) 
• nuclear chromosome, 
telomeric region 
(GO:0000784) 
• DNA helicase complex 
(GO:0033202) 
• CMG complex 
(GO:0071162) 
• nuclear replication fork 
(GO:0043596) 
• origin recognition complex 
(GO:0000808) 




T19 *n.s.e telomeric DNA binding 
(GO:0042162) 
• Pwp2p-containing 
subcomplex of 90S 
preribosome (GO:0034388) 
• nuclear chromosome, 
telomeric region 
(GO:0000784) 
T20 *n.s.e *n.s.e *n.s.e 
T21 *n.s.e *n.s.e *n.s.e 
T22 *n.s.e *n.s.e *n.s.e 
T23 *n.s.e *n.s.e • extracellular space 
(GO:0005615) 
*n.s.e: no significant enrichment 
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Table 19.1: GO analysis for the top 200 downregulated genes with the lowest padj values 




Biological Process Molecular Function Cellular Component 
T10 • ammonium transport 
(GO:0015696) 
• synaptic transmission, 
glutamatergic 
(GO:0035249) 
• regulation of membrane 
potential (GO:0042391) 
• chemical synaptic 
transmission (GO:0007268) 
• glutamate receptor activity 
(GO:0008066) 
• ligand-gated channel 
activity (GO:0022834) 




• plasma membrane region 
(GO:0098590) 
• integral component of 
plasma membrane 
(GO:0005887) 
• neuron projection 
(GO:0043005) 
T11 *n.s.e • UDP-glycosyltransferase 
activity (GO:0008194) 
*n.s.e 
T12 *n.s.e • UDP-glycosyltransferase 
activity (GO:0008194) 
• intrinsic component of 
plasma membrane 
(GO:0031226) 
T13 • fatty acid catabolic process 
(GO:0009062) 
• carboxylic acid catabolic 
process (GO:0046395) 
• cellular lipid catabolic 
process (GO:0044242) 
• carboxylic acid binding 
(GO:0031406) 
*n.s.e 
T14 *n.s.e *n.s.e *n.s.e 
T15 • carboxylic acid catabolic 
process (GO:0046395) 
*n.s.e *n.s.e 
T16 • chemical synaptic 
transmission (GO:0007268) 
*n.s.e • neuron part (GO:0097458) 
T17 • cell-cell adhesion 
(GO:0098609) 
• synaptic vesicle cycle 
(GO:0099504) 
• chemical synaptic 
transmission (GO:0007268) 
• syntaxin binding 
(GO:0019905) 
• signalling receptor activity 
(GO:0038023) 
• cell surface (GO:0009986) 
• integral component of 
plasma membrane 
(GO:0005887) 
• plasma membrane bounded 
cell projection 
(GO:0120025) 
• plasma membrane region 
(GO:0098590) 
• neuron projection 
(GO:0043005) 
T18 • chemical synaptic 
transmission (GO:0007268) 
• ligand-gated ion channel 
activity (GO:0015276) 
• chloride transmembrane 
transporter activity 
(GO:0015108) 
• active transmembrane 
transporter activity 
(GO:0022804) 
• monovalent inorganic cation 
transmembrane transporter 
activity (GO:0015077) 
• active ion transmembrane 
transporter activity 
(GO:0022853) 
• plasma membrane bounded 
cell projection 
(GO:0120025) 
• plasma membrane region 
(GO:0098590) 
• neuron projection 
(GO:0043005) 
*n.s.e: no significant enrichment 
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Table 19.2: GO analysis for the top 200 downregulated genes with the lowest padj values 




Biological Process Molecular Function Cellular Component 
T19 • ribosome biogenesis 
(GO:0042254) 
• ncRNA processing 
(GO:0034470) 
• rRNA processing 
(GO:0006364) 
• carboxylic acid catabolic 
process (GO:0046395) 
• ribosome biogenesis 
(GO:0042254) 
• snoRNA binding 
(GO:0030515) 
• small-subunit processome 
(GO:0032040) 
• Pwp2p-containing 
subcomplex of 90S 
preribosome (GO:0034388) 
• t-UTP complex 
(GO:0034455) 
T20 • maturation of LSU-rRNA 
(GO:0000470) 
• maturation of 5.8S rRNA 
(GO:0000460) 
• snoRNA binding 
(GO:0030515) • Pwp2p-containing 
subcomplex of 90S 
preribosome (GO:0034388) 
• small nucleolar 
ribonucleoprotein complex 
(GO:0005732) 
• preribosome, large subunit 
precursor (GO:0030687) 
• small-subunit processome 
(GO:0032040) 
• t-UTP complex 
(GO:0034455) 
T21 • rRNA processing 
(GO:0006364) 
• snoRNA binding 
(GO:0030515) • Pwp2p-containing 
subcomplex of 90S 
preribosome (GO:0034388) 
• small-subunit processome 
(GO:0032040) 
• t-UTP complex 
(GO:0034455) 
T22 *n.s.e *n.s.e • extracellular matrix 
(GO:0031012) 
• protein-containing complex 
(GO:0032991) 
• extracellular space 
(GO:0005615) 
• intracellular organelle part 
(GO:0044446) 
T23 *n.s.e *n.s.e • extracellular matrix 
(GO:0031012) 
• extracellular space 
(GO:0005615) 
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Table 20.1: GO analysis for the top 200 upregulated genes with the lowest padj values 




Biological Process Molecular Function Cellular Component 
T10 *n.s.e *n.s.e *n.s.e 
T11 • non-recombinational repair 
(GO:0000726) 
• double-strand break repair 
via nonhomologous end 
joining (GO:0006303) 
• telomere maintenance 
(GO:0000723) 
• telomere organization 
(GO:0032200) 
• telomeric DNA binding 
(GO:0042162) 
• site of double-strand break 
(GO:0035861) 
• nuclear chromosome, 
telomeric region 
(GO:0000784) 
T12 • L-alpha-amino acid 
transmembrane transport 
(GO:1902475) 
• double-strand break repair 
via nonhomologous end 
joining (GO:0006303) 
• double-strand break repair 
(GO:0006302) 
• DNA duplex unwinding 
(GO:0032508) 
• catalytic activity, acting on 
DNA (GO:0140097) 
• oxidoreductase activity 
(GO:0016491) 
• telomeric DNA binding 
(GO:0042162) 




T13 *n.s.e *n.s.e *n.s.e 
T14 • response to ionizing 
radiation (GO:0010212) 
• double-strand break repair 
via NHEJ (GO:0006303) 
• chromosome organization 
involved in meiotic cell 
cycle (GO:0070192) 
• telomere maintenance 
(GO:0000723) 
• telomeric DNA binding 
(GO:0042162) 
• condensed nuclear 
chromosome (GO:0000794) 
• nuclear chromosome part 
(GO:0044454) 
• nuclear chromosome, 
telomeric region 
(GO:0000784) 
T15 *n.s.e *n.s.e *n.s.e 
T16 • RNA metabolic process 
(GO:0016070) 
• DNA duplex unwinding 
(GO:0032508) 
• cellular response to abiotic 
stimulus (GO:0071214) 
• positive regulation of 
mitotic cell cycle 
(GO:0045931) 
• protein-DNA complex 
assembly (GO:0065004) 
• response to ionizing 
radiation (GO:0010212) 
• translesion synthesis 
(GO:0019985) 
• double-strand break repair 
via HR (GO:0000724) 
• telomere maintenance 
(GO:0000723) 
• DNA-dependent DNA 
replication (GO:0006261) 




• DNA-dependent ATPase 
activity (GO:0008094) 
• exonuclease activity 
(GO:0004527) 
• DNA-directed DNA 
polymerase activity 
(GO:0003887) 
• telomeric DNA binding 
(GO:0042162) 
• single-stranded DNA 
binding (GO:0003697) 




• GINS complex 
(GO:0000811) 
• nuclear chromosome, 
telomeric region 
(GO:0000784) 
• origin recognition complex 
(GO:0000808) 
• nuclear chromatin 
(GO:0000790) 
• condensed nuclear 
chromosome (GO:0000794) 
• site of double-strand break 
(GO:0035861) 
• DNA helicase complex 
(GO:0033202) 
• replication fork 
(GO:0005657) 
*n.s.e: no significant enrichment 
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Table 20.2: GO analysis for the top 200 upregulated genes with the lowest padj values 




Biological Process Molecular Function Cellular Component 




• nuclear lumen 
(GO:0031981) 
• intracellular organelle 
lumen (GO:0070013) 





• nucleoside monophosphate 
kinase activity 
(GO:0050145) 
• damaged DNA binding 
(GO:0003684) 
• nucleosome binding 
(GO:0031491) 
• DNA-directed DNA 
polymerase activity 
(GO:0003887) 
• DNA-dependent ATPase 
activity (GO:0008094) 
• telomeric DNA binding 
(GO:0042162) 
• DNA replication origin 
binding (GO:0003688) 
• single-stranded DNA 
binding (GO:0003697) 
• pre-replicative complex 
assembly involved in 
nuclear cell cycle DNA 
replication (GO:0006267) 
• mitotic DNA replication 
(GO:1902969) 
• mitotic recombination 
(GO:0006312) 
• regulation of mitotic cell 
cycle phase transition 
(GO:1901990) 
• protein K11-linked 
ubiquitination 
(GO:0070979) 
• double-strand break repair 
via break-induced 
replication (GO:0000727) 
• positive regulation of 
mitotic cell cycle 
(GO:0045931) 
• DNA strand elongation 
involved in DNA replication 
(GO:0006271) 
• DNA replication initiation 
(GO:0006270) 
• DNA replication 
(GO:0006260) 
• nuclear chromatin 
(GO:0000790) 
• U5 snRNP (GO:0005682) 
• condensed nuclear 
chromosome (GO:0000794) 
• replisome (GO:0030894) 
• DNA helicase complex 
(GO:0033202) 
• U4 snRNP (GO:0005687) 
• nuclear pre-replicative 
complex (GO:0005656) 
• GINS complex 
(GO:0000811) 
• CMG complex 
(GO:0071162) 
• MCM core complex 
(GO:0097373) 
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Table 20.3: GO analysis for the top 200 upregulated genes with the lowest padj values 




Biological Process Molecular Function Cellular Component 
T19 • response to ionizing 
radiation (GO:0010212) 
• meiotic nuclear division 
(GO:0140013) 
• mitotic sister chromatid 
segregation (GO:0000070) 
• cellular response to abiotic 
stimulus (GO:0071214) 
• nucleotide-excision repair 
(GO:0006289) 
• telomere maintenance 
(GO:0000723) 
• mitotic recombination 
(GO:0006312) 
• DNA-dependent DNA 
replication (GO:0006261) 




• DNA biosynthetic process 
(GO:0071897) 
• nucleoside monophosphate 
kinase activity 
(GO:0050145) 
• DNA-directed DNA 
polymerase activity 
(GO:0003887) 




• telomeric DNA binding 
(GO:0042162) 
• damaged DNA binding 
(GO:0003684) 
• single-stranded DNA 
binding (GO:0003697) 
• U4/U6 x U5 tri-snRNP 
complex (GO:0046540) 
• DNA helicase complex 
(GO:0033202) 
• MCM core complex 
(GO:0097373) 
• nuclear chromosome, 
telomeric region 
(GO:0000784) 
• U4 snRNP (GO:0005687) 
• replisome (GO:0030894) 
• GINS complex 
(GO:0000811) 
• CMG complex 
(GO:0071162) 




• replication fork 
(GO:0005657) 
T20 *n.s.e *n.s.e *n.s.e 
T21 *n.s.e *n.s.e *n.s.e 
T22 *n.s.e *n.s.e *n.s.e 
T23 • small molecule metabolic 
process (GO:0044281) 
*n.s.e *n.s.e 




























Given the rigorous control that is required to rapidly transform an embryo from an 
unrelated lineage into larvae with fully developed organs, well-coordinated processes 
consisting of a myriad of factors are needed to establish the new cell identities. In this study, 
following the identification of two candidate lncRNAs that presented homozygous lethal 
phenotypes, I presented a more detailed characterisation of the molecular consequences for 
the loss of one of them. To date, thousands of lncRNA transcripts have been identified but 
few have been characterised. Despite the increasing number of transcriptomic studies 
generated over the years, specific mechanistic function of lncRNAs and their mode of action 
remained unidentified. To address these questions, we made use of mutants of lncRNA 
candidates that were selected based on RAMPAGE data (Batut et al., 2017) in chapter 3. 
Drosophila has been used widely over last century in genetic research and characterisation of 
the various stages of development. Embryogenesis, specifically, can be considered to be one 
of the most well-studied ones. To study the function of these lncRNAs in vivo, I made use of 
CRISPR-Cas9 technology to remove the TSS region and replaced it with a fluorescence 
marker. The two lncRNA candidates, lncRNA-9 and lncRNA-3, were found to be embryonic 
lethal and pupal lethal, respectively. 
 
Further to generating these flies, I have taken initial steps towards characterising the tissue 
expression of these two lncRNAs using publicly available data. Our initial information was 
limited to their genomic loci and their expression in the adult head. The brain is a fascinating 
organ that have been extensively studied with one of the greatest numbers of unique cell-type 
specific lncRNAs (Qureshi et al., 2010; Andersen et al., 2018). To investigate the localisation 
of these lncRNA candidates, we made use of the modENCODE database that included ChIP-
Seq and RNA sequencing data from multiple tissues and developmental stages of Drosophila. 
Besides the adult head, the lncRNA-3 transcript was found to be highly expressed in the 
neurons and neuroblast of the central nervous system of L3 larvae. Compared to lncRNA-3, 
the lncRNA-9 transcript was found to have low-moderate expression in the adult head and 
neurons of the central nervous system. With the increasing number of lncRNA transcripts heir 
expression and specificity. Chromatin marks that surround the promoter region of each 
individual lncRNA have been characterised. The authors had made use of a computational 
approach which utilises RNA-seq and ChIP-seq datasets to improve the annotation of curated 
lncRNAs (Chen et al., 2016). While it is reported that an absence of chromatin signatures 
related to active transcription were seen in more than half of the curated lncRNAs, further 
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investigations will be needed to understand the impact that these regulatory elements have in 
defining one type of lncRNA from another which would affect its biological functions. In 
addition, little is known about the impact that the chromatin marks have on the expression of 
the lncRNA genomic loci and more specific genome-wide investigation is needed to 
understand their operation and the selective constraints that have acted on the lncRNA.  
 
During this study, another important question that I addressed was whether lncRNA-3 and 
lncRNA-9 exert their effect in a cis or trans. A lncRNA gene whose primary function is 
exerted in trans would be rescued by the expression of the lncRNA on a separate chromosome 
whereas a cis-acting lncRNA will not. I therefore generated flies that expressed BAC rescue 
clones for each of the lncRNA from other chromosomes than the lncRNA locus. When 
expressed from a BAC transgene, lncRNA-3 and lncRNA-9 did not rescue the lethal 
phenotype caused by lncRNA deletion. These results suggest that lncRNA-3 and lncRNA-9 
function in cis rather than in a trans-acting manner. 
 
In this chapter, a further investigation of the molecular phenotype of lncRNA-9 was 
carried out. To have a better understanding of the subcellular localisation of the lncRNA 
transcript, in situ RNA fluorescence hybridization assays were used to study the localisation 
of lncRNA-9 (Raj et al., 2008; Crosetto et al., 2015). RNA fluorescence in situ hybridization 
(RNA FISH) allowed me to directly assess the expression and subcellular localization of 
lncRNA-9. RNA-FISH experiments from staged embryos using oligo probe sets from 
RNAscope  and single-molecule hybridization chain reaction (HCR) were used to determine 
the localisation of lncRNA-9 within the embryo (Wang et al., 2012; Choi et al., 2016).  Our 
results indicated that lncRNA-9 is localised in the nucleus and co-expressed with specific 
neuronal cells in the ventral nerve cord. This finding confirmed the information obtained from 
modENCODE that the lncRNA was detected in the central nervous system and in neurons. 
The advantage of using both of these RNA FISH methods is their ability to amplify the signal 
to produce a stronger fluorescence and higher signal-to-noise ratios. In addition, both methods 
gave us better confidence of the results as similar transcript localisation was observed. I have 
previously used single-molecule RNA FISH (smFISH) oligo probes obtained from Stellaris 
but due to the lack of transcript structure information, we were only able to generate less than 
25 oligonucleotides for each lncRNA candidate (minimum requirement was 25 per gene). 
Low fluorescence smFISH signals combined with high background autofluorescence in 
Drosophila embryos made it challenging to obtain any localisation information with this oligo 
probe set (results not shown). I have settled for HCR probes from molecular technologies as 
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the method had published protocols that are suitable for whole-mount embryos and it allowed 
us to perform multiplexed experiments with antibodies. Given the success with the HCR 
method for lncRNA-9, we also aim to decipher the localisation of lncRNA-3 in the 
developing embryo and adult CNS in the future once we have validated the phenotype of the 
lncRNA. While RNA FISH is a very powerful technique for the analysis of lncRNA 
localisation, extensive troubleshooting and validation strategies such as the use of alternative 
techniques or probing with extra of oligo sets is crucial to ensuring the validity of RNA FISH 
signals. 
 
To understand the downstream genes that are affected by lncRNA-9 loss, RNA-
sequencing libraries were generated using wildtype and homozygous null mutant embryos 
collected at hourly time points that corresponded to the expression profile of the lncRNA. Our 
preliminary DESeq analysis revealed a list of genes whose expression were significantly 
changed upon the loss of the lncRNA transcript at each timepoint. Much focus was placed at 
examining a small subset of genes. To enrich for gene clusters within the list of genes, two 
approaches were used. I first performed a GO analysis using gene lists that were filtered for 
the top 200 genes with the largest changes in padj values. The second approach took into 
account the log fold changes of genes (downregulated or upregulated) before ranking them. 
GO enrichment analysis revealed clusters of genes related to Drosophila nervous system 
processes such as ion transmembrane channel activities, neuron projection and chemical 
synapse transmission. Furthermore, one of the candidates from the pathway analysis, SecCl, is 
located approximately 200 kbp downstream from the lncRNA transcript and its expression is 
downregulated upon the loss of lncRNA-9. Furthermore, several glycine receptors were also 
downregulated in the same class. Due to the large distance of SecCl from the transcriptional 
start site of lncRNA-9, further validation will be needed to examine if this is due to secondary 
effects. Previous studies made use of neighbouring mRNA− lncRNA pairing to identify 
lncRNAs that act in cis. Most of these approaches were performed computationally due to the 
lack of systematic ways of performing this task (Cabili et al., 2011; Sigova et al., 2013). It 
was also shown that actual physical interaction between two genes is not limited by the 
genomic distance (Khyzha et al., 2019) and other factors have to be taken into consideration.  
In this study, I made use of the information derived from the GO consortium database 
to search for functional enrichment. Each of the principal GO domains consists of a hierarchy 
of terms that can be of broad functions down to specific levels. While there are many 
advantages for using GO term analyses for functional enrichment, there remain some 
drawbacks of this approach. One of the major drawbacks is the quality of the databases and 
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whether it is manually curated or purely based on predictions that could skew the results. The 
use of high-quality ontologies is essential and it is noteworthy that it is not always accurate to 
assume that the genes in a group are associated with each other. The second issues with this 
approach is that I have only selected for the genes that have high padj values and during this 
process of selection, many genes whose expression is moderately changed will be omitted. 
While it is a common approach to look for the most differentially expressed genes or those 
with the most significant padj values, most of the pathways in the GO analysis are made up of 
several components rather than a single factor. It is thus a common problem that during the 
analysis, no significant enrichment was detected.  
 
While the results presented here show that lncRNA-9 is expressed in some neurons in 
the CNS and suggest that is likely able to influence synaptic transmission, we were not yet 
able to establish how the lncRNA drives the observed downstream changes in gene 
expression. One potential candidate might be Tap, which is very close to the lncRNA and 
being a transcription factor could be responsible for changes in many downstream targets. 
Likewise, we cannot formally confirm whether these signatures observed, especially for genes 
surrounding the lncRNA are directly caused by the lncRNA absence (i.e. they are primary 
targets of lncRNA-9) or a by-product of arrested development and defects in neuronal cells in 
the lncRNA mutant. Further validation work will be required to determine how this ncRNA 
mediates these changes and which changes are ultimately responsible for the lethality. We are 
in the process of testing various antibodies for neurons and synapses of the nervous system to 
perform combined RNA-FISH and IF experiments to look at their localisation in the embryo 
alongside lncRNA-9. Additionally, to study the biochemical partners of the lncRNA that 
mediate this phenotype, methods such as RNA Antisense Purification with Mass 
Spectrometry (RAP-MS) would reveal lncRNA interacting partners involved in regulating 
different process (McHugh and Guttman, 2018). Similarly, methods such as RNA-DAMID 
and CHART-seq have been used to identify genomic binding sites of Drosophila roX2 
lncRNAs and these protocols would be helpful for us given their proven protocols for 
identifying the binding sites of a lncRNA in Drosophila (Simon et al., 2011; Cheetham and 
Brand, 2018). To perform these experiments, we would need to determine the full-length 
transcript of lncRNA-9 with methods such as 5’ and 3’ RACE as well as Northern Blot 
analysis. Noteworthy, we have not been successful in using computational de novo assembly 
methods such as Trinity to determine the full-length transcript.  
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Another open question that will remain to be addressed is how the changes observed 
ultimately lead to the lethality observed in the embryos. Even in this respect, Tap might be a 
given that the phenotype for flies lacking Tap is closely similar that observed in lncRNA-9 
mutants. Even though there are a few escapers to early larval stages, the majority of the Tap 
mutants were reported as embryonic lethal (Yuan et al., 2016). To address this question a 
rescue experiment could be attempted to check if Tap overexpression is able to rescue the 
phenotype produced by lncRNA-9 absence.  
 
Overall, using various experiments and analyses, I have attempted to functionally 
characterise the candidate lncRNA-9. Due to the challenging nature of research on lncRNAs, 
further experimental efforts will be necessary to gain a full understanding of how these 
ncRNAs act. Within the Drosophila CNS, different cells and genes work in synchrony in this 
complex system.  Many lncRNA transcripts have been identified and suggested to function in 
the nervous system. Similar to lncRNA-9, the other candidate, lncRNA-3, was found to be 
highly expressed in the CNS and it would be interesting to understand the functional 
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Supplementary Table 1.1: Top 100 most DE genes with the lowest padj values (T10) 
 
Rank Gene Symbol padj value 
log2 





1 Hsc70-2 1.48E-72 -5.415  51 GILT2 6.37E-14 1.162 
2 CG5687 9.66E-50 4.917  52 lncRNA:CR44536 6.70E-14 9.477 
3 w 5.49E-48 -4.729  53 asRNA:CR45140 7.21E-14 -3.122 
4 mthl8 1.06E-47 -8.077  54 CG43338 1.04E-13 -1.946 
5 Grik 1.13E-42 -6.430  55 Ugt35A1 1.23E-13 -1.607 
6 lncRNA:CR43459 2.70E-33 -2.815  56 CG42337 1.68E-13 -1.865 
7 Drsl5 2.46E-31 10.500  57 CG10407 1.89E-13 -1.964 
8 ZnT77C 3.32E-30 -2.605  58 lncRNA:CR46075 2.52E-13 -4.143 
9 CG33337 4.52E-30 -8.391  59 CG2064 2.55E-13 2.279 
10 CG11319 1.14E-27 -2.771  60 CR44383 4.78E-13 -5.397 
11 AstC-R2 1.00E-26 -3.354  61 asRNA:CR44960 5.21E-13 4.839 
12 CG14990 5.03E-25 -3.361  62 CG34155 5.61E-13 -2.170 
13 CG31098 1.11E-24 2.392  63 lncRNA:CR44743 6.75E-13 -3.970 
14 asRNA:CR45835 1.89E-24 -5.508  64 prom 6.75E-13 6.116 
15 SecCl 1.89E-24 -2.422  65 Cyp9c1 8.83E-13 -2.575 
16 CG9360 7.61E-24 -4.968  66 CR43105 8.83E-13 6.337 
17 Cyp4p2 1.52E-23 -3.466  67 CG13033 1.12E-12 3.921 
18 CR42490 1.88E-23 -7.155  68 CG30059 1.13E-12 3.166 
19 CG31157 5.50E-22 -4.925  69 Ugt302K1 1.30E-12 -6.782 
20 asRNA:CR45822 7.92E-22 -9.710  70 CG34354 1.30E-12 -2.050 
21 asRNA:CR44029 1.14E-21 -3.618  71 lncRNA:CR45127 2.04E-12 -6.788 
22 CG42822 2.92E-21 4.245  72 CG12493 3.38E-12 3.152 
23 lncRNA:CR44466 2.59E-20 -3.699  73 CG4752 3.68E-12 -1.601 
24 dpr20 4.60E-20 -2.459  74 Cib2 4.04E-12 -2.107 
25 CG42365 1.30E-18 -3.244  75 CG18278 4.13E-12 3.007 
26 CG11236 1.77E-17 -3.078  76 CG34384 5.83E-12 -1.677 
27 lncRNA:CR44754 1.89E-17 -3.561  77 CG43155 8.23E-12 -2.520 
28 CG31288 5.32E-17 3.671  78 Est-6 8.31E-12 3.376 
29 Cyp12c1 5.98E-17 -3.330  79 Cngl 1.11E-11 -1.772 
30 mthl4 6.19E-17 -2.731  80 CG3842 1.23E-11 -1.783 
31 CG14301 6.19E-17 -2.345  81 CG33128 1.53E-11 -5.242 
32 CG32195 8.33E-17 -2.381  82 Ugt303B3 2.35E-11 -2.360 
33 nAChRalpha7 1.86E-16 -2.410  83 CG16799 2.54E-11 -1.943 
34 mGluR 5.47E-16 -2.363  84 CG15515 3.98E-11 4.901 
35 NLaz 1.36E-15 -3.099  85 narya 4.45E-11 6.225 
36 CG14356 1.86E-15 -3.244  86 yellow-d2 8.42E-11 -4.515 
37 CG18547 2.17E-15 1.632  87 lncRNA:CR46006 8.43E-11 -1.787 
38 CG10445 2.20E-15 3.352  88 dsb 8.95E-11 -3.181 
39 CG14204 2.30E-15 -4.167  89 lncRNA:CR44467 1.00E-10 -2.540 
40 CG31676 2.36E-15 -2.110  90 Ptp52F 1.08E-10 2.283 
41 yellow-h 2.57E-15 -2.258  91 CG1494 1.08E-10 -2.240 
42 CG33468 3.50E-15 -3.941  92 CG6044 1.18E-10 -1.750 
43 nompC 4.03E-15 -1.919  93 tgy 1.59E-10 -2.073 
44 St3 7.58E-15 -2.511  94 CG1358 2.86E-10 2.062 
45 TyrR 1.03E-14 2.293  95 mmd 3.86E-10 -1.654 
46 Scgalpha 1.17E-14 -2.292  96 Cyp4e3 4.24E-10 3.486 
47 CG31997 2.00E-14 -2.233  97 Had2 4.58E-10 -3.141 
48 CG9568 2.51E-14 -1.949  98 lncRNA:CR31781 5.08E-10 -1.757 
49 Ect3 4.79E-14 -2.122  99 List 5.36E-10 2.495 
50 AOX1 4.99E-14 1.831  100 unc79 5.73E-10 -1.561 
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Supplementary Table 1.2: Top 100 most DE genes with the lowest padj values (T11) 
 
Rank Gene Symbol padj value 
log2 





1 Hsc70-2 1.26E-70 -5.496  51 Ku80 3.88E-14 2.689 
2 CG5687 7.85E-68 5.880  52 DNApol-zeta 4.19E-14 2.031 
3 mthl8 6.82E-61 -6.800  53 LManV 5.18E-14 3.654 
4 w 9.73E-52 -4.932  54 Rev7 7.28E-14 2.430 
5 CG18547 2.19E-41 2.660  55 ms(3)76Ba 7.35E-14 7.292 
6 Grik 1.13E-36 -5.499  56 Argk 1.08E-13 -2.096 
7 CG31098 3.50E-31 2.715  57 SP1029 1.71E-13 1.205 
8 CG33337 1.07E-30 -7.625  58 TyrR 1.77E-13 2.226 
9 CG42822 3.14E-30 4.829  59 mthl4 1.85E-13 -2.373 
10 CG31288 7.26E-28 5.053  60 Cyp12d1-d 3.89E-13 3.904 
11 Drsl5 8.81E-28 9.519  61 asRNA:CR45171 3.89E-13 4.756 
12 lncRNA:CR44536 1.29E-27 8.828  62 CG17904 4.76E-13 1.113 
13 CR42490 9.96E-26 -7.018  63 zye 4.76E-13 2.981 
14 AOX1 2.30E-25 2.477  64 Mco1 7.51E-13 2.717 
15 ZnT77C 1.02E-24 -2.352  65 Cpr62Bb 7.70E-13 3.001 
16 asRNA:CR45835 3.37E-24 -4.658  66 drd 9.18E-13 2.507 
17 CG2064 2.31E-23 3.021  67 CG31633 1.23E-12 1.339 
18 CG1358 8.40E-23 3.211  68 Irbp 1.78E-12 2.497 
19 asRNA:CR45822 1.22E-22 -9.914  69 CR40190 1.86E-12 -1.303 
20 CG11236 1.25E-22 -4.285  70 CG2909 2.01E-12 2.586 
21 lncRNA:CR44754 4.89E-22 -3.700  71 asRNA:CR44960 3.79E-12 4.823 
22 Mocs1 5.78E-22 2.919  72 lncRNA:CR44466 3.90E-12 -2.449 
23 agt 1.66E-21 3.768  73 CG3520 4.25E-12 2.075 
24 asRNA:CR44029 9.50E-21 -3.507  74 FoxP 4.58E-12 -2.238 
25 CG31157 5.07E-20 -4.540  75 CG15553 6.20E-12 -4.886 
26 lncRNA:CR43459 6.30E-20 -2.163  76 Cyp12d1-p 8.43E-12 3.879 
27 CG14204 7.41E-19 -5.443  77 CG14990 9.42E-12 -2.159 
28 CG3448 3.27E-18 2.509  78 Tina-1 9.90E-12 -1.200 
29 sni 1.43E-17 1.552  79 CG5704 1.22E-11 2.528 
30 frm 1.81E-17 2.653  80 CG30427 1.23E-11 2.196 
31 CG42319 2.34E-17 2.770  81 CG14695 1.47E-11 3.443 
32 rad50 2.77E-17 2.656  82 Blos1 1.72E-11 -0.961 
33 CG9360 3.87E-17 -4.242  83 smp-30 2.17E-11 -2.513 
34 Cyp4p2 1.91E-16 -2.805  84 Spn77Bc 2.19E-11 -3.199 
35 asRNA:CR45140 2.11E-16 -3.485  85 NijC 2.19E-11 -1.705 
36 CG10445 3.47E-16 3.415  86 CG4847 2.46E-11 2.434 
37 CG14301 3.59E-16 -2.354  87 Cyp9b2 2.48E-11 -2.884 
38 CG12766 8.83E-16 5.035  88 lncRNA:CR45242 2.48E-11 2.473 
39 Nop17l 1.18E-15 -1.194  89 CG3165 2.56E-11 1.850 
40 CG7054 2.01E-15 2.356  90 obe 2.82E-11 1.388 
41 lncRNA:CR46075 2.17E-15 -4.615  91 narya 2.82E-11 6.692 
42 CR43105 2.54E-15 7.038  92 mthl3 3.78E-11 2.854 
43 Ect3 2.56E-15 -2.213  93 lncRNA:CR44743 4.47E-11 -3.456 
44 TwdlG 3.03E-15 3.168  94 CG14694 5.81E-11 -3.007 
45 CG31676 3.25E-15 -2.103  95 CG33281 5.83E-11 2.717 
46 CG32694 3.67E-15 2.826  96 CG15098 9.43E-11 2.489 
47 CG12224 5.71E-15 -2.072  97 slif 1.10E-10 2.088 
48 CG10407 5.71E-15 2.895  98 CG7607 1.13E-10 -2.259 
49 CG14907 9.34E-15 2.034  99 Cyp6a13 1.42E-10 1.755 
50 bnk 3.74E-14 2.096  100 CG10638 1.79E-10 1.634 
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Supplementary Table 1.3: Top 100 most DE genes with the lowest padj values (T12) 
 
Rank Gene Symbol padj value 
log2 





1 Hsc70-2 1.41E-58 -5.053  51 Tsp74F 5.96E-14 1.855 
2 mthl8 1.95E-55 -6.770  52 CG31157 7.55E-14 -3.764 
3 w 1.24E-48 -4.809  53 NLaz 2.27E-13 -2.878 
4 CG5687 4.05E-41 4.426  54 CG6293 3.53E-13 3.253 
5 asRNA:CR45822 2.21E-37 -8.646  55 Scgalpha 4.96E-13 -2.155 
6 Grik 4.04E-30 -5.009  56 narya 4.96E-13 7.707 
7 lncRNA:CR43459 4.88E-25 -2.444  57 Drsl5 5.01E-13 10.137 
8 asRNA:CR44029 1.20E-24 -3.974  58 Had2 1.08E-12 -3.408 
9 CG18547 9.63E-24 2.023  59 alpha-Est2 2.55E-12 -2.108 
10 sni 2.31E-23 1.788  60 lncRNA:CR45242 2.86E-12 -3.278 
11 CG11319 3.54E-23 -2.310  61 zye 2.86E-12 2.936 
12 CG10445 2.29E-22 4.210  62 lncRNA:CR44754 3.03E-12 -3.603 
13 CG10407 3.34E-22 -2.611  63 CG15820 4.13E-12 -2.302 
14 CG9360 4.76E-22 -4.846  64 FoxP 4.13E-12 6.035 
15 CG18278 5.76E-21 4.132  65 Cyp12d1-d 4.60E-12 3.521 
16 CG42822 1.42E-20 3.666  66 CG4267 4.69E-12 3.383 
17 Cpr56F 5.34E-20 3.928  67 CG33288 5.19E-12 -2.131 
18 asRNA:CR45140 1.48E-19 -4.254  68 AstC-R2 8.04E-12 -2.226 
19 asRNA:CR45835 2.70E-19 -4.427  69 DNApol-zeta 9.04E-12 1.852 
20 Mco1 8.04E-19 2.104  70 Cyp4p2 1.18E-11 -2.359 
21 CG2064 8.04E-19 2.740  71 CG14301 1.18E-11 -2.284 
22 CG31098 8.04E-19 3.890  72 CG31626 1.23E-11 3.383 
23 CG11236 5.70E-18 -4.081  73 CG13046 1.23E-11 4.622 
24 CG30059 3.97E-17 3.716  74 CG12766 1.69E-11 3.716 
25 Fancl 8.93E-17 2.643  75 Ku80 1.75E-11 2.436 
26 SecCl 9.61E-17 -2.003  76 CG8560 1.75E-11 -2.512 
27 AOX1 1.00E-16 2.024  77 asRNA:CR45171 1.96E-11 3.960 
28 ZnT77C 1.35E-16 -1.941  78 NijC 2.30E-11 -1.757 
29 Picot 2.47E-16 2.825  79 Gk2 2.64E-11 1.485 
30 CG31288 3.91E-16 3.622  80 Calx 2.64E-11 2.020 
31 lncRNA:CR44466 9.31E-16 -3.020  81 ms(3)76Ba 2.93E-11 8.744 
32 lncRNA:CR44536 1.15E-15 -2.246  82 Toll-9 3.00E-11 -2.969 
33 Ect3 1.15E-15 8.399  83 CG8768 3.42E-11 -1.855 
34 mthl3 1.19E-15 3.651  84 Spn88Ea 3.56E-11 1.449 
35 CR43105 1.32E-15 5.917  85 CG4766 3.71E-11 -2.185 
36 CG33337 3.99E-15 -6.973  86 prom 3.79E-11 4.396 
37 CG11584 4.88E-15 5.627  87 CG14882 3.88E-11 1.478 
38 slif 5.18E-15 2.461  88 CG15649 4.05E-11 4.628 
39 CG31676 7.35E-15 -2.059  89 Argk 4.32E-11 -1.882 
40 rad50 1.03E-14 2.459  90 CG17292 6.97E-11 1.337 
41 CG14204 1.15E-14 -4.704  91 CG33128 8.08E-11 -4.607 
42 aralar1 1.31E-14 1.781  92 Tb 8.51E-11 5.841 
43 Cpr67Fa1 1.47E-14 5.803  93 Irbp 8.68E-11 2.309 
44 CG1358 2.19E-14 2.409  94 lncRNA:CR46006 9.10E-11 -1.788 
45 CG4730 2.28E-14 2.963  95 CG3842 1.05E-10 -1.705 
46 CG4842 2.32E-14 2.960  96 CG32694 1.15E-10 2.371 
47 tut 3.75E-14 3.947  97 TwdlB 1.37E-10 5.091 
48 lncRNA:CR44743 4.78E-14 -4.355  98 Irk1 1.68E-10 1.222 
49 CG3165 5.22E-14 2.070  99 CG42337 1.81E-10 -1.489 
50 CG14990 5.67E-14 -2.370  100 CG6180 2.74E-10 1.841 
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Supplementary Table 1.4: Top 100 most DE genes with the lowest padj values (T13) 
 
Rank Gene Symbol padj value 
log2 





1 CG5687 1.15E-50 4.729  51 asRNA:CR44960 5.46E-11 4.637 
2 mthl8 3.00E-45 -7.019  52 CG9521 6.18E-11 6.192 
3 CG18547 1.86E-44 2.744  53 sni 6.58E-11 1.200 
4 Hsc70-2 9.29E-41 -3.913  54 CG2909 6.62E-11 2.459 
5 CG42822 3.46E-39 5.615  55 Cpr76Bc 1.04E-10 -2.415 
6 w 1.22E-35 -4.060  56 CG10799 1.07E-10 3.061 
7 TwdlU 2.77E-32 -5.023  57 CG10638 1.60E-10 1.657 
8 CG2064 3.39E-29 3.390  58 CG31676 1.63E-10 -1.689 
9 CG11236 9.30E-26 -4.210  59 narya 1.68E-10 6.528 
10 lncRNA:CR44536 1.06E-24 9.243  60 Rev7 2.17E-10 2.061 
11 Drsl5 2.64E-23 10.139  61 ZnT35C 2.30E-10 1.675 
12 CG2233 3.10E-21 3.974  62 CG9360 2.67E-10 -3.294 
13 CG10407 8.84E-21 -2.584  63 CG31157 3.24E-10 -3.338 
14 lncRNA:CR43459 3.91E-19 -2.131  64 alpha-Est2 4.62E-10 -1.749 
15 asRNA:CR44029 1.42E-18 -3.435  65 Bin1 7.42E-10 1.685 
16 CG11319 3.30E-17 -1.894  66 CG30059 1.02E-09 2.865 
17 CG31288 3.30E-17 3.175  67 lncRNA:CR44754 1.30E-09 -2.486 
18 CG12766 6.00E-17 4.156  68 Had2 1.50E-09 -2.882 
19 Cyp6a18 6.05E-17 -3.002  69 CG31606 1.71E-09 4.812 
20 CR43105 1.07E-16 5.807  70 Bace 1.83E-09 3.289 
21 ppk 1.11E-16 3.968  71 CG7465 2.24E-09 5.482 
22 CG3165 3.35E-16 2.241  72 lncRNA:CR45039 2.28E-09 3.693 
23 NLaz 7.10E-16 -3.141  73 CG3842 2.80E-09 -1.609 
24 CG31098 5.39E-15 1.838  74 CG10960 3.41E-09 -1.086 
25 mthl3 1.17E-14 3.270  75 Cpr11A 3.56E-09 2.389 
26 Cyp6a13 1.19E-14 1.792  76 prom 4.07E-09 3.574 
27 asRNA:CR44030 3.89E-14 3.241  77 Grik 4.56E-09 -2.613 
28 CG33337 6.02E-14 -5.668  78 LManV 6.15E-09 2.546 
29 asRNA:CR45835 1.17E-13 -3.317  79 CR43697 7.79E-09 2.172 
30 CG8369 1.57E-13 3.714  80 CG8541 8.11E-09 3.409 
31 CG6163 1.67E-13 -3.402  81 mthl4 8.94E-09 -1.991 
32 Odc1 2.03E-13 3.518  82 TwdlH 8.94E-09 2.687 
33 asRNA:CR45140 3.79E-13 -3.624  83 CG14569 8.99E-09 5.362 
34 AOX1 7.32E-13 1.756  84 Cyp6w1 1.34E-08 2.553 
35 CG3397 1.28E-12 2.707  85 CR43696 1.68E-08 3.332 
36 ms(3)76Ba 2.07E-12 7.908  86 CR42530 1.70E-08 2.785 
37 asRNA:CR45171 2.22E-12 4.212  87 CR42490 1.94E-08 -7.927 
38 CG31706 3.08E-12 5.484  88 CR40190 1.94E-08 -1.117 
39 SCAP 6.72E-12 1.806  89 Syp 2.29E-08 -2.491 
40 CG15515 6.72E-12 5.110  90 Cib2 2.61E-08 -1.494 
41 Nop17l 7.36E-12 -1.054  91 CG4259 2.75E-08 2.579 
42 CG18278 8.53E-12 3.139  92 CG7408 3.48E-08 -1.753 
43 Prp31 9.62E-12 1.479  93 CG14907 3.63E-08 1.524 
44 CG17904 1.83E-11 1.060  94 yellow-d2 3.77E-08 -2.721 
45 CG13694 2.00E-11 2.871  95 FucTC 3.95E-08 2.204 
46 CG4730 2.38E-11 2.634  96 Ugt302E1 4.39E-08 3.723 
47 CR43186 2.98E-11 4.486  97 Cyp28d1 4.59E-08 2.421 
48 asRNA:CR45822 3.75E-11 -9.048  98 Cyp12e1 4.88E-08 -2.440 
49 Ku80 4.39E-11 2.411  99 lncRNA:CR44603 4.93E-08 -2.915 
50 CG33128 4.53E-11 -4.663  100 CG7054 5.55E-08 1.663 
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Supplementary Table 1.5: Top 100 most DE genes with the lowest padj values (T14) 
 
Rank Gene Symbol padj value 
log2 





1 mthl8 1.82E-60 -6.716  51 Hmgcl 6.69E-13 -1.928 
2 w 9.75E-44 -4.637  52 Drsl5 6.69E-13 4.188 
3 Hsc70-2 2.67E-42 -3.921  53 asRNA:CR45171 6.69E-13 10.097 
4 TwdlU 6.94E-40 -5.793  54 Sid 7.06E-13 -2.695 
5 CG42822 4.80E-34 5.095  55 CG13907 8.21E-13 -1.298 
6 lncRNA:CR43459 1.03E-32 -2.766  56 lncRNA:CR46006 8.70E-13 -1.999 
7 NLaz 4.58E-31 -4.365  57 CG5171 1.13E-12 -2.900 
8 CG11236 1.43E-30 -3.283  58 CG31676 1.13E-12 -1.817 
9 CG18547 2.50E-27 2.148  59 CG4842 1.87E-12 2.560 
10 yellow-d2 6.57E-25 -4.974  60 ms(3)76Ba 2.14E-12 9.278 
11 ppk 8.04E-25 4.013  61 CG6300 2.34E-12 4.618 
12 CG2233 8.04E-25 4.474  62 Rev7 2.54E-12 2.282 
13 lncRNA:CR44536 7.13E-24 9.017  63 agt 2.54E-12 2.728 
14 CG10445 3.36E-22 4.368  64 Ugt302E1 3.14E-12 3.932 
15 asRNA:CR44029 5.31E-22 -3.715  65 asRNA:CR45822 3.28E-12 -8.954 
16 CR42490 9.69E-22 -6.943  66 asRNA:CR45140 4.90E-12 -3.087 
17 CG31706 1.50E-21 4.424  67 sni 5.07E-12 1.246 
18 CG2064 5.51E-21 2.877  68 Bin1 5.29E-12 1.846 
19 CG3165 5.59E-21 2.538  69 CG3842 5.51E-12 -1.829 
20 CG8541 6.63E-20 3.854  70 CG13813 5.68E-12 -4.232 
21 CG14014 2.68E-19 3.088  71 SCAP 7.47E-12 1.784 
22 CG10407 3.49E-19 -2.451  72 tut 7.61E-12 3.504 
23 DNApol-zeta 1.10E-18 2.379  73 Ugt35B1 1.15E-11 -1.962 
24 CG1494 1.43E-18 -2.965  74 CG33337 1.16E-11 -3.781 
25 Cyp12e1 1.95E-18 -3.423  75 narya 1.49E-11 6.086 
26 CG18278 1.42E-17 3.779  76 Act87E 1.83E-11 -1.336 
27 CG11319 1.94E-17 -1.867  77 CG7054 2.53E-11 1.961 
28 CG30059 4.36E-17 3.814  78 CG10799 3.02E-11 -2.064 
29 Cyp6a18 9.78E-17 -2.540  79 Ir76b 3.02E-11 3.157 
30 lncRNA:CR44466 1.91E-16 -3.358  80 CG32369 3.62E-11 -1.366 
31 Syp 3.22E-16 -3.536  81 alpha-Est2 4.13E-11 -1.789 
32 Ect3 6.74E-16 -2.259  82 asRNA:CR44030 5.35E-11 2.940 
33 CG14406 4.28E-15 -3.237  83 CG14204 1.04E-10 -4.008 
34 CG13694 8.41E-15 2.859  84 CG5961 1.32E-10 -1.379 
35 CG42365 1.67E-14 -2.886  85 CR42530 1.46E-10 3.179 
36 mthl3 1.73E-14 2.450  86 CG6293 1.65E-10 2.898 
37 CG5687 1.73E-14 3.116  87 CG14356 1.95E-10 -2.539 
38 asRNA:CR42547 6.19E-14 -3.249  88 VhaM9.7-a 3.09E-10 -1.475 
39 CG4730 6.19E-14 2.894  89 Cpr11A 3.09E-10 2.485 
40 asRNA:CR45835 6.65E-14 -5.278  90 CG10910 3.27E-10 4.034 
41 Odc1 7.64E-14 3.151  91 CG33301 3.35E-10 5.327 
42 Nop17l 1.12E-13 -1.123  92 CG12766 3.69E-10 2.856 
43 CG3397 1.15E-13 -4.026  93 Irbp 3.92E-10 2.248 
44 CG31157 1.15E-13 2.845  94 FoxP 6.29E-10 -1.991 
45 CG9360 2.73E-13 -3.714  95 lncRNA:CR44754 8.09E-10 -2.209 
46 Cpr76Bc 3.13E-13 -2.908  96 CG14823 8.63E-10 -3.247 
47 CR43105 3.42E-13 5.113  97 fusl 8.93E-10 -1.806 
48 Grik 3.62E-13 -3.149  98 Syx4 1.31E-09 -1.472 
49 SecCl 5.44E-13 -1.752  99 CG11318 1.44E-09 2.390 
50 CG14456 6.46E-13 -2.082  100 rad50 1.61E-09 1.972 
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Supplementary Table 1.6: Top 100 most DE genes with the lowest padj values (T15) 
 
Rank Gene Symbol padj value 
log2 





1 mthl8 3.14E-62 -7.362  51 Odc1 4.86E-14 2.976 
2 CG2233 9.47E-39 4.925  52 CR43105 4.86E-14 4.164 
3 w 4.31E-37 -4.152  53 CR43697 5.87E-14 2.739 
4 ppk 1.16E-34 5.430  54 sni 5.93E-14 1.337 
5 CG42822 1.47E-33 4.567  55 Hmgcl 7.72E-14 -2.001 
6 NLaz 8.91E-28 -4.137  56 Cyp6a18 9.77E-14 -2.210 
7 lncRNA:CR43459 8.91E-28 -2.559  57 Nop17l 1.04E-13 -1.119 
8 CG18547 2.30E-27 2.129  58 CG10445 1.13E-13 3.486 
9 Hsc70-2 4.40E-27 -2.961  59 CG31103 1.25E-13 3.831 
10 CG2064 1.67E-26 3.231  60 lncRNA:CR44536 1.30E-13 10.088 
11 CG11236 1.07E-23 -2.665  61 CG10513 2.22E-13 3.062 
12 yellow-d2 3.50E-23 -4.323  62 CG33301 2.95E-13 4.895 
13 CG11659 3.50E-23 5.851  63 CG7054 4.13E-13 2.099 
14 CG6300 9.64E-23 6.128  64 CG31104 8.14E-13 4.452 
15 CG31706 2.03E-22 3.610  65 CG10638 1.09E-12 1.804 
16 CG6163 6.24E-22 -4.434  66 CG31288 1.09E-12 2.409 
17 CG1494 7.70E-22 -3.147  67 Ect3 1.45E-12 -2.004 
18 Cyp12e1 2.11E-21 -3.558  68 Cyp6a13 1.60E-12 1.486 
19 asRNA:CR44029 5.52E-21 -3.577  69 Cpr67B 2.66E-12 4.077 
20 CG12766 1.20E-20 3.981  70 CG17738 4.23E-12 4.400 
21 CG10560 2.64E-20 4.066  71 CG31098 4.33E-12 1.612 
22 CG12643 8.39E-20 2.912  72 CG31778 5.22E-12 2.321 
23 CG8541 8.89E-20 3.389  73 yellow-d 7.29E-12 2.886 
24 CG17549 2.82E-19 3.691  74 CG3397 8.07E-12 2.471 
25 Drsl5 6.15E-19 7.234  75 Mdr50 9.33E-12 2.801 
26 Bin1 1.02E-18 2.310  76 CG14694 1.05E-11 -3.269 
27 CG32241 1.52E-18 6.256  77 CR45470 1.09E-11 4.766 
28 CG14406 2.30E-18 -2.918  78 asRNA:CR44960 1.11E-11 5.073 
29 Ugt302E1 1.14E-17 6.677  79 hpRNA:CR33940 1.21E-11 -2.956 
30 CG7299 2.13E-17 4.084  80 Cyp12a4 1.21E-11 4.138 
31 Jon74E 2.23E-17 4.819  81 CG14204 1.26E-11 -4.606 
32 CG11413 2.82E-17 3.856  82 CR40190 1.54E-11 -1.290 
33 SCAP 3.12E-17 2.151  83 Gbp3 1.59E-11 2.571 
34 asRNA:CR45835 7.48E-17 -4.280  84 CG31676 1.64E-11 -1.716 
35 CG11852 2.17E-16 5.811  85 Cpr11B 1.73E-11 4.414 
36 TwdlU 2.60E-16 -4.116  86 CG12825 1.89E-11 2.072 
37 yip2 4.21E-16 -1.959  87 lncRNA:CR44466 2.22E-11 -2.732 
38 CG6910 6.89E-16 5.494  88 Rev7 2.68E-11 2.144 
39 CG10799 1.04E-15 3.843  89 Syp 2.99E-11 -3.072 
40 CG40198 1.15E-15 5.176  90 Cyp6w1 3.14E-11 2.712 
41 CG15597 2.11E-15 3.966  91 CG11319 4.12E-11 -1.467 
42 Ugt37A3 2.78E-15 4.220  92 asRNA:CR45140 4.36E-11 -2.855 
43 asRNA:CR45822 3.33E-15 -8.007  93 lncRNA:CR45039 4.46E-11 4.151 
44 CG31157 8.36E-15 -4.240  94 CG9682 4.68E-11 5.290 
45 CG11318 9.49E-15 2.774  95 CG5767 5.55E-11 6.039 
46 CG3165 1.06E-14 2.134  96 CG9877 8.73E-11 5.528 
47 CG10407 2.48E-14 -2.103  97 Cht5 9.46E-11 2.806 
48 CG17191 2.84E-14 5.388  98 DNApol-zeta 1.37E-10 1.779 
49 Grik 2.87E-14 -3.254  99 CG34195 1.59E-10 -1.735 
50 asRNA:CR44030 3.28E-14 3.610  100 mthl3 1.71E-10 2.501 
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Supplementary Table 1.7: Top 100 most DE genes with the lowest padj values (T16) 
 
Rank Gene Symbol padj value 
log2 





1 mthl8 6.77E-73 -6.334  51 lncRNA:CR44536 3.41E-15 10.068 
2 CG14406 1.21E-51 -5.214  52 DNApol-zeta 4.03E-15 2.128 
3 NLaz 9.70E-38 -4.814  53 CG10232 4.87E-15 -2.513 
4 w 1.26E-34 -4.111  54 CG1304 5.64E-15 -5.135 
5 CG1494 3.89E-34 -3.971  55 CG11413 6.23E-15 -3.229 
6 CG11236 1.66E-30 -3.128  56 CG11000 1.07E-14 -1.682 
7 yellow-d2 4.27E-30 -5.293  57 Tmem18 1.13E-14 2.318 
8 ppk 1.13E-28 5.242  58 SecCl 1.34E-14 -1.804 
9 Hsc70-2 1.30E-28 -3.164  59 sni 1.34E-14 1.349 
10 Ect3 6.90E-27 -2.954  60 Ir76b 1.40E-14 -2.231 
11 CG11319 6.02E-26 -2.249  61 CG14823 2.37E-14 -3.826 
12 Grik 3.75E-25 -4.495  62 asRNA:CR44030 2.37E-14 3.475 
13 CG14661 4.81E-25 -3.295  63 Syt12 2.58E-14 -1.787 
14 Ugt302E1 2.06E-24 4.851  64 Drsl5 2.63E-14 6.305 
15 CG42807 1.87E-23 -3.159  65 yip2 4.40E-14 -1.824 
16 lncRNA:CR43459 2.02E-23 -2.361  66 Lk 4.71E-14 -3.938 
17 CG9864 8.53E-23 -3.256  67 Ssrp 4.77E-14 1.998 
18 CG30059 3.96E-22 4.812  68 Fen1 5.97E-14 2.349 
19 CG3690 8.63E-22 -3.520  69 MED28 7.87E-14 1.747 
20 asRNA:CR44029 1.14E-21 -3.694  70 CG32104 9.55E-14 1.708 
21 CG6296 2.68E-21 -3.182  71 CG32243 1.03E-13 2.615 
22 CG3165 6.88E-21 2.550  72 CG34276 1.57E-13 -2.777 
23 CG18278 7.69E-21 4.226  73 Nup43 1.57E-13 1.995 
24 CG12643 1.45E-20 2.974  74 CG5171 1.58E-13 -2.997 
25 Bin1 1.80E-20 2.424  75 Ugt35E1 1.79E-13 -2.488 
26 CG13159 4.47E-20 -5.625  76 NaPi-T 2.08E-13 -2.765 
27 CG6300 4.47E-20 5.660  77 Mes4 2.60E-13 2.293 
28 Ugt35B1 4.50E-20 -2.457  78 CG12863 3.61E-13 2.076 
29 CG3819 7.50E-20 -5.152  79 Nmdar1 3.61E-13 -1.688 
30 Cyp12e1 8.70E-20 -3.418  80 CG5961 3.63E-13 -1.511 
31 CG11659 2.06E-19 5.154  81 CG7300 3.66E-13 -3.372 
32 Cyp6a18 9.15E-19 -2.597  82 CG1239 4.95E-13 3.334 
33 lncRNA:CR44754 9.15E-19 -2.808  83 CG32815 5.66E-13 -1.835 
34 CG13813 1.05E-18 -5.335  84 Obp56b 6.13E-13 -3.424 
35 asRNA:CR45835 1.22E-18 -5.646  85 asRNA:CR42547 8.26E-13 -2.837 
36 MFS14 2.96E-18 -1.893  86 CG17977 1.13E-12 1.984 
37 CG10445 5.96E-18 3.832  87 CG7011 1.48E-12 1.273 
38 CG10407 6.82E-18 -2.323  88 Hira 1.69E-12 1.995 
39 CG14456 1.53E-17 -2.137  89 btl 1.94E-12 -2.348 
40 CG14694 1.53E-17 -4.796  90 CG3270 2.27E-12 -2.874 
41 tut 3.26E-17 4.355  91 JMJD7 2.34E-12 2.335 
42 CG42822 7.27E-17 3.285  92 Obp99a 3.06E-12 -2.854 
43 CR42490 2.30E-16 -6.495  93 RunxA 3.24E-12 -2.467 
44 dpr21 3.39E-16 -2.111  94 Mat1 4.06E-12 2.213 
45 Irbp 4.26E-16 2.855  95 alpha-Est2 4.16E-12 -1.837 
46 Btnd 7.09E-16 -3.184  96 CG8664 4.55E-12 -3.009 
47 CG31676 7.59E-16 -2.036  97 Rev7 4.66E-12 2.263 
48 CG2064 7.59E-16 2.497  98 Oseg4 4.78E-12 -2.044 
49 Act87E 1.93E-15 -1.549  99 kar 4.81E-12 -1.924 
50 lncRNA:CR46006 1.98E-15 -2.190  100 CG2233 4.83E-12 2.534 
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Supplementary Table 1.8: Top 100 most DE genes with the lowest padj values (T17) 
 
Rank Gene Symbol padj value 
log2 





1 mthl8 8.84E-61 -5.974  51 CG18278 1.54E-14 3.271 
2 CG14406 1.66E-51 -5.532  52 Ugt37A3 1.54E-14 3.575 
3 CG1494 1.97E-36 -4.178  53 CG2233 1.77E-14 2.807 
4 w 9.15E-34 -4.408  54 Nop17l 1.78E-14 -1.151 
5 ppk 5.47E-32 5.556  55 Nmdar1 1.78E-14 -1.779 
6 asRNA:CR44179 7.99E-32 -3.352  56 Obp56b 2.02E-14 -3.881 
7 lncRNA:CR43459 5.23E-31 -2.738  57 CG14694 2.53E-14 -3.609 
8 Ugt302E1 4.22E-28 5.547  58 Ir76b 3.02E-14 -2.214 
9 NLaz 6.63E-25 -3.936  59 pigs 3.49E-14 -2.042 
10 yellow-d2 6.63E-25 -5.902  60 CG3819 4.85E-14 -4.335 
11 CG11319 6.66E-25 -2.208  61 Ugt35E1 7.08E-14 -2.536 
12 lncRNA:CR44536 6.66E-25 9.201  62 CG6300 7.52E-14 4.575 
13 CG11236 4.65E-24 -2.821  63 CG11659 8.02E-14 4.223 
14 Hsc70-2 2.29E-23 -2.878  64 lncRNA:CR31781 1.46E-13 -2.027 
15 CG3165 1.04E-22 2.646  65 CG42822 1.53E-13 2.987 
16 lncRNA:CR44754 1.10E-21 -3.276  66 CR43105 2.18E-13 3.501 
17 CG14961 1.99E-21 -4.058  67 tut 2.43E-13 3.554 
18 Cyp6a18 1.18E-20 -2.834  68 side 2.43E-13 -1.799 
19 CG12643 2.92E-20 2.962  69 Btnd 2.59E-13 -2.921 
20 asRNA:CR44029 5.47E-20 -3.570  70 lncRNA:CR46006 4.32E-13 -2.036 
21 CG4730 6.13E-20 3.504  71 CG3552 5.60E-13 1.791 
22 Grik 1.58E-19 -4.049  72 ZnT77C 6.38E-13 -1.687 
23 Ect3 1.78E-19 -2.535  73 ms(3)76Ba 7.07E-13 9.471 
24 CG42807 2.32E-19 -2.593  74 bma 1.04E-12 -1.718 
25 CG14661 4.04E-19 -2.744  75 CG3270 1.09E-12 -2.911 
26 CG11000 2.33E-18 -1.891  76 NaPi-T 1.97E-12 -2.664 
27 CG30091 5.08E-18 -4.205  77 Orcokinin 2.11E-12 -2.417 
28 CG6296 1.71E-17 -2.863  78 Cyp4ac3 2.47E-12 -3.043 
29 CG10407 1.98E-17 -2.302  79 narya 2.49E-12 6.259 
30 dpr21 2.55E-17 -2.315  80 CG10232 3.81E-12 -2.266 
31 Syt12 2.58E-17 -2.003  81 CR43697 5.72E-12 2.890 
32 CG10445 7.85E-17 3.799  82 CG2064 8.03E-12 2.146 
33 CG9864 1.00E-16 -2.781  83 Oseg4 8.03E-12 -2.034 
34 CG6398 3.92E-16 1.248  84 MFS14 8.23E-12 -1.525 
35 asRNA:CR45822 4.46E-16 -6.959  85 CG6163 8.40E-12 -3.046 
36 asRNA:CR44030 5.40E-16 4.041  86 SecCl 8.78E-12 -1.619 
37 CG3690 6.19E-16 -3.069  87 Hug 9.10E-12 -3.111 
38 Bin1 8.20E-16 2.129  88 CG14234 1.17E-11 -2.232 
39 CG13813 1.27E-15 -4.985  89 GlyT 1.22E-11 -2.175 
40 CG5316 1.31E-15 1.366  90 RunxA 1.22E-11 -2.529 
41 CG1304 1.44E-15 -5.253  91 lncRNA:CR45039 1.27E-11 4.894 
42 Lk 1.49E-15 -4.166  92 CG14456 1.86E-11 -1.711 
43 CG33128 1.68E-15 -5.267  93 CG13743 2.00E-11 -1.533 
44 CG5961 1.94E-15 -1.653  94 asRNA:CR42547 2.05E-11 -2.876 
45 CG31676 2.87E-15 -2.016  95 CG33337 2.11E-11 -3.007 
46 CG32815 3.19E-15 -2.013  96 CG42540 2.31E-11 -1.738 
47 CG30059 4.29E-15 3.389  97 Ugt35B1 2.60E-11 -1.905 
48 asRNA:CR45835 6.31E-15 -5.431  98 Capa 2.77E-11 -3.592 
49 Cyp12e1 9.26E-15 -2.960  99 CR42530 2.78E-11 3.251 
50 Drsl5 1.04E-14 6.384  100 Pxd 2.88E-11 -1.608 
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Supplementary Table 1.9: Top 100 most DE genes with the lowest padj values (T18) 
 
Rank Gene Symbol padj value 
log2 





1 mthl8 2.66E-50 -6.129  51 CG30026 2.85E-17 -2.412 
2 CG14406 2.77E-49 -6.271  52 MFS14 3.01E-17 -1.833 
3 CG42807 3.27E-42 -3.253  53 CG3270 3.19E-17 -3.350 
4 CG3690 3.97E-38 -3.665  54 RpA-70 3.94E-17 2.848 
5 lncRNA:CR43459 7.70E-38 -3.024  55 beta4GalNAcTA 5.22E-17 -1.670 
6 CG6296 6.77E-37 -4.149  56 Mes4 5.23E-17 2.677 
7 w 1.44E-33 -4.518  57 CG12643 8.07E-17 2.664 
8 Ugt302E1 5.07E-33 5.623  58 SmD3 8.99E-17 2.503 
9 CG1494 2.43E-32 -3.896  59 Usp5 1.24E-16 2.505 
10 CG11236 3.00E-32 -3.340  60 lncRNA:CR46006 1.34E-16 -2.303 
11 CG3819 3.16E-30 -5.478  61 CG9826 1.56E-16 -3.086 
12 NaPi-T 2.84E-29 -3.939  62 CG18327 1.70E-16 -2.971 
13 CG11319 2.38E-28 -2.340  63 CG31676 1.73E-16 -2.083 
14 ppk 3.10E-28 4.726  64 CG9344 1.94E-16 2.587 
15 asRNA:CR45822 3.96E-28 -6.521  65 CG31249 1.94E-16 1.946 
16 lncRNA:CR44536 8.80E-27 8.700  66 CG5246 2.10E-16 -3.803 
17 Btnd 3.28E-26 -3.922  67 CG32104 3.03E-16 1.903 
18 Ugt35E1 5.30E-26 -3.347  68 CG8745 4.01E-16 -3.120 
19 Ugt35B1 1.45E-25 -3.129  69 Orc4 1.42E-15 2.747 
20 lncRNA:CR44754 3.99E-25 -3.800  70 Gpb5 1.51E-15 -2.961 
21 dpr21 4.57E-24 -2.574  71 MED16 1.82E-15 2.130 
22 AcCoAS 1.91E-23 -2.102  72 Cpsf73 2.10E-15 2.197 
23 CG3165 7.64E-22 2.613  73 Psf3 3.47E-15 2.682 
24 Bin1 8.05E-22 2.519  74 CR40190 4.34E-15 -1.484 
25 Hsc70-2 3.84E-21 -2.807  75 alpha-Est2 4.34E-15 -2.050 
26 Cyp6a18 4.10E-21 -2.885  76 SecCl 4.35E-15 -1.796 
27 CG11000 4.37E-21 -2.007  77 Orcokinin 4.54E-15 -2.524 
28 CG5961 6.43E-21 -1.908  78 DIP-lambda 4.84E-15 -1.938 
29 Grik 6.43E-21 -4.326  79 CG9864 5.44E-15 -2.600 
30 asRNA:CR45835 1.09E-20 -4.422  80 yellow-d2 5.71E-15 -5.588 
31 Syt12 1.80E-20 -2.172  81 Ugt37A3 5.71E-15 3.563 
32 Obp99d 2.20E-20 -3.567  82 Obp56b 1.07E-14 -3.466 
33 CG1304 4.86E-20 -5.925  83 CG32581 1.12E-14 -1.324 
34 Ssrp 4.89E-20 2.392  84 CG10407 1.20E-14 -2.066 
35 asRNA:CR44029 2.14E-19 -3.568  85 SCOT 1.21E-14 -1.380 
36 CG18278 4.96E-19 4.082  86 Cyp12e1 1.23E-14 -2.980 
37 CG14661 1.33E-18 -2.620  87 nAChRalpha7 1.25E-14 -1.932 
38 CG30059 1.50E-18 4.064  88 JMJD7 1.60E-14 2.548 
39 sni 2.41E-18 1.521  89 Ect3 1.92E-14 -2.165 
40 ZnT77C 3.38E-18 -2.012  90 Ir76b 2.36E-14 -2.232 
41 Mal-A8 3.66E-18 -3.053  91 Gal 2.66E-14 -2.195 
42 Pxd 4.46E-18 -2.104  92 CG10361 2.83E-14 -2.367 
43 Irbp 7.88E-18 3.020  93 tut 3.07E-14 3.793 
44 MED28 7.88E-18 2.025  94 beta4GalNAcTB 3.35E-14 1.762 
45 lncRNA:CR31781 9.44E-18 -2.315  95 CG31191 3.35E-14 -1.597 
46 CG10445 1.31E-17 3.956  96 CG32302 4.47E-14 -2.939 
47 CG6733 1.56E-17 -3.337  97 NijC 4.63E-14 -1.963 
48 DNApol-zeta 1.64E-17 2.296  98 daw 5.06E-14 -2.050 
49 CG33337 1.64E-17 -3.663  99 Cdc23 5.60E-14 2.739 
50 beta4GalT7 2.54E-17 2.923  100 Act87E 5.60E-14 -1.463 
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Supplementary Table 1.10: Top 100 most DE genes with the lowest padj values (T19) 
 
Rank Gene Symbol padj value 
log2 





1 CG3819 1.21E-47 -6.621  51 CG5402 4.79E-15 -3.256 
2 CG14406 1.03E-41 -6.876  52 CG11000 4.79E-15 -1.693 
3 mthl8 2.89E-41 -6.721  53 Ect3 5.29E-15 -2.239 
4 CG3690 1.15E-36 -3.271  54 Syt12 1.17E-14 -1.829 
5 CG1494 6.61E-35 -4.463  55 CG17219 1.65E-14 -1.752 
6 lncRNA:CR43459 3.02E-30 -2.721  56 CG5246 1.65E-14 -3.238 
7 CG11236 7.95E-30 -3.148  57 Gpb5 2.26E-14 -3.008 
8 w 6.57E-28 -3.843  58 CG14014 3.67E-14 2.166 
9 CG42807 1.82E-27 -2.519  59 CG8745 5.86E-14 -2.926 
10 ppk 2.38E-26 5.295  60 asRNA:CR44030 9.44E-14 4.200 
11 CG5961 2.53E-26 -2.143  61 Gal 1.07E-13 -2.157 
12 asRNA:CR45822 2.88E-26 -6.754  62 CG15784 1.08E-13 3.543 
13 Ugt302E1 3.67E-26 7.029  63 Mccc2 1.42E-13 -1.816 
14 NaPi-T 4.35E-26 -3.654  64 dpr21 1.69E-13 -1.882 
15 CG11319 6.23E-25 -2.196  65 Lk 1.72E-13 -3.495 
16 Hsc70-2 6.89E-25 -3.035  66 Gba1a 1.72E-13 -2.540 
17 CG12643 1.77E-23 3.204  67 CG9799 2.84E-13 -1.575 
18 Bin1 3.12E-23 2.614  68 lncRNA:CR44466 3.49E-13 -3.594 
19 lncRNA:CR44536 4.57E-23 8.965  69 Orcokinin 3.85E-13 -2.338 
20 lncRNA:CR44754 2.47E-22 -3.478  70 CG33124 4.80E-13 -2.607 
21 CG6733 3.38E-22 -3.782  71 RpA-70 5.03E-13 2.496 
22 CG33337 1.12E-21 -4.040  72 lncRNA:CR31781 5.82E-13 -1.982 
23 CG6296 8.29E-21 -2.976  73 CG4730 8.23E-13 2.848 
24 CG10407 1.79E-20 -2.478  74 ACC 9.72E-13 -1.795 
25 CG2064 1.10E-19 2.803  75 DAT 1.01E-12 -2.120 
26 Btnd 3.27E-19 -3.311  76 beta4GalNAcTA 1.20E-12 -1.445 
27 Ugt35E1 4.92E-19 -2.773  77 NHP2 1.20E-12 -1.274 
28 nop5 5.22E-19 -0.895  78 FASN1 1.24E-12 -2.310 
29 CG3270 5.83E-19 -3.510  79 Cyp6a18 1.24E-12 -2.204 
30 CG1304 7.76E-19 -5.757  80 Ugt37A3 1.49E-12 3.232 
31 AcCoAS 1.78E-18 -1.869  81 Uhg2 1.60E-12 -1.823 
32 Grik 1.02E-17 -3.859  82 Alg9 1.78E-12 2.649 
33 CG10638 2.13E-17 2.154  83 CG18278 2.06E-12 3.225 
34 asRNA:CR44029 2.56E-17 -3.331  84 CG14823 2.30E-12 -3.859 
35 Ugt35B1 3.60E-17 -2.545  85 CG1671 2.34E-12 -1.519 
36 CG18327 8.69E-17 -2.927  86 CG9344 2.37E-12 2.394 
37 asRNA:CR45835 2.10E-16 -5.034  87 Gclc 2.50E-12 -1.357 
38 MFS14 2.24E-16 -1.795  88 CG11659 3.20E-12 3.923 
39 bnk 2.45E-16 2.859  89 l(1)G0020 3.65E-12 -1.543 
40 CG10445 2.46E-16 4.214  90 CG7966 3.91E-12 -1.864 
41 Obp99d 2.64E-16 -3.065  91 CG5599 3.91E-12 -1.422 
42 CG3165 5.02E-16 2.244  92 CG11158 4.56E-12 -1.928 
43 Nop17l 7.53E-16 -1.205  93 CG6638 4.83E-12 -1.471 
44 Art8 8.24E-16 -1.530  94 ZnT77C 4.83E-12 -1.633 
45 CG3397 1.07E-15 3.363  95 tut 5.12E-12 3.709 
46 Mal-A8 2.30E-15 -2.849  96 NijC 7.64E-12 -1.924 
47 CG3902 2.42E-15 -1.940  97 CG8064 8.80E-12 -1.448 
48 Ku80 3.20E-15 2.969  98 CG6770 9.27E-12 1.448 
49 GstD5 3.71E-15 5.036  99 CG3552 9.71E-12 1.782 
50 CG9826 4.36E-15 -2.909  100 CG6300 9.71E-12 4.169 
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Supplementary Table 1.11: Top 100 most DE genes with the lowest padj values (T20) 
 
Rank Gene Symbol padj value 
log2 





1 mthl8 5.72E-41 -6.948  51 CG13694 3.59E-13 2.812 
2 Ugt302E1 5.72E-41 7.413  52 CG11319 3.88E-13 -1.596 
3 CG3819 5.16E-40 -5.936  53 CG10407 3.88E-13 -1.973 
4 lncRNA:CR44536 1.23E-38 8.758  54 CG8654 4.11E-13 2.161 
5 lncRNA:CR43459 6.03E-33 -2.857  55 CG17977 6.07E-13 2.272 
6 ppk 8.94E-33 5.586  56 CG9515 6.11E-13 -1.375 
7 Hsc70-2 1.04E-31 -3.384  57 U3-55K 6.17E-13 -1.517 
8 CG12643 1.88E-31 3.675  58 Phae2 6.25E-13 2.575 
9 CG2064 1.63E-27 3.308  59 Cat 6.25E-13 1.134 
10 CG3690 2.90E-27 -2.703  60 Mys45A 6.83E-13 -1.201 
11 Obp99d 4.94E-25 -3.749  61 CG42807 6.83E-13 -1.686 
12 w 2.52E-24 -3.523  62 Art8 8.03E-13 -1.379 
13 CG14406 1.03E-20 -8.079  63 Bin1 9.22E-13 1.925 
14 CG34166 1.57E-20 3.678  64 CG6733 1.18E-12 -2.857 
15 nop5 2.22E-20 -0.931  65 NHP2 1.41E-12 -1.274 
16 CG34195 5.16E-20 -2.447  66 CG13078 1.74E-12 4.605 
17 CG33337 1.94E-19 -3.949  67 firl 1.77E-12 -2.463 
18 Cyp6a17 5.09E-19 2.720  68 CG3552 2.99E-12 1.830 
19 asRNA:CR45835 5.68E-18 -4.098  69 CG8665 3.50E-12 2.760 
20 Odc2 2.21E-17 3.837  70 CG34105 3.72E-12 8.519 
21 Grik 4.44E-17 -3.864  71 CG16775 6.25E-12 -3.840 
22 CG3270 2.04E-16 -3.294  72 asRNA:CR45822 6.27E-12 -8.667 
23 Ugt35B1 2.35E-16 -3.095  73 CG4335 7.47E-12 3.166 
24 Cyp28d2 4.11E-16 2.694  74 CG10445 8.88E-12 3.212 
25 CG5961 6.63E-16 -1.670  75 CG42319 9.08E-12 2.159 
26 Ugt37A1 7.47E-16 4.062  76 CG11158 1.11E-11 -1.906 
27 CG11236 7.67E-16 -2.208  77 PH4alphaMP 1.30E-11 -2.505 
28 CG18327 1.16E-15 -2.836  78 CG6654 2.05E-11 1.479 
29 CG10474 1.25E-15 -5.445  79 CG6763 2.22E-11 -2.756 
30 GstD5 1.48E-15 5.108  80 Fit2 2.52E-11 -1.347 
31 CG1494 1.85E-15 -2.710  81 CG13003 2.65E-11 -2.104 
32 mrt 2.29E-15 1.598  82 l(2)09851 3.43E-11 -1.056 
33 CG1304 3.74E-15 -5.187  83 Lk 3.52E-11 -3.210 
34 asRNA:CR44030 2.10E-14 4.628  84 Ugt37A3 3.91E-11 3.015 
35 CG5402 2.43E-14 -3.335  85 CG8064 4.09E-11 -1.412 
36 NaPi-T 2.51E-14 -2.698  86 Cyp4e3 4.10E-11 4.746 
37 CG6770 2.81E-14 1.611  87 asRNA:CR44029 6.19E-11 -2.607 
38 lncRNA:CR44754 2.85E-14 -3.193  88 lncRNA:CR46006 6.64E-11 -1.878 
39 CR43697 5.22E-14 3.489  89 DNApol-zeta 6.68E-11 1.799 
40 aay 6.10E-14 -0.933  90 CG3165 7.00E-11 1.844 
41 CG6296 8.04E-14 -2.414  91 CG30414 7.08E-11 2.257 
42 CG31300 8.65E-14 2.842  92 CG10175 8.09E-11 -1.962 
43 CG5157 8.77E-14 2.072  93 CG31683 9.29E-11 1.207 
44 CG17219 8.97E-14 -1.697  94 Drsl2 1.00E-10 6.622 
45 CG7458 1.06E-13 -1.264  95 CG15784 1.02E-10 3.123 
46 CG6712 1.34E-13 -1.364  96 lncRNA:CR45039 1.29E-10 5.578 
47 CG33124 1.47E-13 -2.699  97 lncRNA:CR43496 1.62E-10 2.260 
48 lncRNA:CR44662 1.47E-13 3.419  98 Nop56 1.62E-10 -1.062 
49 CG3397 2.28E-13 2.673  99 Cpr51A 1.70E-10 -2.729 
50 Reg-2 2.63E-13 1.966  100 Prat2 1.91E-10 2.114 
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Supplementary Table 1.12: Top 100 most DE genes with the lowest padj values (T21) 
 
Rank Gene Symbol padj value 
log2 





1 mthl8 1.82E-52 -5.952  51 CG5599 3.17E-12 -1.439 
2 Hsc70-2 1.66E-43 -4.141  52 lncRNA:CR45039 3.39E-12 4.659 
3 CG3819 7.77E-42 -6.100  53 CG42319 8.06E-12 2.182 
4 CG3690 1.56E-34 -3.058  54 CG31300 8.06E-12 2.608 
5 Ugt302E1 1.19E-33 6.930  55 lncRNA:CR44662 8.06E-12 3.155 
6 asRNA:CR45822 2.74E-33 -6.185  56 Mal-A8 1.01E-11 -2.453 
7 ppk 1.58E-30 6.079  57 asRNA:CR45171 1.25E-11 4.244 
8 Obp99d 3.10E-29 -4.099  58 CG31683 1.34E-11 1.257 
9 lncRNA:CR43459 1.26E-28 -2.648  59 NaPi-T 1.66E-11 -2.419 
10 CG12643 8.59E-27 3.403  60 CG18858 1.79E-11 1.145 
11 CG2064 2.56E-26 3.234  61 upSET 1.84E-11 1.504 
12 lncRNA:CR44536 4.28E-26 9.532  62 Iyd 2.18E-11 2.843 
13 CG14406 5.40E-26 -7.290  63 asRNA:CR44029 2.30E-11 -2.653 
14 Cyp6a17 1.88E-24 3.090  64 CG2765 2.51E-11 -0.816 
15 w 2.11E-23 -3.522  65 CG8654 2.82E-11 2.012 
16 Odc2 4.48E-22 4.641  66 Mccc2 3.01E-11 -1.661 
17 Cyp28d2 1.47E-20 3.052  67 CG4335 3.23E-11 3.203 
18 Grik 1.61E-20 -4.347  68 CG12896 4.98E-11 -3.256 
19 CG11319 2.47E-20 -1.989  69 CR43105 6.04E-11 2.957 
20 asRNA:CR45835 5.63E-20 -4.483  70 CG10474 6.47E-11 -4.491 
21 CG42807 1.52E-19 -2.085  71 U3-55K 7.40E-11 -1.392 
22 CG8665 1.93E-19 3.521  72 CG6638 8.52E-11 -1.405 
23 CG6398 8.38E-19 1.354  73 CG34166 8.82E-11 2.657 
24 Nop17l 1.93E-18 -1.298  74 CG11000 9.32E-11 -1.439 
25 ms(3)76Ba 2.00E-18 7.810  75 lncRNA:CR44754 1.07E-10 -2.466 
26 CG1494 9.66E-18 -2.954  76 CG16704 1.08E-10 3.248 
27 CG3165 4.60E-17 2.307  77 CG30059 1.27E-10 3.030 
28 CG11236 3.13E-16 -2.247  78 CR43697 1.39E-10 2.799 
29 aay 9.52E-16 -0.989  79 CAH2 1.58E-10 -1.316 
30 CG6296 1.22E-15 -2.567  80 Cyp4e3 1.94E-10 3.764 
31 Oseg4 2.61E-15 -2.348  81 Ugt36D1 1.95E-10 1.767 
32 CG5961 3.46E-15 -1.634  82 CG18327 2.32E-10 -2.265 
33 CG1304 8.80E-15 -5.127  83 Obp56b 3.18E-10 -2.820 
34 Lk 2.17E-14 -3.824  84 CG34215 3.82E-10 2.217 
35 CG13907 1.04E-13 -1.355  85 lectin-24A 3.88E-10 3.816 
36 CG10407 1.20E-13 -2.002  86 CG10932 3.96E-10 -1.807 
37 CG5316 1.29E-13 1.294  87 CG17977 4.99E-10 1.942 
38 asRNA:CR44030 1.35E-13 4.472  88 l(2)09851 7.80E-10 -0.992 
39 dpr21 2.42E-13 -1.929  89 CG8064 8.34E-10 -1.330 
40 CG3270 5.38E-13 -2.929  90 Cpr64Ac 1.07E-09 -6.785 
41 Bin1 8.79E-13 1.933  91 CG31157 1.07E-09 -3.214 
42 Gpb5 1.03E-12 -2.951  92 Cyp12d1-d 1.45E-09 2.555 
43 CG13962 1.04E-12 4.178  93 CG6665 1.72E-09 1.214 
44 CG33337 1.16E-12 -3.140  94 mrt 1.76E-09 1.252 
45 CG10445 1.23E-12 3.339  95 CG10638 1.78E-09 1.578 
46 CG4730 1.34E-12 2.825  96 CG6770 1.84E-09 -3.912 
47 GstD5 1.81E-12 4.571  97 CG13159 1.84E-09 1.307 
48 CG34195 1.93E-12 -1.825  98 CG15432 2.18E-09 1.123 
49 Ugt37A3 1.97E-12 3.224  99 Dph3 2.31E-09 -1.121 
50 Ade2 2.39E-12 -1.323  100 CG5402 2.35E-09 -2.595 
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Supplementary Table 1.13: Top 100 most DE genes with the lowest padj values (T22) 
 
Rank Gene Symbol padj value 
log2 





1 mthl8 5.83E-55 -7.742  51 scaf 1.51E-15 -2.465 
2 Ugt302E1 1.37E-54 6.009  52 asRNA:CR45822 2.21E-15 -8.055 
3 ppk 9.95E-44 6.363  53 lncRNA:CR42646 3.25E-15 -4.595 
4 CG3819 3.37E-37 -5.676  54 CG34105 5.55E-15 10.276 
5 lncRNA:CR44536 2.59E-36 8.895  55 CG14567 6.56E-15 -4.585 
6 Grik 4.63E-34 -5.493  56 ChLD3 6.68E-15 -4.835 
7 CG14406 4.17E-31 -8.008  57 CG14961 8.08E-15 -3.266 
8 CG9360 8.11E-31 -5.666  58 CG7912 8.08E-15 2.676 
9 Cyp28d2 6.82E-30 3.647  59 Gadd45 8.91E-15 -3.039 
10 CG10407 1.08E-29 -2.884  60 CG7724 1.79E-14 -2.068 
11 firl 3.35E-29 -3.741  61 asRNA:CR45140 1.96E-14 -3.224 
12 lncRNA:CR43459 2.46E-28 -2.626  62 ThrRS 2.32E-14 -0.917 
13 CG33337 1.19E-27 -4.905  63 Dyrk2 3.09E-14 -1.271 
14 Hsc70-2 1.98E-27 -2.979  64 Muc91C 3.09E-14 -6.742 
15 Obp99d 2.89E-27 -4.292  65 CG13606 3.09E-14 -2.376 
16 Odc2 3.59E-26 4.643  66 CG8654 3.53E-14 2.192 
17 GstE1 6.56E-26 -3.279  67 CG3552 4.34E-14 1.806 
18 Keap1 2.60E-24 -1.539  68 CG6654 4.38E-14 1.606 
19 CG30091 7.34E-23 -4.497  69 CG34437 4.82E-14 -3.220 
20 CG12643 2.26E-22 3.033  70 Cpr35B 5.04E-14 -3.000 
21 CG14186 3.46E-22 -3.301  71 CG12863 5.04E-14 2.090 
22 Cpr51A 5.12E-21 -3.889  72 Cyp6a17 5.04E-14 2.276 
23 w 5.12E-21 -3.251  73 Cpr65Ea 5.04E-14 -4.352 
24 asRNA:CR44030 1.05E-20 4.500  74 TwdlC 5.04E-14 -6.512 
25 ZnT77C 1.68E-20 -2.124  75 Lk 7.89E-14 -3.869 
26 asRNA:CR44179 6.32E-20 -2.722  76 tut 9.93E-14 3.865 
27 CG6296 1.99E-18 -2.768  77 CG2064 1.00E-13 2.292 
28 Ect3 2.86E-18 -2.468  78 Cul2 1.07E-13 -2.179 
29 CG17977 2.98E-18 2.419  79 CG12164 1.09E-13 -4.740 
30 CG32104 5.80E-18 1.888  80 Mfap1 1.20E-13 -1.669 
31 CG9733 6.47E-18 -4.916  81 Rlip 1.35E-13 1.198 
32 NLaz 7.56E-18 -3.322  82 CG13063 1.74E-13 -4.915 
33 asRNA:CR45835 1.12E-17 -5.173  83 CG11601 2.01E-13 1.421 
34 CG2150 1.53E-17 -5.286  84 CG15731 2.04E-13 -7.146 
35 Oseg4 2.91E-17 -2.492  85 CG13403 2.35E-13 -2.691 
36 Obp99a 6.23E-17 -3.364  86 dyl 2.99E-13 -6.455 
37 Phk-3 7.18E-17 -2.600  87 CG2962 3.79E-13 -6.592 
38 Cpr64Ac 7.18E-17 -9.004  88 Trh 3.98E-13 -2.079 
39 CR43697 8.95E-17 3.778  89 lncRNA:CR45039 3.98E-13 4.974 
40 Sb 1.08E-16 -4.441  90 CG1494 3.98E-13 -2.425 
41 CG42807 1.11E-16 -1.926  91 CR45470 5.52E-13 4.728 
42 CG13159 1.20E-16 -5.140  92 CG3690 5.52E-13 -1.850 
43 CG5402 1.72E-16 -3.529  93 Nop17l 6.20E-13 -1.076 
44 CG30026 3.61E-16 -2.349  94 CG13699 6.28E-13 -5.671 
45 TwdlX 4.24E-16 -2.194  95 ple 6.53E-13 -3.207 
46 CG43204 5.57E-16 -3.724  96 CG7300 9.45E-13 -3.176 
47 lncRNA:CR44754 5.57E-16 -3.252  97 Lectin-galC1 1.27E-12 3.439 
48 CG11413 6.89E-16 -3.276  98 Ugt317A1 1.53E-12 -2.552 
49 CG7406 6.89E-16 -6.665  99 Ccp84Ac 1.78E-12 -6.208 
50 CG31869 1.17E-15 -2.465  100 e 1.78E-12 -2.260 
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Supplementary Table 1.14: Top 100 most DE genes with the lowest padj values (T23) 
 
Rank Gene Symbol padj value 
log2 





1 mthl8 1.31E-71 -6.680  51 Sb 1.77E-15 -4.290 
2 Ugt302E1 1.08E-41 4.851  52 w 1.93E-15 -2.735 
3 ppk 2.91E-39 6.051  53 CG34105 3.18E-15 10.417 
4 CG3819 4.20E-36 -5.567  54 CG15022 3.53E-15 -5.273 
5 lncRNA:CR43459 5.25E-35 -2.928  55 scaf 3.90E-15 -2.431 
6 CG10407 1.44E-34 -3.113  56 Spn43Aa 3.90E-15 -5.054 
7 Hsc70-2 2.69E-34 -3.593  57 twz 4.47E-15 2.342 
8 Keap1 4.03E-32 -1.771  58 CG7227 4.62E-15 -2.900 
9 Grik 8.11E-31 -5.199  59 ZnT35C 6.23E-15 2.010 
10 firl 2.83E-30 -3.748  60 lncRNA:CR45039 9.76E-15 4.980 
11 ZnT77C 1.35E-29 -2.550  61 CG43386 1.88E-14 -2.832 
12 lncRNA:CR44536 7.07E-29 9.014  62 asRNA:CR44030 2.42E-14 3.659 
13 Odc2 2.19E-28 4.900  63 asRNA:CR45822 2.97E-14 -7.730 
14 Cyp28d2 2.42E-28 3.559  64 Fnta 3.81E-14 0.998 
15 CG14406 4.89E-27 -8.159  65 CR43697 4.21E-14 3.464 
16 CG1494 2.56E-26 -3.638  66 Trh 5.01E-14 -2.143 
17 Obp99d 6.07E-25 -3.966  67 CG14186 5.89E-14 -2.586 
18 CG12643 4.50E-23 3.096  68 CG4783 5.89E-14 -6.475 
19 GstE1 9.67E-23 -3.079  69 CG31098 5.95E-14 1.725 
20 CG6296 1.50E-21 -2.984  70 CG17672 6.37E-14 -4.208 
21 Cpr51A 1.54E-21 -3.989  71 Cyp4p1 8.79E-14 -3.065 
22 Phk-3 2.25E-21 -2.926  72 CG42319 1.14E-13 2.312 
23 Cpr65Ea 5.55E-21 -5.436  73 CG12769 1.42E-13 -2.550 
24 asRNA:CR45140 2.17E-20 -3.898  74 Dyrk2 1.45E-13 -1.241 
25 CG7912 2.31E-20 3.167  75 CG12491 1.45E-13 9.199 
26 mrt 3.26E-20 1.823  76 Vajk4 2.13E-13 -6.242 
27 CG30091 1.99E-19 -4.036  77 DIP-lambda 2.19E-13 -1.811 
28 CG33337 1.99E-19 -3.979  78 Ugt317A1 2.25E-13 -2.652 
29 Ect3 1.29E-18 -2.490  79 slbo 2.25E-13 -4.825 
30 CG31869 1.36E-18 -2.690  80 CG9733 2.25E-13 -4.027 
31 ThrRS 1.37E-18 -1.046  81 CG2150 2.25E-13 -4.554 
32 CG7724 1.40E-18 -2.352  82 CG33346 2.50E-13 -4.160 
33 CG9360 5.03E-18 -4.303  83 CG33468 2.54E-13 -5.060 
34 asRNA:CR45835 1.07E-17 -3.737  84 CG8654 2.54E-13 2.115 
35 CG13159 1.30E-17 -5.306  85 CG5402 2.54E-13 -3.017 
36 Cyp6a23 1.30E-17 -2.424  86 CG34038 2.67E-13 -3.197 
37 Cul2 1.76E-17 -2.471  87 CG16935 2.68E-13 1.675 
38 CG42807 5.11E-17 -1.941  88 PPP1R15 2.96E-13 -0.963 
39 CG30026 8.86E-17 -2.325  89 CG13699 3.71E-13 -5.877 
40 e 1.27E-16 -2.627  90 CG13659 3.71E-13 -2.983 
41 Spn100A 1.39E-16 -3.582  91 asRNA:CR44029 4.51E-13 -2.822 
42 CG6654 1.47E-16 1.759  92 CG17977 5.26E-13 2.174 
43 lncRNA:CR42646 1.76E-16 -4.892  93 CG8001 6.76E-13 1.362 
44 asRNA:CR44179 2.77E-16 -2.376  94 CG4702 7.29E-13 -4.080 
45 CG43204 5.00E-16 -3.667  95 CG13813 7.38E-13 -5.568 
46 CG31810 6.25E-16 -2.786  96 Cad88C 7.39E-13 -2.806 
47 CG12164 6.25E-16 -5.214  97 CG10353 8.42E-13 1.688 
48 cysu 7.91E-16 -3.746  98 CG33993 8.42E-13 -4.254 
49 mRpS9 8.65E-16 0.901  99 CG11147 8.52E-13 -2.565 
50 ckd 1.34E-15 -2.190  100 Eip74EF 1.14E-12 -2.907 
 
  Chapter 4: A role for lncRNA-9 in the Drosophila nervous system 
 
222 
Supplementary Table 2.1: Top 100 downregulated genes with the lowest padj values 
(T10) 
 
Rank Gene Symbol padj value 
log2 





1 Hsc70-2 1.48E-72 -5.415  51 Cyp9c1 8.83E-13 -2.575 
2 w 5.49E-48 -4.729  52 Ugt302K1 1.30E-12 -6.782 
3 mthl8 1.06E-47 -8.077  53 CG34354 1.30E-12 -2.050 
4 Grik 1.13E-42 -6.430  54 lncRNA:CR45127 2.04E-12 -6.788 
5 lncRNA:CR43459 2.70E-33 -2.815  55 CG4752 3.68E-12 -1.601 
6 ZnT77C 3.32E-30 -2.605  56 Cib2 4.04E-12 -2.107 
7 CG33337 4.52E-30 -8.391  57 CG34384 5.83E-12 -1.677 
8 CG11319 1.14E-27 -2.771  58 CG43155 8.23E-12 -2.520 
9 AstC-R2 1.00E-26 -3.354  59 Cngl 1.11E-11 -1.772 
10 CG14990 5.03E-25 -3.361  60 CG3842 1.23E-11 -1.783 
11 asRNA:CR45835 1.89E-24 -5.508  61 CG33128 1.53E-11 -5.242 
12 SecCl 1.89E-24 -2.422  62 Ugt303B3 2.35E-11 -2.360 
13 CG9360 7.61E-24 -4.968  63 CG16799 2.54E-11 -1.943 
14 Cyp4p2 1.52E-23 -3.466  64 yellow-d2 8.42E-11 -4.515 
15 CR42490 1.88E-23 -7.155  65 lncRNA:CR46006 8.43E-11 -1.787 
16 CG31157 5.50E-22 -4.925  66 dsb 8.95E-11 -3.181 
17 asRNA:CR45822 7.92E-22 -9.710  67 lncRNA:CR44467 1.00E-10 -2.540 
18 asRNA:CR44029 1.14E-21 -3.618  68 CG1494 1.08E-10 -2.240 
19 lncRNA:CR44466 2.59E-20 -3.699  69 CG6044 1.18E-10 -1.750 
20 dpr20 4.60E-20 -2.459  70 tgy 1.59E-10 -2.073 
21 CG42365 1.30E-18 -3.244  71 mmd 3.86E-10 -1.654 
22 CG11236 1.77E-17 -3.078  72 Had2 4.58E-10 -3.141 
23 lncRNA:CR44754 1.89E-17 -3.561  73 lncRNA:CR31781 5.08E-10 -1.757 
24 Cyp12c1 5.98E-17 -3.330  74 unc79 5.73E-10 -1.561 
25 mthl4 6.19E-17 -2.731  75 Pxd 6.98E-10 -1.612 
26 CG14301 6.19E-17 -2.345  76 CG4409 7.16E-10 -1.917 
27 CG32195 8.33E-17 -2.381  77 Orcokinin 8.36E-10 -2.022 
28 nAChRalpha7 1.86E-16 -2.410  78 CG33521 1.18E-09 -1.897 
29 mGluR 5.47E-16 -2.363  79 Cyp6d4 1.30E-09 -2.341 
30 NLaz 1.36E-15 -3.099  80 FoxP 1.33E-09 -1.979 
31 CG14356 1.86E-15 -3.244  81 CG8768 1.35E-09 -1.718 
32 CG14204 2.30E-15 -4.167  82 CaMKI 1.85E-09 -1.473 
33 CG31676 2.36E-15 -2.110  83 antr 1.95E-09 -2.790 
34 yellow-h 2.57E-15 -2.258  84 kek6 2.02E-09 -1.266 
35 CG33468 3.50E-15 -3.941  85 CR40190 2.04E-09 -1.133 
36 nompC 4.03E-15 -1.919  86 lncRNA:CR45226 2.07E-09 -8.420 
37 St3 7.58E-15 -2.511  87 ttm2 2.18E-09 -3.545 
38 Scgalpha 1.17E-14 -2.292  88 Ugt302C1 2.48E-09 -1.264 
39 CG31997 2.00E-14 -2.233  89 CG15818 2.55E-09 -1.978 
40 CG9568 2.51E-14 -1.949  90 ATPsynCF6L 2.80E-09 -7.910 
41 Ect3 4.79E-14 -2.122  91 CG10051 2.96E-09 -1.863 
42 asRNA:CR45140 7.21E-14 -3.122  92 Eip63F-1 3.04E-09 -1.740 
43 CG43338 1.04E-13 -1.946  93 GluRIIE 3.66E-09 -1.774 
44 Ugt35A1 1.23E-13 -1.607  94 Argk 3.66E-09 -1.710 
45 CG42337 1.68E-13 -1.865  95 hpRNA:CR33940 3.71E-09 -2.540 
46 CG10407 1.89E-13 -1.964  96 CG15765 4.61E-09 -1.620 
47 lncRNA:CR46075 2.52E-13 -4.143  97 CG10232 5.26E-09 -2.058 
48 CR44383 4.78E-13 -5.397  98 Jheh3 6.04E-09 -1.660 
49 CG34155 5.61E-13 -2.170  99 CG11149 6.12E-09 -2.124 
50 lncRNA:CR44743 6.75E-13 -3.970  100 CG42566 8.77E-09 -1.420 
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Supplementary Table 2.2: Top 100 downregulated genes with the lowest padj values 
(T11) 
 
Rank Gene Symbol padj value 
log2 





1 Hsc70-2 1.26E-70 -5.496  51 Toll-9 1.38E-09 -2.232 
2 mthl8 6.82E-61 -6.800  52 ATPsynCF6L 1.52E-09 -8.038 
3 w 9.73E-52 -4.932  53 CG46301 1.77E-09 -1.953 
4 Grik 1.13E-36 -5.499  54 CG15483 2.13E-09 -8.447 
5 CG33337 1.07E-30 -7.625  55 lncRNA:CR45127 2.71E-09 -8.419 
6 CR42490 9.96E-26 -7.018  56 niki 2.71E-09 -2.644 
7 ZnT77C 1.02E-24 -2.352  57 Ugt302K1 2.89E-09 -6.504 
8 asRNA:CR45835 3.37E-24 -4.658  58 CG10764 3.43E-09 -3.514 
9 asRNA:CR45822 1.22E-22 -9.914  59 Scgalpha 3.55E-09 -1.789 
10 CG11236 1.25E-22 -4.285  60 mGluR 5.82E-09 -1.723 
11 lncRNA:CR44754 4.89E-22 -3.700  61 lncRNA:CR45226 6.45E-09 -6.558 
12 asRNA:CR44029 9.50E-21 -3.507  62 lncRNA:CR46064 6.68E-09 -1.187 
13 CG31157 5.07E-20 -4.540  63 CaMKI 6.98E-09 -1.420 
14 lncRNA:CR43459 6.30E-20 -2.163  64 CG32006 9.16E-09 -1.636 
15 CG14204 7.41E-19 -5.443  65 CG16965 1.08E-08 -2.699 
16 CG9360 3.87E-17 -4.242  66 CG11319 1.21E-08 -1.414 
17 Cyp4p2 1.91E-16 -2.805  67 CG11034 1.42E-08 -1.975 
18 asRNA:CR45140 2.11E-16 -3.485  68 CG13305 1.43E-08 -1.676 
19 CG14301 3.59E-16 -2.354  69 asRNA:CR43730 1.70E-08 -1.934 
20 Nop17l 1.18E-15 -1.194  70 dsb 1.72E-08 -2.836 
21 lncRNA:CR46075 2.17E-15 -4.615  71 lncRNA:CR44024 2.22E-08 -2.018 
22 Ect3 2.56E-15 -2.213  72 CG16799 2.41E-08 -1.646 
23 CG31676 3.25E-15 -2.103  73 CG8768 2.79E-08 -1.592 
24 CG10407 5.71E-15 -2.072  74 asRNA:CR44031 3.16E-08 -2.023 
25 Argk 1.08E-13 -2.096  75 ttm2 3.46E-08 -3.302 
26 mthl4 1.85E-13 -2.373  76 Had2 5.53E-08 -2.580 
27 CR40190 1.86E-12 -1.303  77 CG32448 8.13E-08 -1.358 
28 lncRNA:CR44466 3.90E-12 -2.449  78 asRNA:CR45999 8.39E-08 -1.618 
29 FoxP 4.58E-12 -2.238  79 asRNA:CR31514 1.02E-07 -2.741 
30 CG15553 6.20E-12 -4.886  80 AstC-R2 1.02E-07 -1.737 
31 CG14990 9.42E-12 -2.159  81 CG11158 1.02E-07 -1.509 
32 Tina-1 9.90E-12 -1.200  82 CG11109 1.05E-07 -0.903 
33 Blos1 1.72E-11 -0.961  83 CG15177 1.73E-07 -7.858 
34 smp-30 2.17E-11 -2.513  84 CG5961 1.92E-07 -1.119 
35 Spn77Bc 2.19E-11 -3.199  85 lncRNA:CR46006 2.12E-07 -1.465 
36 NijC 2.19E-11 -1.705  86 CG7791 2.36E-07 -0.998 
37 lncRNA:CR45242 2.48E-11 -2.884  87 CG33465 2.67E-07 -2.537 
38 lncRNA:CR44743 4.47E-11 -3.456  88 CG4766 2.81E-07 -1.694 
39 CG14694 5.81E-11 -3.007  89 Arl4 3.05E-07 -0.948 
40 CG7607 1.13E-10 -2.259  90 DhpD 3.53E-07 -1.366 
41 lncRNA:CR44498 2.67E-10 -3.296  91 CG1494 3.71E-07 -1.775 
42 asRNA:CR42547 2.86E-10 -2.244  92 CG16789 3.92E-07 -1.731 
43 Jheh3 3.10E-10 -1.777  93 lncRNA:CR42719 4.01E-07 -1.992 
44 NLaz 3.39E-10 -2.487  94 BBS8 4.56E-07 -1.757 
45 CG33128 5.40E-10 -4.764  95 CG43222 4.58E-07 -1.719 
46 SecCl 8.58E-10 -1.492  96 CG3216 4.85E-07 -2.427 
47 CG12502 9.37E-10 -2.759  97 Amt 4.96E-07 -3.810 
48 Ugt35A1 1.06E-09 -1.339  98 dpr20 5.11E-07 -1.359 
49 su(w[a]) 1.12E-09 -0.828  99 CR43671 5.23E-07 -4.541 
50 asRNA:CR44053 1.25E-09 -2.177  100 asRNA:CR44018 5.47E-07 -2.328 
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Supplementary Table 2.3: Top 100 downregulated genes with the lowest padj values 
(T12) 
 
Rank Gene Symbol padj value 
log2 





1 Hsc70-2 1.41E-58 -5.053  51 pigs 5.94E-10 -1.709 
2 mthl8 1.95E-55 -6.770  52 niki 5.95E-10 -3.362 
3 w 1.24E-48 -4.809  53 dpr21 6.22E-10 -2.377 
4 asRNA:CR45822 2.21E-37 -8.646  54 CG32815 7.21E-10 -1.623 
5 Grik 4.04E-30 -5.009  55 asRNA:CR44053 1.12E-09 -2.370 
6 lncRNA:CR43459 4.88E-25 -2.444  56 Ugt302K1 1.39E-09 -5.800 
7 asRNA:CR44029 1.20E-24 -3.974  57 CG12502 1.57E-09 -3.076 
8 CG11319 3.54E-23 -2.310  58 Ugt303B3 2.11E-09 -2.053 
9 CG10407 3.34E-22 -2.611  59 Cib2 2.60E-09 -1.709 
10 CG9360 4.76E-22 -4.846  60 Ugt303A1 2.82E-09 -2.113 
11 asRNA:CR45140 1.48E-19 -4.254  61 CG10232 2.82E-09 -2.079 
12 asRNA:CR45835 2.70E-19 -4.427  62 nAChRalpha7 2.87E-09 -1.728 
13 CG11236 5.70E-18 -4.081  63 CG1494 3.85E-09 -2.109 
14 SecCl 9.61E-17 -2.003  64 Spn77Bc 4.34E-09 -3.078 
15 ZnT77C 1.35E-16 -1.941  65 ttm2 4.71E-09 -3.984 
16 lncRNA:CR44466 9.31E-16 -3.020  66 Cyp12c1 5.14E-09 -2.416 
17 Ect3 1.15E-15 -2.246  67 asRNA:CR31514 5.34E-09 -3.301 
18 CG33337 3.99E-15 -6.973  68 Cyp6d4 5.66E-09 -2.249 
19 CG31676 7.35E-15 -2.059  69 lncRNA:CR44603 5.87E-09 -3.298 
20 CG14204 1.15E-14 -4.704  70 Cyp4ad1 6.09E-09 -1.808 
21 lncRNA:CR44743 4.78E-14 -4.355  71 CR40190 6.47E-09 -1.114 
22 CG14990 5.67E-14 -2.370  72 CR42490 8.02E-09 -7.956 
23 CG31157 7.55E-14 -3.764  73 CG7607 9.42E-09 -2.532 
24 NLaz 2.27E-13 -2.878  74 CG16799 1.19E-08 -1.751 
25 Scgalpha 4.96E-13 -2.155  75 CG4465 1.28E-08 -3.821 
26 Had2 1.08E-12 -3.408  76 hiro 1.35E-08 -2.071 
27 alpha-Est2 2.55E-12 -2.108  77 ATPsynCF6L 1.43E-08 -7.516 
28 lncRNA:CR45242 2.86E-12 -3.278  78 CG15765 1.67E-08 -1.546 
29 lncRNA:CR44754 3.03E-12 -3.603  79 Cpr76Bc 1.69E-08 -2.214 
30 FoxP 4.13E-12 -2.302  80 Ugt49C1 1.74E-08 -2.271 
31 CG33288 5.19E-12 -2.131  81 lncRNA:CR42719 2.67E-08 -2.408 
32 AstC-R2 8.04E-12 -2.226  82 CG43968 2.74E-08 -3.393 
33 Cyp4p2 1.18E-11 -2.359  83 BBS8 2.81E-08 -1.933 
34 CG14301 1.18E-11 -2.284  84 CG33465 3.46E-08 -2.832 
35 CG8560 1.75E-11 -2.512  85 Trh 3.88E-08 -2.309 
36 NijC 2.30E-11 -1.757  86 dimm 3.88E-08 -1.799 
37 Toll-9 3.00E-11 -2.969  87 lncRNA:CR44498 3.93E-08 -3.878 
38 CG8768 3.42E-11 -1.855  88 tap 4.33E-08 -1.996 
39 CG4766 3.71E-11 -2.185  89 CG5961 4.44E-08 -1.174 
40 Argk 4.32E-11 -1.882  90 CG10337 4.58E-08 -1.676 
41 CG33128 8.08E-11 -4.607  91 mthl4 6.02E-08 -1.819 
42 lncRNA:CR46006 9.10E-11 -1.788  92 lncRNA:CR46075 6.66E-08 -3.385 
43 CG3842 1.05E-10 -1.705  93 VhaM9.7-a 6.66E-08 -1.286 
44 CG42337 1.81E-10 -1.489  94 asRNA:CR45999 6.69E-08 -1.619 
45 CG4839 3.19E-10 -1.518  95 Teh3 6.99E-08 -1.942 
46 CG14694 3.30E-10 -3.792  96 lncRNA:CR44467 7.10E-08 -2.059 
47 CG3734 3.31E-10 -2.176  97 CG6125 8.49E-08 -3.042 
48 mGluR 4.73E-10 -1.838  98 smp-30 8.54E-08 -2.092 
49 Jheh3 5.91E-10 -1.751  99 Nmdar1 8.54E-08 -1.351 
50 CG46301 5.94E-10 -2.000  100 lncRNA:CR46064 9.09E-08 -1.124 
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Supplementary Table 2.4: Top 100 downregulated genes with the lowest padj values 
(T13) 
 
Rank Gene Symbol padj value 
log2 





1 mthl8 3.00E-45 -7.019  51 ATPsynCF6L 6.60E-07 -6.837 
2 Hsc70-2 9.29E-41 -3.913  52 lncRNA:CR45242 8.48E-07 -2.518 
3 w 1.22E-35 -4.060  53 FoxP 9.07E-07 -1.645 
4 TwdlU 2.77E-32 -5.023  54 Burs 9.24E-07 -1.547 
5 CG11236 9.30E-26 -4.210  55 Dhfr 9.31E-07 -1.619 
6 CG10407 8.84E-21 -2.584  56 Dlic 1.04E-06 -0.673 
7 lncRNA:CR43459 3.91E-19 -2.131  57 CG7607 1.11E-06 -2.713 
8 asRNA:CR44029 1.42E-18 -3.435  58 CG14694 1.29E-06 -2.665 
9 CG11319 3.30E-17 -1.894  59 CG14715 1.34E-06 -2.152 
10 Cyp6a18 6.05E-17 -3.002  60 Marc 2.10E-06 -1.972 
11 NLaz 7.10E-16 -3.141  61 CG8560 2.10E-06 -1.855 
12 CG33337 6.02E-14 -5.668  62 Ect3 2.44E-06 -1.426 
13 asRNA:CR45835 1.17E-13 -3.317  63 asRNA:CR44018 2.60E-06 -2.166 
14 CG6163 1.67E-13 -3.402  64 niki 3.11E-06 -2.082 
15 asRNA:CR45140 3.79E-13 -3.624  65 su(w[a]) 3.11E-06 -0.672 
16 Nop17l 7.36E-12 -1.054  66 CG9766 3.42E-06 -1.899 
17 asRNA:CR45822 3.75E-11 -9.048  67 Cyp311a1 3.82E-06 -2.485 
18 CG33128 4.53E-11 -4.663  68 Tret1-2 4.50E-06 -2.422 
19 Cpr76Bc 1.04E-10 -2.415  69 CG14406 4.79E-06 -3.745 
20 CG31676 1.63E-10 -1.689  70 CG6125 5.32E-06 -2.727 
21 CG9360 2.67E-10 -3.294  71 CG6638 5.60E-06 -1.046 
22 CG31157 3.24E-10 -3.338  72 Jheh3 7.06E-06 -1.353 
23 alpha-Est2 4.62E-10 -1.749  73 CG31029 7.44E-06 -2.444 
24 lncRNA:CR44754 1.30E-09 -2.486  74 CG11997 9.53E-06 -3.226 
25 Had2 1.50E-09 -2.882  75 DhpD 9.58E-06 -1.243 
26 CG3842 2.80E-09 -1.609  76 CG6984 1.01E-05 -1.222 
27 CG10960 3.41E-09 -1.086  77 CG5961 1.27E-05 -0.999 
28 Grik 4.56E-09 -2.613  78 hpRNA:CR33940 1.39E-05 -2.077 
29 mthl4 8.94E-09 -1.991  79 CG15483 1.53E-05 -6.274 
30 CR42490 1.94E-08 -7.927  80 CG5599 1.60E-05 -0.977 
31 CR40190 1.94E-08 -1.117  81 CG8768 1.68E-05 -1.299 
32 Syp 2.29E-08 -2.491  82 CG32581 1.92E-05 -0.812 
33 Cib2 2.61E-08 -1.494  83 CG14456 1.93E-05 -1.574 
34 CG7408 3.48E-08 -1.753  84 Hmgcl 1.98E-05 -1.231 
35 yellow-d2 3.77E-08 -2.721  85 CG4839 2.25E-05 -1.046 
36 Cyp12e1 4.88E-08 -2.440  86 Trh 2.29E-05 -1.508 
37 lncRNA:CR44603 4.93E-08 -2.915  87 asRNA:CR45281 2.52E-05 -1.508 
38 ZnT77C 5.67E-08 -1.348  88 asRNA:CR31514 2.83E-05 -1.834 
39 Sid 6.58E-08 -2.123  89 dpr21 3.26E-05 -1.388 
40 CG14990 1.03E-07 -1.728  90 ttm2 3.81E-05 -2.879 
41 lncRNA:CR44466 1.24E-07 -1.992  91 Tina-1 4.54E-05 -0.792 
42 CG1494 2.35E-07 -1.857  92 CG34195 4.54E-05 -1.149 
43 lncRNA:CR46006 2.35E-07 -1.499  93 CG3734 4.63E-05 -1.506 
44 Ugt36E1 3.86E-07 -1.774  94 CG10932 5.40E-05 -1.277 
45 asRNA:CR44053 3.89E-07 -2.471  95 CG5171 5.43E-05 -1.812 
46 SecCl 4.61E-07 -1.278  96 CG33288 5.68E-05 -1.265 
47 Spn77Bc 5.33E-07 -2.698  97 Ugt303A1 5.89E-05 -1.472 
48 Scgalpha 5.39E-07 -1.574  98 CG15553 6.10E-05 -4.241 
49 CG11034 6.18E-07 -1.794  99 lncRNA:CR44498 6.54E-05 -3.602 
50 CaMKI 6.40E-07 -1.268  100 JhI-26 7.14E-05 -1.480 
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Supplementary Table 2.5: Top 100 downregulated genes with the lowest padj values 
(T14) 
 
Rank Gene Symbol padj value 
log2 





1 mthl8 1.82E-60 -6.716  51 lncRNA:CR44754 8.09E-10 -2.209 
2 w 9.75E-44 -4.637  52 CG14823 8.63E-10 -3.247 
3 Hsc70-2 2.67E-42 -3.921  53 fusl 8.93E-10 -1.806 
4 TwdlU 6.94E-40 -5.793  54 Syx4 1.31E-09 -1.472 
5 lncRNA:CR43459 1.03E-32 -2.766  55 CG6638 1.89E-09 -1.310 
6 NLaz 4.58E-31 -4.365  56 Invadolysin 3.47E-09 -0.918 
7 CG11236 1.43E-30 -3.283  57 cmpy 3.83E-09 -1.408 
8 yellow-d2 6.57E-25 -4.974  58 CG9801 3.95E-09 -1.393 
9 asRNA:CR44029 5.31E-22 -3.715  59 Had2 3.98E-09 -2.750 
10 CR42490 9.69E-22 -6.943  60 niki 5.81E-09 -2.467 
11 CG10407 3.49E-19 -2.451  61 Gpb5 6.20E-09 -2.468 
12 CG1494 1.43E-18 -2.965  62 su(w[a]) 6.24E-09 -0.800 
13 Cyp12e1 1.95E-18 -3.423  63 Scgalpha 7.80E-09 -1.755 
14 CG11319 1.94E-17 -1.867  64 Ldsdh1 9.30E-09 -1.722 
15 Cyp6a18 9.78E-17 -2.540  65 CG12099 9.30E-09 -0.940 
16 lncRNA:CR44466 1.91E-16 -3.358  66 asRNA:CR31514 1.11E-08 -2.424 
17 Syp 3.22E-16 -3.536  67 St3 1.14E-08 -1.899 
18 Ect3 6.74E-16 -2.259  68 Lip1 1.14E-08 -1.969 
19 CG14406 4.28E-15 -3.237  69 Obp46a 1.57E-08 -3.004 
20 CG42365 1.67E-14 -2.886  70 CaMKI 1.98E-08 -1.389 
21 asRNA:CR42547 6.19E-14 -3.249  71 CG6163 2.04E-08 -2.585 
22 asRNA:CR45835 6.65E-14 -5.278  72 lncRNA:CR44024 2.06E-08 -2.057 
23 Nop17l 1.12E-13 -1.123  73 sage 2.12E-08 -1.651 
24 CG31157 1.15E-13 -4.026  74 CG4250 2.41E-08 -2.017 
25 CG9360 2.73E-13 -3.714  75 CG4839 2.72E-08 -1.283 
26 Cpr76Bc 3.13E-13 -2.908  76 kar 2.74E-08 -1.579 
27 Grik 3.62E-13 -3.149  77 Cib2 3.22E-08 -1.410 
28 SecCl 5.44E-13 -1.752  78 Mct1 3.71E-08 -1.500 
29 CG14456 6.46E-13 -2.082  79 Obp99c 3.99E-08 -2.192 
30 Hmgcl 6.69E-13 -1.928  80 CG12868 4.03E-08 -1.802 
31 Sid 7.06E-13 -2.695  81 lncRNA:CR31386 4.33E-08 -2.720 
32 CG13907 8.21E-13 -1.298  82 CG8768 6.56E-08 -1.555 
33 lncRNA:CR46006 8.70E-13 -1.999  83 lncRNA:CR45242 7.80E-08 -2.712 
34 CG5171 1.13E-12 -2.900  84 lncRNA:CR42719 8.35E-08 -1.999 
35 CG31676 1.13E-12 -1.817  85 yellow-h 9.87E-08 -1.536 
36 asRNA:CR45822 3.28E-12 -8.954  86 CG14990 1.17E-07 -1.693 
37 asRNA:CR45140 4.90E-12 -3.087  87 CG32006 1.17E-07 -1.536 
38 CG3842 5.51E-12 -1.829  88 lncRNA:CR45556 1.18E-07 -3.697 
39 CG13813 5.68E-12 -4.232  89 Gadd45 1.20E-07 -2.188 
40 Ugt35B1 1.15E-11 -1.962  90 lncRNA:CR44230 1.27E-07 -3.494 
41 CG33337 1.16E-11 -3.781  91 Obp99a 1.35E-07 -2.241 
42 Act87E 1.83E-11 -1.336  92 CG31810 1.98E-07 -1.796 
43 Ir76b 3.02E-11 -2.064  93 CG33124 2.30E-07 -1.985 
44 CG32369 3.62E-11 -1.366  94 mGluR 2.61E-07 -1.529 
45 alpha-Est2 4.13E-11 -1.789  95 et 2.79E-07 -1.703 
46 CG14204 1.04E-10 -4.008  96 CG9766 2.80E-07 -1.928 
47 CG5961 1.32E-10 -1.379  97 side 3.31E-07 -1.311 
48 CG14356 1.95E-10 -2.539  98 lncRNA:CR44467 3.65E-07 -1.992 
49 VhaM9.7-a 3.09E-10 -1.475  99 CG6044 3.65E-07 -1.095 
50 FoxP 6.29E-10 -1.991  100 CG13502 3.67E-07 -1.594 
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Supplementary Table 2.6: Top 100 downregulated genes with the lowest padj values 
(T15) 
 
Rank Gene Symbol padj value 
log2 





1 mthl8 3.14E-62 -7.362  51 Obp46a 4.86E-09 -3.256 
2 w 4.31E-37 -4.152  52 CG14456 6.81E-09 -1.547 
3 NLaz 8.91E-28 -4.137  53 Snx21 1.03E-08 -1.199 
4 lncRNA:CR43459 8.91E-28 -2.559  54 Ugt35B1 1.51E-08 -1.534 
5 Hsc70-2 4.40E-27 -2.961  55 CG13445 1.56E-08 -4.122 
6 CG11236 1.07E-23 -2.665  56 FoxP 1.97E-08 -1.776 
7 yellow-d2 3.50E-23 -4.323  57 CG6638 2.01E-08 -1.226 
8 CG6163 6.24E-22 -4.434  58 CG5961 2.36E-08 -1.203 
9 CG1494 7.70E-22 -3.147  59 CG13907 2.87E-08 -1.032 
10 Cyp12e1 2.11E-21 -3.558  60 CG42365 4.45E-08 -2.127 
11 asRNA:CR44029 5.52E-21 -3.577  61 Spn77Bc 4.59E-08 -2.784 
12 CG14406 2.30E-18 -2.918  62 su(w[a]) 4.68E-08 -0.754 
13 asRNA:CR45835 7.48E-17 -4.280  63 CG10232 8.18E-08 -1.789 
14 TwdlU 2.60E-16 -4.116  64 CG12896 8.92E-08 -2.686 
15 yip2 4.21E-16 -1.959  65 CG6431 1.05E-07 -4.250 
16 asRNA:CR45822 3.33E-15 -8.007  66 lncRNA:CR31386 1.20E-07 -2.165 
17 CG31157 8.36E-15 -4.240  67 CaMKI 1.38E-07 -1.308 
18 CG10407 2.48E-14 -2.103  68 Mccc2 1.89E-07 -1.337 
19 Grik 2.87E-14 -3.254  69 amd 1.97E-07 -2.498 
20 Hmgcl 7.72E-14 -2.001  70 kar 2.00E-07 -1.486 
21 Cyp6a18 9.77E-14 -2.210  71 dpr21 2.00E-07 -1.421 
22 Nop17l 1.04E-13 -1.119  72 alpha-Est2 2.12E-07 -1.429 
23 Ect3 1.45E-12 -2.004  73 lncRNA:CR45556 2.19E-07 -4.478 
24 CG14694 1.05E-11 -3.269  74 Pgant3 2.81E-07 -1.464 
25 hpRNA:CR33940 1.21E-11 -2.956  75 Act87E 3.05E-07 -1.051 
26 CG14204 1.26E-11 -4.606  76 Invadolysin 3.09E-07 -0.809 
27 CR40190 1.54E-11 -1.290  77 ATPsynCF6L 3.27E-07 -6.813 
28 CG31676 1.64E-11 -1.716  78 CG4766 3.42E-07 -1.766 
29 lncRNA:CR44466 2.22E-11 -2.732  79 CG43968 3.55E-07 -2.481 
30 Syp 2.99E-11 -3.072  80 CG6836 4.06E-07 -1.965 
31 CG11319 4.12E-11 -1.467  81 ect 5.74E-07 -3.230 
32 asRNA:CR45140 4.36E-11 -2.855  82 St3 6.42E-07 -1.679 
33 CG34195 1.59E-10 -1.735  83 asRNA:CR44179 7.13E-07 -1.502 
34 CG13813 1.73E-10 -3.953  84 niki 7.14E-07 -1.999 
35 CG33128 2.27E-10 -4.145  85 lncRNA:CR44754 7.14E-07 -1.585 
36 Lip1 3.73E-10 -2.132  86 CG13312 8.63E-07 -3.691 
37 CG14715 3.82E-10 -2.663  87 asRNA:CR44018 9.88E-07 -2.046 
38 CG5599 3.82E-10 -1.312  88 Ir76b 9.99E-07 -1.468 
39 lncRNA:CR46006 4.15E-10 -1.742  89 Orct 1.12E-06 -1.693 
40 SecCl 5.36E-10 -1.506  90 Prx2540-1 1.50E-06 -2.479 
41 CG5938 1.06E-09 -0.846  91 CG7255 1.89E-06 -1.034 
42 CG13827 1.12E-09 -1.533  92 SCOT 1.92E-06 -0.912 
43 CG7402 1.37E-09 -2.514  93 CG9766 1.95E-06 -1.703 
44 CG5171 1.99E-09 -2.487  94 CG31029 2.83E-06 -2.390 
45 CR42490 2.76E-09 -8.060  95 Gpb5 2.87E-06 -1.825 
46 CG14823 3.13E-09 -2.881  96 Sid 2.91E-06 -1.828 
47 Obp99a 3.60E-09 -2.462  97 Syt12 3.09E-06 -1.162 
48 CG32581 3.60E-09 -1.045  98 Etf-QO 3.68E-06 -0.857 
49 CG34276 3.97E-09 -2.183  99 Cib2 3.96E-06 -1.166 
50 CG6984 4.54E-09 -1.520  100 CR41379 4.17E-06 -1.843 
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Supplementary Table 2.7: Top 100 downregulated genes with the lowest padj values 
(T16) 
 
Rank Gene Symbol padj value 
log2 





1 mthl8 6.77E-73 -6.334  51 Nmdar1 3.61E-13 -1.688 
2 CG14406 1.21E-51 -5.214  52 CG5961 3.63E-13 -1.511 
3 NLaz 9.70E-38 -4.814  53 CG7300 3.66E-13 -3.372 
4 w 1.26E-34 -4.111  54 CG32815 5.66E-13 -1.835 
5 CG1494 3.89E-34 -3.971  55 Obp56b 6.13E-13 -3.424 
6 CG11236 1.66E-30 -3.128  56 asRNA:CR42547 8.26E-13 -2.837 
7 yellow-d2 4.27E-30 -5.293  57 btl 1.94E-12 -2.348 
8 Hsc70-2 1.30E-28 -3.164  58 CG3270 2.27E-12 -2.874 
9 Ect3 6.90E-27 -2.954  59 Obp99a 3.06E-12 -2.854 
10 CG11319 6.02E-26 -2.249  60 RunxA 3.24E-12 -2.467 
11 Grik 3.75E-25 -4.495  61 alpha-Est2 4.16E-12 -1.837 
12 CG14661 4.81E-25 -3.295  62 CG8664 4.55E-12 -3.009 
13 CG42807 1.87E-23 -3.159  63 Oseg4 4.78E-12 -2.044 
14 lncRNA:CR43459 2.02E-23 -2.361  64 kar 4.81E-12 -1.924 
15 CG9864 8.53E-23 -3.256  65 CG30026 5.37E-12 -1.943 
16 CG3690 8.63E-22 -3.520  66 CG31157 8.76E-12 -3.643 
17 asRNA:CR44029 1.14E-21 -3.694  67 CG30091 8.99E-12 -3.489 
18 CG6296 2.68E-21 -3.182  68 SiaT 1.05E-11 -2.405 
19 CG13159 4.47E-20 -5.625  69 CG5402 1.38E-11 -2.679 
20 Ugt35B1 4.50E-20 -2.457  70 CG10877 1.53E-11 -1.272 
21 CG3819 7.50E-20 -5.152  71 lncRNA:CR31386 2.18E-11 -2.909 
22 Cyp12e1 8.70E-20 -3.418  72 CG6847 3.03E-11 -2.114 
23 lncRNA:CR44754 9.15E-19 -2.808  73 CG8003 3.09E-11 -1.542 
24 Cyp6a18 9.15E-19 -2.597  74 CG16854 4.17E-11 -1.807 
25 CG13813 1.05E-18 -5.335  75 CG18095 5.16E-11 -1.931 
26 asRNA:CR45835 1.22E-18 -5.646  76 CG32581 5.16E-11 -1.141 
27 MFS14 2.96E-18 -1.893  77 CG43968 5.81E-11 -2.956 
28 CG10407 6.82E-18 -2.323  78 Spn77Bc 5.87E-11 -3.373 
29 CG14694 1.53E-17 -4.796  79 pigs 6.00E-11 -1.779 
30 CG14456 1.53E-17 -2.137  80 CG14204 6.34E-11 -3.818 
31 CR42490 2.30E-16 -6.495  81 Orct 7.46E-11 -2.235 
32 dpr21 3.39E-16 -2.111  82 CG14234 8.52E-11 -2.132 
33 Btnd 7.09E-16 -3.184  83 LysD 1.00E-10 -3.694 
34 CG31676 7.59E-16 -2.036  84 lncRNA:CR31781 1.06E-10 -1.786 
35 Act87E 1.93E-15 -1.549  85 CR40190 1.33E-10 -1.219 
36 lncRNA:CR46006 1.98E-15 -2.190  86 SCOT 2.09E-10 -1.164 
37 CG10232 4.87E-15 -2.513  87 CG12896 2.25E-10 -3.105 
38 CG1304 5.64E-15 -5.135  88 CG42540 2.51E-10 -1.648 
39 CG11413 6.23E-15 -3.229  89 asRNA:CR44179 2.53E-10 -1.863 
40 CG11000 1.07E-14 -1.682  90 CG4766 2.87E-10 -2.265 
41 SecCl 1.34E-14 -1.804  91 CG11905 2.96E-10 -2.209 
42 Ir76b 1.40E-14 -2.231  92 Gpb5 3.32E-10 -2.340 
43 CG14823 2.37E-14 -3.826  93 VhaM9.7-a 3.79E-10 -1.450 
44 Syt12 2.58E-14 -1.787  94 snu 5.01E-10 -1.645 
45 yip2 4.40E-14 -1.824  95 CG5246 5.19E-10 -3.206 
46 Lk 4.71E-14 -3.938  96 Pxd 5.90E-10 -1.490 
47 CG34276 1.57E-13 -2.777  97 CG9826 7.03E-10 -2.483 
48 CG5171 1.58E-13 -2.997  98 natalisin 7.38E-10 -2.022 
49 Ugt35E1 1.79E-13 -2.488  99 asRNA:CR45822 8.40E-10 -8.161 
50 NaPi-T 2.08E-13 -2.765  100 Orcokinin 8.40E-10 -2.073 
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Supplementary Table 2.8: Top 100 downregulated genes with the lowest padj values 
(T17) 
 
Rank Gene Symbol padj value 
log2 





1 mthl8 8.84E-61 -5.974  51 bma 1.04E-12 -1.718 
2 CG14406 1.66E-51 -5.532  52 CG3270 1.09E-12 -2.911 
3 CG1494 1.97E-36 -4.178  53 NaPi-T 1.97E-12 -2.664 
4 w 9.15E-34 -4.408  54 Orcokinin 2.11E-12 -2.417 
5 asRNA:CR44179 7.99E-32 -3.352  55 Cyp4ac3 2.47E-12 -3.043 
6 lncRNA:CR43459 5.23E-31 -2.738  56 CG10232 3.81E-12 -2.266 
7 yellow-d2 6.63E-25 -5.902  57 Oseg4 8.03E-12 -2.034 
8 NLaz 6.63E-25 -3.936  58 MFS14 8.23E-12 -1.525 
9 CG11319 6.66E-25 -2.208  59 CG6163 8.40E-12 -3.046 
10 CG11236 4.65E-24 -2.821  60 SecCl 8.78E-12 -1.619 
11 Hsc70-2 2.29E-23 -2.878  61 Hug 9.10E-12 -3.111 
12 lncRNA:CR44754 1.10E-21 -3.276  62 CG14234 1.17E-11 -2.232 
13 CG14961 1.99E-21 -4.058  63 RunxA 1.22E-11 -2.529 
14 Cyp6a18 1.18E-20 -2.834  64 GlyT 1.22E-11 -2.175 
15 asRNA:CR44029 5.47E-20 -3.570  65 CG14456 1.86E-11 -1.711 
16 Grik 1.58E-19 -4.049  66 CG13743 2.00E-11 -1.533 
17 Ect3 1.78E-19 -2.535  67 asRNA:CR42547 2.05E-11 -2.876 
18 CG42807 2.32E-19 -2.593  68 CG33337 2.11E-11 -3.007 
19 CG14661 4.04E-19 -2.744  69 CG42540 2.31E-11 -1.738 
20 CG11000 2.33E-18 -1.891  70 Ugt35B1 2.60E-11 -1.905 
21 CG30091 5.08E-18 -4.205  71 Capa 2.77E-11 -3.592 
22 CG6296 1.71E-17 -2.863  72 Pxd 2.88E-11 -1.608 
23 CG10407 1.98E-17 -2.302  73 natalisin 3.36E-11 -2.186 
24 dpr21 2.55E-17 -2.315  74 side-III 3.48E-11 -1.493 
25 Syt12 2.58E-17 -2.003  75 Tomosyn 3.74E-11 -1.440 
26 CG9864 1.00E-16 -2.781  76 Hasp 4.10E-11 -2.031 
27 asRNA:CR45822 4.46E-16 -6.959  77 lncRNA:CR42646 5.34E-11 -3.945 
28 CG3690 6.19E-16 -3.069  78 Appl 5.35E-11 -1.616 
29 CG13813 1.27E-15 -4.985  79 CG8003 5.52E-11 -1.531 
30 CG1304 1.44E-15 -5.253  80 lncRNA:CR31386 5.89E-11 -3.431 
31 Lk 1.49E-15 -4.166  81 CG6218 5.89E-11 -1.592 
32 CG33128 1.68E-15 -5.267  82 CG6688 7.24E-11 -2.021 
33 CG5961 1.94E-15 -1.653  83 nSyb 7.69E-11 -1.522 
34 CG31676 2.87E-15 -2.016  84 CG31191 7.94E-11 -1.396 
35 CG32815 3.19E-15 -2.013  85 CG34354 9.43E-11 -1.732 
36 asRNA:CR45835 6.31E-15 -5.431  86 Dscam2 1.14E-10 -1.414 
37 Cyp12e1 9.26E-15 -2.960  87 Ac13E 1.28E-10 -0.953 
38 Nmdar1 1.78E-14 -1.779  88 CG30026 1.42E-10 -1.865 
39 Nop17l 1.78E-14 -1.151  89 CG1090 1.74E-10 -1.601 
40 Obp56b 2.02E-14 -3.881  90 tbc 1.93E-10 -1.958 
41 CG14694 2.53E-14 -3.609  91 CG14880 2.16E-10 -1.762 
42 Ir76b 3.02E-14 -2.214  92 CG12896 2.62E-10 -3.105 
43 pigs 3.49E-14 -2.042  93 CG6638 2.63E-10 -1.361 
44 CG3819 4.85E-14 -4.335  94 CG16854 2.77E-10 -1.785 
45 Ugt35E1 7.08E-14 -2.536  95 jus 2.77E-10 -1.552 
46 lncRNA:CR31781 1.46E-13 -2.027  96 CG31157 3.24E-10 -3.460 
47 side 2.43E-13 -1.799  97 beat-Vc 3.61E-10 -1.634 
48 Btnd 2.59E-13 -2.921  98 Lip1 4.75E-10 -2.185 
49 lncRNA:CR46006 4.32E-13 -2.036  99 yip2 5.05E-10 -1.534 
50 ZnT77C 6.38E-13 -1.687  100 CG4577 5.39E-10 -2.039 
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Supplementary Table 2.9: Top 100 downregulated genes with the lowest padj values 
(T18) 
 
Rank Gene Symbol padj value 
log2 





1 mthl8 2.66E-50 -6.129  51 Orcokinin 4.54E-15 -2.524 
2 CG14406 2.77E-49 -6.271  52 DIP-lambda 4.84E-15 -1.938 
3 CG42807 3.27E-42 -3.253  53 CG9864 5.44E-15 -2.600 
4 CG3690 3.97E-38 -3.665  54 yellow-d2 5.71E-15 -5.588 
5 lncRNA:CR43459 7.70E-38 -3.024  55 Obp56b 1.07E-14 -3.466 
6 CG6296 6.77E-37 -4.149  56 CG32581 1.12E-14 -1.324 
7 w 1.44E-33 -4.518  57 CG10407 1.20E-14 -2.066 
8 CG1494 2.43E-32 -3.896  58 SCOT 1.21E-14 -1.380 
9 CG11236 3.00E-32 -3.340  59 Cyp12e1 1.23E-14 -2.980 
10 CG3819 3.16E-30 -5.478  60 nAChRalpha7 1.25E-14 -1.932 
11 NaPi-T 2.84E-29 -3.939  61 Ect3 1.92E-14 -2.165 
12 CG11319 2.38E-28 -2.340  62 Ir76b 2.36E-14 -2.232 
13 asRNA:CR45822 3.96E-28 -6.521  63 Gal 2.66E-14 -2.195 
14 Btnd 3.28E-26 -3.922  64 CG10361 2.83E-14 -2.367 
15 Ugt35E1 5.30E-26 -3.347  65 CG31191 3.35E-14 -1.597 
16 Ugt35B1 1.45E-25 -3.129  66 CG32302 4.47E-14 -2.939 
17 lncRNA:CR44754 3.99E-25 -3.800  67 NijC 4.63E-14 -1.963 
18 dpr21 4.57E-24 -2.574  68 daw 5.06E-14 -2.050 
19 AcCoAS 1.91E-23 -2.102  69 Act87E 5.60E-14 -1.463 
20 Hsc70-2 3.84E-21 -2.807  70 Mccc2 7.08E-14 -1.821 
21 Cyp6a18 4.10E-21 -2.885  71 CG5599 7.08E-14 -1.513 
22 CG11000 4.37E-21 -2.007  72 CG14823 7.32E-14 -4.453 
23 Grik 6.43E-21 -4.326  73 Vha26 1.07E-13 -1.207 
24 CG5961 6.43E-21 -1.908  74 Vha16-1 1.07E-13 -1.164 
25 asRNA:CR45835 1.09E-20 -4.422  75 CG42540 1.15E-13 -1.888 
26 Syt12 1.80E-20 -2.172  76 CG30091 1.19E-13 -3.524 
27 Obp99d 2.20E-20 -3.567  77 CG18095 1.29E-13 -2.144 
28 CG1304 4.86E-20 -5.925  78 CG3902 1.45E-13 -1.807 
29 asRNA:CR44029 2.14E-19 -3.568  79 CG33124 1.69E-13 -2.623 
30 CG14661 1.33E-18 -2.620  80 CG43778 1.74E-13 -1.899 
31 ZnT77C 3.38E-18 -2.012  81 Ggamma30A 1.76E-13 -1.802 
32 Mal-A8 3.66E-18 -3.053  82 CG2765 1.97E-13 -0.868 
33 Pxd 4.46E-18 -2.104  83 Nmdar1 1.98E-13 -1.694 
34 lncRNA:CR31781 9.44E-18 -2.315  84 CG31446 1.99E-13 -2.130 
35 CG6733 1.56E-17 -3.337  85 bma 3.07E-13 -1.732 
36 CG33337 1.64E-17 -3.663  86 CG32379 3.15E-13 -4.855 
37 CG30026 2.85E-17 -2.412  87 CG31097 4.86E-13 -2.167 
38 MFS14 3.01E-17 -1.833  88 Dh44 5.00E-13 -1.729 
39 CG3270 3.19E-17 -3.350  89 CG4752 5.02E-13 -1.596 
40 beta4GalNAcTA 5.22E-17 -1.670  90 CG8199 5.03E-13 -1.685 
41 lncRNA:CR46006 1.34E-16 -2.303  91 CG8664 5.13E-13 -2.832 
42 CG9826 1.56E-16 -3.086  92 Gba1a 5.41E-13 -2.500 
43 CG18327 1.70E-16 -2.971  93 DAT 6.22E-13 -2.107 
44 CG31676 1.73E-16 -2.083  94 Nop17l 6.38E-13 -1.074 
45 CG5246 2.10E-16 -3.803  95 NLaz 6.63E-13 -2.791 
46 CG8745 4.01E-16 -3.120  96 FASN1 7.66E-13 -2.307 
47 Gpb5 1.51E-15 -2.961  97 lncRNA:CR42719 9.68E-13 -2.431 
48 alpha-Est2 4.34E-15 -2.050  98 Cyp9h1 1.03E-12 -2.122 
49 CR40190 4.34E-15 -1.484  99 CG40470 1.54E-12 -1.886 
50 SecCl 4.35E-15 -1.796  100 Cbp53E 1.64E-12 -1.797 
  Chapter 4: A role for lncRNA-9 in the Drosophila nervous system 
 
231 
Supplementary Table 2.10: Top 100 downregulated genes with the lowest padj values 
(T19) 
 
Rank Gene Symbol padj value 
log2 





1 CG3819 1.21E-47 -6.621  51 CG9799 2.84E-13 -1.575 
2 CG14406 1.03E-41 -6.876  52 lncRNA:CR44466 3.49E-13 -3.594 
3 mthl8 2.89E-41 -6.721  53 Orcokinin 3.85E-13 -2.338 
4 CG3690 1.15E-36 -3.271  54 CG33124 4.80E-13 -2.607 
5 CG1494 6.61E-35 -4.463  55 lncRNA:CR31781 5.82E-13 -1.982 
6 lncRNA:CR43459 3.02E-30 -2.721  56 ACC 9.72E-13 -1.795 
7 CG11236 7.95E-30 -3.148  57 DAT 1.01E-12 -2.120 
8 w 6.57E-28 -3.843  58 beta4GalNAcTA 1.20E-12 -1.445 
9 CG42807 1.82E-27 -2.519  59 NHP2 1.20E-12 -1.274 
10 CG5961 2.53E-26 -2.143  60 FASN1 1.24E-12 -2.310 
11 asRNA:CR45822 2.88E-26 -6.754  61 Cyp6a18 1.24E-12 -2.204 
12 NaPi-T 4.35E-26 -3.654  62 Uhg2 1.60E-12 -1.823 
13 CG11319 6.23E-25 -2.196  63 CG14823 2.30E-12 -3.859 
14 Hsc70-2 6.89E-25 -3.035  64 CG1671 2.34E-12 -1.519 
15 lncRNA:CR44754 2.47E-22 -3.478  65 Gclc 2.50E-12 -1.357 
16 CG6733 3.38E-22 -3.782  66 l(1)G0020 3.65E-12 -1.543 
17 CG33337 1.12E-21 -4.040  67 CG7966 3.91E-12 -1.864 
18 CG6296 8.29E-21 -2.976  68 CG5599 3.91E-12 -1.422 
19 CG10407 1.79E-20 -2.478  69 CG11158 4.56E-12 -1.928 
20 Btnd 3.27E-19 -3.311  70 ZnT77C 4.83E-12 -1.633 
21 Ugt35E1 4.92E-19 -2.773  71 CG6638 4.83E-12 -1.471 
22 nop5 5.22E-19 -0.895  72 NijC 7.64E-12 -1.924 
23 CG3270 5.83E-19 -3.510  73 CG8064 8.80E-12 -1.448 
24 CG1304 7.76E-19 -5.757  74 Cyp305a1 1.23E-11 -1.706 
25 AcCoAS 1.78E-18 -1.869  75 PH4alphaMP 1.23E-11 -2.451 
26 Grik 1.02E-17 -3.859  76 lncRNA:CR46006 1.32E-11 -1.895 
27 asRNA:CR44029 2.56E-17 -3.331  77 CG7458 1.48E-11 -1.143 
28 Ugt35B1 3.60E-17 -2.545  78 CG10361 1.56E-11 -2.116 
29 CG18327 8.69E-17 -2.927  79 CG14298 1.56E-11 -2.037 
30 asRNA:CR45835 2.10E-16 -5.034  80 CG16775 1.88E-11 -3.582 
31 MFS14 2.24E-16 -1.795  81 CG31191 3.08E-11 -1.415 
32 Obp99d 2.64E-16 -3.065  82 CG32302 3.16E-11 -2.624 
33 Nop17l 7.53E-16 -1.205  83 CG8199 4.52E-11 -1.563 
34 Art8 8.24E-16 -1.530  84 CG11034 4.90E-11 -2.220 
35 Mal-A8 2.30E-15 -2.849  85 Orct 5.68E-11 -2.238 
36 CG3902 2.42E-15 -1.940  86 Hmgcl 6.23E-11 -1.723 
37 CG9826 4.36E-15 -2.909  87 CG13907 6.38E-11 -1.192 
38 CG5402 4.79E-15 -3.256  88 DIP-lambda 7.18E-11 -1.652 
39 CG11000 4.79E-15 -1.693  89 natalisin 8.91E-11 -2.038 
40 Ect3 5.29E-15 -2.239  90 yellow-d2 1.18E-10 -3.836 
41 Syt12 1.17E-14 -1.829  91 Obp56b 1.22E-10 -2.876 
42 CG17219 1.65E-14 -1.752  92 Mys45A 1.25E-10 -1.081 
43 CG5246 1.65E-14 -3.238  93 CG31676 1.63E-10 -1.656 
44 Gpb5 2.26E-14 -3.008  94 CG14661 2.08E-10 -1.916 
45 CG8745 5.86E-14 -2.926  95 CG4783 2.85E-10 -8.661 
46 Gal 1.07E-13 -2.157  96 CG31157 2.85E-10 -3.497 
47 Mccc2 1.42E-13 -1.816  97 Pxd 2.87E-10 -1.656 
48 dpr21 1.69E-13 -1.882  98 CG17026 3.27E-10 -2.226 
49 Lk 1.72E-13 -3.495  99 Had2 3.30E-10 -2.558 
50 Gba1a 1.72E-13 -2.540  100 Nmdar1 3.31E-10 -1.480 
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Supplementary Table 2.11: Top 100 downregulated genes with the lowest padj values 
(T20) 
 
Rank Gene Symbol padj value 
log2 





1 mthl8 5.72E-41 -6.948  51 asRNA:CR44029 6.19E-11 -2.607 
2 CG3819 5.16E-40 -5.936  52 lncRNA:CR46006 6.64E-11 -1.878 
3 lncRNA:CR43459 6.03E-33 -2.857  53 CG10175 8.09E-11 -1.962 
4 Hsc70-2 1.04E-31 -3.384  54 Nop56 1.62E-10 -1.062 
5 CG3690 2.90E-27 -2.703  55 Cpr51A 1.70E-10 -2.729 
6 Obp99d 4.94E-25 -3.749  56 CG30091 2.65E-10 -3.035 
7 w 2.52E-24 -3.523  57 CG7227 2.65E-10 -2.438 
8 CG14406 1.03E-20 -8.079  58 DAT 2.79E-10 -1.907 
9 nop5 2.22E-20 -0.931  59 CG6638 2.79E-10 -1.362 
10 CG34195 5.16E-20 -2.447  60 Capa 3.21E-10 -3.030 
11 CG33337 1.94E-19 -3.949  61 pit 3.87E-10 -1.089 
12 asRNA:CR45835 5.68E-18 -4.098  62 CG15083 4.13E-10 -1.326 
13 Grik 4.44E-17 -3.864  63 Ugt35E1 4.29E-10 -2.010 
14 CG3270 2.04E-16 -3.294  64 Dph3 6.82E-10 -1.149 
15 Ugt35B1 2.35E-16 -3.095  65 AcCoAS 8.62E-10 -1.356 
16 CG5961 6.63E-16 -1.670  66 Mtr3 9.16E-10 -1.099 
17 CG11236 7.67E-16 -2.208  67 Mccc2 1.08E-09 -1.530 
18 CG18327 1.16E-15 -2.836  68 yellow-d2 1.10E-09 -4.043 
19 CG10474 1.25E-15 -5.445  69 Pus1 1.14E-09 -1.571 
20 CG1494 1.85E-15 -2.710  70 Nop17l 1.53E-09 -0.927 
21 CG1304 3.74E-15 -5.187  71 Mal-A8 1.59E-09 -2.189 
22 CG5402 2.43E-14 -3.335  72 ChLD3 2.00E-09 -3.810 
23 NaPi-T 2.51E-14 -2.698  73 CG14598 2.24E-09 -1.969 
24 lncRNA:CR44754 2.85E-14 -3.193  74 CG14204 2.91E-09 -3.276 
25 aay 6.10E-14 -0.933  75 CG9799 3.07E-09 -1.308 
26 CG6296 8.04E-14 -2.414  76 CG7300 3.12E-09 -2.695 
27 CG17219 8.97E-14 -1.697  77 CG15877 3.27E-09 -1.215 
28 CG7458 1.06E-13 -1.264  78 CG18273 3.38E-09 -1.012 
29 CG6712 1.34E-13 -1.364  79 Obp56b 3.45E-09 -2.639 
30 CG33124 1.47E-13 -2.699  80 CG13606 3.54E-09 -1.847 
31 CG10407 3.88E-13 -1.973  81 MFS14 3.63E-09 -1.333 
32 CG11319 3.88E-13 -1.596  82 dpr21 5.16E-09 -1.541 
33 CG9515 6.11E-13 -1.375  83 CG13907 5.29E-09 -1.083 
34 U3-55K 6.17E-13 -1.517  84 CG2972 5.48E-09 -0.887 
35 CG42807 6.83E-13 -1.686  85 Aprt 7.03E-09 -1.243 
36 Mys45A 6.83E-13 -1.201  86 Mccc1 8.19E-09 -1.207 
37 Art8 8.03E-13 -1.379  87 lncRNA:CR46064 9.59E-09 -1.241 
38 CG6733 1.18E-12 -2.857  88 Syt12 9.75E-09 -1.399 
39 NHP2 1.41E-12 -1.274  89 l(1)G0020 1.04E-08 -1.300 
40 firl 1.77E-12 -2.463  90 CG43181 1.06E-08 -4.469 
41 CG16775 6.25E-12 -3.840  91 alpha-Est2 1.06E-08 -1.585 
42 asRNA:CR45822 6.27E-12 -8.667  92 CG34437 1.12E-08 -2.331 
43 CG11158 1.11E-11 -1.906  93 CG31157 1.12E-08 -3.070 
44 PH4alphaMP 1.30E-11 -2.505  94 CG6724 1.16E-08 -1.259 
45 CG6763 2.22E-11 -2.756  95 Pxd 1.22E-08 -1.537 
46 Fit2 2.52E-11 -1.347  96 CG14298 1.49E-08 -1.733 
47 CG13003 2.65E-11 -2.104  97 CG8745 1.89E-08 -2.259 
48 l(2)09851 3.43E-11 -1.056  98 Gba1a 2.51E-08 -1.981 
49 Lk 3.52E-11 -3.210  99 CG5599 2.74E-08 -1.169 
50 CG8064 4.09E-11 -1.412  100 CG1785 3.50E-08 -0.873 
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Supplementary Table 2.12: Top 100 downregulated genes with the lowest padj values 
(T21) 
 
Rank Gene Symbol padj value 
log2 





1 mthl8 1.82E-52 -5.952  51 CG13159 1.84E-09 -3.912 
2 Hsc70-2 1.66E-43 -4.141  52 Dph3 2.31E-09 -1.121 
3 CG3819 7.77E-42 -6.100  53 CG5402 2.35E-09 -2.595 
4 CG3690 1.56E-34 -3.058  54 CG11158 2.39E-09 -1.715 
5 asRNA:CR45822 2.74E-33 -6.185  55 LysD 2.67E-09 -3.270 
6 Obp99d 3.10E-29 -4.099  56 CG6163 3.65E-09 -2.745 
7 lncRNA:CR43459 1.26E-28 -2.648  57 nop5 3.71E-09 -0.621 
8 CG14406 5.40E-26 -7.290  58 Prx2540-1 4.52E-09 -2.972 
9 w 2.11E-23 -3.522  59 ChLD3 6.11E-09 -3.634 
10 Grik 1.61E-20 -4.347  60 CG3902 6.34E-09 -1.478 
11 CG11319 2.47E-20 -1.989  61 CG8199 7.91E-09 -1.402 
12 asRNA:CR45835 5.63E-20 -4.483  62 Mccc1 8.51E-09 -1.212 
13 CG42807 1.52E-19 -2.085  63 Art8 1.26E-08 -1.126 
14 Nop17l 1.93E-18 -1.298  64 Hmgcl 1.32E-08 -1.529 
15 CG1494 9.66E-18 -2.954  65 MFS14 1.56E-08 -1.293 
16 CG11236 3.13E-16 -2.247  66 SelR 1.75E-08 -1.329 
17 aay 9.52E-16 -0.989  67 Pus1 1.90E-08 -1.473 
18 CG6296 1.22E-15 -2.567  68 Mtr3 1.95E-08 -1.023 
19 Oseg4 2.61E-15 -2.348  69 CG6733 2.02E-08 -2.335 
20 CG5961 3.46E-15 -1.634  70 CG16727 2.16E-08 -2.120 
21 CG1304 8.80E-15 -5.127  71 CG8745 2.18E-08 -2.263 
22 Lk 2.17E-14 -3.824  72 Capa 3.52E-08 -2.696 
23 CG13907 1.04E-13 -1.355  73 CG3348 3.92E-08 -3.819 
24 CG10407 1.20E-13 -2.002  74 ValRS 4.07E-08 -1.056 
25 dpr21 2.42E-13 -1.929  75 Btnd 4.15E-08 -2.135 
26 CG3270 5.38E-13 -2.929  76 CG11779 4.34E-08 -1.016 
27 Gpb5 1.03E-12 -2.951  77 Spn77Bc 4.46E-08 -3.129 
28 CG33337 1.16E-12 -3.140  78 CG4783 4.75E-08 -7.799 
29 CG34195 1.93E-12 -1.825  79 yellow-d2 4.75E-08 -4.118 
30 Pfas 2.39E-12 -1.323  80 lncRNA:roX2 4.78E-08 -1.778 
31 CG5599 3.17E-12 -1.439  81 CG9799 5.61E-08 -1.217 
32 Mal-A8 1.01E-11 -2.453  82 l(1)G0020 5.71E-08 -1.247 
33 NaPi-T 1.66E-11 -2.419  83 CG34005 6.25E-08 -3.520 
34 asRNA:CR44029 2.30E-11 -2.653  84 Syt12 6.29E-08 -1.334 
35 CG2765 2.51E-11 -0.816  85 blp 6.45E-08 -1.008 
36 Mccc2 3.01E-11 -1.661  86 ZnT77C 1.00E-07 -1.305 
37 CG12896 4.98E-11 -3.256  87 firl 1.29E-07 -1.871 
38 CG10474 6.47E-11 -4.491  88 AdSL 1.29E-07 -1.038 
39 U3-55K 7.40E-11 -1.392  89 lncRNA:CR31781 1.30E-07 -1.514 
40 CG6638 8.52E-11 -1.405  90 CG17219 1.30E-07 -1.220 
41 CG11000 9.32E-11 -1.439  91 lncRNA:CR45223 1.38E-07 -1.879 
42 lncRNA:CR44754 1.07E-10 -2.466  92 Mys45A 1.38E-07 -0.913 
43 CAH2 1.58E-10 -1.316  93 NijC 1.48E-07 -1.580 
44 CG18327 2.32E-10 -2.265  94 CG6712 1.51E-07 -1.003 
45 Obp56b 3.18E-10 -2.820  95 CG33124 1.59E-07 -1.982 
46 CG10932 3.96E-10 -1.807  96 Ugt35B1 1.71E-07 -1.831 
47 l(2)09851 7.80E-10 -0.992  97 ATP7 1.93E-07 -0.876 
48 CG8064 8.34E-10 -1.330  98 PH4alphaMP 2.16E-07 -1.976 
49 Cpr64Ac 1.07E-09 -6.785  99 NHP2 2.17E-07 -0.968 
50 CG31157 1.07E-09 -3.214  100 CG9281 2.44E-07 -0.821 
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Supplementary Table 2.13: Top 100 downregulated genes with the lowest padj values 
(T22) 
 
Rank Gene Symbol padj value 
log2 





1 mthl8 5.83E-55 -7.742  51 Muc91C 3.09E-14 -6.742 
2 CG3819 3.37E-37 -5.676  52 CG13606 3.09E-14 -2.376 
3 Grik 4.63E-34 -5.493  53 Dyrk2 3.09E-14 -1.271 
4 CG14406 4.17E-31 -8.008  54 CG34437 4.82E-14 -3.220 
5 CG9360 8.11E-31 -5.666  55 TwdlC 5.04E-14 -6.512 
6 CG10407 1.08E-29 -2.884  56 Cpr65Ea 5.04E-14 -4.352 
7 firl 3.35E-29 -3.741  57 Cpr35B 5.04E-14 -3.000 
8 lncRNA:CR43459 2.46E-28 -2.626  58 Lk 7.89E-14 -3.869 
9 CG33337 1.19E-27 -4.905  59 Cul2 1.07E-13 -2.179 
10 Hsc70-2 1.98E-27 -2.979  60 CG12164 1.09E-13 -4.740 
11 Obp99d 2.89E-27 -4.292  61 Mfap1 1.20E-13 -1.669 
12 GstE1 6.56E-26 -3.279  62 CG13063 1.74E-13 -4.915 
13 Keap1 2.60E-24 -1.539  63 CG15731 2.04E-13 -7.146 
14 CG30091 7.34E-23 -4.497  64 CG13403 2.35E-13 -2.691 
15 CG14186 3.46E-22 -3.301  65 dyl 2.99E-13 -6.455 
16 Cpr51A 5.12E-21 -3.889  66 CG2962 3.79E-13 -6.592 
17 w 5.12E-21 -3.251  67 CG1494 3.98E-13 -2.425 
18 ZnT77C 1.68E-20 -2.124  68 Trh 3.98E-13 -2.079 
19 asRNA:CR44179 6.32E-20 -2.722  69 CG3690 5.52E-13 -1.850 
20 CG6296 1.99E-18 -2.768  70 Nop17l 6.20E-13 -1.076 
21 Ect3 2.86E-18 -2.468  71 CG13699 6.28E-13 -5.671 
22 CG9733 6.47E-18 -4.916  72 ple 6.53E-13 -3.207 
23 NLaz 7.56E-18 -3.322  73 CG7300 9.45E-13 -3.176 
24 asRNA:CR45835 1.12E-17 -5.173  74 Ugt317A1 1.53E-12 -2.552 
25 CG2150 1.53E-17 -5.286  75 Ccp84Ac 1.78E-12 -6.208 
26 Oseg4 2.91E-17 -2.492  76 e 1.78E-12 -2.260 
27 Obp99a 6.23E-17 -3.364  77 CG31810 2.22E-12 -2.422 
28 Cpr64Ac 7.18E-17 -9.004  78 Lcp3 2.86E-12 -7.147 
29 Phk-3 7.18E-17 -2.600  79 sage 3.13E-12 -2.121 
30 Sb 1.08E-16 -4.441  80 CG12519 3.59E-12 -5.190 
31 CG42807 1.11E-16 -1.926  81 slbo 3.90E-12 -4.542 
32 CG13159 1.20E-16 -5.140  82 CG14147 4.62E-12 -6.470 
33 CG5402 1.72E-16 -3.529  83 CG43386 4.92E-12 -2.543 
34 CG30026 3.61E-16 -2.349  84 Ilp8 5.47E-12 -5.078 
35 TwdlX 4.24E-16 -2.194  85 CG31157 6.89E-12 -3.404 
36 CG43204 5.57E-16 -3.724  86 CG31775 7.50E-12 -2.018 
37 lncRNA:CR44754 5.57E-16 -3.252  87 Cpr64Ab 8.12E-12 -6.970 
38 CG7406 6.89E-16 -6.665  88 CG15022 1.00E-11 -4.479 
39 CG11413 6.89E-16 -3.276  89 CG42586 1.17E-11 -1.994 
40 CG31869 1.17E-15 -2.465  90 CG7432 1.20E-11 -4.515 
41 scaf 1.51E-15 -2.465  91 Spn100A 2.05E-11 -2.857 
42 asRNA:CR45822 2.21E-15 -8.055  92 CG12964 2.33E-11 -3.154 
43 lncRNA:CR42646 3.25E-15 -4.595  93 CG34115 3.44E-11 -4.948 
44 CG14567 6.56E-15 -4.585  94 CG14257 4.50E-11 -4.326 
45 ChLD3 6.68E-15 -4.835  95 CG43181 4.73E-11 -5.208 
46 CG14961 8.08E-15 -3.266  96 CG11147 5.46E-11 -2.366 
47 Gadd45 8.91E-15 -3.039  97 CG33494 5.69E-11 -2.064 
48 CG7724 1.79E-14 -2.068  98 cysu 6.38E-11 -2.988 
49 asRNA:CR45140 1.96E-14 -3.224  99 dsb 7.22E-11 -2.965 
50 ThrRS 2.32E-14 -0.917  100 CG16772 7.83E-11 -4.439 
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Supplementary Table 2.14: Top 100 downregulated genes with the lowest padj values 
(T23) 
 
Rank Gene Symbol padj value 
log2 





1 mthl8 1.31E-71 -6.680  51 CG14186 5.89E-14 -2.586 
2 CG3819 4.20E-36 -5.567  52 CG17672 6.37E-14 -4.208 
3 lncRNA:CR43459 5.25E-35 -2.928  53 Cyp4p1 8.79E-14 -3.065 
4 CG10407 1.44E-34 -3.113  54 CG12769 1.42E-13 -2.550 
5 Hsc70-2 2.69E-34 -3.593  55 Dyrk2 1.45E-13 -1.241 
6 Keap1 4.03E-32 -1.771  56 Vajk4 2.13E-13 -6.242 
7 Grik 8.11E-31 -5.199  57 DIP-lambda 2.19E-13 -1.811 
8 firl 2.83E-30 -3.748  58 Ugt317A1 2.25E-13 -2.652 
9 ZnT77C 1.35E-29 -2.550  59 slbo 2.25E-13 -4.825 
10 CG14406 4.89E-27 -8.159  60 CG2150 2.25E-13 -4.554 
11 CG1494 2.56E-26 -3.638  61 CG9733 2.25E-13 -4.027 
12 Obp99d 6.07E-25 -3.966  62 CG33346 2.50E-13 -4.160 
13 GstE1 9.67E-23 -3.079  63 CG33468 2.54E-13 -5.060 
14 CG6296 1.50E-21 -2.984  64 CG5402 2.54E-13 -3.017 
15 Cpr51A 1.54E-21 -3.989  65 CG34038 2.67E-13 -3.197 
16 Phk-3 2.25E-21 -2.926  66 PPP1R15 2.96E-13 -0.963 
17 Cpr65Ea 5.55E-21 -5.436  67 CG13699 3.71E-13 -5.877 
18 asRNA:CR45140 2.17E-20 -3.898  68 CG13659 3.71E-13 -2.983 
19 CG30091 1.99E-19 -4.036  69 asRNA:CR44029 4.51E-13 -2.822 
20 CG33337 1.99E-19 -3.979  70 CG4702 7.29E-13 -4.080 
21 Ect3 1.29E-18 -2.490  71 CG13813 7.38E-13 -5.568 
22 CG31869 1.36E-18 -2.690  72 Cad88C 7.39E-13 -2.806 
23 ThrRS 1.37E-18 -1.046  73 CG33993 8.42E-13 -4.254 
24 CG7724 1.40E-18 -2.352  74 CG11147 8.52E-13 -2.565 
25 CG9360 5.03E-18 -4.303  75 Eip74EF 1.14E-12 -2.907 
26 asRNA:CR45835 1.07E-17 -3.737  76 Ccp84Ac 1.43E-12 -6.313 
27 CG13159 1.30E-17 -5.306  77 Ugt37C2 1.55E-12 -2.025 
28 Cyp6a23 1.30E-17 -2.424  78 CG15731 2.16E-12 -6.830 
29 Cul2 1.76E-17 -2.471  79 CG8027 2.40E-12 -2.017 
30 CG42807 5.11E-17 -1.941  80 CG14147 2.45E-12 -6.917 
31 CG30026 8.86E-17 -2.325  81 Vajk1 2.48E-12 -5.076 
32 e 1.27E-16 -2.627  82 CG7300 2.62E-12 -3.114 
33 Spn100A 1.39E-16 -3.582  83 Cpr35B 2.62E-12 -2.818 
34 lncRNA:CR42646 1.76E-16 -4.892  84 Ugt36E1 3.33E-12 -2.286 
35 asRNA:CR44179 2.77E-16 -2.376  85 CG33494 3.37E-12 -2.170 
36 CG43204 5.00E-16 -3.667  86 b 3.80E-12 -4.112 
37 CG12164 6.25E-16 -5.214  87 NLaz 4.03E-12 -2.704 
38 CG31810 6.25E-16 -2.786  88 CG11319 4.85E-12 -1.514 
39 cysu 7.91E-16 -3.746  89 CG42272 5.21E-12 -2.356 
40 ckd 1.34E-15 -2.190  90 GatB 5.33E-12 -1.606 
41 Sb 1.77E-15 -4.290  91 Gadd45 6.04E-12 -2.713 
42 w 1.93E-15 -2.735  92 dsb 1.15E-11 -3.105 
43 CG15022 3.53E-15 -5.273  93 Obp99a 1.16E-11 -2.768 
44 Spn43Aa 3.90E-15 -5.054  94 CG12519 1.25E-11 -5.090 
45 scaf 3.90E-15 -2.431  95 Cpr64Ac 1.29E-11 -7.399 
46 CG7227 4.62E-15 -2.900  96 CG2962 1.59E-11 -6.132 
47 CG43386 1.88E-14 -2.832  97 CG34437 1.91E-11 -2.628 
48 asRNA:CR45822 2.97E-14 -7.730  98 CG34115 2.55E-11 -5.302 
49 Trh 5.01E-14 -2.143  99 lncRNA:CR43144 3.16E-11 -3.932 
50 CG4783 5.89E-14 -6.475  100 Gpb5 3.40E-11 -2.368 
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Supplementary Table 3.1: Top 100 upregulated genes with the lowest padj values (T10) 
 
Rank Gene Symbol padj value 
log2 





1 CG5687 9.66E-50 4.917  51 CG3520 1.22E-07 1.598 
2 Drsl5 2.46E-31 10.500  52 Tsp42Eb 1.38E-07 2.173 
3 CG31098 1.11E-24 2.392  53 RpS19b 1.49E-07 1.980 
4 CG42822 2.92E-21 4.245  54 CR42530 1.75E-07 2.566 
5 CG31288 5.32E-17 3.671  55 Cyp28d1 1.80E-07 2.280 
6 CG18547 2.17E-15 1.632  56 CG7714 2.17E-07 3.091 
7 CG10445 2.20E-15 3.352  57 CG3165 3.02E-07 1.470 
8 TyrR 1.03E-14 2.293  58 CG15369 4.23E-07 3.702 
9 AOX1 4.99E-14 1.831  59 Mocs1 4.62E-07 1.638 
10 GILT2 6.37E-14 1.162  60 CG14400 4.67E-07 5.894 
11 lncRNA:CR44536 6.70E-14 9.477  61 TwdlH 4.71E-07 3.212 
12 CG2064 2.55E-13 2.279  62 CG34267 5.20E-07 4.699 
13 asRNA:CR44960 5.21E-13 4.839  63 CG3635 5.47E-07 1.956 
14 prom 6.75E-13 6.116  64 CG12766 7.18E-07 2.591 
15 CR43105 8.83E-13 6.337  65 CG14196 7.20E-07 2.039 
16 CG13033 1.12E-12 3.921  66 Odc1 7.38E-07 2.992 
17 CG30059 1.13E-12 3.166  67 CG9521 9.59E-07 4.689 
18 CG12493 3.38E-12 3.152  68 CG15023 9.80E-07 4.266 
19 CG18278 4.13E-12 3.007  69 CG34166 1.04E-06 2.223 
20 Est-6 8.31E-12 3.376  70 SP1029 1.05E-06 0.839 
21 CG15515 3.98E-11 4.901  71 Idgf1 1.05E-06 2.818 
22 narya 4.45E-11 6.225  72 sni 1.06E-06 0.916 
23 Ptp52F 1.08E-10 2.283  73 CG31706 1.07E-06 3.856 
24 CG1358 2.86E-10 2.062  74 CG6933 1.09E-06 2.721 
25 Cyp4e3 4.24E-10 3.486  75 Ku80 1.37E-06 1.801 
26 List 5.36E-10 2.495  76 Cyp9b2 1.57E-06 1.726 
27 CG10353 8.25E-10 1.482  77 CG13323 1.63E-06 3.068 
28 CG7912 8.32E-10 2.305  78 CG32335 1.68E-06 1.695 
29 sit 1.03E-09 4.314  79 CG43373 1.93E-06 1.739 
30 CG9449 3.66E-09 2.472  80 CG4563 2.01E-06 4.246 
31 TM4SF 4.69E-09 2.232  81 Muc26B 2.08E-06 3.058 
32 mthl3 5.10E-09 2.550  82 NijA 2.26E-06 2.240 
33 CG14302 5.38E-09 4.001  83 CG5023 2.41E-06 2.887 
34 CG31606 9.26E-09 7.636  84 CG4730 2.51E-06 1.888 
35 Cyp12d1-d 9.41E-09 2.588  85 CG7248 2.66E-06 3.148 
36 CG5039 1.19E-08 1.911  86 lncRNA:CR44662 2.81E-06 2.454 
37 CG32237 1.67E-08 5.165  87 CG7465 2.94E-06 4.335 
38 agt 1.74E-08 2.217  88 CG43896 3.12E-06 3.013 
39 CR43697 1.91E-08 2.148  89 CG33272 3.37E-06 4.808 
40 ms(3)76Ba 2.21E-08 7.790  90 CG5704 3.42E-06 1.797 
41 Bace 3.24E-08 3.283  91 lncRNA:CR44150 3.56E-06 2.905 
42 CG10953 3.47E-08 4.627  92 CG42319 3.65E-06 1.593 
43 CR43186 4.07E-08 4.124  93 l(2)03659 3.74E-06 1.496 
44 CG3270 4.25E-08 2.431  94 DNApol-zeta 3.75E-06 1.307 
45 asRNA:CR45171 5.30E-08 3.316  95 Lcp65Ac 3.83E-06 3.967 
46 CanA1 5.32E-08 4.174  96 CG14565 4.40E-06 4.859 
47 TwdlP 7.00E-08 4.517  97 CG14445 4.74E-06 3.142 
48 CG14275 7.12E-08 1.948  98 CG4982 4.75E-06 3.501 
49 lncRNA:CR45039 7.89E-08 3.081  99 CG34005 5.65E-06 4.200 
50 CG10031 9.47E-08 3.117  100 CG5084 6.13E-06 3.302 
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Supplementary Table 3.2: Top 100 upregulated genes with the lowest padj values (T11) 
 
Rank Gene Symbol padj value 
log2 





1 CG5687 7.85E-68 5.880  51 Cyp9b2 2.48E-11 2.473 
2 CG18547 2.19E-41 2.660  52 CG3165 2.56E-11 1.850 
3 CG31098 3.50E-31 2.715  53 obe 2.82E-11 1.388 
4 CG42822 3.14E-30 4.829  54 narya 2.82E-11 6.692 
5 CG31288 7.26E-28 5.053  55 mthl3 3.78E-11 2.854 
6 Drsl5 8.81E-28 9.519  56 CG33281 5.83E-11 2.717 
7 lncRNA:CR44536 1.29E-27 8.828  57 CG15098 9.43E-11 2.489 
8 AOX1 2.30E-25 2.477  58 slif 1.10E-10 2.088 
9 CG2064 2.31E-23 3.021  59 Cyp6a13 1.42E-10 1.755 
10 CG1358 8.40E-23 3.211  60 CG10638 1.79E-10 1.634 
11 Mocs1 5.78E-22 2.919  61 CG10657 2.30E-10 2.274 
12 agt 1.66E-21 3.768  62 Picot 2.67E-10 2.223 
13 CG3448 3.27E-18 2.509  63 Fancl 2.92E-10 2.103 
14 sni 1.43E-17 1.552  64 CG14196 3.89E-10 2.481 
15 frm 1.81E-17 2.653  65 Prp31 5.01E-10 1.345 
16 CG42319 2.34E-17 2.770  66 ftz-f1 5.10E-10 2.237 
17 rad50 2.77E-17 2.656  67 CG18278 5.80E-10 2.712 
18 CG10445 3.47E-16 3.415  68 CG11073 6.11E-10 2.209 
19 CG12766 8.83E-16 5.035  69 CG15649 6.56E-10 3.383 
20 CG7054 2.01E-15 2.356  70 CG3397 7.14E-10 2.452 
21 CR43105 2.54E-15 7.038  71 CG30059 7.15E-10 2.726 
22 TwdlG 3.03E-15 3.168  72 CG12493 7.52E-10 2.927 
23 CG32694 3.67E-15 2.826  73 CG3008 8.35E-10 1.169 
24 CG12224 5.71E-15 2.895  74 CG7179 1.04E-09 1.826 
25 CG14907 9.34E-15 2.034  75 Cpr56F 1.27E-09 2.588 
26 bnk 3.74E-14 2.096  76 CG7080 1.65E-09 3.572 
27 Ku80 3.88E-14 2.689  77 TM4SF 1.70E-09 2.321 
28 DNApol-zeta 4.19E-14 2.031  78 Ptp52F 2.19E-09 2.268 
29 LManV 5.18E-14 3.654  79 List 2.22E-09 2.323 
30 Rev7 7.28E-14 2.430  80 CG31102 2.31E-09 2.078 
31 ms(3)76Ba 7.35E-14 7.292  81 Dh44-R2 3.52E-09 1.535 
32 SP1029 1.71E-13 1.205  82 CG3635 5.18E-09 2.246 
33 TyrR 1.77E-13 2.226  83 CG6293 5.25E-09 2.701 
34 Cyp12d1-d 3.89E-13 3.904  84 RpA-70 5.31E-09 2.051 
35 asRNA:CR45171 3.89E-13 4.756  85 Proc-R 5.50E-09 2.043 
36 CG17904 4.76E-13 1.113  86 CG5697 8.85E-09 3.552 
37 zye 4.76E-13 2.981  87 Arc2 8.90E-09 1.972 
38 Mco1 7.51E-13 2.717  88 Tb 1.22E-08 4.419 
39 Cpr62Bb 7.70E-13 3.001  89 Est-6 1.31E-08 2.962 
40 drd 9.18E-13 2.507  90 CG5568 1.42E-08 3.802 
41 CG31633 1.23E-12 1.339  91 sit 1.44E-08 4.032 
42 Irbp 1.78E-12 2.497  92 CR43186 1.69E-08 5.856 
43 CG2909 2.01E-12 2.586  93 lncRNA:CR45039 1.81E-08 3.279 
44 asRNA:CR44960 3.79E-12 4.823  94 CR42530 1.93E-08 2.744 
45 CG3520 4.25E-12 2.075  95 CG13285 2.12E-08 1.994 
46 Cyp12d1-p 8.43E-12 3.879  96 CG10031 2.27E-08 3.291 
47 CG5704 1.22E-11 2.528  97 Bace 2.44E-08 3.285 
48 CG30427 1.23E-11 2.196  98 CG4267 3.36E-08 2.819 
49 CG14695 1.47E-11 3.443  99 Mur29B 3.70E-08 2.209 
50 CG4847 2.46E-11 2.434  100 CG31606 3.86E-08 7.300 
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Supplementary Table 3.3: Top 100 upregulated genes with the lowest padj values (T12) 
 
Rank Gene Symbol padj value 
log2 





1 CG5687 4.05E-41 4.426  51 Tb 8.51E-11 5.841 
2 CG18547 9.63E-24 2.023  52 Irbp 8.68E-11 2.309 
3 sni 2.31E-23 1.788  53 CG32694 1.15E-10 2.371 
4 CG10445 2.29E-22 4.210  54 TwdlB 1.37E-10 5.091 
5 CG18278 5.76E-21 4.132  55 Irk1 1.68E-10 1.222 
6 CG42822 1.42E-20 3.666  56 CG6180 2.74E-10 1.841 
7 Cpr56F 5.34E-20 3.928  57 CG3397 3.01E-10 2.507 
8 CG31098 8.04E-19 2.104  58 CG2841 3.31E-10 1.372 
9 CG2064 8.04E-19 2.740  59 Cpr62Bb 4.15E-10 2.678 
10 Mco1 8.04E-19 3.890  60 Cyp12d1-p 4.39E-10 3.501 
11 CG30059 3.97E-17 3.716  61 Top3alpha 4.42E-10 1.987 
12 Fancl 8.93E-17 2.643  62 CG5704 4.61E-10 2.319 
13 AOX1 1.00E-16 2.024  63 Cht6 5.00E-10 1.898 
14 Picot 2.47E-16 2.825  64 CG8563 5.07E-10 3.481 
15 CG31288 3.91E-16 3.622  65 EbpIII 5.73E-10 2.121 
16 lncRNA:CR44536 1.15E-15 8.399  66 SCAP 5.99E-10 1.626 
17 mthl3 1.19E-15 3.651  67 EAChm 7.47E-10 4.231 
18 CR43105 1.32E-15 5.917  68 CG34461 7.52E-10 3.764 
19 CG11584 4.88E-15 5.627  69 SLO2 7.73E-10 1.803 
20 slif 5.18E-15 2.461  70 Vajk1 8.12E-10 4.434 
21 rad50 1.03E-14 2.459  71 TwdlL 8.13E-10 4.604 
22 aralar1 1.31E-14 1.781  72 LManV 9.31E-10 3.534 
23 Cpr67Fa1 1.47E-14 5.803  73 Axs 9.80E-10 1.884 
24 CG1358 2.19E-14 2.409  74 Ipk2 1.02E-09 1.883 
25 CG4730 2.28E-14 2.963  75 CG7080 1.09E-09 3.602 
26 CG4842 2.32E-14 2.960  76 Cpr62Bc 1.12E-09 4.472 
27 tut 3.75E-14 3.947  77 Prip 1.43E-09 2.541 
28 CG3165 5.22E-14 2.070  78 Jafrac1 1.82E-09 2.845 
29 Tsp74F 5.96E-14 1.855  79 RpA-70 2.37E-09 2.089 
30 CG6293 3.53E-13 3.253  80 CG30427 2.44E-09 1.965 
31 narya 4.96E-13 7.707  81 CG10638 2.77E-09 1.536 
32 Drsl5 5.01E-13 10.137  82 CG3520 2.77E-09 1.750 
33 zye 2.86E-12 2.936  83 olf186-M 2.87E-09 2.267 
34 CG15820 4.13E-12 6.035  84 CG15212 2.93E-09 5.710 
35 Cyp12d1-d 4.60E-12 3.521  85 TwdlW 3.21E-09 2.745 
36 CG4267 4.69E-12 3.383  86 CG9896 5.33E-09 1.919 
37 DNApol-zeta 9.04E-12 1.852  87 Rev7 6.09E-09 1.901 
38 CG13046 1.23E-11 3.383  88 CG17904 6.13E-09 0.922 
39 CG31626 1.23E-11 4.622  89 CG15279 6.25E-09 2.171 
40 CG12766 1.69E-11 3.716  90 CG15213 6.36E-09 4.481 
41 Ku80 1.75E-11 2.436  91 CG3552 6.63E-09 1.440 
42 asRNA:CR45171 1.96E-11 3.960  92 asRNA:CR44960 8.13E-09 4.851 
43 Calx 2.64E-11 1.485  93 TwdlG 8.69E-09 2.370 
44 Gk2 2.64E-11 2.020  94 agt 9.12E-09 2.217 
45 ms(3)76Ba 2.93E-11 8.744  95 CG7601 9.67E-09 1.311 
46 Spn88Ea 3.56E-11 1.449  96 Ssrp 1.15E-08 1.552 
47 prom 3.79E-11 4.396  97 Dip-B 1.22E-08 1.074 
48 CG14882 3.88E-11 1.478  98 bgm 1.23E-08 1.245 
49 CG15649 4.05E-11 4.628  99 CR43186 1.28E-08 5.068 
50 CG17292 6.97E-11 1.337  100 Cpr67Fa2 1.60E-08 5.020 
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Supplementary Table 3.4: Top 100 upregulated genes with the lowest padj values (T13) 
 
Rank Gene Symbol padj value 
log2 





1 CG5687 1.15E-50 4.729  51 CR43697 7.79E-09 2.172 
2 CG18547 1.86E-44 2.744  52 CG8541 8.11E-09 3.409 
3 CG42822 3.46E-39 5.615  53 TwdlH 8.94E-09 2.687 
4 CG2064 3.39E-29 3.390  54 CG14569 8.99E-09 5.362 
5 lncRNA:CR44536 1.06E-24 9.243  55 Cyp6w1 1.34E-08 2.553 
6 Drsl5 2.64E-23 10.139  56 CR43696 1.68E-08 3.332 
7 CG2233 3.10E-21 3.974  57 CR42530 1.70E-08 2.785 
8 CG31288 3.30E-17 3.175  58 CG4259 2.75E-08 2.579 
9 CG12766 6.00E-17 4.156  59 CG14907 3.63E-08 1.524 
10 CR43105 1.07E-16 5.807  60 FucTC 3.95E-08 2.204 
11 ppk 1.11E-16 3.968  61 Ugt302E1 4.39E-08 3.723 
12 CG3165 3.35E-16 2.241  62 Cyp28d1 4.59E-08 2.421 
13 CG31098 5.39E-15 1.838  63 CG7054 5.55E-08 1.663 
14 mthl3 1.17E-14 3.270  64 CG5612 5.67E-08 2.476 
15 Cyp6a13 1.19E-14 1.792  65 DNApol-zeta 5.82E-08 1.541 
16 asRNA:CR44030 3.89E-14 3.241  66 CG12825 6.51E-08 1.783 
17 CG8369 1.57E-13 3.714  67 Cpr78Cb 7.28E-08 2.532 
18 Odc1 2.03E-13 3.518  68 CG32237 7.83E-08 5.015 
19 AOX1 7.32E-13 1.756  69 lncRNA:CR45388 8.01E-08 3.397 
20 CG3397 1.28E-12 2.707  70 CG13614 9.39E-08 2.865 
21 ms(3)76Ba 2.07E-12 7.908  71 CG14695 1.08E-07 2.749 
22 asRNA:CR45171 2.22E-12 4.212  72 CG31633 1.14E-07 1.051 
23 CG31706 3.08E-12 5.484  73 agt 1.23E-07 2.104 
24 SCAP 6.72E-12 1.806  74 Hml 1.23E-07 3.233 
25 CG15515 6.72E-12 5.110  75 Lst 1.57E-07 2.258 
26 CG18278 8.53E-12 3.139  76 TwdlP 1.85E-07 4.424 
27 Prp31 9.62E-12 1.479  77 CG13618 2.07E-07 2.981 
28 CG17904 1.83E-11 1.060  78 lncRNA:CR43496 2.21E-07 1.731 
29 CG13694 2.00E-11 2.871  79 CG14302 2.58E-07 3.077 
30 CG4730 2.38E-11 2.634  80 CG34334 2.85E-07 4.414 
31 CR43186 2.98E-11 4.486  81 CG10445 3.09E-07 2.280 
32 Ku80 4.39E-11 2.411  82 CG6654 3.43E-07 1.159 
33 asRNA:CR44960 5.46E-11 4.637  83 CG31832 3.65E-07 7.003 
34 CG9521 6.18E-11 6.192  84 CG43799 4.32E-07 1.867 
35 sni 6.58E-11 1.200  85 CG4982 4.49E-07 3.868 
36 CG2909 6.62E-11 2.459  86 CG34267 4.75E-07 4.770 
37 CG10799 1.07E-10 3.061  87 CG3635 6.25E-07 1.895 
38 CG10638 1.60E-10 1.657  88 Cpr76Bb 8.20E-07 5.030 
39 narya 1.68E-10 6.528  89 Spn88Ea 8.73E-07 1.127 
40 Rev7 2.17E-10 2.061  90 CG11318 8.98E-07 2.168 
41 ZnT35C 2.30E-10 1.675  91 CG33310 1.04E-06 2.656 
42 Bin1 7.42E-10 1.685  92 SP1029 1.27E-06 0.848 
43 CG30059 1.02E-09 2.865  93 lncRNA:CR44092 1.63E-06 2.632 
44 CG31606 1.71E-09 4.812  94 CG33281 1.70E-06 1.879 
45 Bace 1.83E-09 3.289  95 CR45470 1.73E-06 3.281 
46 CG7465 2.24E-09 5.482  96 CG12480 1.79E-06 4.099 
47 lncRNA:CR45039 2.28E-09 3.693  97 rad50 1.92E-06 1.623 
48 Cpr11A 3.56E-09 2.389  98 CG10353 1.99E-06 1.206 
49 prom 4.07E-09 3.574  99 CG8736 3.49E-06 3.528 
50 LManV 6.15E-09 2.546  100 Edg78E 3.54E-06 2.767 
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Supplementary Table 3.5: Top 100 upregulated genes with the lowest padj values (T14) 
 
Rank Gene Symbol padj value 
log2 





1 CG42822 4.80E-34 5.095  51 CR43696 3.56E-09 2.695 
2 CG18547 2.50E-27 2.148  52 CG10638 4.18E-09 1.528 
3 CG2233 8.04E-25 4.013  53 CG32104 4.59E-09 1.344 
4 ppk 8.04E-25 4.474  54 CG9877 4.96E-09 5.226 
5 lncRNA:CR44536 7.13E-24 9.017  55 CG7290 5.21E-09 4.941 
6 CG10445 3.36E-22 4.368  56 CG31098 5.31E-09 1.399 
7 CG31706 1.50E-21 4.424  57 CG11659 7.49E-09 3.525 
8 CG2064 5.51E-21 2.877  58 Cyp12a4 7.49E-09 3.656 
9 CG3165 5.59E-21 2.538  59 CG34334 1.21E-08 4.785 
10 CG8541 6.63E-20 3.854  60 CG31288 1.35E-08 2.069 
11 CG14014 2.68E-19 3.088  61 LManVI 1.37E-08 4.023 
12 DNApol-zeta 1.10E-18 2.379  62 CG7953 1.45E-08 4.423 
13 CG18278 1.42E-17 3.779  63 CR45470 1.47E-08 3.458 
14 CG30059 4.36E-17 3.814  64 lncRNA:CR45039 1.58E-08 3.517 
15 CG13694 8.41E-15 2.859  65 Ku80 1.64E-08 2.091 
16 CG5687 1.73E-14 2.450  66 CG12825 1.98E-08 1.805 
17 mthl3 1.73E-14 3.116  67 Cyp28d1 2.25E-08 2.399 
18 CG4730 6.19E-14 2.894  68 CR43186 3.49E-08 3.516 
19 Odc1 7.64E-14 3.151  69 asRNA:CR44960 3.50E-08 3.850 
20 CG3397 1.15E-13 2.845  70 Lip3 4.79E-08 4.267 
21 CR43105 3.42E-13 5.113  71 CG15820 4.79E-08 4.466 
22 asRNA:CR45171 6.69E-13 4.188  72 CG11601 4.81E-08 1.113 
23 Drsl5 6.69E-13 10.097  73 MED28 8.63E-08 1.267 
24 CG4842 1.87E-12 2.560  74 Ugt37A2 1.06E-07 3.650 
25 ms(3)76Ba 2.14E-12 9.278  75 DNApol-eta 1.08E-07 1.817 
26 CG6300 2.34E-12 4.618  76 CG12863 1.15E-07 1.553 
27 Rev7 2.54E-12 2.282  77 CG9682 1.28E-07 4.634 
28 agt 2.54E-12 2.728  78 CG14907 1.42E-07 1.444 
29 Ugt302E1 3.14E-12 3.932  79 Cyp6a13 1.80E-07 1.179 
30 sni 5.07E-12 1.246  80 CG6283 1.90E-07 4.452 
31 Bin1 5.29E-12 1.846  81 Hml 1.92E-07 3.084 
32 SCAP 7.47E-12 1.784  82 Cyp12d1-d 1.94E-07 2.530 
33 tut 7.61E-12 3.504  83 CG5039 2.04E-07 1.898 
34 narya 1.49E-11 6.086  84 CG13658 2.25E-07 2.912 
35 CG7054 2.53E-11 1.961  85 Rh50 2.27E-07 2.169 
36 CG10799 3.02E-11 3.157  86 FucTC 2.52E-07 2.052 
37 asRNA:CR44030 5.35E-11 2.940  87 lncRNA:CR44662 2.59E-07 2.517 
38 CR42530 1.46E-10 3.179  88 CG31832 2.59E-07 7.020 
39 CG6293 1.65E-10 2.898  89 Jon99Fi 2.79E-07 5.545 
40 Cpr11A 3.09E-10 2.485  90 Jon25Bi 2.86E-07 5.151 
41 CG10910 3.27E-10 4.034  91 CG17191 5.10E-07 4.244 
42 CG33301 3.35E-10 5.327  92 CG6910 5.29E-07 3.549 
43 CG12766 3.69E-10 2.856  93 CG14302 5.60E-07 2.636 
44 Irbp 3.92E-10 2.248  94 CG17134 5.66E-07 3.665 
45 CG11318 1.44E-09 2.390  95 CG45207 5.72E-07 4.255 
46 rad50 1.61E-09 1.972  96 CG14882 5.91E-07 1.165 
47 CG6763 1.73E-09 2.571  97 CG3552 5.91E-07 1.276 
48 CG10560 1.86E-09 3.308  98 RpA-70 6.20E-07 1.795 
49 Cpr67B 1.87E-09 3.685  99 Cyp6w1 6.99E-07 2.187 
50 Lst 1.91E-09 2.415  100 CG18180 7.12E-07 6.170 
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Supplementary Table 3.6: Top 100 upregulated genes with the lowest padj values (T15) 
 
Rank Gene Symbol padj value 
log2 





1 CG2233 9.47E-39 4.925  51 CG3397 8.07E-12 2.471 
2 ppk 1.16E-34 5.430  52 Mdr50 9.33E-12 2.801 
3 CG42822 1.47E-33 4.567  53 CR45470 1.09E-11 4.766 
4 CG18547 2.30E-27 2.129  54 asRNA:CR44960 1.11E-11 5.073 
5 CG2064 1.67E-26 3.231  55 Cyp12a4 1.21E-11 4.138 
6 CG11659 3.50E-23 5.851  56 Gbp3 1.59E-11 2.571 
7 CG6300 9.64E-23 6.128  57 Cpr11B 1.73E-11 4.414 
8 CG31706 2.03E-22 3.610  58 CG12825 1.89E-11 2.072 
9 CG12766 1.20E-20 3.981  59 Rev7 2.68E-11 2.144 
10 CG10560 2.64E-20 4.066  60 Cyp6w1 3.14E-11 2.712 
11 CG12643 8.39E-20 2.912  61 lncRNA:CR45039 4.46E-11 4.151 
12 CG8541 8.89E-20 3.389  62 CG9682 4.68E-11 5.290 
13 CG17549 2.82E-19 3.691  63 CG5767 5.55E-11 6.039 
14 Drsl5 6.15E-19 7.234  64 CG9877 8.73E-11 5.528 
15 Bin1 1.02E-18 2.310  65 Cht5 9.46E-11 2.806 
16 CG32241 1.52E-18 6.256  66 DNApol-zeta 1.37E-10 1.779 
17 Ugt302E1 1.14E-17 6.677  67 mthl3 1.71E-10 2.501 
18 CG7299 2.13E-17 4.084  68 CG10562 1.73E-10 2.228 
19 Jon74E 2.23E-17 4.819  69 CG5810 1.73E-10 3.048 
20 CG11413 2.82E-17 3.856  70 bgm 1.90E-10 1.374 
21 SCAP 3.12E-17 2.151  71 CG30047 1.96E-10 3.012 
22 CG11852 2.17E-16 5.811  72 Cyp28d1 2.18E-10 2.648 
23 CG6910 6.89E-16 5.494  73 Cyp4d14 2.24E-10 3.336 
24 CG10799 1.04E-15 3.843  74 CG10912 2.38E-10 2.310 
25 CG40198 1.15E-15 5.176  75 CG3604 2.93E-10 2.208 
26 CG15597 2.11E-15 3.966  76 Cpr49Ad 2.98E-10 6.358 
27 Ugt37A3 2.78E-15 4.220  77 asRNA:CR45206 3.02E-10 5.268 
28 CG11318 9.49E-15 2.774  78 CG14219 3.34E-10 3.794 
29 CG3165 1.06E-14 2.134  79 Crys 3.36E-10 3.687 
30 CG17191 2.84E-14 5.388  80 CG31321 4.15E-10 2.982 
31 asRNA:CR44030 3.28E-14 3.610  81 CG7290 4.93E-10 5.166 
32 Odc1 4.86E-14 2.976  82 CR43696 6.25E-10 2.427 
33 CR43105 4.86E-14 4.164  83 CR43186 6.96E-10 3.212 
34 CR43697 5.87E-14 2.739  84 CG11585 7.97E-10 4.989 
35 sni 5.93E-14 1.337  85 lncRNA:CR44662 8.42E-10 2.800 
36 CG10445 1.13E-13 3.486  86 CG43799 8.90E-10 2.183 
37 CG31103 1.25E-13 3.831  87 CG10559 9.36E-10 2.390 
38 lncRNA:CR44536 1.30E-13 10.088  88 thetaTry 9.66E-10 3.882 
39 CG10513 2.22E-13 3.062  89 CG6271 1.08E-09 5.027 
40 CG33301 2.95E-13 4.895  90 CG34026 1.22E-09 3.458 
41 CG7054 4.13E-13 2.099  91 CG42808 1.29E-09 2.527 
42 CG31104 8.14E-13 4.452  92 l(3)mbn 1.32E-09 5.598 
43 CG10638 1.09E-12 1.804  93 CG14275 1.74E-09 2.093 
44 CG31288 1.09E-12 2.409  94 CG10910 1.88E-09 3.653 
45 Cyp6a13 1.60E-12 1.486  95 CG13694 1.97E-09 2.164 
46 Cpr67B 2.66E-12 4.077  96 CG31272 2.25E-09 1.748 
47 CG17738 4.23E-12 4.400  97 CG30059 3.06E-09 2.885 
48 CG31098 4.33E-12 1.612  98 CG4842 3.38E-09 2.043 
49 CG31778 5.22E-12 2.321  99 asRNA:CR45171 3.56E-09 3.613 
50 yellow-d 7.29E-12 2.886  100 CG4607 3.61E-09 2.440 
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Supplementary Table 3.7: Top 100 upregulated genes with the lowest padj values (T16) 
 
Rank Gene Symbol padj value 
log2 





1 ppk 1.13E-28 5.242  51 Pol32 4.74E-11 2.780 
2 Ugt302E1 2.06E-24 4.851  52 Rad9 5.80E-11 2.405 
3 CG30059 3.96E-22 4.812  53 RpA-70 1.29E-10 2.226 
4 CG3165 6.88E-21 2.550  54 DNApol-alpha60 1.44E-10 2.853 
5 CG18278 7.69E-21 4.226  55 Psf3 1.48E-10 2.188 
6 CG12643 1.45E-20 2.974  56 beta4GalNAcTB 1.77E-10 1.505 
7 Bin1 1.80E-20 2.424  57 Sil1 1.98E-10 1.417 
8 CG6300 4.47E-20 5.660  58 lncRNA:CR42861 1.98E-10 2.103 
9 CG11659 2.06E-19 5.154  59 mdlc 2.30E-10 2.967 
10 CG10445 5.96E-18 3.832  60 CG1890 2.49E-10 1.996 
11 tut 3.26E-17 4.355  61 TORIP 2.84E-10 1.761 
12 CG42822 7.27E-17 3.285  62 CG7601 4.59E-10 1.409 
13 Irbp 4.26E-16 2.855  63 CR45470 4.76E-10 4.156 
14 CG2064 7.59E-16 2.497  64 agt 4.98E-10 2.453 
15 lncRNA:CR44536 3.41E-15 10.068  65 asRNA:CR45171 5.91E-10 3.657 
16 DNApol-zeta 4.03E-15 2.128  66 CG3226 6.23E-10 2.348 
17 Tmem18 1.13E-14 2.318  67 beta4GalT7 6.70E-10 2.101 
18 sni 1.34E-14 1.349  68 rumi 7.61E-10 2.797 
19 asRNA:CR44030 2.37E-14 3.475  69 Nup133 8.20E-10 1.459 
20 Drsl5 2.63E-14 6.305  70 rad50 8.76E-10 1.983 
21 Ssrp 4.77E-14 1.998  71 narya 1.19E-09 7.188 
22 Fen1 5.97E-14 2.349  72 CG3552 1.21E-09 1.508 
23 MED28 7.87E-14 1.747  73 EMC2A 1.21E-09 1.028 
24 CG32104 9.55E-14 1.708  74 thoc6 1.36E-09 2.003 
25 CG32243 1.03E-13 2.615  75 CG14881 1.91E-09 2.299 
26 Nup43 1.57E-13 1.995  76 Vlet 2.06E-09 1.384 
27 Mes4 2.60E-13 2.293  77 DNApol-eta 2.26E-09 1.993 
28 CG12863 3.61E-13 2.076  78 Orc4 2.68E-09 2.070 
29 CG1239 4.95E-13 3.334  79 CG5535 3.06E-09 1.453 
30 CG17977 1.13E-12 1.984  80 CG9344 3.06E-09 1.833 
31 CG7011 1.48E-12 1.273  81 DNAlig1 3.31E-09 2.655 
32 Hira 1.69E-12 1.995  82 slx1 3.32E-09 2.812 
33 JMJD7 2.34E-12 2.335  83 mus201 3.34E-09 1.541 
34 Mat1 4.06E-12 2.213  84 Ugt37A3 3.52E-09 2.829 
35 Rev7 4.66E-12 2.263  85 dare 3.85E-09 1.246 
36 CG2233 4.83E-12 2.534  86 CG3520 4.41E-09 1.737 
37 RnrL 7.15E-12 2.579  87 ms(3)76Ba 4.55E-09 8.148 
38 CG11601 7.85E-12 1.376  88 CG5568 5.04E-09 3.868 
39 Cpsf73 1.17E-11 1.891  89 mei-41 5.63E-09 1.991 
40 SCAP 1.33E-11 1.752  90 APC4 5.89E-09 2.138 
41 Cdc23 1.50E-11 2.487  91 CG14882 6.91E-09 1.285 
42 mtSSB 2.18E-11 1.929  92 CG14230 7.41E-09 1.528 
43 CG31249 2.39E-11 1.561  93 hay 8.38E-09 1.128 
44 CG10638 2.57E-11 1.698  94 Usp5 8.93E-09 1.785 
45 Ku80 2.72E-11 2.423  95 lncRNA:CR45039 9.46E-09 3.638 
46 Phax 3.01E-11 1.449  96 PIG-C 1.01E-08 2.004 
47 bip1 3.03E-11 3.236  97 stet 1.01E-08 3.209 
48 DNApol-delta 4.05E-11 2.935  98 Nmt 1.02E-08 2.324 
49 CG4730 4.20E-11 2.562  99 CG5986 1.15E-08 1.343 
50 CG15443 4.27E-11 1.824  100 Sem1 1.18E-08 1.745 
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Supplementary Table 3.8: Top 100 upregulated genes with the lowest padj values (T17) 
 
Rank Gene Symbol padj value 
log2 





1 ppk 5.47E-32 5.556  51 Cpr49Ad 5.70E-08 3.861 
2 Ugt302E1 4.22E-28 5.547  52 CG31104 5.90E-08 2.468 
3 lncRNA:CR44536 6.66E-25 9.201  53 CG9344 7.22E-08 1.689 
4 CG3165 1.04E-22 2.646  54 Tmem18 8.01E-08 1.615 
5 CG12643 2.92E-20 2.962  55 CG17977 8.87E-08 1.495 
6 CG4730 6.13E-20 3.504  56 CG7694 1.02E-07 1.669 
7 CG10445 7.85E-17 3.799  57 CG18814 1.03E-07 2.311 
8 CG6398 3.92E-16 1.248  58 Phax 1.29E-07 1.167 
9 asRNA:CR44030 5.40E-16 4.041  59 CG15432 1.31E-07 0.979 
10 Bin1 8.20E-16 2.129  60 CG31633 1.35E-07 1.020 
11 CG5316 1.31E-15 1.366  61 CG2921 2.56E-07 0.876 
12 CG30059 4.29E-15 3.389  62 CG5323 2.92E-07 1.234 
13 Drsl5 1.04E-14 6.384  63 CG10638 3.38E-07 1.335 
14 CG18278 1.54E-14 3.271  64 SmE 3.62E-07 1.619 
15 Ugt37A3 1.54E-14 3.575  65 CG11601 3.87E-07 1.031 
16 CG2233 1.77E-14 2.807  66 RhoGEF4 4.06E-07 2.461 
17 CG6300 7.52E-14 4.575  67 CG32243 4.14E-07 1.825 
18 CG11659 8.02E-14 4.223  68 CG15443 4.56E-07 1.419 
19 CG42822 1.53E-13 2.987  69 Qtzl 4.74E-07 1.147 
20 CR43105 2.18E-13 3.501  70 Vlet 4.95E-07 1.171 
21 tut 2.43E-13 3.554  71 CG30496 4.95E-07 1.338 
22 CG3552 5.60E-13 1.791  72 CG3631 4.95E-07 1.208 
23 ms(3)76Ba 7.07E-13 9.471  73 mal 5.28E-07 1.223 
24 narya 2.49E-12 6.259  74 c(3)G 5.49E-07 1.997 
25 CR43697 5.72E-12 2.890  75 l(1)10Bb 7.52E-07 1.335 
26 CG2064 8.03E-12 2.146  76 shv 7.96E-07 0.605 
27 lncRNA:CR45039 1.27E-11 4.894  77 MED11 9.55E-07 1.216 
28 CR42530 2.78E-11 3.251  78 Cyp4e3 9.95E-07 3.213 
29 CR45470 4.08E-11 4.389  79 SCCRO4 1.27E-06 1.583 
30 CG12863 4.93E-11 1.843  80 lncRNA:CR45225 1.41E-06 4.222 
31 asRNA:CR45171 4.95E-11 3.613  81 Sil1 1.87E-06 1.077 
32 CG7011 5.42E-11 1.164  82 CG5039 2.23E-06 1.701 
33 lncRNA:CR42861 9.35E-11 2.120  83 CG7483 2.34E-06 0.982 
34 Cyp28d2 1.34E-10 2.201  84 Usp39 2.66E-06 1.494 
35 Odc2 1.36E-10 3.361  85 Uhg3 2.67E-06 1.225 
36 CR44003 4.27E-10 3.783  86 EMC2A 2.85E-06 0.809 
37 lncRNA:CR43496 7.17E-10 1.969  87 dare 3.04E-06 1.013 
38 CR43186 8.35E-10 2.927  88 TORIP 3.47E-06 1.323 
39 CG17177 1.68E-09 5.234  89 CG6066 3.53E-06 1.684 
40 asRNA:CR44960 3.47E-09 4.933  90 adp 3.68E-06 0.849 
41 slx1 4.17E-09 2.718  91 CG7137 4.09E-06 0.956 
42 CG7601 7.51E-09 1.308  92 CG5882 4.32E-06 2.048 
43 rtet 9.28E-09 1.591  93 CG6910 4.57E-06 3.085 
44 CG5986 1.19E-08 1.345  94 CG17904 4.59E-06 0.750 
45 sni 1.20E-08 1.015  95 spn-F 4.70E-06 1.280 
46 l(3)mbn 1.31E-08 2.858  96 CG9586 4.71E-06 0.952 
47 SCAP 4.62E-08 1.449  97 CG11777 4.88E-06 1.374 
48 CG10560 4.62E-08 1.805  98 mRpS18B 4.91E-06 0.865 
49 Drsl2 5.55E-08 6.253  99 mia 5.63E-06 1.214 
50 Arp6 5.56E-08 0.709  100 CG5704 5.63E-06 1.716 
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Supplementary Table 3.9: Top 100 upregulated genes with the lowest padj values (T18) 
 
Rank Gene Symbol padj value 
log2 





1 Ugt302E1 5.07E-33 5.623  51 Fen1 2.97E-12 2.170 
2 ppk 3.10E-28 4.726  52 CG3397 3.03E-12 2.648 
3 lncRNA:CR44536 8.80E-27 8.700  53 thoc6 3.03E-12 2.278 
4 CG3165 7.64E-22 2.613  54 dgt3 4.18E-12 4.289 
5 Bin1 8.05E-22 2.519  55 Nup43 4.18E-12 1.863 
6 Ssrp 4.89E-20 2.392  56 Pol31 7.14E-12 3.544 
7 CG18278 4.96E-19 4.082  57 CG6654 8.34E-12 1.476 
8 CG30059 1.50E-18 4.064  58 Xpd 8.86E-12 2.677 
9 sni 2.41E-18 1.521  59 grsm 8.88E-12 2.972 
10 Irbp 7.88E-18 3.020  60 slx1 9.68E-12 3.311 
11 MED28 7.88E-18 2.025  61 CG31251 1.06E-11 2.756 
12 CG10445 1.31E-17 3.956  62 Mis12 1.17E-11 3.294 
13 DNApol-zeta 1.64E-17 2.296  63 CG12863 1.25E-11 1.921 
14 beta4GalT7 2.54E-17 2.923  64 CG2064 1.63E-11 2.089 
15 RpA-70 3.94E-17 2.848  65 Nup133 1.63E-11 1.578 
16 Mes4 5.23E-17 2.677  66 asRNA:CR45171 1.91E-11 3.984 
17 CG12643 8.07E-17 2.664  67 CG17266 2.51E-11 2.714 
18 SmD3 8.99E-17 2.503  68 Cdk2 3.05E-11 3.517 
19 Usp5 1.24E-16 2.505  69 RnrS 3.05E-11 2.987 
20 CG9344 1.94E-16 2.587  70 Ssb-c31a 3.05E-11 1.957 
21 CG31249 1.94E-16 1.946  71 tam 3.17E-11 2.081 
22 CG32104 3.03E-16 1.903  72 Mlh1 3.27E-11 2.188 
23 Orc4 1.42E-15 2.747  73 ms(3)76Ba 3.30E-11 8.564 
24 MED16 1.82E-15 2.130  74 dre4 3.51E-11 1.927 
25 Cpsf73 2.10E-15 2.197  75 Drsl5 3.60E-11 5.097 
26 Psf3 3.47E-15 2.682  76 Caf1-105 3.65E-11 4.169 
27 Ugt37A3 5.71E-15 3.563  77 Dsor1 4.78E-11 2.058 
28 JMJD7 1.60E-14 2.548  78 lncRNA:CR45039 6.31E-11 4.609 
29 tut 3.07E-14 3.793  79 CG17470 6.44E-11 4.604 
30 beta4GalNAcTB 3.35E-14 1.762  80 RnrL 6.81E-11 2.436 
31 asRNA:CR44030 5.60E-14 3.375  81 Npl4 1.06E-10 1.718 
32 Cdc23 5.60E-14 2.739  82 Orc2 1.10E-10 3.879 
33 Alg9 5.60E-14 2.677  83 Prp31 1.11E-10 1.388 
34 Mat1 6.39E-14 2.375  84 CR31953 1.14E-10 4.267 
35 RPA2 8.27E-14 3.595  85 DNApol-delta 1.40E-10 2.828 
36 Hira 8.29E-14 2.104  86 CG17977 1.46E-10 1.860 
37 DNApol-alpha60 8.94E-14 3.297  87 dpa 1.49E-10 2.486 
38 Ndc80 1.40E-13 3.805  88 SmD1 1.98E-10 2.822 
39 LSm7 1.99E-13 1.816  89 tos 2.38E-10 4.760 
40 Ku80 2.90E-13 2.655  90 CG8420 2.42E-10 3.216 
41 CG7544 3.15E-13 2.895  91 Exd2 2.45E-10 1.291 
42 DNAlig1 3.57E-13 3.214  92 CG12942 2.57E-10 2.622 
43 mtSSB 3.57E-13 2.078  93 CG10336 2.61E-10 3.971 
44 PCNA 3.82E-13 3.456  94 Sem1 2.64E-10 1.897 
45 Phax 6.23E-13 1.552  95 DNApol-alpha73 2.71E-10 3.583 
46 CG11601 8.38E-13 1.439  96 janA 2.93E-10 1.888 
47 CG31075 1.16E-12 2.309  97 SmF 3.25E-10 2.289 
48 SmE 1.48E-12 2.170  98 CG12321 3.31E-10 1.524 
49 CG4730 1.93E-12 2.730  99 ida 3.45E-10 3.000 
50 Arp6 2.95E-12 0.895  100 Pop2 3.71E-10 1.473 
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Supplementary Table 3.10: Top 100 upregulated genes with the lowest padj values (T19) 
 
Rank Gene Symbol padj value 
log2 





1 ppk 2.38E-26 5.295  51 CG32243 7.71E-10 2.215 
2 Ugt302E1 3.67E-26 7.029  52 Prat2 8.34E-10 2.083 
3 CG12643 1.77E-23 3.204  53 CG5157 1.42E-09 1.727 
4 Bin1 3.12E-23 2.614  54 Grip71 1.44E-09 4.372 
5 lncRNA:CR44536 4.57E-23 8.965  55 Ndc80 1.72E-09 3.227 
6 CG2064 1.10E-19 2.803  56 Surf1 1.86E-09 1.889 
7 CG10638 2.13E-17 2.154  57 CG34166 1.86E-09 2.459 
8 bnk 2.45E-16 2.859  58 beta4GalNAcTB 2.04E-09 1.444 
9 CG10445 2.46E-16 4.214  59 Vlet 2.31E-09 1.420 
10 CG3165 5.02E-16 2.244  60 MED16 2.92E-09 1.649 
11 CG3397 1.07E-15 3.363  61 beta4GalT7 3.08E-09 2.137 
12 Ku80 3.20E-15 2.969  62 Pif1A 3.41E-09 2.635 
13 GstD5 3.71E-15 5.036  63 tam 4.02E-09 1.909 
14 CG14014 3.67E-14 2.166  64 CR45470 4.17E-09 4.173 
15 asRNA:CR44030 9.44E-14 4.200  65 CG5039 4.36E-09 2.317 
16 CG15784 1.08E-13 3.543  66 Drsl2 4.36E-09 6.804 
17 RpA-70 5.03E-13 2.496  67 trsn 4.56E-09 1.857 
18 CG4730 8.23E-13 2.848  68 asRNA:CR45171 5.22E-09 3.494 
19 Ugt37A3 1.49E-12 3.232  69 Ipk1 6.20E-09 1.595 
20 Alg9 1.78E-12 2.649  70 Rev7 6.69E-09 2.052 
21 CG18278 2.06E-12 3.225  71 TORIP 6.94E-09 1.651 
22 CG9344 2.37E-12 2.394  72 thoc6 7.83E-09 1.958 
23 CG11659 3.20E-12 3.923  73 CG14881 8.24E-09 2.341 
24 tut 5.12E-12 3.709  74 LSm7 8.91E-09 1.496 
25 CG6770 9.27E-12 1.448  75 Psf3 9.00E-09 2.023 
26 CG3552 9.71E-12 1.782  76 Cdc23 9.35E-09 2.167 
27 CG6300 9.71E-12 4.169  77 CG12224 1.26E-08 2.105 
28 Cyp6a17 1.23E-11 2.115  78 CR44003 1.69E-08 3.732 
29 Tmem18 1.43E-11 2.204  79 Hira 1.84E-08 1.653 
30 CG30059 1.69E-11 3.128  80 CG12863 1.86E-08 1.655 
31 MED28 2.45E-11 1.674  81 CG5568 1.87E-08 3.757 
32 rad50 2.69E-11 2.175  82 Usp5 2.16E-08 1.768 
33 CG7601 3.15E-11 1.516  83 slx1 3.04E-08 2.779 
34 CG6654 4.73E-11 1.460  84 asRNA:CR44960 3.22E-08 5.005 
35 DNApol-zeta 4.78E-11 1.819  85 CG5882 3.24E-08 3.103 
36 CG17977 7.08E-11 2.061  86 CG15547 3.24E-08 2.314 
37 Ssb-c31a 7.43E-11 2.008  87 Pop2 4.06E-08 1.329 
38 CG11601 1.18E-10 1.320  88 agt 4.24E-08 2.212 
39 Ssrp 1.19E-10 1.741  89 RPA2 4.80E-08 2.718 
40 ms(3)76Ba 1.19E-10 8.503  90 CG31075 5.68E-08 1.843 
41 CG17177 1.76E-10 5.886  91 CG34348 5.74E-08 1.426 
42 CR43697 2.02E-10 2.954  92 Pol31 6.18E-08 2.900 
43 Bsg25A 2.12E-10 1.722  93 CG7011 6.26E-08 1.003 
44 CG3085 2.21E-10 2.921  94 CG17266 6.45E-08 2.320 
45 Irbp 4.12E-10 2.262  95 CG15443 6.46E-08 1.531 
46 narya 4.35E-10 5.958  96 CR42530 6.48E-08 2.926 
47 CG32104 6.02E-10 1.494  97 CG33213 6.89E-08 2.860 
48 Mes4 6.24E-10 2.050  98 krimp 6.99E-08 4.196 
49 lncRNA:CR45039 6.24E-10 4.626  99 Prp31 7.53E-08 1.194 
50 CG13694 6.25E-10 2.399  100 mdlc 8.63E-08 2.544 
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Supplementary Table 3.11: Top 100 upregulated genes with the lowest padj values (T20) 
 
Rank Gene Symbol padj value 
log2 





1 Ugt302E1 5.72E-41 7.413  51 Thor 8.47E-10 1.493 
2 lncRNA:CR44536 1.23E-38 8.758  52 CG12224 1.03E-09 2.213 
3 ppk 8.94E-33 5.586  53 Pif1A 1.06E-09 2.597 
4 CG12643 1.88E-31 3.675  54 CG34220 1.08E-09 2.326 
5 CG2064 1.63E-27 3.308  55 Lip3 1.39E-09 4.379 
6 CG34166 1.57E-20 3.678  56 CG12491 1.39E-09 9.465 
7 Cyp6a17 5.09E-19 2.720  57 CG18858 1.42E-09 1.041 
8 Odc2 2.21E-17 3.837  58 twz 1.65E-09 1.841 
9 Cyp28d2 4.11E-16 2.694  59 CG10638 1.91E-09 1.566 
10 Ugt37A1 7.47E-16 4.062  60 CG17177 2.00E-09 8.124 
11 GstD5 1.48E-15 5.108  61 CG10936 2.24E-09 1.654 
12 mrt 2.29E-15 1.598  62 CG31633 2.32E-09 1.185 
13 asRNA:CR44030 2.10E-14 4.628  63 lncRNA:CR43493 3.63E-09 2.498 
14 CG6770 2.81E-14 1.611  64 CG5882 3.66E-09 3.741 
15 CR43697 5.22E-14 3.489  65 FucTC 4.92E-09 2.279 
16 CG31300 8.65E-14 2.842  66 GstD6 6.65E-09 2.341 
17 CG5157 8.77E-14 2.072  67 RabX1 9.37E-09 1.223 
18 lncRNA:CR44662 1.47E-13 3.419  68 CG30059 1.05E-08 2.697 
19 CG3397 2.28E-13 2.673  69 CG7912 1.06E-08 2.046 
20 Reg-2 2.63E-13 1.966  70 CG33189 2.03E-08 2.512 
21 CG13694 3.59E-13 2.812  71 Cyp12d1-d 2.04E-08 2.327 
22 CG8654 4.11E-13 2.161  72 CG16704 3.29E-08 2.736 
23 CG17977 6.07E-13 2.272  73 CG11601 3.41E-08 1.139 
24 Cat 6.25E-13 1.134  74 asRNA:CR44960 4.73E-08 4.735 
25 Phae2 6.25E-13 2.575  75 CG32335 5.04E-08 1.969 
26 Bin1 9.22E-13 1.925  76 CG15547 5.43E-08 2.251 
27 CG13078 1.74E-12 4.605  77 CG18278 5.69E-08 2.502 
28 CG3552 2.99E-12 1.830  78 Lectin-galC1 5.78E-08 2.986 
29 CG8665 3.50E-12 2.760  79 CG5316 6.31E-08 0.979 
30 CG34105 3.72E-12 8.519  80 asRNA:CR45136 1.01E-07 2.841 
31 CG4335 7.47E-12 3.166  81 Lerp 1.18E-07 1.071 
32 CG10445 8.88E-12 3.212  82 CG5009 1.50E-07 1.013 
33 CG42319 9.08E-12 2.159  83 Ku80 1.50E-07 1.970 
34 CG6654 2.05E-11 1.479  84 CG18563 1.63E-07 2.912 
35 Ugt37A3 3.91E-11 3.015  85 Npc2c 1.75E-07 3.396 
36 Cyp4e3 4.10E-11 4.746  86 lectin-24A 1.77E-07 3.114 
37 DNApol-zeta 6.68E-11 1.799  87 Sardh 2.05E-07 1.898 
38 CG3165 7.00E-11 1.844  88 asRNA:CR45171 2.75E-07 3.136 
39 CG30414 7.08E-11 2.257  89 CG31817 3.07E-07 2.815 
40 CG31683 9.29E-11 1.207  90 Pepck2 4.14E-07 2.122 
41 Drsl2 1.00E-10 6.622  91 Ugt36D1 4.20E-07 1.433 
42 CG15784 1.02E-10 3.123  92 Mics1 4.20E-07 3.228 
43 lncRNA:CR45039 1.29E-10 5.578  93 CG15369 4.54E-07 3.005 
44 lncRNA:CR43496 1.62E-10 2.260  94 CG12522 4.54E-07 5.449 
45 Prat2 1.91E-10 2.114  95 CR43105 4.66E-07 2.197 
46 CG31104 3.31E-10 2.488  96 lncRNA:CR45517 4.83E-07 1.702 
47 Iyd 3.96E-10 2.660  97 LManIII 5.04E-07 3.623 
48 CG31075 4.13E-10 2.067  98 narya 5.56E-07 6.111 
49 ms(3)76Ba 4.13E-10 8.256  99 sni 5.62E-07 0.921 
50 CG34215 4.43E-10 2.190  100 mthl13 6.11E-07 2.927 
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Supplementary Table 3.12: Top 100 upregulated genes with the lowest padj values (T21) 
 
Rank Gene Symbol padj value 
log2 





1 Ugt302E1 1.19E-33 6.930  51 sni 4.27E-09 1.073 
2 ppk 1.58E-30 6.079  52 CG31633 4.27E-09 1.169 
3 CG12643 8.59E-27 3.403  53 mv 4.71E-09 1.552 
4 CG2064 2.56E-26 3.234  54 CG43110 5.26E-09 2.412 
5 lncRNA:CR44536 4.28E-26 9.532  55 Phae2 5.32E-09 2.136 
6 Cyp6a17 1.88E-24 3.090  56 lncRNA:CR43496 5.52E-09 2.017 
7 Odc2 4.48E-22 4.641  57 CG12491 5.53E-09 8.329 
8 Cyp28d2 1.47E-20 3.052  58 CG3397 5.58E-09 2.173 
9 CG8665 1.93E-19 3.521  59 CG15547 5.84E-09 2.433 
10 CG6398 8.38E-19 1.354  60 CG34105 6.28E-09 9.376 
11 ms(3)76Ba 2.00E-18 7.810  61 CG2493 6.98E-09 1.839 
12 CG3165 4.60E-17 2.307  62 Cyp6d2 7.39E-09 2.515 
13 CG5316 1.29E-13 1.294  63 Sardh 7.41E-09 2.106 
14 asRNA:CR44030 1.35E-13 4.472  64 Tmem131 8.26E-09 1.751 
15 Bin1 8.79E-13 1.933  65 CG30414 1.34E-08 1.981 
16 CG13962 1.04E-12 4.178  66 narya 1.36E-08 5.337 
17 CG10445 1.23E-12 3.339  67 CG6201 1.64E-08 1.569 
18 CG4730 1.34E-12 2.825  68 CG31104 1.75E-08 2.262 
19 GstD5 1.81E-12 4.571  69 Dab 2.02E-08 0.855 
20 Ugt37A3 1.97E-12 3.224  70 CG11475 2.14E-08 3.549 
21 lncRNA:CR45039 3.39E-12 4.659  71 CG8155 2.44E-08 1.668 
22 CG42319 8.06E-12 2.182  72 Dlip3 2.75E-08 1.165 
23 CG31300 8.06E-12 2.608  73 cno 2.76E-08 1.423 
24 lncRNA:CR44662 8.06E-12 3.155  74 CG18278 3.12E-08 2.529 
25 asRNA:CR45171 1.25E-11 4.244  75 CG10936 3.88E-08 1.544 
26 CG31683 1.34E-11 1.257  76 CG15784 4.85E-08 2.698 
27 CG18858 1.79E-11 1.145  77 RhoGEF4 4.93E-08 2.656 
28 upSET 1.84E-11 1.504  78 FucTC 5.39E-08 2.153 
29 Iyd 2.18E-11 2.843  79 rtet 5.61E-08 1.526 
30 CG8654 2.82E-11 2.012  80 asRNA:CR44960 6.49E-08 3.830 
31 CG4335 3.23E-11 3.203  81 Qtzl 7.19E-08 1.238 
32 CR43105 6.04E-11 2.957  82 poe 7.48E-08 1.283 
33 CG34166 8.82E-11 2.657  83 unk 7.79E-08 1.119 
34 CG16704 1.08E-10 3.248  84 qkr58E-3 1.24E-07 1.094 
35 CG30059 1.27E-10 3.030  85 CG7900 1.31E-07 1.668 
36 CR43697 1.39E-10 2.799  86 Pif1A 1.31E-07 2.295 
37 Cyp4e3 1.94E-10 3.764  87 PAN2 1.31E-07 1.044 
38 Ugt36D1 1.95E-10 1.767  88 SP1029 1.31E-07 0.906 
39 CG34215 3.82E-10 2.217  89 CROT 1.31E-07 1.600 
40 lectin-24A 3.88E-10 3.816  90 Drsl2 1.31E-07 7.822 
41 CG17977 4.99E-10 1.942  91 ash1 1.38E-07 1.862 
42 Cyp12d1-d 1.45E-09 2.555  92 DNApol-zeta 1.39E-07 1.475 
43 CG6665 1.72E-09 1.214  93 CG13694 1.51E-07 2.058 
44 mrt 1.76E-09 1.252  94 cnn 1.51E-07 1.165 
45 CG10638 1.78E-09 1.578  95 hob 1.75E-07 1.831 
46 CG6770 1.84E-09 1.307  96 CG3552 2.56E-07 1.367 
47 CG15432 2.18E-09 1.123  97 CR42530 2.63E-07 2.696 
48 CG5882 2.37E-09 4.176  98 Reg-2 3.19E-07 1.438 
49 l(2)gl 2.80E-09 1.192  99 slx1 3.46E-07 2.526 
50 CR45470 4.00E-09 4.010  100 CG6686 3.72E-07 1.290 
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Supplementary Table 3.13: Top 100 upregulated genes with the lowest padj values (T22) 
 
Rank Gene Symbol padj value 
log2 





1 Ugt302E1 1.37E-54 6.009  51 FucTC 6.68E-10 2.349 
2 ppk 9.95E-44 6.363  52 Sclp 6.91E-10 1.407 
3 lncRNA:CR44536 2.59E-36 8.895  53 CG3397 8.36E-10 2.134 
4 Cyp28d2 6.82E-30 3.647  54 narya 8.36E-10 6.139 
5 Odc2 3.59E-26 4.643  55 Pif1A 1.10E-09 2.409 
6 CG12643 2.26E-22 3.033  56 ZnT35C 1.22E-09 1.592 
7 asRNA:CR44030 1.05E-20 4.500  57 CG10344 1.29E-09 1.590 
8 CG17977 2.98E-18 2.419  58 fabp 1.66E-09 1.651 
9 CG32104 5.80E-18 1.888  59 CG18858 1.78E-09 1.004 
10 CR43697 8.95E-17 3.778  60 CG8001 2.29E-09 1.139 
11 CG34105 5.55E-15 10.276  61 mRpL39 2.35E-09 0.988 
12 CG7912 8.08E-15 2.676  62 CG7488 2.41E-09 0.902 
13 CG8654 3.53E-14 2.192  63 asRNA:CR44960 2.82E-09 3.782 
14 CG3552 4.34E-14 1.806  64 CG14711 3.76E-09 0.893 
15 CG6654 4.38E-14 1.606  65 PH4alphaPV 3.80E-09 1.406 
16 CG12863 5.04E-14 2.090  66 CG42319 4.03E-09 1.863 
17 Cyp6a17 5.04E-14 2.276  67 CG33506 4.31E-09 0.991 
18 tut 9.93E-14 3.865  68 CG6770 4.42E-09 1.257 
19 CG2064 1.00E-13 2.292  69 CG5882 4.56E-09 2.670 
20 Rlip 1.35E-13 1.198  70 CG13603 4.93E-09 1.219 
21 CG11601 2.01E-13 1.421  71 CG33189 4.96E-09 2.254 
22 lncRNA:CR45039 3.98E-13 4.974  72 CG43110 6.52E-09 2.246 
23 CR45470 5.52E-13 4.728  73 CG6870 6.62E-09 2.266 
24 Lectin-galC1 1.27E-12 3.439  74 CG12375 7.77E-09 0.859 
25 CG12491 2.57E-12 10.696  75 Atg12 8.77E-09 1.386 
26 ms(3)76Ba 3.07E-12 9.067  76 Phae2 9.07E-09 2.044 
27 CG9344 5.17E-12 2.179  77 Ssb-c31a 1.02E-08 1.714 
28 CG30059 5.67E-12 3.005  78 CG3165 1.07E-08 1.599 
29 CG17177 7.85E-12 5.066  79 CG31633 1.14E-08 1.091 
30 CG34215 8.77E-12 2.321  80 CR43696 1.23E-08 2.127 
31 Drsl2 8.77E-12 6.204  81 l(3)mbn 1.33E-08 2.637 
32 CG4730 1.25E-11 2.640  82 Paics 1.36E-08 1.187 
33 lncRNA:CR42861 1.98E-11 2.182  83 Mics1 1.39E-08 3.856 
34 lncRNA:CR44662 1.99E-11 2.906  84 CG33225 1.48E-08 4.269 
35 mrt 7.37E-11 1.325  85 lncRNA:CR44442 1.48E-08 4.272 
36 CG10353 8.70E-11 1.543  86 CG17294 1.72E-08 1.542 
37 CG31098 9.63E-11 1.502  87 lncRNA:CR43493 1.72E-08 2.175 
38 CG18278 1.06E-10 2.778  88 mus201 1.83E-08 1.457 
39 CG17803 1.21E-10 1.622  89 lncRNA:CR43242 1.90E-08 2.090 
40 CG5612 1.21E-10 2.199  90 CG7054 2.17E-08 1.622 
41 CG3939 1.29E-10 1.209  91 CG7900 2.18E-08 1.699 
42 twz 1.87E-10 1.925  92 Cyp4e3 2.77E-08 2.632 
43 CG10445 2.00E-10 2.686  93 CG14499 2.98E-08 3.978 
44 ORMDL 2.36E-10 0.911  94 CG17568 2.99E-08 1.276 
45 Fnta 2.86E-10 0.835  95 CG2246 3.21E-08 0.977 
46 CG4335 3.97E-10 2.573  96 niki 3.28E-08 1.645 
47 CG30392 4.49E-10 1.368  97 CG34348 3.32E-08 1.425 
48 mRpL54 5.43E-10 1.175  98 S1P 3.89E-08 1.406 
49 CG4627 5.80E-10 1.546  99 CG42822 3.89E-08 2.106 
50 CG14882 6.06E-10 1.388  100 CG13339 4.18E-08 1.137 
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Supplementary Table 3.14: Top 100 upregulated genes with the lowest padj values (T23) 
 
Rank Gene Symbol padj value 
log2 





1 Ugt302E1 1.08E-41 4.851  51 betaTub85D 5.63E-09 2.165 
2 ppk 2.91E-39 6.051  52 CG17834 5.72E-09 1.069 
3 lncRNA:CR44536 7.07E-29 9.014  53 CG33012 6.19E-09 2.006 
4 Odc2 2.19E-28 4.900  54 CG2246 6.38E-09 1.027 
5 Cyp28d2 2.42E-28 3.559  55 RabX1 7.47E-09 1.208 
6 CG12643 4.50E-23 3.096  56 niki 7.95E-09 1.847 
7 CG7912 2.31E-20 3.167  57 CG4335 8.06E-09 2.405 
8 mrt 3.26E-20 1.823  58 CG43110 8.54E-09 2.268 
9 CG6654 1.47E-16 1.759  59 lncRNA:CR44442 8.68E-09 5.215 
10 mRpS9 8.65E-16 0.901  60 axo 1.09E-08 1.550 
11 CG34105 3.18E-15 10.417  61 CG17292 1.22E-08 1.151 
12 twz 4.47E-15 2.342  62 CG44215 1.23E-08 4.838 
13 ZnT35C 6.23E-15 2.010  63 CG34348 1.40E-08 1.472 
14 lncRNA:CR45039 9.76E-15 4.980  64 CG12863 1.50E-08 1.642 
15 asRNA:CR44030 2.42E-14 3.659  65 CG6424 1.52E-08 1.018 
16 Fnta 3.81E-14 0.998  66 CG18324 2.06E-08 1.371 
17 CR43697 4.21E-14 3.464  67 VhaAC39-1 2.08E-08 0.779 
18 CG31098 5.95E-14 1.725  68 CG33189 2.14E-08 2.308 
19 CG42319 1.14E-13 2.312  69 narya 2.22E-08 4.902 
20 CG12491 1.45E-13 9.199  70 mRpL39 2.26E-08 0.940 
21 CG8654 2.54E-13 2.115  71 CG32795 2.35E-08 0.969 
22 CG16935 2.68E-13 1.675  72 CG8837 2.61E-08 1.761 
23 CG17977 5.26E-13 2.174  73 CG4627 2.85E-08 1.451 
24 CG8001 6.76E-13 1.362  74 CG33506 3.16E-08 0.965 
25 CG10353 8.42E-13 1.688  75 CG13694 3.18E-08 2.123 
26 CG5882 2.45E-12 3.426  76 CR43105 3.51E-08 2.369 
27 CG3939 3.51E-12 1.318  77 Lerp 4.13E-08 1.079 
28 Rlip 7.68E-12 1.126  78 swi2 4.53E-08 1.788 
29 CG11601 1.19E-11 1.337  79 CG3520 5.41E-08 1.615 
30 ORMDL 1.50E-11 0.995  80 Sardh 6.28E-08 1.937 
31 Odc1 2.32E-11 2.583  81 CG18278 6.34E-08 2.375 
32 PH4alphaPV 3.30E-11 1.579  82 CG9147 7.72E-08 1.356 
33 l(3)mbn 3.69E-11 3.128  83 Cpr49Ad 8.22E-08 3.737 
34 CG1271 9.52E-11 1.372  84 CG18814 8.65E-08 2.760 
35 Phae2 1.72E-10 2.252  85 CG17803 8.65E-08 1.375 
36 Lectin-galC1 2.13E-10 3.283  86 CG15431 8.88E-08 1.626 
37 FucTC 3.19E-10 2.406  87 Drsl2 9.07E-08 7.734 
38 CG9988 6.51E-10 3.549  88 CG6923 9.27E-08 0.803 
39 CG14499 8.30E-10 4.494  89 CG7054 9.55E-08 1.556 
40 CG4730 1.41E-09 2.418  90 tut 1.00E-07 2.805 
41 sni 1.61E-09 1.064  91 CG32335 1.02E-07 1.770 
42 CG17177 1.63E-09 5.497  92 beta4GalNAcTB 1.07E-07 1.265 
43 CG14711 1.83E-09 0.926  93 CG15044 1.37E-07 1.205 
44 CG34215 2.01E-09 2.068  94 PH4alphaNE1 1.38E-07 1.975 
45 CG8541 2.08E-09 3.860  95 CG5612 1.41E-07 1.834 
46 GABA-B-R3 2.83E-09 1.361  96 CG7900 1.42E-07 1.615 
47 CG2064 2.86E-09 1.869  97 Lpin 1.53E-07 1.208 
48 ms(3)76Ba 2.86E-09 8.430  98 CG43191 1.65E-07 3.188 
49 CG32104 3.85E-09 1.336  99 CR43696 1.84E-07 2.047 
50 CG15356 5.63E-09 1.430  100 Fpgs 2.22E-07 1.400 
 
 
General concluding perspective 
 
 
Within this thesis project, I set out to characterise the functional roles of lncRNAs using 
Drosophila melanogaster as the model organism of choice.  Even though lncRNAs were 
found to be involved in various biological processes, their functional relevance was 
disregarded for a long time. Here, I have presented the approach that I have taken to study 
lncRNA function during Drosophila embryogenesis and demonstrated that lncRNAs could be 
studied in vivo. Using RAMPAGE data, I have first selected for ncRNAs that fulfilled the 
definition of a lncRNA transcript and conserved expression profile across 5 Drosophila 
species. From this, I have identified those that were expressed during Drosophila embryonic 
development and selected 22 of them to determine their functional relevance. 
 
 Using genome editing tools such as CRISPR, I have removed the TSS of our lncRNA 
candidates to generate lncRNA mutants for our study. To determine if they have any function, 
I have created a simple set of tests to identify the phenotype of the mutation. Of the 
candidates lncRNAs that were successfully generated, I have identified two candidate 
lncRNAs that were homozygous lethal. This number is impressive given that we have first 
selected for our lncRNA candidates using a strict filter and the chance of generating a 
lncRNA with a lethal phenotype was 2 in 21. Given this ratio, I would not be surprise if there 
were more lncRNAs in the Drosophila genome with important functions and the deletion of 
these transcripts would be lethal for the fruit fly. That said, as this study was carried out as a 
pilot project with a small number of lncRNA candidates, more large-scale genome editing 
projects would be needed to investigate the number of functional lncRNAs transcripts in the 
genome given the wealth of data that we have about Drosophila today.  
 
As lncRNAs could be involved in a myriad of biological processes, I have designed a 
number of assays to study the molecular phenotype of the lncRNA knockout. Majority of 
these mutants had no obvious anatomical or functional abnormalities such as sterility or 
locomotion issues. This result coincides with other lncRNA-related studies that were 
published recently to understand the role of lncRNA during embryogenesis (Ignacio et al., 
2018; Goudarzi et al., 2019). The reason for the lack of functional readout from the mutants 
could be multi-fold such as redundancy. However, majority of these functional assays 
including ours were centred around the role of lncRNAs in viability and fertility and little was 
done to further characterise them on a behavioural level given that many lncRNAs were found 
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to be highly expressed in the nervous system and might have a cognitive function (Briggs et 
al., 2015; Molyneaux et al., 2015). Therefore, it would be necessary to include more 
behavioural assays when screening lncRNA mutants. To improve on the experimental design, 
using a set of lncRNAs that are expressed in a particular tissue or cell type would allow easier 
planning of phenotypic studies. In a study by McCorkindale et al., 2019, the authors focused 
on critical events that took place during Drosophila embryogenesis and performed RNA-seq 
on various types of neurogenic cells that were purified across consecutive time points. The 
data not only identified conserved lncRNAs that are expressed during Drosophila 
neurogenesis but more importantly, the lncRNAs that that expressed in each cell type is 
known. Using this information, different phenotypic studies can be carried to understand the 
impact of neurogenic lncRNAs loss of function in shaping the nervous system development. 
 
From the phenotypic study that was performed, I have shown that it is relevant to invest 
in time to study lncRNA function in general. Although the 2 lncRNA candidates were 
homozygous lethality, further validation will be needed to authenticate the molecular 
phenoptype for lncRNA-3. During the characterisation of the lncRNA candidate lncRNA-9, it 
was revealed that the lncRNA has a role in the central nervous system. While the GO 
enrichment analysis has pointed to activities related to chemical synaptic transmission, further 
mechanistic studies would be needed to understand how the lncRNA candidate interreacted 
with different biochemical partners for normal physiological behaviours.  
 
  Finally, I have observed a shift away from a protein-centric view in modern biology to 
encompass the roles played by different ncRNAs in gene regulation today. It would be helpful 
to have a better understanding of lncRNA biology as many of them have been overlooked. 
The advert of high throughout sequencing technology has unrevealed thousands of lncRNA 
transcripts that play diverse scanarios. Various studies have focused on identifying lncRNAs 
that are expressed in specific subcellular domains (nuclear and cytoplasmic) or involved in a 
biological process such as dosage compensation (Landskron et al., 2018; Meller et al., 1997).  
Several studies, including ours, have identified lncRNAs that are evident in the Drosophila 
nervous system (Schor et al., 2018; McCorkindale et al., 2019). The challenging task remains 
to unravel the molecular mechanisms by which they act. Further on from this study, it will be 
valuable to investigate how lncRNA-9 and many others that are expressed in the nervous 
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